000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1470|2835|lyfalmen|V1070|1792|00|20|0|2|Vistor hf|Janssen-Cilag AB|||1470||1470|2835 000018|G01AF0501|Pevaryl|krem/sti|0| |15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||00|15|0|4|Vistor hf|Janssen-Cilag AB||||||0 000020|J07AL0201|Prevenar|stl|0| |0,5|ml|1|hgl||J07AL02|01.10.2002||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|7131|10517|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|||7131||7131|10517 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|47648|61189|lyfsjukr|||00|2|0|24|Icepharma hf|Roche|||47648||47648|61189 000055|B03XA0103|NeoRecormon|sts|60000|ae/rörly|1|ml|1|rörlyk|+leysir|B03XA01|01.11.2003||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|128380|161701|lyfsjukr|||00|1|0|60|Icepharma hf|Roche|||128380||128380|161701 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|71395|90754|lyfsjukr|||00|2|0|36|Icepharma hf|Roche|||71395||71395|90754 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|10846|15559|lyfalmen|||00|28|0|14|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||10846||10846|15559 000166|A07FA0201|Precosa|hylki|250|mg|20|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|IKR|1662|3096|lyfalmen|||00|20|0|5|Vistor hf|Laboratories Biocodex|||1662||1662|3096 000182|A07FA0201|Precosa|hylki|250|mg|50|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|IKR|3834|6043|lyfalmen|||00|50|0|12|Vistor hf|Laboratories Biocodex|||3834||3834|6043 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|32270|42361|lyfalmen|||00|28|0|42|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||32270||32270|42361 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|41968|54435|lyfalmen|||00|28|0|56|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||41968||41968|54435 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|21114|28472|lyfalmen|V0813|20642|00|28|0|28|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||21114||21114|28472 000211|J07AL0201|Prevenar|stl|0| |0,5|ml|1|spr|áfyllt sprauta|J07AL02|01.04.2006||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|7131|10517|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|||7131||7131|10517 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|6177|8844|lyfsjukr|||00|1|0|0|Vistor hf|Ferring|||6177||6177|8844 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|7937|15290|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||7937||7937|15290 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|18399|24774|lyfsjukr|||00|5|0|0|Vistor hf|Ferring|||18399||18399|24774 000240|D07AC1301|Elocon|áburður|1|mg/g|50|ml|1|glas||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2014|3573|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|||2014||2014|3573 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|21138|28502|lyfalmen|||00|0|0|1|Vistor hf|N.V. Organon|||21138||21138|28502 000315|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5614|8038|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|||5614||5614|8038 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|41930|54388|lyfalmen|||00|1|0|6|Vistor hf|N.V. Organon|||41930||41930|54388 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5925|8881|lyfalmen|||00|6|0|6|Icepharma hf|M.S.D.|||5925||5925|8881 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3628|lyfsjukr|||00|10|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2534||2534|3628 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3114|lyfsjukr|||00|5|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2175||2175|3114 000530|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|29239|38588|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|||29239||29239|38588 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2046|3617|lyfalmen|||06|5|0|0|Vistor hf|Novartis Healthcare A/S-|||2046||2046|3617 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5428|8206|lyfalmen|||23|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5428||5428|8206 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|4367|6767|lyfalmen|||00|60|0|3|Vistor hf|Janssen-Cilag AB|||4367||4367|6767 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-||||||4411 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|5812|8728|lyfalmen|||00|24|0|0|Vistor hf|Novartis Healthcare A/S-|||5812||5812|8728 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|15623|21318|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|||15623||15623|21318 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|4785|7334|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||||4785|7334 000770|V08BA0104|E-Z paste|pasta|60|%|1|lbs|1|pakki|til inntöku|V08BA01|01.01.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2590|3708|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||2590||2590|3708 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|3958|6212|lyfalmen|||23|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3958||3958|6212 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|125|0|2|Vistor hf|McNeil Denmark ApS||||||0 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|125|0|1|Vistor hf|McNeil Denmark ApS||||||0 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|175068|219827|lyfsjukr|||00|6|0|123|Gróco ehf|Serono Nordic|||175068||175068|219827 000891|M05BA0101|Didronate|töflur|200|mg|60|stk|1|þpakki||M05BA01|01.04.1996||R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|14556|20307|lyfalmen|||00|60|0|30|Sofus Consulting AB|Procter & Gamble-|||14556||14556|20307 000957|H01AC0101|Genotropin|sts|0| |5|mg|1|hgl|+ leysir 1 ml|H01AC01|01.05.2001||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|35601|46191|lyfsjukr|||02|5|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||35601||35601|46191 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|6603|9454|lyfsjukr|||02|0|0|1|Vistor hf|N.V. Organon|||6603||6603|9454 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1792|3272|lyfalmen|||00|10|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1792||1792|3272 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12363|17577|lyfalmen|||00|30|0|240|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12363||12363|17577 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|24908|33195|lyfalmen|||00|100|0|800|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||24908||24908|33195 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2437|4148|lyfalmen|||43|100|0|16|Vistor hf|AstraZeneca A/S DK|||2437||2437|4148 001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.08.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|12293|17490|lyfalmen|||00|98|0|98|Icepharma hf|Solvay Pharmaceuticals|||12293||12293|17490 001337|V08CA0901|Gadovist|stl|1|mmol/ml|30|ml|10|hgl||V08CA09|01.12.2003||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|428280|535076|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|||428280||428280|535076 001346|C09CA0201|Teveten|töflur|400|mg|56|stk|1|þpakki||C09CA02|01.10.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|4868|7446|lyfalmen|||00|56|0|37|Icepharma hf|Solvay Pharmaceuticals|||4868||4868|7446 001386|C10AA0102|Sivacor|töflur|10|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1400|2740|lyfalmen|||00|28|0|19|Actavis Group hf|Actavis hf|||1400||1400|2740 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|33911|44087|lyfsjukr|||02|2|0|5|Vistor hf|N.V. Organon|||33911||33911|44087 001400|C10AA0102|Sivacor|töflur|10|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|868|2018|lyfalmen|V0358|2018|00|98|0|65|Actavis Group hf|Actavis hf|||868||868|2018 001409|C10AA0102|Sivacor|töflur|20|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|928|2100|lyfalmen|||00|28|0|37|Actavis Group hf|Actavis hf|||928||928|2100 001422|C10AA0102|Sivacor|töflur|20|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1050|2265|lyfalmen|V0365|2265|00|98|0|131|Actavis Group hf|Actavis hf|||1050||1050|2265 001431|C10AA0102|Sivacor|töflur|40|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2700|4504|lyfalmen|||00|28|0|75|Actavis Group hf|Actavis hf|||2700||2700|4504 001442|C10AA0102|Sivacor|töflur|40|mg|98|stk|1|plglas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1630|3052|lyfalmen|V0367|3035|00|98|0|261|Actavis Group hf|Actavis hf|||1630||1630|3052 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6961|10287|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|||6961||6961|10287 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|4459|6891|lyfalmen|||10|100|0|40|Vistor hf|Sanofi-aventis Norge AS|||4459||4459|6891 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|883|2039|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|||883||883|2039 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2456|4173|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|||2456||2456|4173 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|27968|36688|lyfsjukr|||00|4104|0|0|Icepharma hf|Fresenius Kabi|||27968||27968|36688 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|SKY|0|0|1|100|CHF|14821|20637|lyfalmen|V0011|18648|00|25|0|5|Icepharma hf|SkyPharma PLC|||14821||14821|20637 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|37903|49057|lyfsjukr|||00|6160|0|6|Icepharma hf|Fresenius Kabi|||37903||37903|49057 001622|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|2|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25720|33889|lyfsjukr|||00|5132|0|5|Icepharma hf|Fresenius Kabi|||25720||25720|33889 001685|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|50|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|7223|10342|lyfsjukr|||02|50|0|0|Vistor hf|Octapharma AB|||7223||7223|10342 001693|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|100|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|11536|16230|lyfsjukr|||02|100|0|0|Vistor hf|Octapharma AB|||11536||11536|16230 001792|N02BA0109|Alka-Seltzer|freyðit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAS|0|0|1|100|DKK|||lyfalmen|||00|20|0|2|Vistor hf|Bayer A/S||||||0 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|1354|1939|lyfsjukr|||02|10|0|10|Vistor hf|Novartis Healthcare A/S-|||1354||1354|1939 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|4350|6744|lyfalmen|||06|15|0|75|K.Pétursson hf|Alcon|||4350||4350|6744 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|1091|2321|lyfalmen|||00|7|0|5|Vistor hf|AstraZeneca A/S DK|||1091||1091|2321 001894|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|glas|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|82582|104682|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||82582||82582|104682 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|2358|4040|lyfalmen|V0791|4040|00|60|0|12|Actavis Group hf|Actavis hf|||2358||2358|4040 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|12969|18331|lyfalmen|V0795|18331|00|60|0|48|Actavis Group hf|Actavis hf|||12969||12969|18331 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|0|100|SEK|4660|7164|lyfalmen|||00|45|0|45|Icepharma hf|Bioglan AB|||4660||4660|7164 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|5475|8270|lyfalmen|V0793|8270|00|60|0|24|Actavis Group hf|Actavis hf|||5475||5475|8270 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9400|13597|lyfalmen|V0456|13476|43|100|0|33|Vistor hf|LEO Pharma A/S|||9400||9400|13597 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|4091|6392|lyfalmen|V0084|6297|00|28|0|19|Vistor hf|AstraZeneca A/S DK|||4091||4091|6392 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|8009|11709|lyfalmen|V0794|11709|00|60|0|36|Actavis Group hf|Actavis hf|||8009||8009|11709 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|8087|11815|lyfalmen|V0086|11596|00|56|0|37|Vistor hf|AstraZeneca A/S DK|||8087||8087|11815 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|1439|2793|lyfalmen|||00|7|0|9|Vistor hf|AstraZeneca A/S DK|||1439||1439|2793 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|5391|8156|lyfalmen|V0085|8040|00|28|0|37|Vistor hf|AstraZeneca A/S DK|||5391||5391|8156 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|SCH|0|0|0|100|SEK|4937|7540|lyfalmen|||00|100|0|27|Icepharma hf|Schering Oy|||4937||4937|7540 002169|B05BA1010|Kabiven Peripheral|irþ|0| |2400|ml|2|pokar|3ja hólfa poki |B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|22334|29673|lyfsjukr|||00|4800|0|5|Icepharma hf|Fresenius Kabi|||22334||22334|29673 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|6589|9782|lyfalmen|||00|50|0|33|Vistor hf|AstraZeneca A/S DK|||6589||6589|9782 002186|B05BA1010|Kabiven Peripheral|irþ|0| |1920|ml|2|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|19975|26736|lyfsjukr|||00|3840|0|4|Icepharma hf|Fresenius Kabi|||19975||19975|26736 002194|B05BA1010|Kabiven Peripheral|irþ|0| |1440|ml|4|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|32686|42562|lyfsjukr|||00|5760|0|6|Icepharma hf|Fresenius Kabi|||32686||32686|42562 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|14293|19980|lyfalmen|V0087|19624|00|100|0|67|Vistor hf|AstraZeneca A/S DK|||14293||14293|19980 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|8597|12507|lyfalmen|||00|50|0|67|Vistor hf|AstraZeneca A/S DK|||8597||8597|12507 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|A|2|0|0|*|0|NON|0|0|0|100|DKK|4078|6374|lyfalmen|||02|10|0|25|Vistor hf|Novo-Nordisk|||4078||4078|6374 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|19214|26106|lyfalmen|V0089|25727|00|100|0|133|Vistor hf|AstraZeneca A/S DK|||19214||19214|26106 002237|D05AX0201|Daivonex|smyrsli|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4338|6727|lyfalmen|||00|60|0|0|Vistor hf|LEO Pharma A/S|||4338||4338|6727 002263|D05AX0201|Daivonex|smyrsli|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7093|10466|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|||7093||7093|10466 002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7433|10927|lyfalmen|||00|120|0|120|Vistor hf|LEO Pharma A/S|||7433||7433|10927 002276|D05AX0201|Daivonex|krem|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4327|6712|lyfalmen|||00|60|0|60|Vistor hf|LEO Pharma A/S|||4327||4327|6712 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A||||||0 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|21873|29417|lyfalmen|||00|98|0|39|Icepharma hf|M.S.D.|||21873||21873|29417 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|105309|132977|lyfsjukr|||00|1|0|2|ZLB Behring AB|Bayer HealthCare AG-|||105309||105309|132977 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|52899|67727|lyfsjukr|||00|1|0|1|ZLB Behring AB|Bayer HealthCare AG-|||52899||52899|67727 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|30322|39618|lyfsjukr|||00|1|0|0|ZLB Behring AB|Bayer HealthCare AG-|||30322||30322|39618 002391|G03AA1201|Yasmin|töflur|0||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2828|4678|lyfalmen|||00|63|0|84|Icepharma hf|Bayer Schering Pharma AG|||||2828|4678 002405|C09AA0206|Enalapril Merck NM|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2007||R|A||0|0|B|0|PCO|0|0|0|100|IKR|510|1532|lyfalmen|||00|50|1|12|Distica|Distica - óskráð lyf|||510||510|1532 002413|G03AA1204|Yasmin 28|töflur|0| |84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2828|4678|lyfalmen|||00|84|0|0|Icepharma hf|Bayer Schering Pharma AG|||2828||2828|4678 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|10|0|10|Actavis Group hf|Actavis hf||||||1241 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|V0982|1895|00|30|0|30|Actavis Group hf|Actavis hf||||||1895 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2079|3662|lyfalmen|V0984|3662|00|100|0|100|Actavis Group hf|Actavis hf|||2079||2079|3662 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|206830|259371|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Ophthalmics Europe Ltd.|||206830||206830|259371 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|204|0|7|Artasan ehf|Novartis Healthcare A/S-A||||||0 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1431|2782|lyfalmen|||07|5|0|25|Icepharma hf|Santen Oy|||1431||1431|2782 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|30985|40444|lyfsjukr|||02|1|0|0|Vistor hf|Allergan|||30985||30985|40444 002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002||R|A|1|0|1|E|0|SEN|0|0|0|100|SEK|67718|86494|lyfalmen|||00|1|0|14|Gróco ehf|Serono Nordic|||67718||67718|86494 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|16851|17607|lyfalmen|V0193|15971|00|98|0|196|Icepharma hf|M.S.D.|||12387||12387|17607 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|14036|19660|lyfalmen|||00|100|0|12|Vistor hf|U.C.B|||14036||14036|19660 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|290875|364007|lyfsjukr|||02|2|0|0|Icepharma hf|Zeneus Pharma Limited-|||290875||290875|364007 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|20686|27939|lyfalmen|V1710|27939|00|100|0|25|Vistor hf|U.C.B|||20686||20686|27939 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|47125|60856|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|||47125||47125|60856 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|9101|13191|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|||9101||9101|13191 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|13578|19090|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|||13578||13578|19090 003195|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|19592|26260|lyfsjukr|||00|2|0|9|Vistor hf|Amgen|||19592||19592|26260 003208|B03XA0201|Aranesp|stl|15|mcg/spr|0,375|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|29187|38205|lyfsjukr|||00|2|0|13|Vistor hf|Amgen|||29187||29187|38205 003230|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|32985|42934|lyfsjukr|||00|2|0|18|Vistor hf|Amgen|||32985||32985|42934 003238|J07AM0101|Tetavax|stl|40|ae|0,5|ml|1|lykja||J07AM01|01.03.2006||R|K||0|0|0|0|LDR|0|0|1|100|IKR|557|1596|lyfalmen|||00|0|1|0|Parlogis hf|Parlogis - óskráð lyf|||557||557|1596 003252|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|48972|62838|lyfsjukr|||00|1|0|27|Vistor hf|Amgen|||48972||48972|62838 003274|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|64256|81866|lyfsjukr|||00|2|0|36|Vistor hf|Amgen|||64256||64256|81866 003296|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|79103|100351|lyfsjukr|||00|2|0|44|Vistor hf|Amgen|||79103||79103|100351 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|212662|266632|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|||212662||212662|266632 003310|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8345|12165|lyfalmen|V0990|12108|00|120|0|30|Vistor hf|AstraZeneca A/S DK|||8345||8345|12165 003318|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|96737|122305|lyfsjukr|||00|1|0|53|Vistor hf|Amgen|||96737||96737|122305 003325|R03AK0702|Symbicort mite Turbuhaler|innúðadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7626|11189|lyfalmen|||00|120|0|15|Vistor hf|AstraZeneca A/S DK|||7626||7626|11189 003340|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|143929|181059|lyfsjukr|||00|2|0|71|Vistor hf|Amgen|||143929||143929|181059 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|þpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|USD|73746|93999|lyfalmen|||00|100|0|33|Icepharma hf|Wyeth Europe|||73746||73746|93999 003355|D01AE1501|Lamisil|úðalausn|10|mg/g|15|ml|1|fl|úðalausn á húð|D01AE15|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A||||||0 003362|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|153872|193438|lyfsjukr|||00|2|0|89|Vistor hf|Amgen|||153872||153872|193438 003386|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|230401|288717|lyfsjukr|||00|1|0|133|Vistor hf|Amgen|||230401||230401|288717 003395|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|spr|áfyllt sprauta|B03XA02|01.12.2003||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|115283|145395|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|||115283||115283|145395 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|4346|6738|lyfalmen|||00|28|0|14|Eli Lilly Danmark A/S|Takeda Europe -|||4346||4346|6738 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PFI|0|0|0|30|DKK|3731|5904|lyfalmen|||00|60|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3731||3731|5904 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|14969|20821|lyfalmen|||00|98|0|49|Eli Lilly Danmark A/S|Takeda Europe -|||14969||14969|20821 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|6682|9908|lyfalmen|||00|28|0|28|Eli Lilly Danmark A/S|Takeda Europe -|||6682||6682|9908 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|22338|29996|lyfalmen|||00|98|0|98|Eli Lilly Danmark A/S|Takeda Europe -|||||22338|29996 003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|922|2092|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|||922||922|2092 003910|B03XA0102|Eprex|stl|6000|ae/spr|0,6|ml|6|spr||B03XA01|01.01.2002||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|65489|83401|lyfsjukr|||51|4|0|36|Vistor hf|Janssen-Cilag AB|||65489||65489|83401 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1170|2428|lyfalmen|V0931|2428|00|28|0|28|Actavis Group hf|Actavis hf|||1170||1170|2428 003932|B03XA0102|Eprex|stl|8000|ae/spr|0,8|ml|6|spr||B03XA01|01.01.2002||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|81874|103801|lyfsjukr|||51|5|0|48|Vistor hf|Janssen-Cilag AB|||81874||81874|103801 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|673|1754|lyfalmen|||67|20|0|10|Vistor hf|Novartis Healthcare A/S-|||673||673|1754 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|4068|6361|lyfalmen|V0933|6361|00|98|0|98|Actavis Group hf|Actavis hf|||4068||4068|6361 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|99320|125521|lyfsjukr|||00|60|0|8|Vistor hf|Abbott Laboratories A/S|||99320||99320|125521 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2834|4686|lyfalmen|V0608|2089|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|||2834||2834|4686 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|35026|45475|lyfsjukr|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|||35026||35026|45475 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|8366|12193|lyfalmen|||00|250|0|15|Vistor hf|Novartis Healthcare A/S-|||8366||8366|12193 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||00|100|0|2|Vistor hf|Janssen-Cilag AB||||||0 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|4272|6638|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4272||4272|6638 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|626|1690|lyfalmen|||00|7|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||626||626|1690 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|VAL|0|0|1|100|DKK|1120|2360|lyfalmen|||10|30|0|15|Icepharma hf|Valeant Pharmaceuticals B.V.|||1120||1120|2360 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PFI|0|1|0|100|DKK|6537|9711|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6537||6537|9711 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|6233|9299|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6233||6233|9299 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|8676|12614|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||8676||8676|12614 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|792|1915|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|||792||792|1915 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|B|0|ORG|0|1|0|100|DKK|6265|9342|lyfalmen|||00|66|0|33|Vistor hf|N.V. Organon|||6265||6265|9342 004338|B03XA0102|Eprex|stl|1000|ae/spr|0,5|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|11358|16008|lyfsjukr|||51|3|0|6|Vistor hf|Janssen-Cilag AB|||11358||11358|16008 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|25702|33866|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||25702||25702|33866 004364|B03XA0102|Eprex|stl|2000|ae/spr|0,5|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|22733|30170|lyfsjukr|||51|3|0|12|Vistor hf|Janssen-Cilag AB|||22733||22733|30170 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|2288|3945|lyfalmen|V1901|3886|00|30|0|30|Vistor hf|Schering-Plough|||2288||2288|3945 004372|B03XA0102|Eprex|stl|4000|ae/spr|0,4|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|44983|57871|lyfsjukr|||51|2|0|24|Vistor hf|Janssen-Cilag AB|||44983||44983|57871 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|8683|12624|lyfalmen|||0|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||8683||8683|12624 004375|B03XA0102|Eprex|stl|3000|ae/spr|0,3|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|34016|44217|lyfsjukr|||51|2|0|18|Vistor hf|Janssen-Cilag AB|||34016||34016|44217 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|5370|8128|lyfalmen|||00|100|0|100|Vistor hf|Schering-Plough|||||5370|8128 004383|B03XA0102|Eprex|stl|10000|ae/spr|1|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|90448|114475|lyfsjukr|||51|6|0|60|Vistor hf|Janssen-Cilag AB|||90448||90448|114475 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|0| |5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|4828|9368|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim|||4828||4828|9368 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3432|5498|lyfalmen|||00|56|0|14|Icepharma hf|Norpharma |||3432||3432|5498 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|665|1743|lyfalmen|||00|100|0|8|Vistor hf|Recip AB|||665||665|1743 004468|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3374|5419|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||3374||3374|5419 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4578|7053|lyfalmen|||00|56|0|19|Icepharma hf|Norpharma |||4578||4578|7053 004487|L01BC0301|Uft|hylki|324|mg|21|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|34718|45091|lyfsjukr|||00|21|0|0|Merck AB|Merck KgaA (M)|||34718||34718|45091 004489|N02AX0208|Zytram|forðatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|6466|9615|lyfalmen|||00|56|0|28|Icepharma hf|Norpharma |||6466||6466|9615 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|8606|12519|lyfalmen|||00|56|0|37|Icepharma hf|Norpharma |||8606||8606|12519 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2065|3643|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2065||2065|3643 004532|L01BC0301|Uft|hylki|324|mg|35|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|57862|73906|lyfsjukr|||00|35|0|0|Merck AB|Merck KgaA (M)|||57862||57862|73906 004543|L01BC0301|Uft|hylki|324|mg|42|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|69435|88314|lyfsjukr|||00|42|0|0|Merck AB|Merck KgaA (M)|||69435||69435|88314 004565|L01BC0301|Uft|hylki|324|mg|28|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|46291|59500|lyfsjukr|||00|28|0|0|Merck AB|Merck KgaA (M)|||46291||46291|59500 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|7274|10712|lyfalmen|||00|90|0|180|Vistor hf|Aventis Pharma |||7274||7274|10712 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2556|4309|lyfalmen|V0926|4309|00|100|0|100|Actavis Group hf|Actavis hf|||2556||2556|4309 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|SEN|0|0|0|100|SEK|39704|51299|lyfsjukr|||00|1|0|4|Gróco ehf|Serono Nordic|||39704||39704|51299 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|2031|3597|lyfalmen|||20|25|0|25|Actavis Group hf|Actavis Group hf|||2031||2031|3597 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dæla|einnotadæl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2676|4472|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2676||2676|4472 004623|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5040|7680|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|||5040||5040|7680 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1836|3332|lyfalmen|V0927|3332|00|28|0|56|Actavis Group hf|Actavis hf|||1836||1836|3332 004636|N06AB0402|Oropram|töflur|40|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|5188|7881|lyfalmen|V0929|7881|00|56|0|112|Actavis Group hf|Actavis hf|||5188||5188|7881 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|5614|8459|lyfalmen|V0930|8459|00|100|0|200|Actavis Group hf|Actavis hf|||5614||5614|8459 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|776|1893|lyfalmen|V0921|1893|00|28|0|14|Actavis Group hf|Actavis hf|||776||776|1893 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2703|4508|lyfalmen|V0922|4508|00|100|0|50|Actavis Group hf|Actavis hf|||2703||2703|4508 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1269|2562|lyfalmen|V0923|2562|00|28|0|28|Actavis Group hf|Actavis hf|||1269||1269|2562 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|0|Vistor hf|Medic Team||||||0 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|45174|58109|lyfsjukr|||00|5|0|7|Vistor hf|Amgen|||45174||45174|58109 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1778|3253|lyfalmen|V0925|3253|00|56|0|56|Actavis Group hf|Actavis hf|||1778||1778|3253 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|150|0|5|Actavis Group hf|Actavis hf||||||0 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|173914|218390|lyfsjukr|||00|19|0|28|Vistor hf|Amgen|||173914||173914|218390 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|SEN|0|0|0|100|SEK|198521|249026|lyfsjukr|||00|5|0|20|Gróco ehf|Serono Nordic|||198521||198521|249026 004746|A10AE0401|Lantus [OptiPen]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiPen|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9708|14015|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|||9708||9708|14015 004811|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|100|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|11507|16194|lyfsjukr|||00|1000|0|3|Actavis Group hf|Actavis Group hf|||11507||11507|16194 004822|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|200|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|21434|28550|lyfsjukr|||00|2000|0|7|Actavis Group hf|Actavis Group hf|||21432||21432|28550 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|686|1771|lyfalmen|||41|24|0|3|Actavis Group hf|Actavis Group hf|||686||686|1771 004863|R03DX0501|Xolair|sts|150|mg|2|ml|1|hgl|+ leysir, lausn|R03DX05|01.01.2006||R|A|4|0|1|0|1|NOE|0|0|0|100|XEU|72908|92638|lyfsjukr|||00|2|0|9|Vistor hf|Novartis Europharm Ltd|||72908||72908|92638 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|5725|8197|lyfsjukr|||00|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5725||5725|8197 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|406|1391|lyfalmen|||41|8|0|2|Actavis Group hf|Actavis Group hf|||406||406|1391 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|693|1781|lyfalmen|||41|14|0|4|Actavis Group hf|Actavis Group hf|||693||693|1781 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1312|2621|lyfalmen|||41|30|0|8|Actavis Group hf|Actavis Group hf|||1312||1312|2621 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|36|0|2|Artasan ehf|Novartis Healthcare A/S-A||||||0 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|96|0|6|Artasan ehf|Novartis Healthcare A/S-A||||||0 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|204|0|14|Artasan ehf|Novartis Healthcare A/S-A||||||0 005085|J07AJ5205|Boostrix|stl|0| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1801|3284|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1801||1801|3284 005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2450|4165|lyfalmen|||00|1|0|0|Icepharma hf|Sanofi Pasteur MSD|||||2450|4165 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|10845|10652|lyfalmen|V0437|9658|00|90|0|90|Vistor hf|Yamanouchi Europe|||7230||7230|10652 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|V0452|1864|10|30|0|4|Actavis Group hf|Actavis hf|||754||754|1864 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|763|1876|lyfalmen|||10|20|0|5|Actavis Group hf|Actavis hf|||763||763|1876 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1076|2301|lyfalmen|V0460|2301|10|30|0|8|Actavis Group hf|Actavis hf|||1076||1076|2301 005241|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|25034|33352|lyfalmen|||00|360|0|90|Vistor hf|AstraZeneca A/S DK|||25034||25034|33352 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|45344|58638|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|||45344||45344|58638 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|2991|4899|lyfalmen|||00|10|0|4|Vistor hf|AstraZeneca UK Ltd|||2991||2991|4899 005330|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyfalmen|||00|500|0|500|Icepharma hf|Napp||||||0 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A||||||0 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1190|2455|lyfalmen|||00|2|0|0|Vistor hf|LEO Pharma A/S|||1190||1190|2455 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|glas|+ dæla|L02AE03|01.04.1996||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|60486|77490|lyfalmen|||00|1|0|84|Vistor hf|AstraZeneca UK Ltd|||||60486|77490 005380|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.04.2004||R|K|1|0|1|*|0|PHO|0|0|0|100|NOK|38885|50597|lyfalmen|||00|2|0|0|Icepharma hf|PhotoCure ASA|||38885||38885|50597 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1570|2971|lyfalmen|||24|200|0|33|Vistor hf|Boehringer Ingelheim|||1570||1570|2971 005503|N05AH0301|Zyprexa|húðuðtfl|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|31264|18004|lyfalmen|V0815|18004|00|28|0|42|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||12706||12706|18004 005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5608|8451|lyfalmen|||00|4|0|28|Icepharma hf|M.S.D.|||5608||5608|8451 005526|N05AH0301|Zyprexa|húðuðtfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|39762|51689|lyfalmen|||00|28|0|56|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||39762||39762|51689 005538|G03AA0702|Microgyn|töflur|0| |63|stk|1|þpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1098|2330|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|||1098||1098|2330 005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|15552|21547|lyfalmen|V0718|21160|00|12|0|84|Icepharma hf|M.S.D.|||15552||15552|21547 005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|0|Actavis Group hf|Actavis hf|||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7234|10657|lyfalmen|||00|30|0|30|Vistor hf|Boehringer Ingelheim International|||7234||7234|10657 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7618|11178|lyfalmen|V0985|11021|00|30|0|30|Vistor hf|Boehringer Ingelheim International|||7618||7618|11178 005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|4373|6775|lyfalmen|||00|0|0|0|Icepharma hf|Baxter|||4373||4373|6775 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1688|3131|lyfalmen|||00|30|0|6|Icepharma hf|Servier|||1688||1688|3131 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|2943|4834|lyfalmen|||00|60|0|11|Icepharma hf|Servier|||2943||2943|4834 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|7813|11443|lyfalmen|||00|180|0|34|Icepharma hf|Servier|||7813||7813|11443 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|4294|6668|lyfalmen|||00|90|0|17|Icepharma hf|Servier|||4294||4294|6668 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf||||||1456 005747|G03CA0317|Aerodiol|nefúði|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|6500|9661|lyfalmen|||00|180|0|90|Icepharma hf|Servier|||6500||6500|9661 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|2515|4253|lyfalmen|||00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|||2515||2515|4253 005766|H01CC0201|Cetrotide|sts|0,25|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|4737|6782|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|||4737||4737|6782 005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|72341|91932|lyfsjukr|||00|15|0|0|Icepharma hf|Bayer Schering Pharma AG|||72341||72341|91932 005787|H01CC0201|Cetrotide|sts|0,25|mg/hgl|7|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|37137|48103|lyfsjukr|||00|7|0|0|Gróco ehf|Serono Nordic|||37137||37137|48103 005789|H01CC0201|Cetrotide|sts|3|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|37137|48103|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|||37137||37137|48103 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|7696|11284|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|||7696||7696|11284 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|3422|5484|lyfalmen|V0939|4670|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|||3422||3422|5484 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|17478|30247|vetorma|||16|5|0|0|Vistor hf|Merial (MSD)|||17478||17478|30247 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|6783|10045|lyfalmen|||00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|||6783||6783|10045 005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|80656|102284|lyfsjukr|||00|20|0|0|Icepharma hf|Bayer Schering Pharma AG|||80656||80656|102284 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|12015|17144|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|||12015||12015|17144 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|5983|8960|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|||5983||5983|8960 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|3320|5346|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |||3320||3320|5346 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|þpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|3152|5118|lyfalmen|||59|8|0|2|Icepharma hf|Roche|||3152||3152|5118 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|933|2107|lyfalmen|||00|1|0|1|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||933||933|2107 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|10865|15585|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |||10865||10865|15585 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|22823|30600|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|||22823||22823|30600 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3887|6115|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|||3887||3887|6115 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|7314|10766|lyfalmen|V1039|10566|00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|||7314||7314|10766 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|10566|12913|lyfalmen|V1110|10353|00|98|0|98|Vistor hf|Novartis Healthcare A/S-|||8896||8896|12913 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|14859|20684|lyfalmen|||00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|||14859||14859|20684 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|4957|7567|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|||4957||4957|7567 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|14929|18213|lyfalmen|V1111|14609|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|||12874||12874|18213 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|90012|113932|lyfsjukr|||00|2|0|1|Gróco ehf|Nycomed Danmark A/S|||90012||90012|113932 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6648|9862|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|||6648||6648|9862 006026|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|34341|44622|lyfsjukr|||00|60|0|0|Icepharma hf|Mayne Pharma Plc|||34341||34341|44622 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|130856|164783|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|||130856||130856|164783 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|A|2,5|0|0|*|0|NON|0|0|0|100|DKK|6504|9667|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|||6504||6504|9667 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|180150|226154|lyfsjukr|||00|3|0|2|Gróco ehf|Nycomed Danmark A/S|||180150||180150|226154 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|91256|115481|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|||91256||91256|115481 006172|S01XA2007|Simplex|augnsm|0| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|760|1872|lyfalmen|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|||760||760|1872 006178|A10AE0402|Lantus [Optiset]|stl|100|ein/ml|3|ml|5|pennar||A10AE04|01.11.2005||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|8606|12519|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|||8606||8606|12519 006212|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|39634|51212|lyfsjukr|||00|1200|0|0|Vistor hf|Bayer HealthCare AG|||39634||39634|51212 006226|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|68143|86706|lyfsjukr|||00|2400|0|0|Vistor hf|Bayer HealthCare AG|||68143||68143|86706 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2433|4142|lyfalmen|||43|40|0|13|Vistor hf|Sanofi-aventis Norge AS|||2433||2433|4142 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|9315|17915|vetalmen|||00|50|0|0|Vistor hf|Boehringer Ingelheim|||9315||9315|17915 006579|D05AX5201|Daivobet|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9889|14260|lyfalmen|V0391|14001|00|60|0|0|Vistor hf|LEO Pharma A/S|||9889||9889|14260 006637|D05AX5201|Daivobet|smyrsli|0| |120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|14682|20464|lyfalmen|V2001|20098|00|120|0|0|Vistor hf|LEO Pharma A/S|||14682||14682|20464 006650|A04AA0301|Navoban|stl|1|mg/ml|5|ml|10|lykjur||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|37036|48295|lyfalmen|||02|50|0|10|Vistor hf|Novartis Healthcare A/S-|||37036||37036|48295 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S||||||0 006785|G03AC0303|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AC03|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|SEK|||lyfalmen|||23|2|0|0|Gróco ehf|Laboratoire HRA Pharma||||||0 006825|A04AA0301|Navoban|hylki|5|mg|5|stk|1|þpakki||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|16408|22613|lyfalmen|||10|5|0|5|Vistor hf|Novartis Healthcare A/S-|||16408||16408|22613 006903|L03AX1301|Copaxone|sts|20|mg/hgl|28|hgl|1|pakki|+ leysir|L03AX13|01.01.2001|30.11.2008|R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|138485|174281|lyfsjukr|||00|28|0|28|Vistor hf|Teva Pharmaceuticals Limited|||138485||138485|174281 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|18485|25199|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|||18485||18485|25199 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4051|6338|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|||4051||4051|6338 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|737|1841|lyfalmen|||00|100|0|2|Vistor hf|Sanofi-aventis Norge AS|||737||737|1841 007123|V03AE0201|Renagel|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.01.2004||R|A|2|0|0|0|0|GZE|0|0|0|100|XEU|32458|42595|lyfalmen|||00|180|0|22|Vistor hf|Genzyme Europe B.V.|||32458||32458|42595 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|25571|48880|vetalmen|||27|20|0|0|Vistor hf|Boehringer Ingelheim Danmark|||25571||25571|48880 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12886|18228|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|||12886||12886|18228 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|1840|3337|lyfalmen|||00|100|0|8|Vistor hf|Sanofi-aventis Norge AS|||1840||1840|3337 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6069|9076|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|||6069||6069|9076 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|19311|26227|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|||19311||19311|26227 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|5951|8916|lyfalmen|||00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|||5951||5951|8916 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8057|11774|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|||8057||8057|11774 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|28198|37291|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|||28198||28198|37291 007223|B01AX0001|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|160688|201924|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||160688||160688|201924 007268|B01AX0001|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|283848|355258|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||283848||283848|355258 007278|C08CA0302|Lomir Retard|forðahlk|2,5|mg|30|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2228|3864|lyfalmen|||10|30|0|15|Vistor hf|Novartis Healthcare A/S-|||2228||2228|3864 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|2837|4690|lyfalmen|||00|3|0|30|Vistor hf|Allergan|||2837||2837|4690 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A||||||0 007337|H01CB0302|Ipstyl Autogel|stl|60|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|157900|198453|lyfsjukr|||00|1|0|20|Icepharma hf|Institut Produits Synthése (IPSEN) AB|||157900||157900|198453 007360|H01CB0302|Ipstyl Autogel|stl|120|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|243009|304414|lyfsjukr|||00|1|0|40|Icepharma hf|Institut Produits Synthése (IPSEN) AB|||243009||243009|304414 007363|H01CB0302|Ipstyl Autogel|stl|90|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|211272|264901|lyfsjukr|||00|1|0|30|Icepharma hf|Institut Produits Synthése (IPSEN) AB|||211272||211272|264901 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A||||||0 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|137860|173503|lyfsjukr|||00|3000|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||137860||137860|173503 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|þpakki||A02BA02|01.09.1983||L|A|5|0|0|E|0|GSK|0|0|0|30|IKR|||lyfalmen|||00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf||||||1580 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|347319|434280|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||347319||347319|434280 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PFI|0|0|0|100|DKK|3741|5917|lyfalmen|V0988|5815|06|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3741||3741|5917 007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|7641|10940|lyfsjukr|||02|50|0|0|Icepharma hf|Clintec parenteral SA|||7641||7641|10940 007449|V03AB0001|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB00|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|127601|160731|lyfsjukr|||00|100|0|0|Swedish Orphan International AB|OPi Orphan Pharma international (S)|||127601||127601|160731 007462|N01AB0801|Sevorane|innönd.l|0| |250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|27193|35723|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|||27193||27193|35723 007494|QP52AA0101|Droncit, vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BHC|0|0|0|0|DKK|||vetorma|||16|7|0|0|Vistor hf|Bayer HealthCare AG||||||3600 007505|G04BD0702|Detrusitol Retard|forðahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7272|10709|lyfalmen|||00|30|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7272||7272|10709 007516|R03BA0701|Asmanex Twisthaler|innúðadu|200|mcg|60|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5238|7949|lyfalmen|||00|60|0|30|Vistor hf|Schering-Plough Europe|||5238||5238|7949 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3233|5228|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|||3233||3233|5228 007538|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5238|7949|lyfalmen|||00|30|0|30|Vistor hf|Schering-Plough Europe|||5238||5238|7949 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|9614|13765|lyfsjukr|||00|1200|0|4|Vistor hf|Bristol-Myers Squibb|||9614||9614|13765 007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22727|30480|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||22727||22727|30480 007549|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|10209|14694|lyfalmen|||00|60|0|60|Vistor hf|Schering-Plough Europe|||10209||10209|14694 007559|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10288|14802|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|||10288||10288|14802 007575|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2673|3827|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|||2673||2673|3827 007609|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2463|4183|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|||2463||2463|4183 007657|QH02AB0602|Prednisolonacetat, vet."Intervet"|stl|10|mg/ml|50|ml|1|hgl||QH02AB06|01.05.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|1990|3927|vetalmen|||58|50|0|0|Icepharma hf|Intervet International B.V.|||1990||1990|3927 007760|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|8096|11827|lyfalmen|||00|30|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8096||8096|11827 007769|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|24586|32795|lyfalmen|||00|100|0|70|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||24586||24586|32795 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3185|lyfalmen|V1075|3185|00|60|0|6|Actavis Group hf|Actavis hf|||1728||1728|3185 007852|G02BB0101|NuvaRing|sk-hring|0| |3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|4299|6674|lyfalmen|||00|3|0|84|Vistor hf|N.V. Organon|||4299||4299|6674 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyfalmen|||00|2500|0|0|Icepharma hf|Baxter Medical AB||||||0 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyfalmen|||00|5000|0|0|Icepharma hf|Baxter||||||0 007920|S01EX0601|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EX06|01.02.2004||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|2763|4590|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|||2763||2763|4590 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1390|2727|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|||1390||1390|2727 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|168390|211513|lyfsjukr|||00|1|0|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||168390||168390|211513 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|XEU|||lyfalmen|||20|15|0|15|Vistor hf|Astellas Pharma A/S||||||0 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|23519|31149|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|||23519||23519|31149 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|729|1830|lyfalmen|||00|30|1|10|Lyfjaver ehf|Lyfjaver - óskráð lyf|||729||729|1830 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|42430|54693|lyfsjukr|||00|1|0|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||42430||42430|54693 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|700|1790|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|||700||700|1790 008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|3744|5921|lyfalmen|||00|1|0|5|Icepharma hf|Roche Registration Limited|||3744||3744|5921 008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|26001|34239|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|||26001||26001|34239 008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|32502|42332|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|||32502||32502|42332 008086|D07AC0101|Betnovat|krem|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|458|1462|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||458||458|1462 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|7125|10509|lyfalmen|||00|6|0|3|Icepharma hf|M.S.D.|||7125||7125|10509 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|97718|123526|lyfsjukr|||00|4|0|27|Vistor hf|Schering-Plough|||97718||97718|123526 008102|D07AC0101|Betnovat|krem|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1451|2809|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1451||1451|2809 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|196453|246451|lyfsjukr|||00|4|0|53|Vistor hf|Schering-Plough|||196453||196453|246451 008123|J07AH0701|Meningitec|stl|10|mcg/hgl|0,5|ml|1|hgl||J07AH07|01.05.2002|31.12.2008|R|K|3|0|0|0|0|WAB|0|0|0|100|USD|4031|6311|lyfalmen|||00|0|0|0|Icepharma hf|Wyeth AB|||4031||4031|6311 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|142459|179229|lyfsjukr|||00|4|0|43|Vistor hf|Schering-Plough|||142459||142459|179229 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|209693|262935|lyfsjukr|||00|4|0|64|Vistor hf|Schering-Plough|||209693||209693|262935 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|244795|306637|lyfsjukr|||00|4|0|80|Vistor hf|Schering-Plough|||244795||244795|306637 008182|J07AH0701|Meningitec|stl|10|mcg/hgl|0,5|ml|10|hgl||J07AH07|01.05.2002|31.12.2008|R|K|3|0|0|0|0|WAB|0|0|0|100|USD|40319|52381|lyfalmen|||00|5|0|0|Icepharma hf|Wyeth AB|||40319||40318|52381 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|XEU|||lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S||||||0 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2148|3755|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2148||2148|3755 008197|R06AX2701|Aerius|saft|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2002||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1227|2505|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|||1227||1227|2505 008219|D07AC0101|Betnovat|áburður|1|mg/ml|20|ml|1|glas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|292|1237|lyfalmen|||20|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||292||292|1237 008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|34242|44499|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|||34242||34242|44499 008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|26737|35153|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|||26735||26735|35153 008243|D07AC0101|Betnovat|áburður|1|mg/g|30|ml|1|glas|í hársvörð|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|479|1490|lyfalmen|||33|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||479||479|1490 008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|33507|43584|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|||33507||33507|43584 008300|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8347|12168|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|||8347||8347|12168 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1244|2529|lyfalmen|V0733|2529|00|20|0|7|Actavis Group hf|Actavis hf|||1244||1244|2529 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2646|4431|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|||2646||2646|4431 008326|D07AC0101|Betnovat|áburður|1|mg/g|100|ml|1|glas|í hársvörð|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1428|2778|lyfalmen|||33|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1428||1428|2778 008334|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8420|12267|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|||8420||8420|12267 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|4869|7448|lyfalmen|V0734|7448|00|100|0|33|Actavis Group hf|Actavis hf|||4869||4869|7448 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|7472|10980|lyfalmen|V0736|10980|00|100|0|50|Actavis Group hf|Actavis hf|||7472||7472|10980 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|9839|14192|lyfalmen|V0738|14192|00|100|0|67|Actavis Group hf|Actavis hf|||9839||9839|14192 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|218702|274151|lyfsjukr|||02|2|0|0|Vistor hf|Genzyme BV|||218702||218702|274151 008383|D07AC0101|Betnovat|smyrsli|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|458|1462|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||458||458|1462 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|823|1957|lyfalmen|V0431|1957|00|100|0|33|Actavis Group PTC ehf|Merck KgaA (A) |||823||823|1957 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|695|1784|lyfalmen|V0430|1784|00|100|0|67|Actavis Group PTC ehf|Merck KgaA (A) |||695||695|1784 008466|D07AC0101|Betnovat|smyrsli|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1451|2809|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1451||1451|2809 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|5357|9271|vetorma|||00|1000|0|0|Icepharma hf|Chanelle Pharmaceuticals |||5357||5357|9271 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|11530|22134|vetalmen|||00|50|0|0|Icepharma hf|Chanelle Pharmaceuticals |||11530||11530|22134 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|E|0|ALF|0|0|1|100|NOK|||lyfalmen|||00|10|0|10|Gróco ehf|Almirall-Prodesfarma S.A.||||||1600 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|þpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|NOK|4625|7117|lyfalmen|||00|100|0|100|Gróco ehf|Almirall-Prodesfarma S.A.|||4625||4625|7117 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|E|0|ALF|0|0|1|100|NOK|||lyfalmen|||00|30|0|30|Gróco ehf|Almirall-Prodesfarma S.A.||||||2877 008545|G03FB0506|NovoFem|filmhtfl|0| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3053|4983|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|||3053||3053|4983 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A||||||0 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|138855|174742|lyfsjukr|||00|2|0|0|Icepharma hf|Roche Registration Limited|||138855||138855|174742 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A||||||0 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|144742|182071|lyfsjukr|||00|2|0|28|Icepharma hf|Roche Registration Limited|||144742||144742|182071 008785|QP52AC1303|Zerofen, vet.|mixtúra|10|%|500|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|2744|4749|vetorma|||00|500|0|0|Icepharma hf|Chanelle Pharmaceuticals |||2744||2744|4749 008831|D11AX1501|Elidel|krem|1|%|15|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|3251|5252|lyfalmen|||00|15|0|15|Vistor hf|Novartis Healthcare A/S-|||3251||3251|5252 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3233|5228|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|||3233||3233|5228 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|2417|4120|lyfalmen|||20|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2417||2417|4120 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6391|9513|lyfalmen|||00|4|0|8|Eli Lilly Danmark A/S|Lilly ICOS Limited|||||6391|9513 008938|H02AB0104|Betapred|stl|4|mg/ml|1|ml|5|lykjur||H02AB01|01.07.2004||R|A||0|0|0|0|LVE|0|0|1|100|IKR|950|2130|lyfalmen|||02|5|1|13|Lyfjaver ehf|Lyfjaver - óskráð lyf|||950||950|2130 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|12589|17858|lyfalmen|||00|8|0|16|Eli Lilly Danmark A/S|Lilly ICOS Limited|||||12589|17858 009065|D11AX1501|Elidel|krem|1|%|30|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|5801|8713|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|||5801||5801|8713 009079|D11AX1501|Elidel|krem|1|%|100|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|17028|23385|lyfalmen|||00|100|0|100|Vistor hf|Novartis Healthcare A/S-|||17028||17028|23385 009137|M05BA0302|Pamidronatdinatrium Mayne 3 mg/ml|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|30339|39640|lyfsjukr|||00|25|0|1|Icepharma hf|Mayne Pharma Plc|||30339||30339|39640 009192|M01AH0401|Dynastat|sts|40|mg/hgl|5|hgl|1|pakki|+leysir 2ml/lykju |M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|7762|11374|lyfalmen|||03|5|0|5|Vistor hf|Pfizer Limited|||7762||7762|11374 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|14734|20529|lyfalmen|||03|10|0|10|Vistor hf|Pfizer Limited|||14734||14734|20529 009275|M05BA0302|Pamidronatdinatrium Mayne 3 mg/ml|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|12512|17445|lyfsjukr|||00|10|0|0|Icepharma hf|Mayne Pharma Plc|||12512||12512|17445 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|64382|82023|lyfsjukr|||00|30|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||64382||64382|82023 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyflausa|||02|400|0|0|Icepharma hf|Fresenius Kabi|||||| 009285|D11AX1401|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|0|0|ASP|0|0|0|100|XEU|6183|9231|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|||6183||6183|9231 009286|M05BA0303|Pamidronatdinatrium Mayne 6 mg/ml|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|16402|22288|lyfsjukr|||00|10|0|1|Icepharma hf|Mayne Pharma Plc|||16402||16402|22288 009297|M05BA0304|Pamidronatdinatrium Mayne 9 mg/ml|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|21551|28698|lyfsjukr|||00|10|0|2|Icepharma hf|Mayne Pharma Plc|||21551||21551|28698 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||00|400|0|0|Icepharma hf|Fresenius Kabi||||||0 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1438|2792|lyfalmen|||23|8|0|21|Vistor hf|Novartis Healthcare A/S-|||1438||1438|2792 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1546|2938|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|||1546||1546|2938 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1822|3313|lyfalmen|||23|8|0|42|Vistor hf|Novartis Healthcare A/S-|||1822||1822|3313 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2096|3685|lyfalmen|||23|8|0|56|Vistor hf|Novartis Healthcare A/S-|||2096||2096|3685 009522|N02BE0101|Panodil|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||04|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S||||||0 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|257178|322054|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||257178||257178|322054 009649|D11AX1401|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|0|0|ASP|0|0|0|100|XEU|6890|10190|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|||6890||6890|10190 009672|J05AB0102|Zovir|töflur|400|mg|55|stk|1|þpakki||J05AB01|01.09.2003||R|A|5|0|0|E|0|GSK|0|0|1|30|GBP|10377|14922|lyfalmen|||00|55|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||10377||10377|14922 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GSC|0|0|0|100|DKK|74289|94357|lyfsjukr|||00|30|0|30|Swedish Orphan International AB|Gilead Science International (S) |||74289||74289|94357 009688|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10287|14800|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|||10287||10287|14800 009830|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|1|spr||B03XA01|01.05.2006||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|43647|56208|lyfsjukr|||00|1|0|20|Icepharma hf|Roche|||43647||43647|56208 009881|A10BD0201|Glucovance|filmhtfl|502,5|mg|30|stk|1|þpakki|500+2,5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|889|2047|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|||889||889|2047 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6951|10273|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|||6951||6951|10273 009905|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6824|10101|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||6824||6824|10101 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8087|11815|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||8087||8087|11815 009913|N06AX1102|Remeron Smelt|munndr.t|15|mg|6|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|580|1627|lyfalmen|||00|6|0|3|Vistor hf|N.V. Organon|||580||580|1627 009942|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7363|10832|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||7363||7363|10832 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8117|11856|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||8117||8117|11856 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6245|9315|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|||6245||6245|9315 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|2463|4183|lyfalmen|V1151|2989|00|30|0|15|Vistor hf|N.V. Organon|||2463||2463|4183 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|4370|6771|lyfalmen|V1152|4328|00|30|0|30|Vistor hf|N.V. Organon|||4370||4370|6771 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|9332|13504|lyfalmen|||00|30|0|45|Vistor hf|N.V. Organon|||9332||9332|13504 010070|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|áfyllt sprauta, lausn|L03AA13|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|198872|249463|lyfsjukr|||00|1|0|20|Vistor hf|Amgen Europe B.V.|||198872||198872|249463 010102|G03GA0502|Gonal-f|sts|75|ae|1|hgl|1|pakki|(5,5 mcg) + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|4850|7422|lyfalmen|||00|1|0|1|Gróco ehf|Serono Europe|||4850||4850|7422 010135|A10BD0201|Glucovance|filmhtfl|505|mg|30|stk|1|þpakki|500+5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|1273|2568|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|||1273||1273|2568 010159|G03GA0502|Gonal-f|sts|75|ae|10|hgl|1|pakki|(5,5 mcg) + leysir |G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|49828|64221|lyfalmen|||00|10|0|10|Gróco ehf|Serono Europe|||49828||49828|64221 010164|G03GA0502|Gonal-f|sts|450|ae|1|hgl|1|pakki|á 0,75ml + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|29899|39409|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|||29899||29899|39409 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|30|DKK|256434|321128|lyfsjukr|||00|60|0|30|Icepharma hf|Roche Registration Limited|||256434||256434|321128 010187|H01AX0101|Somavert|sts|10|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|443267|553735|lyfsjukr|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||443267||443267|553735 010203|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt sprauta|B03XA02|01.04.2005||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|185639|232988|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|||185639||185639|232988 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|8661|12400|lyfsjukr|||00|1|0|0|Icepharma hf|M.S.D.|||8661||8661|12400 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|13564|19072|lyfalmen|V1153|13253|00|96|0|96|Vistor hf|N.V. Organon|||13564||13564|19072 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|20549|27768|lyfalmen|||00|96|0|144|Vistor hf|N.V. Organon|||20549||20549|27768 010312|N06DX0101|Ebixa|töflur|10|mg|30|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|9071|13150|lyfalmen|||00|30|0|15|Lundbeck Export A/S|H. Lundbeck A/S|||9071||9071|13150 010323|N06DX0101|Ebixa|töflur|10|mg|50|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|14816|20631|lyfalmen|||00|50|0|25|Lundbeck Export A/S|H. Lundbeck A/S|||14816||14816|20631 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|26675|35395|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|||26675||26675|35395 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|4104|6410|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |||4104||4104|6410 010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|9451|13666|lyfalmen|||51|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||9451||9451|13666 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|13258|18691|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |||13258||13258|18691 010437|QI09AB1301|Stellamune One|stl|0| |100|ml|10|glös|fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|PZR|0|0|0|100|DKK|78235|149197|vetalmen|||00|1000|0|0|Icepharma hf|Pfizer A/S (Í)|||78235||78235|149197 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|13059|18126|lyfsjukr|||00|2500|0|0|Icepharma hf|Baxter Medical AB|||13059||13059|18126 010534|B05BA0108|Vaminolac|irl|0| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8830|12642|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|||8830||8830|12642 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1407|2750|lyfalmen|||00|5|0|0|Icepharma hf|Santen Oy|||1407||1407|2750 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|4952|7560|lyfalmen|||00|4|0|28|Vistor hf|Sanofi-aventis Norge AS|||4952||4952|7560 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6918|9905|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|||6918||6918|9905 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|12686|17662|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|||12686||12686|17662 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4828|6912|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||4828||4828|6912 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2767|3962|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||2767||2767|3962 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|7890|11547|lyfalmen|||00|9|0|90|Vistor hf|Allergan|||7890||7890|11547 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|12686|17662|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|||12686||12686|17662 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6964|9971|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|||6964||6964|9971 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4642|6646|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||4642||4642|6646 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|12843|18175|lyfalmen|V1080|18175|00|12|0|84|Vistor hf|Sanofi-aventis Norge AS|||12843||12843|18175 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2577|3690|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||2577||2577|3690 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|459535|573989|lyfsjukr|||00|56|0|14|Swedish Orphan International AB|Actelion Registration Ltd. (S)|||459535||459535|573989 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|459535|573989|lyfsjukr|||00|56|0|28|Swedish Orphan International AB|Actelion Registration Ltd. (S)|||459535||459535|573989 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|662485|826661|lyfsjukr|||00|30|0|45|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||662485||662485|826661 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|881697|1099580|lyfsjukr|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||881697||881697|1099580 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|1785|3263|lyfalmen|||10|28|0|28|Actavis Group hf|Actavis hf|||1785||1785|3263 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|GCH|0|0|1|100|SEK|||lyflausa|||00|300|0|20|Icepharma hf|GlaxoSmithKline CH A/S|||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|6037|9033|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|||6037||6037|9033 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|3384|5433|lyfalmen|||10|56|0|56|Actavis Group hf|Actavis hf|||3384||3384|5433 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|50347|64550|lyfsjukr|||03|10|0|0|Icepharma hf|Baxter Medical AB|||50347||50347|64550 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|2896|4146|lyfsjukr|||03|10|0|5|Vistor hf|Recip AB|||2896||2896|4146 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|3096|5042|lyfalmen|||00|28|0|14|Icepharma hf|Wyeth AB|||3096||3096|5042 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|23496|31437|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||23496||23496|31437 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|23496|31437|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||23496||23496|31437 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|GCH|0|0|1|100|SEK|||lyflausa|||00|50|0|17|Icepharma hf|GlaxoSmithKline CH A/S|||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|39323|51142|lyfalmen|V1702|42542|00|56|0|37|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||39323||39323|51142 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|39323|51142|lyfalmen|V1703|42542|00|56|0|56|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||39323||39323|51142 011078|B05AA0702|Hemohes 6%|irl|60|mg/ml|500|ml|1|plpoki|án PVC (Ecobag)|B05AA07|01.05.2002||R|A|2|0|0|0|1|BRA|0|0|0|100|XEU|1695|2427|lyfsjukr|||00|500|0|0|Actavis Group hf|Braun|||1695||1695|2427 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|17996|24590|lyfalmen|||00|100|0|33|Vistor hf|AstraZeneca A/S DK|||17996||17996|24590 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|0|0|MSD|0|0|1|100|XEU|6241|9310|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|||6241||6241|9310 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|0|0|MSD|0|0|1|100|XEU|6241|9310|lyfalmen|||00|28|0|42|Icepharma hf|M.S.D.|||6241||6241|9310 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|25436|33853|lyfalmen|||00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|||25436||25436|33853 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|992|2187|lyfalmen|V0195|2187|00|28|0|7|Actavis Group hf|Actavis hf|||992||992|2187 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|13026|18402|lyfalmen|||02|5|0|167|Lundbeck Export A/S|H. Lundbeck A/S|||13026||13026|18402 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1427|2777|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis hf|||1427||1427|2777 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|4069|6362|lyfalmen|V0197|6362|00|98|0|98|Actavis Group hf|Actavis hf|||4069||4069|6362 011409|R03AK0703|Symbicort forte Turbuhaler|innúðadu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8321|12132|lyfalmen|||00|60|0|30|Vistor hf|AstraZeneca A/S DK|||8321||8321|12132 011453|G04BE0901|Levitra|filmhtfl|5|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|12326|17531|lyfalmen|||00|12|0|6|Vistor hf|Bayer AG-|||12326||12326|17531 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|6879|10176|lyfalmen|||00|30|0|18|Vistor hf|Janssen-Cilag AB|||6879||6879|10176 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|8081|11570|lyfsjukr|||02|10000|0|0|Icepharma hf|Baxter Medical AB|||8081||8081|11570 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|1827|2616|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1827||1827|2616 011547|M01AH0501|Arcoxia|filmhtfl|120|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|0|0|MSD|0|0|1|100|XEU|6241|9310|lyfalmen|||00|28|0|56|Icepharma hf|M.S.D.|||6241||6241|9310 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|8987|13036|lyfalmen|||00|30|0|36|Vistor hf|Janssen-Cilag AB|||8987||8987|13036 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|USD|1727|3408|vetalmen|||00|25|0|0|Icepharma hf|Chanelle Pharmaceuticals |||1727||1727|3408 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|3531|5056|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3531||3531|5056 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|með skammtadælu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1422|2770|lyfalmen|||00|64|0|29|Gróco ehf|Oy Leiras Finland Ab|||1422||1422|2770 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|30|DKK|112484|141910|lyfsjukr|||00|168|0|34|Icepharma hf|Roche Registration Limited|||112484||112484|141910 011810|D11AX1501|Elidel|krem|1|%|60|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|10914|15651|lyfalmen|||00|60|0|60|Vistor hf|Novartis Healthcare A/S-|||10914||10914|15651 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2003|3559|lyfalmen|V0935|3559|00|28|0|56|Actavis Group hf|Actavis hf|||2003||2003|3559 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|7008|10351|lyfalmen|V0937|10351|00|98|0|196|Actavis Group hf|Actavis hf|||7008||7008|10351 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4247|6081|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|||4247||4247|6081 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3857|5522|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|||3857||3857|5522 011986|C10AA0403|Lescol depot|forðatfl|80|mg|28|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4733|7263|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|||4733||4733|7263 011997|C10AA0403|Lescol depot|forðatfl|80|mg|98|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|16292|22469|lyfalmen|||00|98|0|196|Vistor hf|Novartis Healthcare A/S-|||16292||16292|22469 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|47801|61380|lyfsjukr|||00|30|0|30|Icepharma hf|M.S.D.|||47801||47801|61380 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|11659|16662|lyfalmen|||00|90|0|90|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||11659||11659|16662 012260|R01AC0301|Lastin|nefúði|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|IKR|1343|2663|lyfalmen|||00|20|0|36|Icepharma hf|Meda AB|||1343||1343|2663 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6369|9483|lyfalmen|||00|4|0|4|Eli Lilly Danmark A/S|Lilly ICOS Limited|||6369||6369|9483 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|7|0|4|Artasan ehf|Novartis Healthcare A/S-A||||||0 012309|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|6062|10491|vetorma|||00|20|0|0|Icepharma hf|Icepharma hf|||6062||6062|10491 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|825|1960|lyfalmen|||00|30|0|15|Vistor hf|Aventis Pharma |||825||825|1960 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|10650|15293|lyfalmen|||00|30|0|54|Vistor hf|Janssen-Cilag AB|||10650||10650|15293 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A||||||0 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A||||||0 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A||||||0 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A||||||0 012640|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|28488|49300|vetorma|||00|100|0|0|Icepharma hf|Icepharma hf|||28488||28488|49300 012677|A07AA0904|Vancomycin Alpharma|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|25810|34318|lyfalmen|||00|28|0|4|Actavis Group hf|Alpharma ApS|||25810||25810|34318 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|7|0|7|Artasan ehf|Novartis Healthcare A/S-A||||||0 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|USD|559243|698125|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|||559243||559243|698125 012770|G04BE0901|Levitra|filmhtfl|5|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|4395|6805|lyfalmen|||00|4|0|2|Vistor hf|Bayer AG-|||4395||4395|6805 012792|G04BE0901|Levitra|filmhtfl|10|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|4862|7438|lyfalmen|||00|4|0|4|Vistor hf|Bayer AG-|||4862||4862|7438 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|7|0|10|Artasan ehf|Novartis Healthcare A/S-A||||||0 012816|G04BE0901|Levitra|filmhtfl|10|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|14325|20020|lyfalmen|||00|12|0|12|Vistor hf|Bayer AG-|||14325||14325|20020 012838|G04BE0901|Levitra|filmhtfl|20|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|6028|9021|lyfalmen|||00|4|0|8|Vistor hf|Bayer AG-|||6028||6028|9021 012860|G04BE0901|Levitra|filmhtfl|20|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|17430|23885|lyfalmen|||00|12|0|24|Vistor hf|Bayer AG-|||17430||17430|23885 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1815|lyfalmen|||08|80|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||718||718|1815 012921|G03AA1301|Evra|forðapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|4264|6627|lyfalmen|||00|9|0|0|Vistor hf|Janssen-Cilag International N.V.|||4264||4264|6627 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|6453|9597|lyfalmen|||00|30|0|30|Icepharma hf|Laboratoires Besins International|||6453||6453|9597 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|6537|9711|lyfalmen|||00|30|0|20|Vistor hf|Novartis Healthcare A/S-|||6537||6537|9711 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7169|13827|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||7169||7169|13827 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|10669|15319|lyfalmen|||00|30|0|40|Vistor hf|Novartis Healthcare A/S-|||10669||10669|15319 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1859|3668|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1859||1859|3668 013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|1415|2761|lyfalmen|||00|14|0|7|Icepharma hf|Wyeth AB|||1415||1415|2761 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|23519|31149|lyfsjukr|||00|2|0|0|Ísaga ehf|AGA AB|||23519||23519|31149 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|9444|13521|lyfsjukr|||17|2|0|0|Icepharma hf|ZLB GmbH|||9444||9444|13521 013259|B02BD0402|BeneFIX|sts|0| |250|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|36969|47894|lyfsjukr|||00|250|0|1|Icepharma hf|Wyeth Europe|||36969||36969|47894 013270|B02BD0402|BeneFIX|sts|0| |500|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|73943|93927|lyfsjukr|||00|500|0|1|Icepharma hf|Wyeth Europe|||73943||73943|93927 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4708|9139|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||4708||4708|9139 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|11316|21726|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||11316||11316|21726 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1187|2342|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1187||1187|2342 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|193724|243054|lyfsjukr|||00|1|0|3|Lyfjaver ehf|Baxter Medical AB (L)|||193724||193724|243054 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|32287|42065|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Baxter AG (L)|||32287||32287|42065 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|129149|162658|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|||129149||129149|162658 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|62893|80169|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|||62893||62893|80169 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|21627|29111|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|||21627||21627|29111 013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|196687|246743|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|||196687||196687|246743 013593|A01AA3001|Xerodent|munnstfl|0| |90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0|0|Actavis Group hf|Actavis Group hf||||||1367 013660|A10AD0116|Mixtard 30 InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar sprautur|A10AD01|01.03.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|7370|10842|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||7370||7370|10842 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1273|2568|lyfalmen|||00|40|0|5|Vistor hf|Sanofi-aventis Norge AS|||1273||1273|2568 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|492|1508|lyfalmen|||00|30|0|0|Vistor hf|AstraZeneca A/S DK|||492||492|1508 013718|M05BA0801|Zometa|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|48503|62254|lyfsjukr|||00|5|0|1|Vistor hf|Novartis Europharm Ltd|||48503||48503|62254 013720|A10AD0118|Mixtard 30|stl|100|ae/ml|10|ml|1|hgl||A10AD01|01.10.1985|31.12.2008|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2934|4822|lyfalmen|||50|10|0|25|Vistor hf|Novo-Nordisk|||2934||2934|4822 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|4977|7594|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|||4977||4977|7594 013767|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|98|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|17116|23494|lyfalmen|||00|98|0|196|Vistor hf|Novartis Healthcare A/S-|||17116||17116|23494 013804|A10AC0105|Insulatard Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AC01|01.07.1993||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|4875|7456|lyfalmen|||50|15|0|38|Vistor hf|Novo-Nordisk|||4875||4875|7456 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1215||1215|2489 013879|A10AD0120|Mixtard 40 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992|31.12.2008|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5842|8767|lyfalmen|||50|15|0|38|Vistor hf|Novo-Nordisk|||5842||5841|8767 013890|A10AD0119|Mixtard 50 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992|31.12.2008|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5999|8980|lyfalmen|||50|15|0|38|Vistor hf|Novo-Nordisk|||5999||5998|8980 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|7370|10842|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||7370||7370|10842 013909|A10AB0107|Actrapid NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AB01|01.08.2003||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5725|8609|lyfalmen|||51|15|0|38|Vistor hf|Novo-Nordisk|||5725||5725|8609 013913|A10AD0121|Mixtard 30 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992|31.12.2008|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5523|8334|lyfalmen|||50|15|0|38|Vistor hf|Novo-Nordisk|||5523||5522|8334 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2805|4647|lyfalmen|||51|10|0|25|Vistor hf|Novo-Nordisk|||2805||2805|4647 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5275|7999|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||5275||5275|7999 013958|A10AB0103|Actrapid Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AB01|01.02.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|4836|7403|lyfalmen|||51|15|0|38|Vistor hf|Novo-Nordisk|||4836||4836|7403 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|233399|292449|lyfsjukr|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||233399||233399|292449 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|412679|515653|lyfsjukr|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|||412679||412679|515653 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2781|4614|lyfalmen|||71|10|0|25|Vistor hf|Novo-Nordisk|||2781||2781|4614 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|30|SEK|13505|18681|lyfsjukr|||00|50|0|13|Vistor hf|AstraZeneca A/S DK|||13505||13505|18681 014081|N03AX1401|Keppra|mixtúra|100|mg|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|24860|33136|lyfalmen|||00|300|0|20|Vistor hf|U.C.B|||24860||24860|33136 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|63804|81621|lyfalmen|||AC|3|0|38|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||63804||63804|81621 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|38094|49295|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|||38094||38094|49295 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1363|2690|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|||1363||1363|2690 014285|B05BA1020|StructoKabiven elektrolyfri|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|23466|31083|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|||23466||23466|31083 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||29|4|0|0|Vistor hf|Janssen-Cilag AB||||||0 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25839|34037|lyfsjukr|||00|3944|0|0|Icepharma hf|Fresenius Kabi|||25839||25839|34037 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33816|43968|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|||33816||33816|43968 014372|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|23466|31083|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|||23466||23466|31083 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|16398|22600|lyfalmen|||23|1|0|1825|Icepharma hf|Schering Oy|||16398||16398|22600 014541|QA02BX1201|Orbeseal|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PFI|0|0|0|100|XEU|6041|11678|vetalmen|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6041||6041|11678 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|310181|388043|lyfsjukr|||00|60|0|0|Icepharma hf|Roche Registration Limited|||310181||310181|388043 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2555|4308|lyfalmen|||10|28|0|2|Icepharma hf|Norpharma |||2555||2555|4308 014702|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4602|7086|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|||4602||4602|7086 014713|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|15574|21575|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|||15574||15574|21575 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|79955|101411|lyfsjukr|||00|2|0|4|Vistor hf|Amgen Europe B.V.|||79955||79955|101411 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|123772|155964|lyfsjukr|||00|2|0|7|Vistor hf|Amgen Europe B.V.|||123772||123772|155964 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|24224|32344|lyfalmen|||00|60|0|10|Icepharma hf|Novartis Healthcare A/S|||24224||24224|32344 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|72672|92662|lyfalmen|||00|60|0|30|Icepharma hf|Novartis Healthcare A/S|||72672||72672|92662 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|48450|62505|lyfalmen|||00|60|0|20|Icepharma hf|Novartis Healthcare A/S|||48450||48450|62505 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyfalmen|||00|90|0|24|Icepharma hf|Pharma Nord ApS||||||0 015230|R01AC0301|Lastin|nefúði|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|IKR|684|1769|lyfalmen|||00|10|0|18|Icepharma hf|Meda AB|||684||684|1769 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyfalmen|||00|270|0|72|Icepharma hf|Pharma Nord ApS||||||0 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|4886|7471|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||4886||4886|7471 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|10001|14412|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||10001||10001|14412 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|2563|4318|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|||2563||2563|4318 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|2187|3808|lyfalmen|||00|100|1|33|Lyfjaver ehf|Lyfjaver - óskráð lyf|||2187||2187|3808 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1156|2409|lyfalmen|||23|8|0|14|Vistor hf|Novartis Healthcare A/S-|||1156||1156|2409 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2084|3442|lyfalmen|V0832|3442|00|6|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1917||1917|3442 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3042|4556|lyfalmen|V0831|4556|00|12|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2738||2738|4556 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|11227|16076|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||11227||11227|16076 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|366456|458105|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|||366456||366456|458105 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|97402|123133|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|||97402||97402|123133 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6499|9660|lyfalmen|||00|30|0|3|Vistor hf|Orion Corporation|||6499||6499|9660 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14321|20015|lyfalmen|V1732|20015|00|100|0|11|Vistor hf|Orion Corporation|||14321||14321|20015 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6499|9660|lyfalmen|||00|30|0|10|Vistor hf|Orion Corporation|||6499||6499|9660 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|21567|29036|lyfalmen|V1731|25257|00|100|0|33|Vistor hf|Orion Corporation|||21567||21567|29036 015677|N05CF0201|Stilnoct|töflur|10|mg|1000|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|33950|44453|lyfalmen|||00|1000|0|1000|Vistor hf|Sanofi-aventis Norge AS|||33950||33950|44453 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|84775|107412|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|||84775||84775|107412 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|84775|107412|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|||84775||84775|107412 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|84775|107412|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|||84775||84775|107412 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6499|9660|lyfalmen|||00|30|0|7|Vistor hf|Orion Corporation|||6499||6499|9660 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14170|19827|lyfalmen|V1730|19827|00|100|0|22|Vistor hf|Orion Corporation|||14170||14170|19827 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|84775|107412|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|||84775||84775|107412 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|29436|38833|lyfalmen|||00|120|0|10|Vistor hf|Novartis Healthcare A/S-|||29436||29436|38833 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|51196|65924|lyfalmen|||00|120|0|22|Vistor hf|Novartis Healthcare A/S-|||51196||51196|65924 015800|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA04|01.01.1977||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|1037|2248|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|||1037||1037|2248 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3379|5848|vetorma|||16|2|0|0|Vistor hf|Bayer HealthCare AG|||3379||3379|5848 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4749|8218|vetorma|||16|12|0|0|Vistor hf|Bayer HealthCare AG|||4749||4749|8218 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3015|5218|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||3015||3015|5218 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3780|6541|vetorma|||16|3|0|0|Vistor hf|Bayer HealthCare AG|||3780||3780|6541 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|þpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|4816|7376|lyfalmen|||10|50|0|25|Swedish Orphan International AB|Sandoz GmbH (S)|||4816||4816|7376 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4235|7329|vetorma|||16|8|0|0|Vistor hf|Bayer HealthCare AG|||4235||4235|7329 015923|D11AX1401|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AX14|01.10.2007||R|A|3|0|0|0|0|ASP|0|0|0|100|XEU|2465|4186|lyfalmen|||00|10|0|0|Vistor hf|Astellas Pharma A/S|||2465||2465|4186 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1589|2997|lyfalmen|||02|10|0|3|Icepharma hf|Martindale Pharmaceuticals|||1589||1589|2997 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3379|5848|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||3379||3379|5848 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|A|3|0|0|B|0|GSK|0|1|0|30|GBP|1529|2915|lyfalmen|||00|28|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1529||1529|2915 015985|C09AA0401|Coversyl|töflur|8|mg|90|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|16426|22635|lyfalmen|||00|90|0|180|Icepharma hf|Servier|||16426||16426|22635 016000|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|XEU|5247|7961|lyfalmen|||00|6|0|6|Gróco ehf|Laboratorios Almirall S.A.|||5247||5247|7961 016003|C09AA0401|Coversyl|töflur|8|mg|30|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|5525|8338|lyfalmen|||00|30|0|60|Icepharma hf|Servier|||5525||5525|8338 016011|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|XEU|7429|10922|lyfalmen|||00|9|0|9|Gróco ehf|Laboratorios Almirall S.A.|||7429||7429|10922 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13159|18568|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca A/S DK|||13159||13159|18568 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1181|2443|lyfalmen|||02|10|0|1|Icepharma hf|Martindale Pharmaceuticals|||1181||1181|2443 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|19715|26730|lyfalmen|||00|100|0|200|Vistor hf|AstraZeneca A/S DK|||19715||19715|26730 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1252|2539|lyfalmen|||02|20|0|2|Icepharma hf|Martindale Pharmaceuticals|||1252||1252|2539 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|XEU|2709|4514|lyfalmen|||00|3|0|3|Gróco ehf|Laboratorios Almirall S.A.|||2707||2707|4514 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|NOK|||lyfalmen|||00|60|0|0|Vistor hf|Sanofi-aventis Norge AS||||||0 016178|A10BD0301|Avandamet|filmhtfl|502|mg|112|stk|1|þpakki|500+2mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|8232|12012|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|||8232||8232|12012 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|7871|11519|lyfalmen|||00|28|0|11|Vistor hf|Janssen-Cilag AB|||7869||7869|11519 016228|A10BD0301|Avandamet|filmhtfl|501|mg|56|stk|1|þpakki|500+1mg|A10BD03|01.03.2004|31.12.2008|R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|2566|4323|lyfalmen|||00|56|0|28|GlaxoSmithKline ehf|SmithKline Beecham PLC|||2566||2566|4323 016239|A10BD0301|Avandamet|filmhtfl|501|mg|112|stk|1|þpakki|500+1mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|4605|7090|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|||4605||4605|7090 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3485|5570|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3485||3485|5570 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7404|10888|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7404||7404|10888 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|SEE|0|0|0|100|SEK|4895|7483|lyfalmen|||00|0|0|1|Gróco ehf|Serono Europe|||4895||4895|7483 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|11272|16137|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11272||11272|16137 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2341|4017|lyfalmen|||00|14|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2341||2341|4017 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|16531|22766|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||16531||16531|22766 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|11837|16904|lyfalmen|||10|100|0|100|Vistor hf|Novartis Healthcare A/S-|||11837||11837|16904 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|4433|6856|lyfalmen|||00|28|0|6|Vistor hf|Janssen-Cilag AB|||4433||4433|6856 016363|L01BC0108|Cytarabine Pfizer|stl/irl|20|mg/ml|5|ml|5|hgl||L01BC01|01.11.2000||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|4918|7041|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4918||4918|7041 016364|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|2|ml|5|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|6226|8914|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6226||6226|8914 016374|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|18082|24380|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||18082||18082|24380 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PFI|0|0|0|100|DKK|149087|187481|lyfsjukr|||00|70|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||149087||149087|187481 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|9042|12946|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||9042||9042|12946 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3483|5567|lyfalmen|||00|56|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3483||3483|5567 016396|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|8360|11969|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8360||8360|11969 016474|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|5|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|28343|37155|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||28343||28343|37155 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|2|Vistor hf|McNeil Denmark ApS||||||0 016506|N07BA0111|Nicorette Classic|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|4|Vistor hf|McNeil Denmark ApS||||||0 016516|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|45|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|238018|298200|lyfsjukr|||00|225|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||238018||238018|298200 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|210|0|14|Vistor hf|McNeil Denmark ApS||||||0 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|210|0|28|Vistor hf|McNeil Denmark ApS||||||0 016534|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|15|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|83476|105795|lyfsjukr|||00|75|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||83476||83476|105795 016561|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|7|Vistor hf|McNeil Denmark ApS||||||0 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|14|Vistor hf|McNeil Denmark ApS||||||0 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|4|Vistor hf|McNeil Denmark ApS||||||0 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|2|Vistor hf|McNeil Denmark ApS||||||0 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|19760|26786|lyfalmen|V1701|26294|00|28|0|6|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||19760||19760|26786 016605|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|14|Vistor hf|McNeil Denmark ApS||||||0 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|28|Vistor hf|McNeil Denmark ApS||||||0 016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50|Vistor hf|McNeil Denmark ApS||||||7341 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|39520|51387|lyfalmen|||00|56|0|12|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||39520||39520|51387 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2233|lyfalmen|V0466|2233|00|12|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|||1026||1026|2233 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|254799|319092|lyfsjukr|||00|2|0|180|Icepharma hf|Roche|||254799||254799|319092 016671|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.09.2003|31.12.2008|R|A|2|0|0|*|0|LVR|0|1|0|100|IKR|3911|6148|lyfalmen|V0809||00|28|0|7|Lyfjaver ehf|Lyfjaver ehf|||3911||3911|6148 016680|N07BA0112|Nicorette Orange|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004|31.12.2008|L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|210|0|28|Vistor hf|McNeil Denmark ApS||||||0 016682|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.09.2003|31.12.2008|R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|5412|8185|lyfalmen|V0810||00|28|0|14|Lyfjaver ehf|Lyfjaver ehf|||5412||5412|8185 016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|222753|279195|lyfsjukr|||00|6|0|0|Icepharma hf|Ipsen Ltd.|||222753||222753|279195 016688|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|10|mg|56|stk|1|glas||N05AH03|01.09.2003|31.12.2008|R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|20990|28318|lyfalmen|V0812||00|56|0|56|Lyfjaver ehf|Lyfjaver ehf|||20990||20990|28318 016693|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.09.2003|31.12.2008|R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|16502|22730|lyfalmen|V0811||00|56|0|42|Lyfjaver ehf|Lyfjaver ehf|||16502||16502|22730 016699|A10BA0202|Glucophage (Lyfjaver)|töflur|500|mg|400|stk|1|plglas||A10BA02|01.09.2003||R|A|5|0|0|*|0|LVR|0|0|0|100|NOK|2783|4617|lyfalmen|||00|400|0|100|Lyfjaver ehf|Lyfjaver ehf|||2783||2783|4617 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|8712|12663|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|||8712||8712|12663 016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|74251|94310|lyfsjukr|||00|2|0|0|Icepharma hf|Ipsen Ltd.|||74251||74251|94310 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|3955|6208|lyfalmen|V0789|6208|10|200|0|40|Lyfjaver ehf|Lyfjaver ehf|||3955||3955|6208 016739|N07BA0112|Nicorette Orange|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004|31.12.2008|L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|2|Vistor hf|McNeil Denmark ApS||||||0 016761|N07BA0112|Nicorette Orange|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004|31.12.2008|L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|210|0|14|Vistor hf|McNeil Denmark ApS||||||0 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|7211|10626|lyfalmen|V0713|10626|10|200|0|80|Lyfjaver ehf|Lyfjaver ehf|||7211||7211|10626 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|68428|87378|lyfalmen|||00|28|0|28|Vistor hf|Amgen Europe B.V.|||68428||68428|87378 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|101146|128112|lyfalmen|||00|28|0|42|Vistor hf|Amgen Europe B.V.|||101146||101146|128112 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|32915|43164|lyfalmen|||00|28|0|0|Vistor hf|Amgen Europe B.V.|||32915||32915|43164 016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|55913|71797|lyfalmen|||00|2|0|12|Gróco ehf|Serono Europe|||55913||55913|71797 016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|21387|28812|lyfalmen|||00|0|0|4|Gróco ehf|Serono Europe|||21387||21387|28812 016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|32078|42122|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|||32078||32078|42122 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|2622|4399|lyfalmen|||00|14|0|14|Icepharma hf|Wyeth AB|||2622||2622|4399 016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|5089|7746|lyfalmen|||00|28|0|28|Icepharma hf|Wyeth AB|||5089||5089|7746 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|9910|14289|lyfalmen|||00|98|0|49|Icepharma hf|Wyeth AB|||9910||9910|14289 016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|9985|14391|lyfalmen|||00|56|0|56|Icepharma hf|Wyeth AB|||9985||9985|14391 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GSC|0|0|0|100|XEU|42793|55145|lyfsjukr|||00|30|0|30|Swedish Orphan International AB|Gilead Science International (S) |||42793||42793|55145 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|17491|23961|lyfalmen|||00|98|0|98|Icepharma hf|Wyeth AB|||17491||17491|23961 016979|N02AE0103|Norspan|forðapl|5|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3691|5849|lyfalmen|||00|4|0|17|Icepharma hf|Norpharma |||3691||3691|5849 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|19991|38251|vetalmen|||16|60|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||19991||19991|38251 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|34588|44930|lyfsjukr|||00|4824|0|0|Icepharma hf|Fresenius Kabi|||34588||34588|44930 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1628|3050|lyfalmen|||03|3|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1628||1628|3050 017111|A09AA0201|Combizym|töflur|0| |100|stk|1|þpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1648|3077|lyfalmen|||10|100|0|25|Icepharma hf|Daiichi Sankyo Europe GmbH|||1648||1648|3077 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|306381|383312|lyfsjukr|||00|5|0|0|Icepharma hf|SkyPharma PLC|||306381||306381|383312 017145|C08DB0102|Cardizem Retard|forðatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|7376|10850|lyfalmen|||10|60|0|45|Vistor hf|Ferrosan A/S|||7376||7376|10850 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|172083|216111|lyfsjukr|||00|1|0|0|Vistor hf|Janssen-Cilag International N.V.|||172083||172083|216111 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|48303|62005|lyfsjukr|||00|6|0|1|Icepharma hf|Roche|||48303||48303|62005 017204|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|3|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|35750|46376|lyfsjukr|||00|5712|0|0|Icepharma hf|Fresenius Kabi|||35750||35750|46376 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1533|2921|lyfalmen|V0221|2921|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|||1533||1533|2921 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|1,5|0|1|0|1|BIN|0|0|0|100|XEU|160077|201163|lyfsjukr|||00|2|0|28|Icepharma hf|Biogen Idec Ltd|||160077||160077|201163 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|53906|69298|lyfalmen|||00|28|0|0|Icepharma hf|Roche|||53906||53906|69298 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|160900|202505|lyfalmen|||00|84|0|0|Icepharma hf|Roche|||160900||160900|202505 017260|L01XX1903|Irinotecan Mayne|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.04.2007||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|9851|14104|lyfsjukr|||00|2|0|0|Icepharma hf|Mayne Pharma Plc|||9851||9851|14104 017266|N02AE0103|Norspan|forðapl|10|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|6533|9706|lyfalmen|||00|4|0|33|Icepharma hf|Norpharma |||6533||6533|9706 017271|L01XX1903|Irinotecan Mayne|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2007||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|23335|30920|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|||23335||23335|30920 017294|N03AX1202|Gabapentin NM Pharma|hylki|300|mg|100|stk|1|glas||N03AX12|01.10.2007||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|5471|8265|lyfalmen|V0714|8265|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|||5471||5471|8265 017305|N03AX1202|Gabapentin NM Pharma|hylki|400|mg|100|stk|1|glas||N03AX12|01.10.2007||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|7470|10978|lyfalmen|V0715|10978|00|100|0|22|Actavis Group PTC ehf|Merck NM AB|||7470||7470|10978 017326|N02AE0103|Norspan|forðapl|20|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|12200|17374|lyfalmen|||00|4|0|67|Icepharma hf|Norpharma |||12200||12200|17374 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|2871|4736|lyfalmen|||00|100|0|67|Gróco ehf|Nycomed Danmark A/S|||2871||2871|4736 017331|A04AD1201|Emend|hylki|0| |3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|XEU|12149|16993|lyfsjukr|||00|3|0|0|Icepharma hf|M.S.D.|||12149||12149|16993 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|792|1915|lyfalmen|||00|20|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|||792||792|1915 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|3049|4978|lyfalmen|||00|30|0|150|Vistor hf|Recip AB|||3049||3049|4978 017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.06.1999||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7699|11288|lyfalmen|||00|100|0|67|Medico ehf|Solvay Duphar |||7699||7699|11288 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|||1215||1215|2489 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|7134|13760|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||7134||7134|13760 017763|N06DA0401|Reminyl|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|37758|49194|lyfalmen|V1371|49194|00|84|0|84|Vistor hf|Janssen-Cilag AB|||37758||37758|49194 017773|N06DA0401|Reminyl|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|12271|17462|lyfalmen|V1370|17450|00|28|0|14|Vistor hf|Janssen-Cilag AB|||12271||12271|17462 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11939|17042|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11939||11939|17042 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|47176|60919|lyfalmen|||00|84|0|126|Vistor hf|Janssen-Cilag AB|||47176||47176|60919 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11939|17042|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11939||11939|17042 018044|D06BX0103|Rozex|hlaup|7,5|mg/g|30|g|1|túpa||D06BX01|01.01.1998||R|A||0|0|0|0|LDR|0|0|1|100|IKR|922|2092|lyfalmen|||00|30|1|30|Parlogis hf|Parlogis - óskráð lyf|||922||922|2092 018268|G03FA1701|Angemin|töflur|0| |84|stk|1|þpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|6369|9483|lyfalmen|||00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|||6369||6369|9483 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|2878|4746|lyfalmen|||00|28|0|14|Gróco ehf|Daiichi Sankyo Europe GmbH-|||2878||2878|4746 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|4251|6609|lyfalmen|||00|28|0|56|Gróco ehf|Daiichi Sankyo Europe GmbH-|||4251||4251|6609 018453|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|1|spr||L02BA03|01.06.2004||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|62635|79848|lyfsjukr|||00|5|0|0|Vistor hf|AstraZeneca UK Ltd|||62635||62635|79848 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|13311|18757|lyfalmen|||00|98|0|196|Gróco ehf|Daiichi Sankyo Europe GmbH-|||13311||13311|18757 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|9349|13527|lyfalmen|||00|98|0|49|Gróco ehf|Daiichi Sankyo Europe GmbH-|||9349||9349|13527 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|2386|4078|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|||2386||2386|4078 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|2584|4347|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|||2584||2584|4347 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|10980|15741|lyfalmen|||00|98|0|98|Gróco ehf|Daiichi Sankyo Europe GmbH-|||10980||10980|15741 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2875|lyfalmen|||00|42|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1499||1499|2875 018558|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|5|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|17321|23432|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|||17321||17321|23432 018569|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|85647|108498|lyfsjukr|||00|25|0|0|Icepharma hf|Mayne Pharma Plc|||85647||85647|108498 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|3574|5690|lyfalmen|||00|28|0|28|Gróco ehf|Daiichi Sankyo Europe GmbH-|||3574||3574|5690 018591|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|34887|45302|lyfsjukr|||00|17|0|0|Icepharma hf|Mayne Pharma Plc|||34887||34887|45302 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|8810|12796|lyfalmen|||00|30|0|60|Vistor hf|Astellas Pharma A/S|||8810||8810|12796 018617|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|100098|126490|lyfsjukr|||00|50|0|0|Icepharma hf|Mayne Pharma Plc|||100098||100098|126490 018663|J01DD0401|Rocephalin|stþ|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|14570|20007|lyfsjukr|||03|5|0|2|Icepharma hf|Roche|||14570||14570|20007 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|1555|2951|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|||1555||1555|2951 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|23950|32003|lyfalmen|||00|90|0|180|Vistor hf|Astellas Pharma A/S|||23950||23950|32003 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3111|5062|lyfalmen|||00|28|0|14|Vistor hf|Novartis Healthcare A/S-|||3111||3111|5062 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MAC|0|0|1|100|XEU|1183|2446|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck KgaA (A) |||1183||1183|2446 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|7051|10409|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|||7051||7051|10409 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|19288|26199|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|||19288||19288|26199 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|39804|51741|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||39804||39804|51741 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|136735|172103|lyfsjukr|||00|28|0|0|Vistor hf|Teva Pharmaceuticals Limited|||||136735|172103 018803|C10AA0502|Lipitor (Lyfjaver)|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.01.2005|31.12.2008|R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|22673|30413|lyfalmen|V0338||00|100|0|200|Lyfjaver ehf|Lyfjaver ehf|||22673||22673|30413 018814|C10AA0502|Lipitor (Lyfjaver)|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.01.2005|31.12.2008|R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|26641|35352|lyfalmen|V0339||00|100|0|400|Lyfjaver ehf|Lyfjaver ehf|||26641||26640|35352 018894|N06DA0202|Aricept (Lyfjaver)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|51065|65231|lyfalmen|V0375|65231|00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|||50639||50639|65231 018908|N06DA0202|Aricept (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|55432|70399|lyfalmen|V0376|70399|00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|||54790||54790|70399 018927|M05BA0402|Fosamax (Lyfjaver)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.03.2004||R|A|2|0|0|E|0|LVR|0|0|0|100|XEU|15553|21548|lyfalmen|V0718|21160|00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|||15553||15553|21548 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|3316|5340|lyfalmen|||00|30|0|60|Gróco ehf|Almirall-Prodesfarma S.A.|||3316||3316|5340 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|10258|14761|lyfalmen|||00|100|0|200|Gróco ehf|Almirall-Prodesfarma S.A.|||10258||10258|14761 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|60861|77639|lyfsjukr|||43|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|||60861||60861|77639 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|635|1702|lyfalmen|||00|100|0|50|Gróco ehf|Nycomed Danmark A/S|||635||635|1702 018979|C10AA0502|Lipitor (Lyfjaver)|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.01.2005|31.12.2008|R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|15692|21722|lyfalmen|V0337||00|100|0|100|Lyfjaver ehf|Lyfjaver ehf|||15692||15692|21722 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1161|2291|vetalmen|||27|100|0|0|Icepharma hf|Kela Laboratoria NV|||1161||1161|2291 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|13965|19571|lyfalmen|V1052|14510|00|5|0|62|Vistor hf|Janssen-Cilag AB|||13965||13965|19571 019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15656|21677|lyfalmen|||00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|||15656||15656|21677 019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15656|21677|lyfalmen|||00|56|0|28|Lyfjaver ehf|Lyfjaver ehf|||15656||15656|21677 019082|N06DA0302|Exelon (Lyfjaver)|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15347|20561|lyfalmen|V1372|20560|00|56|0|19|Lyfjaver ehf|Lyfjaver ehf|||14760||14760|20561 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|9059|13134|lyfalmen|V1051|10608|00|5|0|42|Vistor hf|Janssen-Cilag AB|||9059||9059|13134 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||20662||20662|27592 019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|7828|11463|lyfalmen|||00|28|0|5|Lyfjaver ehf|Lyfjaver ehf|||7828||7828|11463 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4896|7484|lyfalmen|V1050|5913|00|5|0|21|Vistor hf|Janssen-Cilag AB|||4896||4896|7484 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||23122||23122|30654 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||13480||13480|18650 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||15297||15297|20912 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|15655|21675|lyfalmen|V1053|17261|00|5|0|83|Vistor hf|Janssen-Cilag AB|||15655||15655|21675 019293|B02BC0001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC00|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|60606|77322|lyfsjukr|||00|1|0|0|Gróco ehf|Nycomed Danmark A/S|||60606||60606|77322 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|XEU|790685|986270|lyfsjukr|||00|10|0|0|Gróco ehf|Nycomed Danmark A/S|||790685||790685|986270 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A||||||0 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7272|10709|lyfalmen|||00|56|0|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||7272||7272|10709 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|63241|80603|lyfsjukr|||AC|4|0|0|Icepharma hf|Roche Registration Limited|||63241||63241|80603 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7272|10709|lyfalmen|||00|56|0|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||7272||7272|10709 019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|17896|24465|lyfalmen|||00|140|0|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||17896||17896|24465 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|637|1705|lyfalmen|||00|100|0|100|Gróco ehf|Nycomed Danmark A/S|||637||637|1705 019589|C09CA0401|Aprovel|filmhtfl|150|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3720|5889|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||3720||3720|5889 019600|C09CA0401|Aprovel|filmhtfl|150|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|9294|13453|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||9294||9294|13453 019611|C09CA0401|Aprovel|filmhtfl|300|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|5302|8035|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||5302||5302|8035 019622|C09CA0401|Aprovel|filmhtfl|300|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|17701|24223|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||17701||17701|24223 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A||||||0 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|0|Artasan ehf|Novartis Healthcare A/S-A||||||0 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A||||||0 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A||||||0 019699|C09DA0401|CoAprovel|filmhtfl|162,5|mg|28|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3720|5889|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||3720||3720|5889 019710|C09DA0401|CoAprovel|filmhtfl|162,5|mg|98|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|12989|18356|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||12989||12989|18356 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|6440|9220|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|||6440||6440|9220 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A||||||0 019721|C09DA0401|CoAprovel|filmhtfl|312,5|mg|28|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|5302|8035|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||5302||5302|8035 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A||||||0 019732|C09DA0401|CoAprovel|filmhtfl|312,5|mg|98|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|17701|24223|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||17701||17701|24223 019739|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A||||||0 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|666|1744|lyfalmen|||00|250|0|250|Gróco ehf|Nycomed Danmark A/S|||666||666|1744 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|32080|41807|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|||32080||32080|41807 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|231400|289961|lyfsjukr|||AC|16|0|0|Icepharma hf|Roche Registration Limited|||231400||231400|289961 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A||||||0 019786|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|992|2187|lyfalmen|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB|||992||992|2187 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A||||||0 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|233254|292269|lyfsjukr|||00|1|0|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||233254||233254|292269 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13316|18763|lyfalmen|||00|28|0|4|Icepharma hf|Eli Lilly Danmark A/S|||13316||13316|18763 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13316|18763|lyfalmen|||00|28|0|6|Icepharma hf|Eli Lilly Danmark A/S|||13316||13316|18763 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|63558|81315|lyfalmen|||00|1|0|12|Vistor hf|N.V. Organon|||63558||63558|81315 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13316|18763|lyfalmen|||00|28|0|9|Icepharma hf|Eli Lilly Danmark A/S|||13316||13316|18763 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13316|18763|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Danmark A/S|||13316||13316|18763 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13316|18763|lyfalmen|||00|28|0|21|Icepharma hf|Eli Lilly Danmark A/S|||13316||13316|18763 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|AEU|0|0|0|100|DKK|835609|1042201|lyfsjukr|||02|6|0|9|Vistor hf|Amgen Europe B.V.|||835609||835609|1042201 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|402|1386|lyfalmen|||00|12|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||402||402|1386 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|68966|87730|lyfsjukr|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||68966||68966|87730 019968|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1485|2856|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Merck NM AB|||1485||1485|2856 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|AZD|0|0|1|100|SEK|||lyfalmen|||43|100|0|50|Vistor hf|AstraZeneca A/S DK||||||1345 020134|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A||||||0 020180|C03CC0101|Edecrin|sts|0| |50|mg|1|hgl||C03CC01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|19615|26288|lyfsjukr|||00|50|1|1|Parlogis hf|Parlogis - óskráð lyf|||19615||19615|26288 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A||||||0 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|4742|7276|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|||4742||4742|7276 020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|26890|35663|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||26890||26890|35663 020261|A10BD0301|Avandamet|filmhtfl|1002|mg|56|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005|31.12.2008|R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|4899|7489|lyfalmen|||00|56|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4899||4899|7489 020272|A10BD0301|Avandamet|filmhtfl|1004|mg|56|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005|31.12.2008|R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|8798|12780|lyfalmen|||00|56|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||8798||8798|12780 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stil|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2469|4191|lyfalmen|||04|50|0|50|Lyfjaver ehf|Lyfjaver ehf|||2469||2469|4191 020277|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.02.2007||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|905|2066|lyfalmen|||00|7|0|3|Icepharma hf|Wyeth AB|||903||903|2066 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|10424|14986|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|||10424||10424|14986 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|74034|94357|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|||74034||74034|94357 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|4230|6581|lyfalmen|||00|84|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4230||4230|6581 020398|N06AB1001|Cipralex|dropar|10|mg/ml|28|ml|1|glas||N06AB10|01.11.2005||R|A|2|0|0|B|0|LBK|0|1|0|30|DKK|3857|6075|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|||3857||3857|6075 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|12229|17410|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||12229||12229|17410 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|26202|34806|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|||26202||26202|34806 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|771|1887|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||771||771|1887 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|7357|10824|lyfalmen|||00|28|0|28|Icepharma hf|Servier|||7357||7357|10824 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2250|3894|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2250||2250|3894 020472|C09CA0103|Cozaar (Lyfjaver)|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.09.2004|31.12.2008|R|A|3|0|0|B|0|LVR|0|0|0|100|XEU|12208|17383|lyfalmen|V0197||00|98|0|98|Lyfjaver ehf|Lyfjaver ehf|||12208||12207|17383 020483|C09DA0103|Cozaar Comp (Lyfjaver)|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.08.2004|31.12.2008|R|A|3|0|0|B|0|LVR|0|0|0|100|XEU|12226|17405|lyfalmen|V0198||00|98|0|98|Lyfjaver ehf|Lyfjaver ehf|||12226||12225|17405 020494|N03AX1102|Topimax (Lyfjaver)|töflur|25|mg|60|stk|1|plglas||N03AX11|01.08.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|4591|7071|lyfalmen|V0709|6273|00|60|0|5|Lyfjaver ehf|Lyfjaver ehf|||4591||4591|7071 020510|N03AX1102|Topimax (Lyfjaver)|töflur|50|mg|60|stk|1|plglas||N03AX11|01.07.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|6691|9920|lyfalmen|V0710|9783|00|60|0|10|Lyfjaver ehf|Lyfjaver ehf|||6691||6691|9920 020516|N03AX1102|Topimax (Lyfjaver)|töflur|100|mg|60|stk|1|plglas||N03AX11|01.09.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|13338|18791|lyfalmen|V0711|16666|00|60|0|20|Lyfjaver ehf|Lyfjaver ehf|||13338||13338|18791 020523|N06AB1002|Cipralex (D.A.C.)|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.07.2004||R|A|3|0|0|B|0|DAC|0|1|0|30|DKK|3355|5393|lyfalmen|V0939|4670|00|28|0|28|D.A.C. ehf|D.A.C. ehf|||3355||3355|5393 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|21583|29056|lyfalmen|||00|84|0|84|Icepharma hf|Servier|||21583||21583|29056 020616|G03CA0319|Vagifem (D.A.C.)|sk-tfl|25|mcg|15|stk|1|þpakki|+stjaka|G03CA03|01.07.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|2137|3740|lyfalmen|V0418|3740|05|15|0|15|D.A.C. ehf|D.A.C. ehf|||2137||2137|3740 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|þpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|DKK|||lyfalmen|||00|10|0|20|Gróco ehf|Almirall-Prodesfarma S.A.||||||2321 020649|N03AX1203|Neurontin (D.A.C.)|hylki|300|mg|50|stk|1|þpakki||N03AX12|01.07.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|4561|5287|lyfalmen|||10|50|0|8|D.A.C. ehf|D.A.C. ehf|||3277||3277|5287 020700|L04AA2101|Raptiva|sts|100|mg/ml|125|mg|4|hgl|+ leysir|L04AA21|01.05.2005||R|K|4|0|1|0|1|SEE|0|0|0|100|SEK|169975|213486|lyfsjukr|||00|500|0|50|Gróco ehf|Serono Europe|||169975||169975|213486 020711|G03AC0302|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AC03|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyfalmen|||23|1|0|0|Icepharma hf|Medimpex UK Limited||||||0 020763|R03AK0704|Symbicort Turbuhaler (D.A.C.)|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.08.2004||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|8303|12108|lyfalmen|V0990|12108|00|120|0|30|D.A.C. ehf|D.A.C. ehf|||8303||8303|12108 020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2363|4089|vetorma|||16|8|0|0|Vistor hf|Merial SAS|||2363||2363|4089 020774|L04AB0101|Enbrel|sts|0| |50|mg|4|hgl|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|228129|285888|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|||228129||228129|285888 020826|N06AX1601|Efexor|töflur|37,5|mg|28|stk|1|þpakki||N06AX16|01.10.1996||R|A|3|0|0|B|0|WLN|0|1|0|100|USD|2699|4503|lyfalmen|||00|28|0|10|Icepharma hf|Wyeth Lederle Nordiska|||||2699|4503 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|2928|4814|lyfalmen|V0429|4814|00|3|0|5|D.A.C. ehf|D.A.C. ehf|||2928||2928|4814 021031|R05CB0102|Mucomyst|lausn|200|mg/ml|10|ml|10|hgl|innöndunarvökvi|R05CB01|01.11.2006||R|K|3|0|0|E|0|BIP|0|0|0|100|SEK|5930|8888|lyfalmen|||00|100|0|0|Vistor hf|BioPhausia AB|||5930||5930|8888 021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|6416|9547|lyfalmen|||63|28|0|28|Icepharma hf|M.S.D.|||6416||6416|9547 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2282|3937|lyfalmen|||00|60|0|60|Icepharma hf|Galderma Nordic AB|||2282||2282|3937 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|þpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|714|1809|lyfalmen|||00|12|0|8|D.A.C. ehf|D.A.C. ehf|||714||714|1809 021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.11.2004||R|K|2|0|0|*|0|DAC|0|0|0|100|DKK|3666|5815|lyfalmen|V0988|5815|06|2|0|0|D.A.C. ehf|D.A.C. ehf|||3666||3666|5815 021107|N05AH0403|Seroquel (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N05AH04|01.05.2005||R|A|3|0|0|*|0|DAC|0|1|0|100|SEK|9741|12375|lyfalmen|||00|60|0|15|D.A.C. ehf|D.A.C. ehf|||8500||8500|12375 021120|N03AX1103|Topamax (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|SEK|12886|16666|lyfalmen|V0711|16666|00|60|0|20|D.A.C. ehf|D.A.C. ehf|||11662||11662|16666 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|þpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2233|lyfalmen|V0466|2233|00|12|0|12|D.A.C. ehf|D.A.C. ehf|||1026||1026|2233 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|453|1455|lyfalmen|V0609|1455|00|30|0|15|Actavis Group hf|Actavis hf|||453||453|1455 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|1081|2307|lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann|||1081||1081|2307 021221|R03AC0303|Terbasmin Turbuhaler (D.A.C.)|innönddu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.11.2004||R|A|2|0|0|B|0|DAC|0|0|1|100|SEK|1835|3331|lyfalmen|V0987|3331|23|200|0|50|D.A.C. ehf|D.A.C. ehf|||1835||1835|3331 021226|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.09.2007||R|A|5|0|0|B|0|DAC|0|1|0|30|DKK|4124|3564|lyfalmen|V0931|2428|00|28|0|28|D.A.C. ehf|D.A.C. ehf|||2007||2007|3564 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1187|2451|lyfalmen|V0610|2451|00|100|0|50|Actavis Group hf|Actavis hf|||1187||1187|2451 021232|N06AB0603|Zoloft (D.A.C.)|filmhtfl|100|mg|28|stk|1|þpakki||N06AB06|01.11.2004||R|A|5|0|0|B|0|DAC|0|1|0|30|DKK|6435|5422|lyfalmen|V0935|3559|00|28|0|56|D.A.C. ehf|D.A.C. ehf|||3376||3376|5422 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|16191|22343|lyfalmen|||02|4|0|56|Icepharma hf|Bayer Schering Pharma AG|||16191||16191|22343 021325|R03BB0402|Spiriva (D.A.C.)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.11.2004||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|7502|11021|lyfalmen|V0985|11021|00|30|0|30|D.A.C. ehf|D.A.C. ehf|||7502||7502|11021 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|19652|26652|lyfalmen|||63|98|0|98|Icepharma hf|M.S.D.|||19652||19652|26652 021373|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|5305|8040|lyfalmen|V0085|8040|00|28|0|37|D.A.C. ehf|D.A.C. ehf|||5305||5305|8040 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|þpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|20|0|2|Artasan ehf|Novartis Healthcare A/S-A||||||0 021398|L02BB0303|Casodex (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.11.2004||R|A|5|0|0|*|0|DAC|0|0|0|100|SEK|19759|26785|lyfalmen|V0560|21952|00|30|0|30|D.A.C. ehf|D.A.C. ehf|||19759||19759|26785 021417|R01AD0504|Rhinocort (D.A.C.)|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|1481|2850|lyfalmen|V0965|2850|24|120|0|38|D.A.C. ehf|D.A.C. ehf|||1481||1481|2850 021426|N04BX0203|Comtan (D.A.C.)|filmhtfl|200|mg|100|stk|1|glas||N04BX02|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|15252|18262|lyfalmen|V0729|18262|00|100|0|20|D.A.C. ehf|D.A.C. ehf|||12913||12913|18262 021428|A06AB0201|Dulcolax|eþ-stil|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|DKK|||lyfalmen|||04|6|0|6|Vistor hf|Boehringer Ingelheim||||||1490 021447|N04BC0402|Requip (D.A.C.)|töflur|2|mg|84|stk|1|plglas||N04BC04|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|0|100|GBP|12085|17231|lyfalmen|V0728|17231|00|84|0|28|D.A.C. ehf|D.A.C. ehf|||12085||12085|17231 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|24016|32085|lyfalmen|||63|98|0|49|Icepharma hf|M.S.D.|||24016||24016|32085 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2958|4235|lyfsjukr|||02|100|0|0|Icepharma hf|Fresenius Kabi|||2958||2958|4235 021548|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|200|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|3075|5013|lyfalmen|||23|100|0|25|D.A.C. ehf|D.A.C. ehf|||3075||3075|5013 021559|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|400|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|5033|7670|lyfalmen|||23|100|0|50|D.A.C. ehf|D.A.C. ehf|||5033||5033|7670 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|4938|7541|lyfalmen|||00|30|0|4|Vistor hf|Ferring Lægemidler A/S|||4938||4938|7541 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|15604|21612|lyfalmen|||00|100|0|15|Vistor hf|Ferring Lægemidler A/S|||15604||15604|21612 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12888|18231|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|||12888||12888|18231 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|9202|13328|lyfalmen|||00|30|0|9|Vistor hf|Ferring AB, Svíþjóð|||9202||9202|13328 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|29645|38776|lyfsjukr|||02|1000|0|0|Icepharma hf|Fresenius Kabi|||29645||29645|38776 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|26563|35256|lyfalmen|||00|100|0|30|Vistor hf|Ferring Lægemidler A/S|||26563||26563|35256 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|38741|50100|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|||38741||38741|50100 021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25851|34369|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||25851||25851|34369 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4051|6338|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|||4051||4051|6338 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|18232|24566|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|||18232||18232|24566 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|4874|6978|lyfsjukr|||02|50|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4874||4874|6978 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20696|27951|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20696||20696|27951 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|4406|6820|lyfalmen|V1951|6053|00|28|0|14|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||4406||4406|6820 021829|H01BA0203|Minirin (D.A.C.)|töflur|0,2|mg|30|stk|1|plglas||H01BA02|01.08.2006||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|9490|13719|lyfalmen|||00|30|0|15|D.A.C. ehf|D.A.C. ehf|||9490||9490|13719 021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.02.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|5305|8040|lyfalmen|V0085|8040|00|28|0|37|D.A.C. ehf|D.A.C. ehf|||5305||5305|8040 021950|B05AA0705|HyperHAES|irl|0| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|27164|35687|lyfsjukr|||00|2500|0|2|Icepharma hf|Fresenius Kabi|||27164||27164|35687 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|5915|8867|lyfalmen|||00|28|0|28|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||5915||5915|8867 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|20691|27945|lyfalmen|V1955|25087|00|98|0|98|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||20691||20691|27945 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20696|27951|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20696||20696|27951 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|96453|121951|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|||96453||96453|121951 022087|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.10.1995||R|A|5|0|0|0|0|LAH|0|0|0|100|DKK|756|1492|vetalmen|||16|20|0|0|Vistor hf|LEO Animal Health A/S|||756||756|1492 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|200|0|45|Actavis Group hf|Actavis Group hf||||||0 022132|C10BA0201|Inegy|töflur|30|mg|98|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|31009|40791|lyfalmen|||00|98|0|131|Icepharma hf|M.S.D.|||31009||31009|40791 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|36253|47320|lyfalmen|||00|98|0|261|Icepharma hf|M.S.D.|||36253||36253|47320 022181|C10BA0201|Inegy|töflur|90|mg|98|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|38319|49892|lyfalmen|||00|98|0|523|Icepharma hf|M.S.D.|||38319||38319|49892 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|333614|417217|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|||333614||333614|417217 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|397160|496332|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|||397160||397160|496332 022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|584|1554|lyfalmen|V0917|1554|00|20|0|20|Actavis Group hf|Actavis hf|||526||526|1554 022218|QP52AA5102|Drontal Comp.vet.|töflur|0| |24|stk|1|þpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BHC|0|0|0|100|DKK|10906|18873|vetorma|||00|24|0|0|Vistor hf|Bayer HealthCare AG|||10906||10906|18873 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|25638|34104|lyfalmen|||02|1|0|0|Vistor hf|Allergan|||25638||25638|34104 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2412|4174|vetorma|||00|2|0|0|Vistor hf|Bayer HealthCare AG|||2412||2412|4174 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|3098|5045|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3098||3098|5045 022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|þpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BHC|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer HealthCare AG||||||2009 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|7231|4736|lyfalmen|V0308|3043|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2871||2871|4736 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|11216|7034|lyfalmen|V0310|4428|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4564||4564|7034 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2284|3953|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||2284||2284|3953 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|790|1912|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||790||790|1912 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2297|3958|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2297||2297|3958 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|1479|2559|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||1479||1479|2559 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|4975|7592|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|||4975||4975|7592 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2400|3772|lyfalmen|V0919|3772|00|100|0|100|Actavis Group hf|Actavis hf|||2160||2160|3772 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1554|2727|lyfalmen|V0918|2727|00|60|0|60|Actavis Group hf|Actavis hf|||1390||1390|2727 022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005||R|A|3|0|0|*|0|DAC|0|0|0|100|USD|1535|2923|lyfalmen|||00|50|0|50|D.A.C. ehf|D.A.C. ehf|||1535||1535|2923 022609|A07EC0205|Pentasa (D.A.C)|forðatfl|500|mg|60|stk|1|þpakki||A07EC02|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|4173|6503|lyfalmen|||10|60|0|20|D.A.C. ehf|D.A.C. ehf|||4173||4173|6503 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|16383|22582|lyfalmen|V0192|18543|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|||16383||16383|22582 022802|L01XC0401|MabCampath|irþ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|242651|303968|lyfsjukr|||00|3|0|0|Icepharma hf|Genzyme Europe B.V. (I)|||242651||242651|303968 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy||||||2796 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2750|lyfalmen|||67|30|0|10|Actavis Group hf|Actavis hf|||1407||1407|2750 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4165|lyfalmen|||67|30|0|20|Actavis Group hf|Actavis hf|||2450||2450|4165 022962|V01AA1104|Alutard SQ, hrossaværur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25851|34369|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||25851||25851|34369 022970|V01AA1104|Alutard SQ, hrossaværur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20696|27951|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20696||20696|27951 023036|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|pakki|þp+M-úðari|R03BB01|01.07.1992||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4184|6518|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|||4184||4184|6518 023047|G04BD1001|Emselex|forðatfl|7,5|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6016|9004|lyfalmen|||00|28|0|28|Vistor hf|Novartis Europharm Ltd|||6016||6016|9004 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GSI|0|0|0|100|DKK|127870|161066|lyfsjukr|||00|30|0|0|Lyfjaver ehf|Gilead Science International (L)|||127870||127870|161066 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|31973|41991|lyfalmen|||00|90|0|20|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|||31973||31973|41991 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|42713|55363|lyfalmen|||00|90|0|30|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|||42713||42713|55363 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|21630|29114|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||21630||21630|29114 023146|G04BD1001|Emselex|forðatfl|15|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6076|9086|lyfalmen|||00|28|0|56|Vistor hf|Novartis Europharm Ltd|||6076||6076|9086 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|21850|29388|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||21850||21850|29388 023325|V03AB2501|Lanexat|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.07.1989||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|22179|29480|lyfsjukr|||02|25|0|0|Icepharma hf|Roche|||22179||22179|29480 023329|N03AX1204|Gabapentin Merck NM|hylki|300|mg|100|stk|1|glas||N03AX12|01.05.2004||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|5471|8265|lyfalmen|V0714|8265|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|||5471||5471|8265 023376|N03AX1204|Gabapentin Merck NM|hylki|400|mg|100|stk|1|glas||N03AX12|01.05.2004||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|7470|10978|lyfalmen|V0715|10978|00|100|0|22|Actavis Group PTC ehf|Merck NM AB|||7470||7470|10978 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|0|100|XEU|17559|24046|lyfalmen|||00|34|0|0|Vistor hf|Dentsply DeTrey GmbH|||17559||17559|24046 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|9141|13088|lyfsjukr|||00|0|0|4|Vistor hf|Amgen|||9141||9141|13088 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|35984|46668|lyfsjukr|||00|0|0|18|Vistor hf|Amgen|||35984||35984|46668 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|27234|35774|lyfsjukr|||00|0|0|13|Vistor hf|Amgen|||27234||27234|35774 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|64833|82585|lyfsjukr|||00|0|0|33|Vistor hf|Amgen|||64833||64833|82585 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|43285|55757|lyfsjukr|||00|0|0|22|Vistor hf|Amgen|||43285||43285|55757 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|8506|12178|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter AG|||8506||8506|12178 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|129583|163198|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|||129583||129583|163198 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|21265|28342|lyfsjukr|||00|25|0|0|Icepharma hf|Baxter AG|||21265||21265|28342 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|17800|24029|lyfsjukr|||00|0|0|9|Vistor hf|Amgen|||17800||17800|24029 023468|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|13228|18654|lyfalmen|||00|10|0|20|GlaxoSmithKline ehf|Glaxo Group Limited|||13228||13228|18654 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|42527|54814|lyfsjukr|||00|50|0|0|Icepharma hf|Baxter AG|||42527||42527|54814 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|85050|107755|lyfsjukr|||00|100|0|0|Icepharma hf|Baxter AG|||85050||85050|107755 023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|9260|13407|lyfalmen|||00|3|0|14|GlaxoSmithKline ehf|Glaxo Group Limited|||9260||9260|13407 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|207251|259895|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|||207251||207251|259895 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|170100|213642|lyfsjukr|||00|200|0|0|Icepharma hf|Baxter AG|||170100||170100|213642 023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|18519|25241|lyfalmen|||00|6|0|28|GlaxoSmithKline ehf|Glaxo Group Limited|||18519||18519|25241 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|13890|19478|lyfalmen|||00|4|0|21|GlaxoSmithKline ehf|Glaxo Group Limited|||13890||13890|19478 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|148288|186486|lyfsjukr|||00|120|0|30|Vistor hf|Boehringer Ingelheim International |||148288||148288|186486 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|24210|32326|lyfalmen|||00|100|0|100|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||24210||24210|32326 023544|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|4508|6958|lyfalmen|||00|4|0|7|GlaxoSmithKline ehf|Glaxo Group Limited|||4508||4508|6958 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|3837|6047|lyfalmen|||00|12|0|60|Icepharma hf|Santen Oy|||3837||3837|6047 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|68464|87105|lyfsjukr|||00|120|0|100|Icepharma hf|Roche|||68464||68464|87105 023809|A10AE0404|Lantus [OptiClik]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiClik|A10AE04|01.04.2007||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9703|14008|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|||9703||9703|14008 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|PFL|0|0|0|100|DKK|117124|147687|lyfsjukr|||00|90|0|36|Vistor hf|Pfizer Limited|||117124||117124|147687 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|4059|6349|lyfalmen|||00|100|0|17|Icepharma hf|M.S.D.|||4059||4059|6349 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|USD|97240|122929|lyfsjukr|||00|10|0|5|Icepharma hf|Wyeth Europe|||97238||97238|122929 024037|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.09.2005||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|3359|4809|lyfsjukr|||03|10|0|3|Icepharma hf|NordMedica ApS|||3359||3359|4809 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4227|6577|lyfalmen|||00|5|0|10|Vistor hf|Janssen-Cilag AB|||4227||4227|6577 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|21019|28354|lyfalmen|||00|30|0|30|Lundbeck Export A/S|Teva Pharma GmbH|||21019||21019|28354 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|0| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2211|3166|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||2211||2211|3166 024147|A10BD0301|Avandamet|filmhtfl|1002|mg|112|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|9273|13424|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||9273||9273|13424 024169|A10BD0301|Avandamet|filmhtfl|1004|mg|112|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|16215|22373|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||16215||16215|22373 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|70063|89413|lyfalmen|||00|100|0|100|Lundbeck Export A/S|Teva Pharma GmbH|||70063||70063|89413 024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25851|34369|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||25851||25851|34369 024478|V04CL0024|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8138|11884|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||8138||8138|11884 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|395|1376|lyfalmen|||00|100|0|2|Vistor hf|AstraZeneca A/S DK|||395||395|1376 024482|V04CL0025|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8138|11884|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||8138||8138|11884 024504|V04CL0011|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13712|19256|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13712||13712|19256 024510|V04CL0012|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13712|19256|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13712||13712|19256 024526|V04CL0014|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13735|19285|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13735||13735|19285 024530|N05AH0304|Zyprexa (D.A.C.)|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.08.2005||R|A|3|0|0|*|0|DAC|0|1|0|100|IKR|22041|29626|lyfalmen|V0811|18465|00|56|0|42|D.A.C. ehf|D.A.C. ehf|||22041||22041|29626 024532|V04CL0015|Soluprick SQ ALK203 - Háliðagras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13712|19256|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13712||13712|19256 024559|V04CL0016|Soluprick SQ ALK214 -Axhnoðapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13712|19256|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13712||13712|19256 024565|V04CL0017|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13876|19461|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13876||13876|19461 024576|V04CL0018|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13712|19256|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13712||13712|19256 024583|V04CL0019|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8138|11884|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||8138||8138|11884 024589|V04CL0020|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13712|19256|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13712||13712|19256 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|E|0|NOE|0|0|0|100|DKK|77460|98623|lyfalmen|||00|100|0|125|Vistor hf|Novartis Europharm Ltd|||77460||77460|98623 024600|V04CL0021|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13876|19461|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13876||13876|19461 024603|V04CL0009|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1671|3108|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||1671||1671|3108 024622|V04CL0013|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8138|11884|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||8138||8138|11884 024644|V04CL0023|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8138|11884|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||8138||8138|11884 024670|V04CL0022|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8138|11884|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||8138||8138|11884 024681|V04CL0010|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1671|3108|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||1671||1671|3108 025093|C01BD0102|Trangorex (D.A.C.)|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|NOK|1043|2256|lyfalmen|V0143|2193|70|30|0|30|D.A.C. ehf|D.A.C. ehf|||1043||1043|2256 025126|M05BB0301|Fosavance|töflur|0| |4|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|6124|9151|lyfalmen|||00|4|0|0|Icepharma hf|M.S.D.|||6124||6124|9151 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|976|2165|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||976||976|2165 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20696|27951|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20696||20696|27951 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2793|4631|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2793||2793|4631 025180|R03BA0201|Pulmicort|innúðal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1938|3470|lyfalmen|||0|120|0|15|Vistor hf|AstraZeneca A/S DK|||1938||1938|3470 025191|R03BA0201|Pulmicort|innúðal|200|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|3687|5844|lyfalmen|||0|120|0|30|Vistor hf|AstraZeneca A/S DK|||3687||3687|5844 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20696|27951|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20696||20696|27951 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|722|1820|lyfalmen|||08|100|0|2|Icepharma hf|NordMedica A/S|||722||722|1820 025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|18101|24721|lyfalmen|||00|12|0|0|Icepharma hf|M.S.D.|||18101||18101|24721 025311|J01DB0101|Keflex|töflur|500|mg|14|stk|1|þpakki||J01DB01|01.07.1988||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|794|1918|lyfalmen|||00|14|0|4|Icepharma hf|NordMedica A/S|||794||794|1918 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|106454|134403|lyfsjukr|||00|30|0|60|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||106454||106454|134403 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|105243|132895|lyfsjukr|||00|30|0|30|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||105243||105243|132895 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|10255|19705|vetalmen|||00|20|0|0|Vistor hf|Boehringer Ingelheim|||10255||10255|19705 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|18997|25836|lyfalmen|||00|30|0|0|Vistor hf|ALK-Abello A/S|||18997||18997|25836 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|23106|30952|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|||23106||23106|30952 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|6740|9987|lyfalmen|||00|28|0|112|Vistor hf|Novartis Healthcare A/S-|||6740||6740|9987 025471|N06AB1002|Cipralex (D.A.C.)|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.12.2006||R|A|3|0|0|B|0|DAC|0|1|0|30|DKK|7167|10566|lyfalmen|V1039|10566|00|28|0|56|D.A.C. ehf|D.A.C. ehf|||7167||7167|10566 025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|31097|40901|lyfalmen|||00|1|0|28|Vistor hf|Janssen-Cilag AB|||31097||31097|40901 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.01.2007||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|2003|3559|lyfalmen|V1090|3559|06|5|0|17|D.A.C. ehf|D.A.C. ehf|||2003||2003|3559 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|5616|8462|lyfalmen|||00|1|0|30|Icepharma hf|Roche Registration Limited|||5616||5616|8462 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|16038|22152|lyfalmen|||00|3|0|90|Icepharma hf|Roche Registration Limited|||16038||16038|22152 025676|L01CB0201|Vumon|stl|10|mg/ml|5|ml|10|lykjur||L01CB02|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|34429|44732|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||34429||34429|44732 025677|S01ED5109|Cosopt (D.A.C.)|augndr|5|mg/ml|5|ml|1|glas||S01ED51|01.04.2006||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|2869|4527|lyfalmen|V0989|4527|06|5|0|0|D.A.C. ehf|D.A.C. ehf|||2717||2717|4527 025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|16602|22854|lyfalmen|||00|1|0|14|Vistor hf|Janssen-Cilag AB|||16602||16602|22854 025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|24012|32080|lyfalmen|||00|1|0|21|Vistor hf|Janssen-Cilag AB|||24012||24012|32080 025725|R01AD0505|Rhinocort Turbuhaler (D.A.C.)|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.2007||R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|3899|6132|lyfalmen|V0966|6132|23|200|0|100|D.A.C. ehf|D.A.C. ehf|||3899||3899|6132 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|59311|76027|lyfalmen|||00|100|0|0|Vistor hf|ALK-Abello A/S|||59311||59311|76027 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|5679|8131|lyfsjukr|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|||5679||5679|8131 025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25851|34369|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||25851||25851|34369 025958|M01AE0215|Naproxen Merck NM|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|900|2062|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||900||900|2062 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|3738|6469|vetorma|||16|1|0|0|Vistor hf|Merial (MSD)|||3738||3738|6469 025985|M01AE0215|Naproxen Merck NM|töflur|500|mg|50|stk|1|þpakki||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|928|2100|lyfalmen|||00|50|0|50|Actavis Group PTC ehf|Merck NM AB|||928||928|2100 025994|M01AE0215|Naproxen Merck NM|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|1655|3086|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||1655||1655|3086 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|8460|14640|vetorma|||16|2|0|0|Vistor hf|Merial (MSD)|||8460||8460|14640 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20696|27951|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20696||20696|27951 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1858|3362|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|||1858||1858|3362 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|386|1364|lyfalmen|||00|50|0|1|Vistor hf|Recip AB|||386||386|1364 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|þpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|2890|4762|lyfalmen|||10|50|0|15|Swedish Orphan International AB|Sandoz GmbH (S)|||2890||2890|4762 027235|G03HA0103|Cyproteron Merck NM|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|7432|10926|lyfalmen|||00|50|0|25|Actavis Group PTC ehf|Merck NM AB|||7432||7432|10926 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|1888|3402|lyfalmen|||00|14|0|2|Vistor hf|Eisai Ltd|||1888||1888|3402 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|7556|11094|lyfalmen|||00|56|0|7|Vistor hf|Eisai Ltd|||7556||7556|11094 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|10113|14564|lyfalmen|||00|56|0|14|Vistor hf|Eisai Ltd|||10113||10113|14564 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|13358|18816|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|||13358||13358|18816 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|943|2120|lyfalmen|V0431|1957|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|||943||943|2120 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|899|2060|lyfalmen|V0430|1784|00|100|0|67|Gróco ehf|Nycomed Danmark A/S|||899||899|2060 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|131789|165945|lyfsjukr|||00|105|0|1|Icepharma hf|SP Europe|||131789||131789|165945 027938|C07AA0701|Sotacor|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1992|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|1427|2777|lyfalmen|V0272||00|100|0|50|Vistor hf|Bristol-Myers Squibb|||1427||1427|2777 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|25365|33764|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||25365||25365|33764 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|25365|33764|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||25365||25365|33764 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2707|4514|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||2707||2707|4514 028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22727|30480|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||22727||22727|30480 028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|8697|12643|lyfalmen|||02|1|0|0|Icepharma hf|Aventis Pasteur MSD A/S|||8697||8697|12643 028387|M03BX0104|Baklofen Merck NM|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|1334|2651|lyfalmen|V0712|2637|00|50|0|25|Actavis Group PTC ehf|Merck NM AB|||1334||1334|2651 028405|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1900|3419|lyfalmen|||10|50|0|50|Actavis Group PTC ehf|Merck NM AB|||1900||1900|3419 028498|C08DB0102|Cardizem Retard|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|3516|5609|lyfalmen|V0351|3898|10|60|0|30|Vistor hf|Ferrosan A/S|||3514||3514|5609 028597|D07BB0401|Locoidol|krem|0| |30|g|1|túpa||D07BB04|01.01.1990||R|A|4|0|0|B|0|ASP|0|0|1|100|XEU|966|2151|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||966||966|2151 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|0|0|0|100|DKK|8511|16383|vetalmen|||27|10|0|0|Icepharma hf|Orion Corporation (I)|||8511||8511|16383 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|919|2088|lyfalmen|||02|24|0|4|Vistor hf|Sanofi-aventis Norge AS|||919||919|2088 028787|A04AA0201|Kytril|töflur|1|mg|10|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|12708|18006|lyfalmen|||00|10|0|5|Icepharma hf|Roche as|||12708||12708|18006 029025|D07AC0301|Ibaril|smyrsli|2,5|mg/g|50|g|1|túpa||D07AC03|01.12.1978||R|A|1,5|0|0|B|0|SNO|0|0|1|100|NOK|2108|3701|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|||2108||2108|3701 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1119|2359|lyfalmen|||24|16|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||1119|2359 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|þpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|973|2161|lyfalmen|||00|40|0|13|Vistor hf|Sanofi-aventis Norge AS|||973||973|2161 029298|D07AB0101|Emovat|krem|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|497|1515|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||497||497|1515 029307|A07EA0603|Entocort enema (D.A.C.)|endaþ.dr|0,02|mg/ml|7|stk|1|þpakki||A07EA06|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|7192|10600|lyfalmen|V0297|10600|00|7|0|0|D.A.C. ehf|D.A.C. ehf|||7192||7192|10600 029334|J05AG0302|Stocrin (Lyfjaver)|töflur|600|mg|30|stk|1|glas||J05AG03|01.09.2005|31.12.2008|R|A|2|0|1|0|1|LVR|0|0|0|100|XEU|53513|68490|lyfsjukr|||00|30|0|30|Lyfjaver ehf|Lyfjaver ehf|||53513||53512|68490 029343|L03AB0802|Betaferon (Lyfjaver)|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.09.2005|31.12.2008|R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|163112|204942|lyfsjukr|||00|15|0|30|Lyfjaver ehf|Lyfjaver ehf|||163112||163112|204942 029352|C10AA0103|Zocor (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|8955|6110|lyfalmen|V0358|2018|00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|||3883||3883|6110 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|8104|9626|lyfalmen|V0365|2265|00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|||6474||6474|9626 029370|C10AA0103|Zocor (Lyfjaver)|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|12736|13002|lyfalmen|V0367|3035|00|98|0|261|Lyfjaver ehf|Lyfjaver ehf|||8962||8962|13002 029379|C10AA0103|Zocor (Lyfjaver)|töflur|80|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|1,5|0|0|0|0|LVR|0|0|0|100|XEU|17909|24482|lyfalmen|||00|98|0|523|Lyfjaver ehf|Lyfjaver ehf|||17909||17909|24482 029769|D07AB0101|Emovat|krem|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995|31.12.2008|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|2127|3727|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2127||2127|3727 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|2|Vistor hf|McNeil Denmark ApS||||||0 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|7|Vistor hf|McNeil Denmark ApS||||||0 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|14|Vistor hf|McNeil Denmark ApS||||||0 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|4|Vistor hf|McNeil Denmark ApS||||||0 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|14|Vistor hf|McNeil Denmark ApS||||||0 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|28|Vistor hf|McNeil Denmark ApS||||||0 030054|J05AE0302|Norvir (D.A.C.)|hylki|100|mg|84|stk|1|glas|mjúk hylki|J05AE03|01.12.2008||R|K|2|0|1|0|1|DAC|0|0|0|100|DKK|20094|26885|lyfsjukr|||00|84|0|7|D.A.C. ehf|D.A.C. ehf|||||20094|26885 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|23366|31276|lyfalmen|||00|98|0|49|Vistor hf|Eisai Ltd|||23366||23366|31276 030361|D07AB0101|Emovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|497|1515|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||497||497|1515 030387|D07AB0101|Emovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1960|3500|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1960||1960|3500 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|NAV|0|0|1|100|IKR|||lyfalmen|||00|60|0|25|Icepharma hf|Navamedic ASA||||||0 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|11158|15982|lyfalmen|V1400|15761|00|100|0|33|Vistor hf|Novartis Healthcare A/S-|||11158||11158|15982 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|3788|5981|lyfalmen|||00|100|0|8|Vistor hf|Novartis Healthcare A/S-|||||3788|5981 030940|C07AB0207|Metoprolol Merck NM|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|890|2048|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|||890||890|2048 031039|C07AB0207|Metoprolol Merck NM|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|1298|2602|lyfalmen|||00|100|0|67|Actavis Group PTC ehf|Merck NM AB|||1298||1298|2602 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|2|0|0|E|0|NHE|0|0|1|100|DKK|893|2052|lyfalmen|||23|2|0|2|Artasan ehf|Novartis Healthcare A/S-A|||893||893|2052 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3380|5427|lyfalmen|||17|10|0|25|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||3380||3380|5427 031261|A10AB0604|Apidra [opticlik]|stl|100|ein/ml|3|ml|5|rörlyk||A10AB06|01.04.2007||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|4683|7195|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|||4683||4683|7195 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|2083|3667|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|||2083||2083|3667 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|6725|9967|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|||6725||6725|9967 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|39601|51171|lyfsjukr|||00|5|0|0|Vistor hf|Ferring Lægemidler A/S|||39601||39601|51171 031971|C07AA0704|Sotalol Merck NM|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1818|3307|lyfalmen|V0274|3307|00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||1818||1818|3307 031997|C07AA0704|Sotalol Merck NM|töflur|80|mg|100|stk|1|glas||C07AA07|01.03.2000|31.12.2008|R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|||lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||1145||| 032190|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|1|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032202|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|2|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032236|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|4|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032247|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|5|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032258|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|||||| 032270|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|20|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032281|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|50|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032304|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|600|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|26340|34978|lyfalmen|||00|150|0|10|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||26340||26340|34978 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|4077|7055|vetorma|||27|50|0|0|Vistor hf|Merial (MSD)|||4077||4077|7055 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|14497|25088|vetorma|||27|200|0|0|Vistor hf|Merial (MSD)|||14497||14497|25088 033159|S01FA0103|Isopto Atropin 1 %|augndr|1|%|5|ml|1|glas||S01FA01|01.05.1983||R|A|3|0|0|E|0|ALC|0|0|0|100|USD|502|1519|lyfalmen|||06|5|0|0|K.Pétursson hf|Alcon|||500||500|1519 033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1343|2663|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|||1343||1343|2663 034066|V07AB09|Sterilt Vatten Braun|leysir|0| |5|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|100|0|0|Actavis Group hf|Braun||||||0 034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|802|1929|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||802||802|1929 034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006||R|K|2|0|0|0|0|ARA|0|0|1|100|SEK|2125|3724|lyfalmen|||00|300|0|10|Vistor hf|Astra|||2125||2125|3724 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1967|3510|lyfalmen|||00|6|0|0|Vistor hf|Novartis Healthcare A/S-|||1967||1967|3510 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3372|5416|lyfalmen|||00|12|0|0|Vistor hf|Novartis Healthcare A/S-|||3372||3372|5416 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|9509|13615|lyfsjukr|||02|25|0|0|Vistor hf|LEO Pharma A/S|||9509||9509|13615 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|18630|25379|lyfalmen|||10|300|0|100|Vistor hf|Ferring|||18630||18630|25379 035333|L01BB0502|Fludara (Lyfjaver)|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.05.2006|31.12.2008|R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|103293|130467|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|||103293||103293|130467 035342|L01BB0502|Fludara (Lyfjaver)|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.05.2006|31.12.2008|R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|77319|98130|lyfsjukr|||00|15|0|0|Lyfjaver ehf|Lyfjaver ehf|||77319||77319|98130 035351|L01BB0502|Fludara (Lyfjaver)|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.05.2006|31.12.2008|R|A|3|0|1|0|1|LVR|0|0|0|100|SEK|157994|198570|lyfsjukr|||00|250|0|0|Lyfjaver ehf|Lyfjaver ehf|||157994||157994|198570 035506|N03AX0903|Lamotrin|dreifit.|25|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1435|2788|lyfalmen|||00|56|0|5|Actavis Group hf|Actavis hf|||1435||1435|2788 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3343|lyfalmen|V0703|3343|00|56|0|9|Actavis Group hf|Actavis hf|||1844||1844|3343 035524|N03AX0903|Lamotrin|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3321|5347|lyfalmen|V0705|5347|00|56|0|19|Actavis Group hf|Actavis hf|||3321||3321|5347 035533|N03AX0903|Lamotrin|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|5919|8873|lyfalmen|V0706|8873|00|56|0|37|Actavis Group hf|Actavis hf|||5919||5919|8873 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PFI|0|0|0|100|DKK|129218|162744|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||129218||129218|162744 035824|C01AA0503|Lanoxin|stl|0,25|mg/ml|2|ml|5|lykjur||C01AA05|01.07.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|926|1326|lyfsjukr|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||926||926|1326 035832|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|fl||B05BA02|01.08.1980||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|48402|62128|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||48402||48402|62128 035840|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.03.1978||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|984|2176|lyfalmen|||00|60|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||984||984|2176 035865|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.08.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|525|1553|lyfalmen|||00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||525||525|1553 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|DKK|5732|8619|lyfalmen|||00|60|0|60|Icepharma hf|Meda AS|||5732||5732|8619 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|234811|294207|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|||234811||234811|294207 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|450714|563006|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|||450714||450714|563006 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|900837|1123410|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|||900837||900837|1123410 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|811|1941|lyfalmen|||00|20|0|8|Vistor hf|Recip AB|||811||811|1941 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1297|2600|lyfalmen|||08|60|0|3|Vistor hf|Recip AB|||1297||1297|2600 036541|A03AX1301|Minifom|dropar|0| |30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|30|0|6|Vistor hf|AstraZeneca A/S DK|||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2559|4313|lyfalmen|||08|125|0|6|Vistor hf|Recip AB|||2559||2559|4313 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|776|1893|lyfalmen|||00|30|0|12|Vistor hf|Recip AB|||776||776|1893 037061|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|A|3|0|0|E|0|MNA|0|0|0|100|SEK|6498|9658|lyfalmen|V0437|9658|00|90|0|90|Actavis Group PTC ehf|Merck NM AB|||6498||6498|9658 037176|M01AB0507|Vostar|sþ-tfl|50|mg|30|stk|1|glas||M01AB05|01.04.1988|31.12.2008|R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|30|0|15|Actavis Group hf|Actavis hf||361|361|361|| 037192|M01AB0507|Vostar|sþ-tfl|50|mg|100|stk|1|glas||M01AB05|01.04.1988|31.12.2008|R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|100|0|50|Actavis Group hf|Actavis hf|||890||| 037278|N04BC0404|Requip Depot|forðatfl|2|mg|42|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|7027|10376|lyfalmen|||00|42|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||7027||7027|10376 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|14054|19682|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||14054||14054|19682 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|27563|36501|lyfalmen|||00|84|0|56|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||27563||27563|36501 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|54147|69598|lyfalmen|||00|84|0|112|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||54147||54147|69598 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|3033|4956|lyfalmen|||00|100|0|17|Icepharma hf|Roche|||3033||3033|4956 037531|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1200|2469|lyfalmen|||0|30|0|30|Vistor hf|Schering-Plough|||1200||1200|2469 037754|J01EA0102|Monotrim|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|722|1820|lyfalmen|||00|30|0|8|Vistor hf|Hexal A/S|||722||722|1820 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S||||||2197 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62|Vistor hf|LEO Pharma A/S||||||3685 037861|C03AA0301|Aquazið|töflur|25|mg|100|stk|1|glas||C03AA03|01.05.1983|31.12.2008|R|A|4|0|0|E|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf||812|812|812|| 037929|J01EA0102|Monotrim|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|1942|3476|lyfalmen|||00|100|0|25|Vistor hf|Hexal A/S|||1942||1942|3476 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|30|IKR|664|1633|lyfalmen|V0917|1554|00|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||584||584|1633 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|30|IKR|1766|2949|lyfalmen|V0918|2727|00|60|0|60|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1554||1554|2949 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|30|IKR|2667|4097|lyfalmen|V0919|3772|00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2400||2400|4097 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|1118|2358|lyfalmen|||00|50|0|50|Icepharma hf|Smith & Nephew|||1118||1118|2358 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|228851|286787|lyfsjukr|||00|1|0|0|Vistor hf|Amgen Europe B.V.|||228851||228851|286787 038828|C09AA0401|Coversyl|töflur|4|mg|90|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|10690|15347|lyfalmen|||00|90|0|90|Icepharma hf|Servier|||10690||10690|15347 038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.1982||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|4708|7229|lyfalmen|||00|100|0|33|Medico ehf|Solvay Duphar |||4708||4708|7229 038915|J01FA1004|Zitromax UNO|forðakyr|0| |2|g|1|fl||J01FA10|01.10.2007||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|3183|5160|lyfalmen|||00|2|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3183||3183|5160 039005|L01XA0301|Eloxatin|irþ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|38642|49977|lyfsjukr|||00|10|0|0|Vistor hf|Sanofi-aventis Norge AS|||38642||38642|49977 039014|L01XA0301|Eloxatin|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|67239|85580|lyfsjukr|||00|20|0|0|Vistor hf|Sanofi-aventis Norge AS|||67239||67239|85580 039669|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|glas||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|5999|8981|lyfalmen|||10|100|0|62|Vistor hf|Sanofi-aventis Norge AS|||5999||5999|8981 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1578|2982|lyfalmen|||00|15|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1578||1578|2982 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2420|4124|lyfalmen|||00|22|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2420||2420|4124 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|302|432|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||302||302|432 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|682|976|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||682||682|976 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1150|1647|lyfsjukr|||02|1|0|0|Icepharma hf|Baxter Medical AB|||1150||1150|1647 040287|N03AF0104|Tegretol|töflur|200|mg|200|stk|1|þpakki||N03AF01|01.04.1993||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|4012|6285|lyfalmen|||00|200|0|40|Vistor hf|Novartis Healthcare A/S-|||4012||4012|6285 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|ALC|0|0|0|100|IKR|||lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon||||||1233 041005|L04AB0102|Enbrel (Lyjaver)|sts|0| |25|mg|4|hgl|+ leysir|L04AB01|01.05.2006|31.12.2008|R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|95412|120655|lyfsjukr|||00|100|0|14|Lyfjaver ehf|Lyfjaver ehf|||95412||95412|120655 041059|J07BH0101|Rotarix|mixtduft|0| |1|hgl|1|pakki|+áf.munnspr.m/leysi|J07BH01|01.07.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|9107|13199|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|||9107||9107|13199 041423|G03AA1203|Yasminelle|töflur|0| |63|stk|1|þpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|2994|4903|lyfalmen|||00|63|0|0|Icepharma hf|Bayer Schering Pharma AG|||2994||2994|4903 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|4701|8135|vetorma|||AA|100|0|0|Icepharma hf|Intervet International B.V.|||4701||4701|8135 041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006||R|A|3|0|0|0|0|SAG|0|0|0|100|SEK|183837|231062|lyfalmen|||02|100|0|0|Icepharma hf|Schering AG|||183837||183837|231062 041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|20|0|4|Vistor hf|McNeil Denmark ApS||||||0 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1377|2709|lyfalmen|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|||1377||1377|2709 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|10326|14723|lyfsjukr|||00|500|0|0|Vistor hf|AstraZeneca A/S DK|||10326||10326|14723 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3897|5580|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||3897||3897|5580 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4915|7037|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||4915||4915|7037 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4645|6650|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||4645||4645|6650 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7043|10084|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||7043||7043|10084 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|8085|11576|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||8085||8085|11576 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8843|12661|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|||8843||8843|12661 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4696|6723|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||4696||4696|6723 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3445|4932|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||3445||3445|4932 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2970|4252|lyfsjukr|||02|10000|0|0|Icepharma hf|Fresenius Kabi|||2970||2970|4252 042442|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|40|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|10379|14789|lyfsjukr|||00|2000|0|0|Icepharma hf|Fresenius Kabi|||10379||10379|14789 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|4202|6016|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||4202||4202|6016 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2343|3355|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||2343||2343|3355 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7746|11090|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|||7746||7746|11090 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2627|3761|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||2627||2627|3761 042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dæla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|827|1963|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||827||827|1963 042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|15810|21868|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|||15810||15810|21868 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3650|5226|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||3650||3650|5226 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|4000|0|0|Icepharma hf|Fresenius Kabi||||||0 043232|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|340|1302|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|||340||340|1302 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3223|4615|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|||3223||3223|4615 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3905|6140|lyfalmen|||24|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3905||3905|6140 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|5925|8483|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|||5925||5925|8483 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|603|1659|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||603||603|1659 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1289|2590|lyfalmen|||10|30|0|30|Vistor hf|N.V. Organon|||1289||1289|2590 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyflausa|||02|200|0|0|Icepharma hf|Fresenius Kabi|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||00|200|0|0|Icepharma hf|Fresenius Kabi||||||0 044114|J01DH0202|Meronem (Lyfjaver)|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.02.2008|31.12.2008|R|A|4|0|0|0|1|LVR|0|0|0|100|NOK|28835|37766|lyfsjukr|||00|5000|0|2|Lyfjaver ehf|Lyfjaver ehf|||28835||28834|37766 044124|J01DH0202|Meronem (Lyfjaver)|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.02.2008|31.12.2008|R|A|4|0|0|0|1|LVR|0|0|0|100|NOK|55229|70628|lyfsjukr|||00|10|0|5|Lyfjaver ehf|Lyfjaver ehf|||55229||55229|70628 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|NOK|13223|18648|lyfalmen|V0011|18648|00|25|0|5|Lyfjaver ehf|Lyfjaver ehf|||13223||13223|18648 044624|G04BE0303|Viagra (D.A.C.)|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|0|100|DKK|5929|8886|lyfalmen|V1300|8886|00|4|0|8|D.A.C. ehf|D.A.C. ehf|||5929||5929|8886 045013|L01XX1902|Campto|irþ|20|mg/ml|5|ml|1|hgl||L01XX19|01.01.1999||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|40503|52294|lyfsjukr|||00|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||40503||40503|52294 045104|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|1381|2714|lyfalmen|||10|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1381||1381|2714 045379|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|210|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|7904|11566|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||7904||7904|11566 045388|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|210|0|28|Lyfjaver ehf|Lyfjaver ehf||||||0 045397|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 045406|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf||||||0 045578|N07BA0122|Nicorette (Lyfjaver)|nefúði|500|mcg/sk|200|skammtar|1|glas||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|200|0|3|Lyfjaver ehf|Lyfjaver ehf||||||0 045587|N07BA0122|Nicorette (Lyfjaver)|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf||||||0 045596|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|18|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|18|0|3|Lyfjaver ehf|Lyfjaver ehf||||||0 045605|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|42|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|42|0|7|Lyfjaver ehf|Lyfjaver ehf||||||0 045614|N07BA0123|Nicotinell (Lyfjaver)|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|21|0|32|Lyfjaver ehf|Lyfjaver ehf||||||0 045896|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf||||||0 045905|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 045915|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf||||||0 045924|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf||||||0 045933|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf||||||0 045942|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 045951|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf||||||0 045960|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf||||||0 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|22614|43247|vetalmen|||27|10|0|0|Icepharma hf|Pfizer vet.|||22614||22614|43247 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1943|3477|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||1943||1943|3477 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|IKR|5076|7729|lyfalmen|V1088|7729|02|10|0|1|Icepharma hf|Vian SA|||5076||5076|7729 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|769|1884|lyfalmen|V0001|1884|00|90|0|45|Actavis Group hf|Actavis hf|||769||769|1884 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1215|2489|lyfalmen|V0002|2489|00|90|0|90|Actavis Group hf|Actavis hf|||1215||1215|2489 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1622|3042|lyfalmen|V0003|3042|00|90|0|135|Actavis Group hf|Actavis hf|||1622||1622|3042 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|IKR|8305|12111|lyfalmen|V1089|12111|02|20|0|2|Icepharma hf|Vian SA|||8305||8305|12111 047042|L04AB0101|Enbrel|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|118501|149401|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|||118501||118501|149401 047159|C07AA0704|Sotalol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|918|2086|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|||918||918|2086 047340|J01CA0406|Flemoxin Solutab|lausnart|500|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1181|2443|lyfalmen|||23|14|0|7|Vistor hf|Astellas Pharma A/S|||1181||1181|2443 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18536|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|||13388||13388|18536 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61073|lyfsjukr|||00|50|0|0|Ísaga ehf|AGA AB|||47555||47555|61073 047560|L04AB0101|Enbrel|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|235869|295524|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|||235869||235869|295524 047563|R03DC0101|Accolate|töflur|20|mg|98|stk|1|þpakki||R03DC01|01.04.1998||R|A|3|0|0|B|0|ASZ|0|0|0|100|SEK|9348|13526|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca UK Ltd|||9348||9348|13526 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4770|6829|lyfsjukr|||02|250|0|0|Icepharma hf|Baxter Medical AB|||4770||4770|6829 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7529|10780|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|||7529||7529|10780 048199|A03CA0201|Librax|töflur|0| |100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|VAL|0|0|0|100|DKK|2361|4044|lyfalmen|||00|100|0|0|Icepharma hf|Valeant Pharmaceuticals B.V.|||2361||2361|4044 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|18481|25194|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|||18481||18481|25194 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|4240|6594|lyfalmen|||00|100|0|67|Vistor hf|Recip AB|||4240||4240|6594 048447|G03AA0901|Marvelon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1919|3445|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|||1919||1919|3445 048452|M01AE5101|Ibukod|töflur|0| |30|stk|1|glas|10+200 mg|M01AE51|01.11.2006||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|650|1722|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|||650||650|1722 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|69431|88627|lyfalmen|||00|150|0|38|Icepharma hf|Roche|||69431||69431|88627 048520|N04BD0104|Selegilin Merck NM|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|2684|4483|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||2684||2684|4483 048611|N04BD0104|Selegilin Merck NM|töflur|10|mg|100|stk|1|glas||N04BD01|01.07.1994||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|8849|12849|lyfalmen|||00|100|0|200|Actavis Group PTC ehf|Merck NM AB|||8849||8849|12849 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GCH|0|0|1|100|DKK|515|1539|lyfalmen|V0772|1355|00|100|0|17|Icepharma hf|GlaxoSmithKline CH A/S|||515||515|1539 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|30|IKR|3269|5277|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||3269||3269|5277 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|20426|27615|lyfalmen|||00|3|0|0|Icepharma hf|Roche Registration Limited|||20426||20426|27615 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2924|4808|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|||2924||2924|4808 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||23|60|0|60|Vistor hf|Janssen-Cilag AB||||||0 049524|S01ED5110|Duotrav|augndr|0| |2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|3783|5974|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|||3783||3783|5974 049533|S01ED5110|Duotrav|augndr|0| |2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|11134|15950|lyfalmen|||00|8|0|0|K.Pétursson hf|Alcon|||11134||11134|15950 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|8237|12018|lyfalmen|||23|5|0|5|Icepharma hf|Galderma Nordic AB|||8237||8237|12018 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|954|2018|lyfalmen|V0358|2018|00|98|0|65|PortFarma ehf|PortFarma |||868||868|2018 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1154|2265|lyfalmen|V0365|2265|00|98|0|131|PortFarma ehf|PortFarma |||1050||1050|2265 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1827|3097|lyfalmen|V0367|3097|00|100|0|267|PortFarma ehf|PortFarma |||1663||1663|3097 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4829|lyfalmen|V0343|4435|00|28|0|28|Vistor hf|Novartis Healthcare A/S-|||2939||2939|4829 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2519|4259|lyfalmen|||00|100|0|200|Actavis Group hf|Actavis hf|||2519||2519|4259 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|2162|3774|lyfalmen|||00|30|0|30|Artasan ehf|Novartis Healthcare A/S-A|||2162||2162|3774 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|4132|6448|lyfalmen|||00|100|0|400|Actavis Group hf|Actavis hf|||4132||4132|6448 049750|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|25|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|5367|8124|lyfalmen|||10|30|0|3|D.A.C. ehf|D.A.C. ehf|||5367||5367|8124 049760|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|100|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|19695|26705|lyfalmen|||10|30|0|12|D.A.C. ehf|D.A.C. ehf|||19695||19695|26705 049778|M05BA0405|Fosamax (D.A.C.)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|100|XEU|16088|21160|lyfalmen|V0718|21160|00|12|0|84|D.A.C. ehf|D.A.C. ehf|||15241||15241|21160 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|84215|107033|lyfalmen|||00|300|0|38|Icepharma hf|Roche|||84215||84215|107033 050179|N01AF0301|Pentothal Natrium|sts|2,5|g|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|8531|12214|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|||8531||8531|12214 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BHC|0|0|0|100|SEK|594024|719240|lyfsjukr|||00|112|0|0|Vistor hf|Bayer HealthCare AG|||576203||576203|719240 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4014|6288|lyfalmen|||00|14|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4014||4014|6288 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|14315|20007|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||14315||14315|20007 050651|C02CA0402|Carduran Retard|forðatfl|4|mg|30|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3325|5353|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3325||3325|5353 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|10030|14452|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10030||10030|14452 050914|N02BE0101|Panodil|eþ-stil|1|g|10|stk|1|pakki||N02BE01|01.10.1989||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|511|1534|lyfalmen|||04|10|0|3|Icepharma hf|GlaxoSmithKline CH A/S|||511||511|1534 051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.07.1994||L|A|2|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S||||||0 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1822|3313|lyfalmen|||10|100|0|10|Vistor hf|Desitin Artzneimittel|||1822||1822|3313 051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyfalmen|||00|60|0|0|D.A.C. ehf|D.A.C. ehf||||||0 051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|9698|14001|lyfalmen|V0391|14001|00|60|0|0|D.A.C. ehf|D.A.C. ehf|||9698||9698|14001 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2420|4124|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|||2420||2420|4124 051193|R05CB0102|Mucomyst|freyðit|200|mg|25|stk|1|glas||R05CB01|01.01.1986||R|A|2|0|0|E|0|BIP|0|0|1|100|SEK|501|1520|lyfalmen|||72|25|0|10|Vistor hf|BioPhausia AB|||501||501|1520 051331|R06AX2602|Nefoxef|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MEK|0|0|1|100|SEK|1074|2298|lyfalmen|V1910|2298|00|30|0|30|Actavis Group PTC ehf|Merck NM AB (A)|||1074||1074|2298 051340|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MEK|0|0|1|100|SEK|3239|5236|lyfalmen|V1911|5236|00|100|0|100|Actavis Group PTC ehf|Merck NM AB (A)|||3239||3239|5236 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MEK|0|0|1|100|SEK|1655|3086|lyfalmen|V1912|3086|00|30|0|45|Actavis Group PTC ehf|Merck NM AB (A)|||1655||1655|3086 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MEK|0|0|1|100|SEK|4785|7334|lyfalmen|V1913|7334|00|100|0|150|Actavis Group PTC ehf|Merck NM AB (A)|||4785||4785|7334 051425|R05CB0102|Mucomyst|freyðit|200|mg|100|stk|1|glas||R05CB01|01.01.1986||R|A|2|0|0|E|0|BIP|0|0|1|100|SEK|1898|3416|lyfalmen|||72|100|0|40|Vistor hf|BioPhausia AB|||1898||1898|3416 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|1|0|1|UCB|0|0|0|100|DKK|37464|48510|lyfsjukr|||00|50|0|3|Vistor hf|U.C.B|||37464||37464|48510 051713|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|4021|6297|lyfalmen|V0084|6297|00|28|0|19|D.A.C. ehf|D.A.C. ehf|||4021||4021|6297 051732|C08CA0104|Amlódipín PortFarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|2,5|0|0|B|0|POF|0|0|0|100|IKR|1909|3043|lyfalmen|V0308|3043|00|100|0|0|PortFarma ehf|PortFarma |||1623||1623|3043 051750|C08CA0104|Amlódipín PortFarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|2,5|0|0|B|0|POF|0|0|0|100|IKR|3111|4428|lyfalmen|V0310|4428|00|100|0|0|PortFarma ehf|PortFarma |||2644||2644|4428 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|412563|515508|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||412563||412563|515508 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|831246|1036769|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||831246||831246|1036769 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|840754|1048606|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||840754||840754|1048606 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyfalmen|||00|2|0|2|D.A.C. ehf|D.A.C. ehf||||||0 052498|V03AF0302|Rescuvolin|sts|15|mg|1|stk|25|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|35477|46036|lyfsjukr|||63|25|0|6|Actavis Group hf|Pharmachemie|||35477||35477|46036 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|43727|56308|lyfsjukr|||00|8212|0|8|Icepharma hf|Fresenius Kabi|||43727||43727|56308 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|35131|45606|lyfsjukr|||00|7698|0|8|Icepharma hf|Fresenius Kabi|||35131||35131|45606 052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|47366|60838|lyfsjukr|||63|10|0|8|Actavis Group hf|Pharmachemie|||47366||47366|60838 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|40651|52478|lyfsjukr|||00|7680|0|8|Icepharma hf|Fresenius Kabi|||40651||40651|52478 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33772|43914|lyfsjukr|||00|7200|0|7|Icepharma hf|Fresenius Kabi|||33772||33772|43914 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|45787|58872|lyfsjukr|||00|7880|0|8|Icepharma hf|Fresenius Kabi|||45787||45787|58872 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|42599|54903|lyfsjukr|||00|7616|0|8|Icepharma hf|Fresenius Kabi|||42599||42599|54903 052944|C01DA1402|Monit-L|forðahlk|30|mg|100|stk|1|glas||C01DA14|01.01.1994|31.12.2008|R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1770|3242|lyfalmen|||10|100|0|75|Actavis Group hf|Actavis hf|||1770||1770|3242 053006|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|2684|4483|lyfalmen|V0903|4483|00|100|0|100|Actavis Group PTC ehf|Mylan AB|||2684||2684|4483 053025|G03HB0102|Diane mite|töflur|0| |63|stk|1|þpakki||G03HB01|01.07.1989||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2665|4457|lyfalmen|||23|63|0|63|Icepharma hf|Bayer Schering Pharma AG|||2665||2665|4457 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|81853|103774|lyfsjukr|||00|120|0|30|Vistor hf|Abbott Laboratories Ltd|||81853||81853|103774 053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|6292|9379|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6292||6292|9379 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|34980|45735|lyfalmen|||00|100|0|50|Vistor hf|Sanofi - aventis Deutschland GmbH|||34980||34980|45735 053397|L04AA1301|Arava|töflur|20|mg|30|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|10838|15548|lyfalmen|||00|30|0|30|Vistor hf|Sanofi - aventis Deutschland GmbH|||10838||10838|15548 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|33464|43848|lyfalmen|||00|100|0|100|Vistor hf|Sanofi - aventis Deutschland GmbH|||33464||33464|43848 053546|L04AA1301|Arava|töflur|100|mg|3|stk|1|þpakki||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|5199|7896|lyfalmen|||00|3|0|20|Vistor hf|Sanofi - aventis Deutschland GmbH|||5199||5199|7896 053680|J05AE1001|Prezista|filmhtfl|300|mg|120|stk|1|plglas||J05AE10|01.04.2007||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|121298|152881|lyfsjukr|||43|120|0|0|Vistor hf|Janssen-Cilag International N.V.|||121296||121296|152881 053689|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|20|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|572|1617|lyfalmen|V0902|1617|00|20|0|20|Actavis Group PTC ehf|Mylan AB|||572||572|1617 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|16077|22201|lyfalmen|||00|10|0|50|Icepharma hf|Martindale Pharmaceuticals|||16077||16077|22201 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|1239|2522|lyfalmen|||20|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1239||1239|2522 054130|J01CA0405|Flemoxin|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1471|2837|lyfalmen|V0451|2796|08|100|0|5|Vistor hf|Astellas Pharma A/S|||1471||1471|2837 054148|J01CA0405|Flemoxin|dropar|100|mg/ml|20|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|856|2002|lyfalmen|||28|20|0|2|Vistor hf|Astellas Pharma A/S|||856||856|2002 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2802|4643|lyfalmen|||02|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|||2802||2802|4643 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|1|Vistor hf|AstraZeneca A/S DK||||||0 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|4|0|0|Artasan ehf|Novartis Healthcare A/S-A||||||0 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|30|DKK|77389|98217|lyfsjukr|||00|56|0|22|Icepharma hf|Roche Registration Limited|||77389||77389|98217 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|2|Vistor hf|AstraZeneca A/S DK||||||0 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCB|0|0|1|100|SEK|1331|2647|lyfalmen|||00|200|0|5|Vistor hf|U.C.B|||1331||1331|2647 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|949|2128|lyfalmen|V0914|2128|10|30|0|30|Actavis Group hf|Actavis hf|||949||949|2128 054601|QB03AC9001|Idofer, vet.|stl|200|mg/ml|100|ml|5|fl|plastfl.|QB03AC90|01.05.1999||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|13801|26460|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||13801||13801|26460 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|8345|14441|vetorma|||16|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||8345||8345|14441 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|748|1855|lyfalmen|||10|20|0|5|Vistor hf|Recip AB|||748||748|1855 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|12625|17903|lyfalmen|||10|100|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12625||12625|17903 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3734|5908|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||3734||3734|5908 055434|P03AC0401|Nix|krem|50|mg/g|30|g|1|túpa||P03AC04|01.01.1996|31.12.2008|R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|1526|2911|lyfalmen|||00|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1526||1526|2911 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|36|0|1|Artasan ehf|Novartis Healthcare A/S-A||||||0 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|96|0|3|Artasan ehf|Novartis Healthcare A/S-A||||||0 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|4359|6756|lyfalmen|V0337|6756|00|100|0|100|Actavis Group hf|Actavis hf|||4359||4359|6756 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|6185|9234|lyfalmen|V0338|9234|00|100|0|200|Actavis Group hf|Actavis hf|||6185||6185|9234 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|11516|lyfalmen|V0339|11516|00|100|0|400|Actavis Group hf|Actavis hf|||7867||7867|11516 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1220|2496|lyfalmen|||10|40|0|10|Vistor hf|Recip AB|||1220||1220|2496 056879|V07AY02|Palacos cum Gentamicin (Paranova)|sement|500|mg|40,5|g|2|pakkar|+ leysir|V07AY|01.06.1997||R|A|4|0|0|0|1|PAN|0|0|0|100|DKK|28321|37127|lyfsjukr|||00|81|0|0|xxxxx|Paranova A/S|||28321||28321|37127 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|321365|401967|lyfsjukr|||00|15|0|30|Meda AB|Elan Pharma International|||321365||321365|401967 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|72059|91581|lyfsjukr|||00|30|0|30|PortFarma ehf|PortFarma |||72059||72059|91581 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|20169|26978|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|||20169||20169|26978 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|5|0|1|0|1|NOH|0|0|0|100|DKK|10717|15210|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|||10717||10717|15210 057422|B05XA3102|Tracel|irþ|0| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6978|9991|lyfsjukr|||00|200|0|0|Icepharma hf|Fresenius Kabi|||6978||6978|9991 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|5|0|1|0|1|NOH|0|0|0|100|DKK|5769|8260|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|||5769||5769|8260 057703|J01DD0401|Rocephalin|irþ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|26864|35313|lyfsjukr|||00|5|0|5|Icepharma hf|Roche|||26864||26864|35313 057924|C09DA0401|CoAprovel|filmhtfl|325|mg|28|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|5074|7726|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||5074||5074|7726 057933|C09DA0401|CoAprovel|filmhtfl|325|mg|98|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|18055|24663|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||18055||18055|24663 057978|N07BA0301|Champix|filmhtfl|0| |25|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|5435|8216|lyfalmen|||00|25|0|10|Vistor hf|Pfizer Limited|||5435||5435|8216 057987|N07BA0301|Champix|filmhtfl|1|mg|28|stk|1|þpakki||N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|6073|9082|lyfalmen|||00|28|0|14|Vistor hf|Pfizer Limited|||6073||6073|9082 057996|N07BA0301|Champix|filmhtfl|1|mg|56|stk|1|þpakki||N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|12205|17380|lyfalmen|||00|56|0|28|Vistor hf|Pfizer Limited|||12205||12205|17380 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|462|1467|lyfalmen|||02|5|0|2|Vistor hf|Boehringer Ingelheim|||462||462|1467 058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21817|29347|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||21817||21817|29347 058503|J01EA0105|Trimetoprim AstraZeneca|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|927|2098|lyfalmen|||00|100|0|2|Vistor hf|Recip AB|||927||927|2098 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|122782|154731|lyfsjukr|||00|210|0|21|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||122782||122782|154731 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1476|2843|lyfalmen|||43|100|0|75|Vistor hf|Sanofi-aventis Norge AS|||1476||1476|2843 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2326|3997|lyfalmen|||43|100|0|150|Vistor hf|Sanofi-aventis Norge AS|||2326||2326|3997 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4451|6881|lyfalmen|||51|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4451||4451|6881 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|1547|2940|lyfalmen|||00|250|0|21|Vistor hf|Recip AB|||1547||1547|2940 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|112455|142191|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|||112455||112455|142191 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|33985|44496|lyfalmen|||51|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||33985||33985|44496 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|124035|156291|lyfsjukr|||00|30|0|0|PortFarma ehf|PortFarma |||124035||124035|156291 059823|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.05.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|7839|11223|lyfsjukr|||00|28|0|7|Vistor hf|Schering-Plough|||7839||7839|11223 059824|C07AB0310|Atenolol Merck NM|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|826|1961|lyfalmen|V0290|1589|00|98|0|33|Actavis Group PTC ehf|Merck NM AB|||826||826|1961 059842|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|17775|23997|lyfsjukr|||00|28|0|28|Vistor hf|Schering-Plough|||17775||17775|23997 060087|L04AC0101|Zenapax|irþ|5|mg/ml|5|ml|3|hgl||L04AC01|01.04.2005||R|K|3|0|0|0|1|RRL|0|0|0|100|DKK|184933|232109|lyfsjukr|||00|15|0|0|Icepharma hf|Roche Registration Limited|||184933||184933|232109 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|423962|530018|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|||423962||423962|530018 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|214707|269495|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|||214707||214707|269495 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|107354|135841|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|||107354||107354|135841 060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|8253|12040|lyfalmen|||10|100|0|75|Vistor hf|Novartis Healthcare A/S-|||8253||8253|12040 060905|C01DA0204|Nitromex|tungur.t|0,5|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|24|Actavis Group hf|Actavis Group hf||||||1957 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12|Actavis Group hf|Actavis Group hf||||||1957 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|DKK|||lyfalmen|||23|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||||||0 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|8271|12065|lyfalmen|||00|84|0|84|Vistor hf|N.V. Organon|||||8271|12065 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|26|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||1985 061715|L01XE0901|Torisel|irþ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|USD|199568|250330|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|||199568||199568|250330 061762|N02BA0106|Magnyl|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.12.1983||L|A|1|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|50|0|8|Actavis Group hf|Actavis hf||||||0 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|7145|10230|lyfsjukr|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|||7145||7145|10230 061961|J01XX0901|Cubicin|irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|18771|25237|lyfsjukr|||00|1|0|1|Vistor hf|Novartis Europharm Ltd|||18771||18771|25237 061970|J01XX0901|Cubicin|irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|26568|34945|lyfsjukr|||00|1|0|2|Vistor hf|Novartis Europharm Ltd|||26568||26568|34945 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|548|1584|lyfalmen|||10|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||548||548|1584 062343|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|5166|7851|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5166||5166|7851 062379|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|7730|11330|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||7730||7730|11330 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|8510|12184|lyfsjukr|||02|20|0|0|Icepharma hf|Wyeth AB|||8510||8510|12184 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|964|1380|lyfsjukr|||02|1|0|0|Icepharma hf|Wyeth AB|||964||964|1380 062711|J01EE0103|Primazol|töflur|480|mg|30|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|694|1782|lyfalmen|||00|30|0|8|Actavis Group hf|Actavis hf|||694||694|1782 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|1154|2406|lyfalmen|||10|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1154||1154|2406 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|2215|3846|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis Group hf|||2215||2215|3846 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|19510|33763|vetorma|||16|1000|0|0|Vistor hf|Bayer HealthCare AG|||19510||19510|33763 062935|G03AA1005|Harmonet|töflur|0| |63|stk|1|pakki|þp 20+75 mcg|G03AA10|01.11.1998||R|A|3|0|0|0|0|WEM|0|0|0|100|USD|2213|3844|lyfalmen|||23|63|0|63|Icepharma hf|Wyeth Medica|||2213||2213|3844 062987|J07BM0201|Cervarix|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|17101|23476|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|||17101||17101|23476 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|30|DKK|5564|8391|lyfalmen|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|||5564||5564|8391 063453|J01CA0406|Flemoxin Solutab|lausnart|750|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2245|3887|lyfalmen|||23|14|0|10|Vistor hf|Astellas Pharma A/S|||2245||2245|3887 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|50|Vistor hf|Medic Team||||||0 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|glas||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2649|4435|lyfalmen|V0343|4435|00|28|0|28|Actavis Group hf|Actavis hf|||2649||2649|4435 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|2244|3886|lyfalmen|V1901|3886|00|30|0|30|D.A.C. ehf|D.A.C. ehf|||2244||2244|3886 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|11899|16682|lyfsjukr|||17|2|0|0|Vistor hf|Octapharma AB|||11899||11899|16682 063923|QP54AB5207|Equest Pramox vet|hlaup|0| |11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2747|4754|vetorma|||16|12|0|0|Vistor hf|Fort Dodge Veterinär GmbH|||2747||2747|4754 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|1154|2406|lyfalmen|||10|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1154||1154|2406 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2348|4027|lyfalmen|||10|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2348||2348|4027 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|1175795|1465732|lyfsjukr|||00|1|0|12|Icepharma hf|United Therapeutics Europe Ltd.|||||1175795|1465732 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|470318|587413|lyfsjukr|||00|1|0|5|Icepharma hf|United Therapeutics Europe Ltd.|||||470318|587413 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|2539|4286|lyfalmen|||10|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2539||2539|4286 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|4703182|5857329|lyfsjukr|||00|1|0|47|Icepharma hf|United Therapeutics Europe Ltd.|||||4703182|5857329 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|2351592|2929600|lyfsjukr|||00|1|0|23|Icepharma hf|United Therapeutics Europe Ltd.|||||2351592|2929600 064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|946|2124|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||946||946|2124 065032|D10AF5101|Duac|hlaup|0| |25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|2633|4413|lyfalmen|||38|25|0|0|Vistor hf|Stiefel Laboratories (UK) Ltd.|||2633||2633|4413 065060|J07BD5202|MMR II|bóluefni|0| |0,5|ml|10|hgl|+ leysir|J07BD52|01.11.1998||R|K|2|0|0|0|0|MEX|0|0|0|100|XEU|14163|19818|lyfalmen|||51|5|0|0|Icepharma hf|Aventis Pasteur MSD A/S|||14163||14163|19818 065094|V08AB0901|Visipaque|stl|150|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5486|7855|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||5486||5486|7855 065314|G01AF0201|Canesten|sk-stil|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAS|0|0|0|100|DKK|||lyfalmen|||25|6|0|6|Vistor hf|Bayer A/S||||||0 065332|G01AF0201|Canesten|sk-stil|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAS|0|0|0|100|DKK|||lyfalmen|||25|1|0|5|Vistor hf|Bayer A/S||||||0 065540|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||15297||15297|20912 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|2956|4852|lyfalmen|||06|2|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2956||2956|4852 065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|þpakki||C09CA01|01.03.1999||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|2311|3977|lyfalmen|V0195|2187|00|28|0|7|Icepharma hf|M.S.D.|||2311||2311|3977 066142|N05BA0204|Klordiazepoxið Actavis|töflur|10|mg|50|stk|1|glas||N05BA02|01.10.1995|31.12.2008|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|345|1309|lyfalmen|||00|50|0|17|Actavis Group hf|Actavis hf|||345||345|1309 066241|C03EA0103|Hydramil|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|238|1163|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||238||238|1163 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7805|11432|lyfalmen|||00|60|0|8|Vistor hf|Boehringer Ingelheim International |||7805||7805|11432 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|35902|46565|lyfsjukr|||00|10000|0|10|Icepharma hf|Fresenius Kabi|||35902||35902|46565 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|21|0|10|Artasan ehf|Novartis Healthcare A/S-A||||||0 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|21|0|21|Artasan ehf|Novartis Healthcare A/S-A||||||0 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|21|0|32|Artasan ehf|Novartis Healthcare A/S-A||||||0 066548|QG03FA0401|Prid, vet.|lykkja|10|mg|10|stk|1|pakki|m. hylki|QG03FA04|01.08.1984||R|A|2|0|0|0|0|CES|1|0|0|100|XEU|22676|43366|vetalmen|||16|10|0|0|Icepharma hf|Ceva Sante Animale|||22676||22676|43366 066563|N06AA0405|Klomipramin Merck NM|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|572|1617|lyfalmen|||00|100|0|10|Actavis Group PTC ehf|Merck NM AB|||572||572|1617 066621|N06AA0405|Klomipramin Merck NM|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|854|1684|lyfalmen|V0908|1684|00|100|0|25|Actavis Group PTC ehf|Merck NM AB|||622||622|1684 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6550|lyfsjukr|||02|120|0|0|Icepharma hf|GE Healthcare AS|||4575||4575|6550 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|2343|4020|lyfalmen|V0144|4020|70|30|0|15|D.A.C. ehf|D.A.C. ehf|||2343||2343|4020 067025|J01CA0406|Flemoxin Solutab|lausnart|125|mg|20|stk|1|þpakki||J01CA04|01.01.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|697|1786|lyfalmen|||23|20|0|2|Vistor hf|Astellas Pharma A/S|||697||697|1786 067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|þpakki||N07CA01|01.04.1993||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7699|11288|lyfalmen|||00|84|0|56|Medico ehf|Solvay Duphar |||7699||7699|11288 067579|N05BB0101|Atarax|töflur|25|mg|25|stk|1|þpakki||N05BB01|01.04.1995||R|A|5|0|0|0|0|UCB|0|0|1|100|SEK|381|1357|lyfalmen|||00|25|0|8|Vistor hf|U.C.B|||381||381|1357 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|þpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCB|0|0|0|100|SEK|1331|2647|lyfalmen|||00|100|0|33|Vistor hf|U.C.B|||1331||1331|2647 067641|N05CD0204|Mogadon (D.A.C.)|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|820|1953|lyfalmen|V0901|1953|00|50|0|50|D.A.C. ehf|D.A.C. ehf|||820||820|1953 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1740|3202|lyfalmen|V0551|3202|10|7|0|2|Actavis Group hf|Actavis hf|||1740||1740|3202 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|7143|10534|lyfalmen|V0552|10534|10|30|0|8|Actavis Group hf|Actavis hf|||7143||7143|10534 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|V0554|1864|10|1|0|1|Actavis Group hf|Actavis hf|||754||754|1864 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1441|2796|lyfalmen|V0555|2796|10|2|0|2|Actavis Group hf|Actavis hf|||1441||1441|2796 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2500|4233|lyfalmen|V0556|4233|10|4|0|3|Actavis Group hf|Actavis hf|||2500||2500|4233 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|26738|35474|lyfalmen|V0557|35474|10|30|0|30|Actavis Group hf|Actavis hf|||26738||26738|35474 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|6612|12766|vetalmen|||27|50|0|0|Icepharma hf|Vétoquinol AG|||6612||6612|12766 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|DKK|2238|3877|lyfalmen|||00|20|0|10|Vistor hf|Meda AB (V)|||2238||2238|3877 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|DKK|6600|9797|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|||6600||6600|9797 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Actavis Group hf|Braun|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Actavis Group hf|Braun|||||| 068951|V07AB09|Sterilt Vatten Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|200|0|0|Actavis Group hf|Braun|||||| 068960|V07AB09|Sterilt Vatten Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|400|0|0|Actavis Group hf|Braun|||||| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|DKK|||lyfalmen|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A||||||0 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3211|lyfalmen|||00|14|0|14|Vistor hf|Novartis Healthcare A/S-|||1747||1747|3211 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|16993|lyfalmen|||00|98|0|98|Vistor hf|Novartis Healthcare A/S-|||11903||11903|16993 069833|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|1849|3350|lyfalmen|||00|40|0|10|Icepharma hf|NordMedica A/S|||1849||1849|3350 069842|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|932|2105|lyfalmen|||00|20|0|5|Icepharma hf|NordMedica A/S|||932||932|2105 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|44276|56991|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||44276||44276|56991 070359|L01DB0701|Novantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|35732|46354|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|||35732||35732|46354 070514|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|7667|10977|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||7667||7667|10977 070523|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5453|7807|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||5453||5453|7807 070533|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9578|13713|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||9578||9578|13713 070542|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6095|8727|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||6095||6095|8727 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PSW|1|0|0|100|SEK|5355|10372|vetalmen|||27|100|0|0|Vistor hf|Pharmaxim Sweden AB|||5355||5355|10372 070623|C03AA0301|Aquazið|töflur|12,5|mg|100|stk|1|glas||C03AA03|01.03.1984||R|A|4|0|0|E|0|ACA|0|0|0|100|IKR|748|1855|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|||748||748|1855 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|16879|23199|lyfalmen|||00|100|0|20|Vistor hf|Janssen-Cilag AB|||16879||16879|23199 071076|QA12CE9902|Selevitan, vet.|kyrni|0| |1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PSW|0|0|0|100|SEK|5670|10972|vetalmen|||16|1250|0|0|Vistor hf|Pharmaxim Sweden AB|||5670||5670|10972 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|IKR|728|1828|lyfalmen|||00|100|0|22|Actavis Group hf|Actavis hf|||728||728|1828 071217|C03EA0104|Hydramil mite|töflur|27,5|mg|100|stk|1|glas|2.5+25 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|158|1055|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||158||158|1055 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|59872|76408|lyfsjukr|||00|1|0|8|Vistor hf|Eisai Ltd|||59872||59872|76408 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|299360|374571|lyfsjukr|||00|5|0|42|Vistor hf|Eisai Ltd|||299360||299360|374571 071670|J01CF0101|Diclocil|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.07.1991|31.12.2008|R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|2043|3611|lyfalmen|V0452||10|30|0|4|Vistor hf|Bristol-Myers Squibb|||2043||2042|3611 071712|J01CF0101|Diclocil|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.07.1991|31.12.2008|R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|2501|4234|lyfalmen|V0460||10|30|0|8|Vistor hf|Bristol-Myers Squibb|||2501||2501|4234 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|8432|16233|vetalmen|||27|5|0|0|Vistor hf|Orion-Farmos|||8432||8432|16233 072371|A04AA0201|Kytril|stl|1|mg/ml|3|ml|5|lykjur||A04AA02|01.04.1993||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|14756|20556|lyfalmen|||00|15|0|5|Icepharma hf|Roche as|||14756||14756|20556 072520|V01AA1104|Alutard SQ, hrossaværur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20696|27951|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20696||20696|27951 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|602|862|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|||602||602|862 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|196687|246743|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|||196687||196687|246743 072892|N01AH0301|Sufenta|stl|50|mcg/ml|1|ml|5|lykjur||N01AH03|01.10.1992||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1842|2637|lyfsjukr|||02|5|0|0|Vistor hf|Janssen-Cilag AB|||1842||1842|2637 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|16126|22262|lyfalmen|||00|1|0|20|Icepharma hf|Eli Lilly Nederland|||16126||16126|22262 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|16126|22262|lyfalmen|||00|2|0|40|Icepharma hf|Eli Lilly Nederland|||16126||16126|22262 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1414|2759|lyfalmen|||00|100|0|8|Lundbeck Export A/S|H. Lundbeck A/S|||1414||1414|2759 073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|3493|5581|lyfalmen|||10|100|0|100|Medico ehf|Solvay Pharmaceuticals GmbH|||3493||3493|5581 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1771|3244|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|||1771||1771|3244 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|330|1288|lyfalmen|V0844|999|00|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||330||330|1288 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|890|2048|lyfalmen|V0848|1174|00|50|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||890||890|2048 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1289|2590|lyfalmen|||00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1289||1289|2590 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|558|1598|lyfalmen|V0856|1110|00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||558||558|1598 073866|N05BA1203|Tafil|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|969|2155|lyfalmen|V0860|1437|00|50|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||969||969|2155 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1924|3451|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1924||1924|3451 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|3886|6114|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||3886||3886|6114 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|11316|16197|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||11316||11316|16197 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|4958|7569|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4958||4958|7569 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|16381|22579|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||16381||16381|22579 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|4958|7569|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4958||4958|7569 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|16381|22579|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||16381||16381|22579 074229|A08AA1001|Reductil|hylki|10|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6902|10207|lyfalmen|||00|28|0|28|Vistor hf|Abbott Laboratories A/S|||6902||6902|10207 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|22740|30179|lyfsjukr|||00|50|0|0|Icepharma hf|GE Healthcare AS|||22740||22740|30179 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|248|1177|lyfalmen|||00|25|0|12|Actavis Group hf|Actavis Group hf|||248||248|1177 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|504|1524|lyfalmen|||00|50|0|25|Actavis Group hf|Actavis Group hf|||504||504|1524 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|0| |1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|22408|38778|vetorma|||58|25|0|0|Vistor hf|Scan Vet Animal Health AS|||22408||22408|38778 074674|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.07.1988||R|A|2|0|0|0|0|GAN|0|0|1|100|IKR|1251|2538|lyfalmen|||23|4|0|4|Icepharma hf|Galderma Nordic AB|||1251||1251|2538 074732|A08AA1001|Reductil|hylki|15|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6902|10207|lyfalmen|||00|28|0|42|Vistor hf|Abbott Laboratories A/S|||6902||6902|10207 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1401|2402|lyfalmen|V1910|2298|00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|||1151||1151|2402 075028|C09AA0901|Monopril|töflur|10|mg|98|stk|1|þpakki||C09AA09|01.04.1995|31.12.2008|R|A|2|0|0|B|0|BRS|0|0|0|100|DKK|9828|14177|lyfalmen|||00|98|0|65|Vistor hf|Bristol-Myers Squibb|||9828||9828|14177 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|þpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|1527|2913|lyfalmen|||69|10|0|10|Vistor hf|Janssen-Cilag AB|||1527||1527|2913 075068|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|20|0|1|Vistor hf|McNeil Denmark ApS|||||| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1982|3242|lyfalmen|V1912|3086|00|30|0|45|Vistor hf|Sanofi-aventis Norge AS|||1770||1770|3242 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|90|0|6|Vistor hf|McNeil Denmark ApS|||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1500|2876|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|||1500||1500|2876 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1829|3322|lyfalmen|||00|300|0|300|Actavis Group hf|Actavis hf|||1829||1829|3322 075101|C09AA0901|Monopril|töflur|20|mg|98|stk|1|þpakki||C09AA09|01.04.1995|31.12.2008|R|A|2|0|0|B|0|BRS|0|0|0|100|DKK|14983|20839|lyfalmen|||00|98|0|131|Vistor hf|Bristol-Myers Squibb|||14983||14983|20839 075305|N02BE0108|Paratabs Retard|forðatfl|500|mg|300|stk|1|plglas||N02BE01|01.10.2007||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1536|2925|lyfalmen|||10|300|0|50|Actavis Group hf|Actavis hf|||1536||1536|2925 075382|V01AA0503|Soluprick SQ, rauðölur|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075408|V01AA0504|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075424|V01AA0501|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075440|V01AA0502|Soluprick SQ, hesliviður|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075465|V04CL0006|Soluprick SQ, haliðagras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075481|V04CL0004|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075507|V04CL0005|Soluprick SQ, axhnoðapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075523|V04CL0002|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075549|V04CL0008|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075564|V04CL0003|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075580|V04CL0007|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075606|V04CL0001|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075663|V01AA0302|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V01AA03|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075689|V01AA1103|Soluprick SQ, hrossaværur|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075705|V01AA1102|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075721|V01AA1101|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 075724|B02BD0402|BeneFIX|sts|0| |1000|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|147882|185981|lyfsjukr|||00|1000|0|3|Icepharma hf|Wyeth Europe|||147882||147882|185981 075787|QS02CA0102|Canaural|eyrnadr|0| |25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|VEX|0|0|0|100|DKK|2252|4444|vetalmen|||13|25|0|0|Vistor hf|VetXX A/S|||2252||2252|4444 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|XEU|29150|38477|lyfalmen|||00|98|0|0|Icepharma hf|M.S.D.|||29150||29150|38477 076281|R01AX0301|Atrovent|nefúði|21|mcg/sk|30|ml|1|stauk|380 sk.|R01AX03|01.01.2000||R|A|2|0|0|E|0|BOI|0|0|1|100|DKK|2773|4603|lyfalmen|||24|30|0|33|Vistor hf|Boehringer Ingelheim|||2773||2773|4603 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|738|1792|lyfalmen|V1070|1792|00|20|0|2|PortFarma ehf|PortFarma |||701||701|1792 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2033|3185|lyfalmen|V1075|3185|00|60|0|6|PortFarma ehf|PortFarma |||1728||1728|3185 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2876|4040|lyfalmen|V0791|4040|00|60|0|12|PortFarma ehf|PortFarma |||2358||2358|4040 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|7717|13355|vetorma|||27|100|0|0|Vistor hf|Merial (MSD)|||7717||7717|13355 077215|A03000001|Relistor|stl|20|mg/ml|0,6|ml|1|hgl|lausn|A030000|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|USD|7165|10564|lyfalmen|||0|12|0|0|Icepharma hf|Wyeth Europe|||7165||7165|10564 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|200|1112|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|||200||200|1112 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|505|1526|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||505||505|1526 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|30|GBP|732|1834|lyfalmen|||02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||732||732|1834 077951|M01AB0514|Voltfast (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.04.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|IKR|955|1494|lyfalmen|V0609|1455|10|30|0|15|D.A.C. ehf|D.A.C. ehf|||482||482|1494 078121|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|ASZ|0|0|0|100|SEK|22777|30225|lyfsjukr|||00|1|0|0|Vistor hf|AstraZeneca UK Ltd|||22777||22777|30225 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|478|1489|lyfalmen|||00|20|0|2|Vistor hf|Recip AB|||478||478|1489 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|728|1828|lyfalmen|||00|40|0|5|Vistor hf|Recip AB|||728||728|1828 078709|N06AB0303|Serol|töflur|10|mg|30|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|30|IKR|1226|2504|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|||1226||1226|2504 078717|N06AB0303|Serol|töflur|10|mg|100|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|30|IKR|4110|6418|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|||4110||4110|6418 078741|N06AX0306|Mianserin Merck NM|töflur|30|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|2994|4903|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||2994||2994|4903 078766|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.10.1992||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|4575|6550|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|||4575||4575|6550 078774|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1992||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|3859|5525|lyfsjukr|||00|10|0|0|Icepharma hf|Mayne Pharma Plc|||3859||3859|5525 078782|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|5647|8085|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|||5647||5647|8085 078790|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|16635|22578|lyfsjukr|||00|15|0|0|Icepharma hf|Mayne Pharma Plc|||16635||16635|22578 078824|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|18473|24866|lyfsjukr|||00|45|0|0|Icepharma hf|Mayne Pharma Plc|||18473||18473|24866 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|145034|182435|lyfsjukr|||00|15|0|30|Icepharma hf|Schering AG|||145034||145034|182435 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|9607|8186|lyfalmen|V0197|6362|00|98|0|98|Icepharma hf|M.S.D.|||5413||5413|8186 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2162|3095|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||2162||2162|3095 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|3733|5345|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||3733||3733|5345 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|6708|9604|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||6708||6708|9604 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3616|5747|lyfalmen|||00|10|0|5|Icepharma hf|Roche Registration Limited|||3616||3616|5747 079236|L01CA0206|Vincristine Mayne|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|7547|10805|lyfsjukr|||02|5|0|0|Icepharma hf|Mayne Pharma Plc|||7547||7547|10805 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|21591|29066|lyfalmen|||02|10|0|155|Vistor hf|Schering-Plough|||21591||21591|29066 079616|L01CA0206|Vincristine Mayne|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|11812|16573|lyfsjukr|||02|10|0|0|Icepharma hf|Mayne Pharma Plc|||11812||11812|16573 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2235|3200|lyfsjukr|||03|5|0|2|Vistor hf|Bristol-Myers Squibb|||2235||2235|3200 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1374|lyfalmen|V0514|1374|00|10|0|2|Actavis Group hf|Actavis hf|||393||393|1374 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1706|lyfalmen|V0518|1706|00|20|0|5|Actavis Group hf|Actavis hf|||638||638|1706 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1718|lyfalmen|V0522|1718|00|10|0|5|Actavis Group hf|Actavis hf|||647||647|1718 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2425|lyfalmen|V0526|2425|00|20|0|10|Actavis Group hf|Actavis hf|||1168||1168|2425 080424|G01AF0502|Pevaryl Depot|sk-stil|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||05|1|0|2|Vistor hf|Janssen-Cilag AB||||||0 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2425|4131|lyfalmen|||00|100|0|67|Lundbeck Export A/S|H. Lundbeck A/S|||2425||2425|4131 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|6384|9504|lyfalmen|||00|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6384||6384|9504 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|3442|5511|lyfalmen|||00|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3442||3442|5511 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|32851|56850|vetorma|||27|500|0|0|Vistor hf|Merial (MSD)|||32851||32851|56850 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|19843|26572|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||19843||19843|26572 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|39117|50568|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||39117||39117|50568 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.11.1998||R|A|3,5|0|0|E|0|AZD|0|0|0|100|SEK|28932|38205|lyfalmen|||02|12|0|35|Vistor hf|AstraZeneca A/S DK|||28932||28932|38205 081513|M01AE0102|Ibufen|töflur|200|mg|100|stk|1|glas||M01AE01|01.01.1988|31.12.2008|R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|336|1296|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||336||336|1296 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|10|0|0|Ísaga ehf|AGA AB||||||0 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|20|0|0|Ísaga ehf|AGA AB||||||0 081539|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.01.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|357|1325|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|||357||357|1325 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|50|0|0|Ísaga ehf|AGA AB||||||0 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|5|0|0|Ísaga ehf|AGA AB||||||0 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|600|0|0|Ísaga ehf|AGA AB||||||0 081571|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|2|0|0|Ísaga ehf|AGA AB||||||0 081588|C10AA0302|Pravachol|töflur|40|mg|28|stk|1|þpakki||C10AA03|01.06.1998||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|7694|11282|lyfalmen|||00|28|0|56|Vistor hf|Bristol-Myers Squibb|||7694||7694|11282 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|1|0|0|Ísaga ehf|AGA AB||||||0 081598|V03AN0101|Conoxia|innö.gas|100|%|2,5|l|1|hylki|MO2,5c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|2|0|0|Ísaga ehf|AGA AB||||||0 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|2|0|0|Ísaga ehf|AGA AB||||||0 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|4|0|0|Ísaga ehf|AGA AB||||||0 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|4|0|0|Ísaga ehf|AGA AB||||||0 081680|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|4|0|0|Ísaga ehf|AGA AB||||||0 081689|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|1|0|0|Ísaga ehf|AGA AB||||||0 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2229|3191|lyfsjukr|||02|10|0|3|Icepharma hf|Roche|||2229||2229|3191 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.05.2007||R|A|3|0|0|*|0|DAC|0|1|0|100|IKR|14825|20642|lyfalmen|V0813|20642|00|28|0|28|D.A.C. ehf|D.A.C. ehf|||14825||14825|20642 081987|A10AB0602|Apidra [solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áflylltir|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5238|7949|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|||5238||5238|7949 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap||A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9142|13247|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|||9142||9142|13247 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|36|0|0|Ísaga ehf|AGA AB||||||0 082685|R03BA0502|Flixotide Diskus|innúðadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|3273|5282|lyfalmen|||23|60|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3273||3273|5282 082701|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|631|1697|lyfalmen|||00|60|0|3|Actavis Group PTC ehf|Merck NM AB|||631||631|1697 082719|R03BA0502|Flixotide Diskus|innúðadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|5347|8097|lyfalmen|||23|60|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5347||5347|8097 082792|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|987|2180|lyfalmen|||00|125|0|6|Actavis Group PTC ehf|Merck NM AB|||987||987|2180 082842|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|200|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|1577|2980|lyfalmen|||00|200|0|10|Actavis Group PTC ehf|Merck NM AB|||1577||1577|2980 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|DRL|0|0|0|100|SEK|4957|7567|lyfalmen|||00|100|0|6|Vistor hf|Draco Lakemedel AB|||4957||4957|7567 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|DRL|0|0|0|100|SEK|5447|8230|lyfalmen|||00|40|0|12|Vistor hf|Draco Lakemedel AB|||5445||5445|8230 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|14132|19779|lyfalmen|||00|56|0|9|Vistor hf|Novartis Healthcare A/S-|||14132||14132|19779 082990|N06DA0301|Exelon|hylki|1,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|32028|42060|lyfalmen|||00|112|0|19|Vistor hf|Novartis Healthcare A/S-|||32028||32028|42060 083113|L02BG0301|Arimidex|töflur|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|17265|23680|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca UK Ltd|||17265||17265|23680 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|14759|20560|lyfalmen|V1372|20560|00|56|0|19|Vistor hf|Novartis Healthcare A/S-|||14759||14759|20560 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|DRL|0|0|0|100|SEK|6926|10239|lyfalmen|||00|40|0|25|Vistor hf|Draco Lakemedel AB|||6926||6926|10239 083204|N06DA0301|Exelon|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|30695|40400|lyfalmen|||00|112|0|37|Vistor hf|Novartis Healthcare A/S-|||30695||30695|40400 083360|G03GA0501|Gonal-F|sts|75|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|47475|61291|lyfalmen|||03|10|0|10|Gróco ehf|Serono Nordic|||47475||47475|61291 083451|G03GA0501|Gonal-F|sts|150|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|96455|122271|lyfalmen|||03|10|0|20|Gróco ehf|Serono Nordic|||96455||96455|122271 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|82480|104555|lyfsjukr|||00|450|0|30|Vistor hf|Abbott Laboratories A/S|||82480||82480|104555 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|32028|42060|lyfalmen|||00|112|0|75|Vistor hf|Novartis Healthcare A/S-|||32028||32028|42060 083964|L02AE0101|Suprefact|nefúði|0,1|mg/sk|10|g|4|stk|+ sk-dæla|L02AE01|01.10.1987||R|A|2.5|0|1|0|1|SNO|0|0|0|100|NOK|39763|51372|lyfsjukr|||23|40|0|33|Vistor hf|Sanofi-aventis Norge AS|||39763||39763|51372 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|8029|11496|lyfsjukr|||02|11|0|7|Vistor hf|Sanofi-aventis Norge AS|||8029||8029|11496 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|289|1233|lyfalmen|||02|10|0|2|Gróco ehf|Nycomed Danmark A/S|||289||289|1233 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|557|1596|lyfalmen|||02|20|0|5|Gróco ehf|Nycomed Danmark A/S|||557||557|1596 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|68204|86781|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||68204||68204|86781 084673|P01BC0103|Kinin Actavis|töflur|100|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1161|2416|lyfalmen|||00|100|0|7|Actavis Group hf|Actavis hf|||1161||1161|2416 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|88937|112594|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||88937||88937|112594 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|106036|133882|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||106036||106036|133882 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|22875|30347|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||22875||22875|30347 084699|P01BC0103|Kinin Actavis|töflur|250|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|2458|4176|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||2458||2458|4176 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|34230|44484|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||34230||34230|44484 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|45533|58556|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||45533||45533|58556 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|1015|2218|lyfalmen|||00|10|0|0|Vistor hf|Eisai Ltd|||1015||1015|2218 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|11733|16763|lyfalmen|||00|60|0|0|Vistor hf|Eisai Ltd|||11733||11733|16763 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|39115|50883|lyfalmen|||00|100|0|0|Vistor hf|Eisai Ltd|||39115||39115|50883 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|20938|28253|lyfalmen|||10|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||20938||20938|28253 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|3264|5270|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|||3264||3264|5270 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|32028|42060|lyfalmen|||00|112|0|56|Vistor hf|Novartis Healthcare A/S-|||32028||32028|42060 085407|R03AC0206|Ventoline|lausn|1|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|805|1933|lyfalmen|||00|50|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||805||805|1933 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl|með rotvörn|B01AB04|01.04.1993||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|14058|19370|lyfsjukr|||00|4|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||14058||14058|19370 085542|G03GA0202|Menopur|sts|0| |75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|21795|29320|lyfalmen|||00|375|0|12|Vistor hf|Ferring Lægemidler A/S|||21795||21795|29320 085551|G03GA0202|Menopur|sts|0| |75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|38776|50461|lyfalmen|||00|750|0|25|Vistor hf|Ferring Lægemidler A/S|||38776||38776|50461 085829|S01EB0104|Pilokarpin|augndr|2|%|0,15|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1929|3458|lyfalmen|||00|3|1|8|Parlogis hf|Parlogis - óskráð lyf|||1929||1929|3458 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4867|5545|lyfalmen|V1911|5236|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|||3467||3467|5545 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5852|7797|lyfalmen|V1913|7334|00|100|0|150|Vistor hf|Sanofi-aventis Norge AS|||5126||5126|7797 086199|J01DD0202|Fortum|sts|500|mg/hgl|5|hgl|1|pakki||J01DD02|01.08.2002|31.12.2008|R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|5703|8165|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5703||5703|8165 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|8918|12768|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||8918||8918|12768 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|14726|20201|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||14726||14726|20201 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|68162|86729|lyfsjukr|||00|1|0|9|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||68162||68162|86729 087014|J05AF1101|Sebivo|filmhtfl|600|mg|28|stk|1|þpakki||J05AF11|01.07.2008||R|A|2|0|1|0|1|NOH|0|0|0|100|DKK|79541|100896|lyfsjukr|||00|28|0|0|Vistor hf|Novartis Healthcare A/S-|||79541||79541|100896 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3471|5551|lyfalmen|||00|28|0|28|Vistor hf|N.V. Organon|||3471||3471|5551 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|glas|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|30|0|14|Vistor hf|Janssen-Cilag AB|||||| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|172562|216707|lyfsjukr|||00|60|0|0|Vistor hf|Pfizer Limited|||172562||172562|216707 087270|C07AB0309|Atenolol Actavis|töflur|50|mg|100|stk|1|glas||C07AB03|01.10.1985|31.12.2008|R|A|4|0|0|B|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|100|0|67|Actavis Group hf|Actavis hf||610|610|610|| 087296|C07AB0309|Atenolol Actavis|töflur|100|mg|100|stk|1|glas||C07AB03|01.10.1985||R|A|4|0|0|B|0|ACA|0|0|0|100|IKR|815|1946|lyfalmen|V0306|1946|00|100|0|133|Actavis Group hf|Actavis hf|||815||815|1946 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|261|1195|lyfalmen|||00|10|0|10|Vistor hf|Sanofi-aventis Norge AS|||261||261|1195 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|230|1152|lyfalmen|V0886|1152|00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|||230||230|1152 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|2722|4534|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|||2722||2722|4534 087445|A02BX1301|Gaviscon|mixtúra|0| |500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|30|IKR|||lyfalmen|||01|500|0|0|Vistor hf|Nordic Drugs AB||||||0 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|SER|0|0|0|100|SEK|789|1911|lyfalmen|||00|5|0|28|Gróco ehf|Serono|||789||789|1911 087760|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf||||||0 087769|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2004||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 087778|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 087787|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf||||||0 087796|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf||||||0 087805|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 087814|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 087823|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf||||||0 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|15877|21952|lyfalmen|V0560|21952|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|||15877||15877|21952 087932|A02BX1301|Gaviscon|tuggutfl|0| |20|stk|1|þpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|30|DKK|||lyflausa|||00|20|0|0|Vistor hf|Nordic Drugs AB|||||| 088006|N07BA0126|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf||||||0 088015|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf||||||0 088051|L03AB0503|IntronA (Lyfjaver)|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|25393|33482|lyfsjukr|||00|1|0|9|Lyfjaver ehf|Lyfjaver ehf|||25393||25393|33482 088224|L03AB0503|IntronA (Lyfjaver)|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|41360|53361|lyfsjukr|||00|1|0|15|Lyfjaver ehf|Lyfjaver ehf|||41360||41360|53361 088233|L03AB0503|IntronA (Lyfjaver)|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|84660|107269|lyfsjukr|||00|1|0|30|Lyfjaver ehf|Lyfjaver ehf|||84660||84660|107269 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1402|2743|lyfalmen|||00|120|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||1402||1402|2743 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1659|3092|lyfalmen|||14|20|0|20|Icepharma hf|Meda AB|||1659||1659|3092 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|8223|11999|lyfalmen|||14|100|0|100|Icepharma hf|Meda AB|||8223||8223|11999 088393|A03FA0101|Primperan|eþ-stil|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|478|1489|lyfalmen|||04|6|0|4|Vistor hf|Sanofi-aventis Norge AS|||478||478|1489 088632|C09CA0302|Diovan (D.A.C.)|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.05.2007||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|16053|17896|lyfalmen|V1111|14609|00|98|0|196|D.A.C. ehf|D.A.C. ehf|||12619||12619|17896 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|þpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|173165|217458|lyfsjukr|||00|70|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||173165|217458 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|52841|65341|lyfalmen|V0561|65341|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|||50728||50728|65341 089003|G03CA0308|Progynon|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1317|2628|lyfalmen|V0408|2134|00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|||1317||1317|2628 089094|A02BX1301|Gaviscon|tuggutfl|0| |120|stk|1|þpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|30|DKK|||lyflausa|||00|120|0|0|Vistor hf|Nordic Drugs AB|||||| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|172562|216707|lyfsjukr|||00|60|0|0|Vistor hf|Pfizer Limited|||172562||172562|216707 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2228|3864|lyfalmen|V0352|1798|00|100|0|25|Vistor hf|Ferrosan A/S|||2228||2228|3864 090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|43648|56209|lyfsjukr|||00|20|0|0|Vistor hf|Merck KgaA (V)|||43648||43648|56209 090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|218236|273571|lyfsjukr|||00|100|0|0|Vistor hf|Merck KgaA (V)|||218236||218236|273571 090451|L04AB0102|Enbrel (Lyjaver)|sts|0| |50|mg|4|hgl|+ leysir|L04AB01|01.06.2007|31.12.2008|R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|186155|233630|lyfsjukr|||00|200|0|29|Lyfjaver ehf|Lyfjaver ehf|||186155||186155|233630 090460|L04AB0102|Enbrel (Lyjaver)|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|82691|104818|lyfsjukr|||00|100|0|14|Lyfjaver ehf|Lyfjaver ehf|||82691||82691|104818 090469|L04AB0102|Enbrel (Lyjaver)|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|172427|216539|lyfsjukr|||00|200|0|29|Lyfjaver ehf|Lyfjaver ehf|||172427||172427|216539 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1807|3293|lyfalmen|||24|16|0|30|Vistor hf|Sanofi-aventis Norge AS|||1807||1807|3293 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|420|1410|lyfalmen|||00|60|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|||420||420|1410 091360|C08DB0108|Korzem-R|forðatfl|120|mg|60|stk|1|þpakki||C08DB01|01.04.2008||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2253|3898|lyfalmen|V0351|3898|10|60|0|30|Actavis Group hf|Actavis hf|||2253||2253|3898 091642|L03AX1302|Copaxone (Lyfjaver)|stl|20|mg/spr|28|spr|1|pakki|lausn|L03AX13|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|135848|170998|lyfsjukr|||00|28|0|0|Lyfjaver ehf|Lyfjaver ehf|||135848||135848|170998 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1772|2264|lyfalmen|V0001|1884|00|90|0|45|Vistor hf|Aventis Pharma |||1049||1049|2264 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3188|3099|lyfalmen|V0002|2489|00|90|0|90|Vistor hf|Aventis Pharma |||1664||1664|3099 092014|L03AB0703|Rebif (Lyfjaver)|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|135867|171022|lyfsjukr|||00|6|0|61|Lyfjaver ehf|Lyfjaver ehf|||135867||135867|171022 092024|L03AB0703|Rebif (Lyfjaver)|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|174958|219690|lyfsjukr|||00|6|0|123|Lyfjaver ehf|Lyfjaver ehf|||174958||174958|219690 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7806|15040|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||7806||7806|15040 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|7400|10883|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||7400||7400|10883 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A|5|0|0|*|0|DAC|0|1|0|100|DKK|10995|15761|lyfalmen|V1400|15761|00|100|0|33|D.A.C. ehf|D.A.C. ehf|||10995||10995|15761 092769|C09DA0305|Diovan Comp 320/12,5 mg|filmhtfl|332,5|mg|98|stk|1|þpakki|320/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|28275|37387|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|||||28275|37387 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|þpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|28275|37387|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|||||28275|37387 093215|L01XC0602|Erbitux (Lyfjaver)|irl|2|mg/ml|50|ml|1|hgl|lausn|L01XC06|01.06.2007|31.12.2008|R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|40675|52508|lyfsjukr|||00|50|0|0|Lyfjaver ehf|Lyfjaver ehf|||40675||40675|52508 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|5555|8379|lyfalmen|||00|1|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5555||5555|8379 093496|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|SCH|0|0|0|100|SEK|6783|10045|lyfalmen|||00|60|0|32|Icepharma hf|Schering Oy|||6783||6783|10045 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|28233|48859|vetorma|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||28233||28233|48859 093625|B03AA0702|Ferlen-R|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.04.1993||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|100|0|50|Actavis Group hf|Actavis hf|||||| 093641|QN05CM9202|Xylapan, vet.|stl|20|mg/ml|50|ml|1|hgl||QN05CM92|01.04.1992|31.12.2008|R|A|3|0|0|0|0|VEQ|1|0|0|100|CHF|5124|9932|vetalmen|||00|50|0|0|Icepharma hf|Vétoquinol AG|||5124||5124|9932 093708|L01DB0701|Novantrone|irþ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|18015|24296|lyfsjukr|||00|5|0|0|Icepharma hf|Wyeth AB|||18015||18015|24296 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|18911|25729|lyfalmen|||10|28|0|30|Icepharma hf|Norpharma |||18911||18911|25729 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|62350|79811|lyfalmen|||10|98|0|261|Icepharma hf|Norpharma |||62350||62350|79811 093823|S01EC0102|Diamox Depot|forðahlk|250|mg|100|stk|1|hylki||S01EC01|01.04.1998||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|2248|3891|lyfalmen|||10|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|||2248||2248|3891 093849|S01EC0102|Diamox Depot|forðahlk|500|mg|100|stk|1|hylki||S01EC01|01.12.1972||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|4496|6942|lyfalmen|||10|100|0|67|Icepharma hf|Goldshield Pharmaceuticals Ltd|||4496||4496|6942 093969|G03FB0507|Trisekvens (D.A.C.)|töflur|0| |84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|2798|4637|lyfalmen|V0385|4637|23|84|0|84|D.A.C. ehf|D.A.C. ehf|||2798||2798|4637 094132|QM01A0001|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|1902|3753|vetalmen|||00|8|0|0|Vistor hf|Boehringer Ingelheim|||1902||1902|3753 094287|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|13887|19474|lyfalmen|||00|50|0|5|Vistor hf|Astellas Phama Europe B.V.|||13887||13887|19474 094296|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|19892|26951|lyfalmen|||00|50|0|10|Vistor hf|Astellas Phama Europe B.V.|||19892||19892|26951 094305|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|89510|113622|lyfalmen|||00|50|0|10|Vistor hf|Astellas Phama Europe B.V.|||89508||89508|113622 094933|A03000001|Relistor|stl|20|mg/ml|0,6|ml|7|hgl|lausn|A030000|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|USD|50105|64566|lyfalmen|||0|84|0|0|Icepharma hf|Wyeth Europe|||50105||50105|64566 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|2980|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1577||1577|2980 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|3530|5631|lyfalmen|||00|50|0|100|Actavis Group hf|Actavis Group hf|||3530||3530|5631 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|16041|22156|lyfalmen|||00|28|0|0|Vistor hf|Janssen-Cilag International N.V.|||16041||16041|22156 095662|N05AX1301|Invega|forðatfl|3|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|38630|50279|lyfalmen|||00|56|0|0|Vistor hf|Janssen-Cilag International N.V.|||38630||38630|50279 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|16041|22156|lyfalmen|||00|28|0|0|Vistor hf|Janssen-Cilag International N.V.|||16041||16041|22156 095689|N05AX1301|Invega|forðatfl|6|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|35005|45766|lyfalmen|||00|56|0|0|Vistor hf|Janssen-Cilag International N.V.|||35005||35005|45766 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|16041|22156|lyfalmen|||00|28|0|0|Vistor hf|Janssen-Cilag International N.V.|||16041||16041|22156 095716|N05AX1301|Invega|forðatfl|9|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|61634|78919|lyfalmen|||00|56|0|0|Vistor hf|Janssen-Cilag International N.V.|||61634||61634|78919 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|3886|7573|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3886||3886|7573 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|5128|9939|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5128||5128|9939 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|9338|17959|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9338||9338|17959 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2489|3564|lyfsjukr|||02|60|0|0|Icepharma hf|Baxter Medical AB|||2489||2489|3564 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|14590|20032|lyfsjukr|||17|10|0|0|Vistor hf|Octapharma AB|||14590||14590|20032 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|145899|183512|lyfsjukr|||17|100|0|0|Vistor hf|Octapharma AB|||145899||145899|183512 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|1487|2858|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||1487||1487|2858 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|17157|23545|lyfalmen|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|||17157||17157|23545 096351|S01AA1302|Fucithalmic (D.A.C.)|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.06.2007||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|843|1855|lyfalmen|V1500|1855|07|5|0|0|D.A.C. ehf|D.A.C. ehf|||748||748|1855 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|17157|23545|lyfalmen|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|||17157||17157|23545 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1641|3067|lyfalmen|||00|30|0|18|Icepharma hf|Servier|||1641||1641|3067 096688|N06DA0301|Exelon|forðapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|34316|44908|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||34316||34316|44908 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|94621|119671|lyfsjukr|||00|1|0|0|Vistor hf|Pfizer Limited|||94621||94621|119671 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|3663|3936|lyfalmen|V0426|3936|00|20|0|5|D.A.C. ehf|D.A.C. ehf|||2281||2281|3936 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1185|2448|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|||1185||1185|2448 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13690|18912|lyfsjukr|||00|20|1|0|Distica|Distica - óskráð lyf|||13690||13690|18912 097642|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|1|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1849|3350|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1849||1849|3350 097790|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|9305|9734|lyfalmen|V0714|8265|10|100|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6554||6554|9734 097816|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12189|12785|lyfalmen|V0715|10978|10|100|0|22|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8802||8802|12785 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4139|3826|lyfalmen|V0003|3042|00|90|0|135|Vistor hf|Aventis Pharma |||2200||2200|3826 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4556|lyfalmen|V0831|4556|00|12|0|12|Actavis Group hf|Actavis Group PTC ehf|||2738||2738|4556 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3442|lyfalmen|V0832|3442|00|6|0|12|Actavis Group hf|Actavis Group PTC ehf|||1917||1917|3442 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1583|2989|lyfalmen|V1151|2989|00|30|0|15|Actavis Group hf|Actavis Group PTC ehf|||1583||1583|2989 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|7010|10353|lyfalmen|V1110|10353|00|98|0|98|Actavis Group hf|Actavis hf|||7010||7010|10353 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|10146|14609|lyfalmen|V1111|14609|00|98|0|196|Actavis Group hf|Actavis hf|||10146||10146|14609 098228|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|10|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|17981|24571|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||17981||17981|24571 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|669|1748|lyfalmen|||06|5|1|25|Distica|Distica - óskráð lyf|||669||669|1748 098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21589|29061|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||21587||21587|29061 099242|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.04.1988||R|A|3|0|0|E|0|LEP|0|0|1|100|DKK|763|1876|lyfalmen|V1500|1855|07|5|0|0|Vistor hf|LEO Pharma A/S|||763||763|1876 099476|N05AH0404|Quetiapin Merck NM|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|5544|8364|lyfalmen|V0725|8364|00|100|0|6|Actavis Group PTC ehf|Merck NM AB (A)|||5544||5544|8364 099485|N05AH0404|Quetiapin Merck NM|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|12659|17945|lyfalmen|V0726|17945|00|100|0|25|Actavis Group PTC ehf|Merck NM AB (A)|||12659||12659|17945 099494|N05AH0404|Quetiapin Merck NM|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|20485|27689|lyfalmen|V0727|27689|00|100|0|50|Actavis Group PTC ehf|Merck NM AB (A)|||20485||20485|27689 099620|N02AX0210|Nobligan (D.A.C.)|hylki|50|mg|20|stk|1|pakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|609|1667|lyfalmen|V0730|1238|10|20|0|3|D.A.C. ehf|D.A.C. ehf|||609||609|1667 099705|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyfalmen|||00|500|0|500|Icepharma hf|Mundipharma||||||0 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyfalmen|||00|500|0|500|Icepharma hf|Mundipharma||||||0 099746|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf||||||0 099755|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf||||||0 099861|H01AC0104|Saizen|sts|0| |3,33|mg|10|hgl|+ leysir|H01AC01|01.07.1992|31.12.2008|R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|143350|180338|lyfsjukr|||02|33|0|50|Gróco ehf|Serono Nordic|||143350||143350|180338 100008|V08AB0501|Ultravist|stl/irl|300|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|46433|59677|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|||46433||46433|59677 100016|V08AB0501|Ultravist|stl/irl|300|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|68734|87441|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|||68734||68734|87441 100024|V08AB0501|Ultravist|stl/irl|370|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|50277|64462|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|||50277||50277|64462 100032|V08AB0501|Ultravist|stl/irl|370|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|111633|140851|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|||111633||111633|140851 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|14001|19616|lyfalmen|||00|28|0|7|Eli Lilly Danmark A/S|Lilly ICOS Limited|||||14001|19616 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|14001|19616|lyfalmen|||00|28|0|14|Eli Lilly Danmark A/S|Lilly ICOS Limited|||||14001|19616 100305|G03GA0701|Luveris|sts|75|ae/hgl|1|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|13426|18900|lyfalmen|||00|1|0|1|Gróco ehf|Ares-Serono|||13426||13426|18900 100412|M01AC0101|Felden|töflur|20|mg|30|stk|1|þpakki||M01AC01|01.01.1997||R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|2176|3793|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2176||2176|3793 101386|R06AX1301|Clarityn|mixtúra|1|mg/ml|100|ml|1|glas||R06AX13|01.10.1995||L|A|3|0|0|E|0|SCP|0|0|1|100|DKK|||lyfalmen|||00|100|0|10|Vistor hf|Schering-Plough||||||2018 101543|G03GA0701|Luveris|sts|75|ae/hgl|3|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|40276|52329|lyfalmen|||00|3|0|3|Gróco ehf|Ares-Serono|||40276||40276|52329 101550|G03GA0701|Luveris|sts|75|ae/hgl|10|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|134255|169332|lyfalmen|||00|10|0|10|Gróco ehf|Ares-Serono|||134255||134255|169332 101691|C08CA0502|Adalat Oros|forðatfl|20|mg|28|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|2004|3560|lyfalmen|||00|28|0|19|Vistor hf|Bayer HealthCare AG|||2004||2004|3560 101709|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|6288|9374|lyfalmen|||00|98|0|65|Vistor hf|Bayer HealthCare AG|||6288||6288|9374 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|2570|4328|lyfalmen|V1152|4328|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|||2570||2570|4328 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|9147|13253|lyfalmen|V1153|13253|00|96|0|96|Actavis Group hf|Actavis Group PTC ehf|||9147||9147|13253 101769|N02AX0211|Nobligan Retard (D.A.C.)|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|9384|13575|lyfalmen|V0736|10980|00|100|0|50|D.A.C. ehf|D.A.C. ehf|||9384||9384|13575 102863|C01DA1401|Imdur|forðatfl|60|mg|28|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1460|2822|lyfalmen|||43|28|0|42|Vistor hf|AstraZeneca A/S DK|||1460||1460|2822 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2991|4899|lyfalmen|V0139|2746|43|98|0|147|Vistor hf|AstraZeneca A/S DK|||2991||2991|4899 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1994||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|2332|3339|lyfsjukr|||02|50|0|0|Vistor hf|AstraZeneca UK Ltd|||2332||2332|3339 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1988||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|4839|6928|lyfsjukr|||00|50|0|0|Vistor hf|AstraZeneca UK Ltd|||4839||4839|6928 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|1,25|0|0|B|0|POF|0|0|0|100|XEU|7557|9980|lyfalmen|V0198|9980|00|98|0|98|PortFarma ehf|PortFarma |||6735||6735|9980 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|A|1,25|0|0|B|0|POF|0|0|0|100|XEU|12512|15971|lyfalmen|V0193|15971|00|98|0|196|PortFarma ehf|PortFarma |||11150||11150|15971 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|4295|6362|lyfalmen|V0197|6362|00|98|0|98|PortFarma ehf|PortFarma |||4069||4069|6362 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|30|GBP|2597|3853|lyfalmen|V0507|3853|00|10|0|2|PortFarma ehf|PortFarma |||2220||2220|3853 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|30|GBP|10795|13356|lyfalmen|V0508|13317|00|40|0|7|PortFarma ehf|PortFarma |||9223||9223|13356 103678|N06AX1604|Venlafaxin Portfarma|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|15733|19625|lyfalmen|V0955|19625|00|100|0|75|PortFarma ehf|PortFarma |||14008||14008|19625 103687|N06AX1604|Venlafaxin Portfarma|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|29942|35373|lyfalmen|V0956|35373|00|100|0|150|PortFarma ehf|PortFarma |||26657||26657|35373 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5|Vistor hf|Orion Pharma||||||1823 103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||00|1|0|1|Vistor hf|Orion Pharma||||||0 104034|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||13480||13480|18650 104356|N05BA0204|Klordiazepoxið Actavis|töflur|5|mg|30|stk|1|glas||N05BA02|01.10.1995|31.12.2008|R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|193|1102|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|||193||193|1102 104372|N05BA0204|Klordiazepoxið Actavis|töflur|5|mg|100|stk|1|glas||N05BA02|01.10.1995|31.12.2008|R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|475|1485|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||475||475|1485 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|3958|6212|lyfalmen|||23|2|0|10|Vistor hf|Ferring Lægemidler A/S|||3958||3958|6212 104498|N05CH0101|Circadin|forðatfl|2|mg|21|stk|1|þpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2732|4548|lyfalmen|||00|21|0|0|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|||2732||2732|4548 104760|A07EC0202|Pentasa|eþ-stil|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|9985|14391|lyfalmen|||04|28|0|19|Vistor hf|Ferring|||9985||9985|14391 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|5794|8703|lyfalmen|||56|700|0|5|Vistor hf|Ferring|||5794||5794|8703 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|7099|10474|lyfalmen|||10|100|0|33|Vistor hf|Ferring|||7099||7099|10474 105023|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5432|7777|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||5432||5432|7777 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|4021|6297|lyfalmen|V0084|6297|00|28|0|19|D.A.C. ehf|D.A.C. ehf|||4021||4021|6297 105287|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|7926|11596|lyfalmen|V0086|11596|00|56|0|37|D.A.C. ehf|D.A.C. ehf|||7926||7926|11596 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|14007|19624|lyfalmen|V0087|19624|00|100|0|67|D.A.C. ehf|D.A.C. ehf|||14007||14007|19624 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|18909|25727|lyfalmen|V0089|25727|00|100|0|133|D.A.C. ehf|D.A.C. ehf|||18909||18909|25727 105379|N03AG0601|Gabitril|töflur|10|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|19878|26933|lyfalmen|||00|100|0|33|Icepharma hf|Cephalon France|||19878||19878|26933 105387|N03AG0601|Gabitril|töflur|15|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|16400|22603|lyfalmen|||00|50|0|25|Icepharma hf|Cephalon France|||16400||16400|22603 105395|N03AG0601|Gabitril|töflur|15|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|29819|39310|lyfalmen|||00|100|0|50|Icepharma hf|Cephalon France|||29819||29819|39310 105403|N03AG0601|Gabitril|töflur|5|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|8200|11968|lyfalmen|||00|50|0|8|Icepharma hf|Cephalon France|||8200||8200|11968 105437|N03AG0601|Gabitril|töflur|5|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|14909|20747|lyfalmen|||00|100|0|17|Icepharma hf|Cephalon France|||14909||14909|20747 105445|N03AG0601|Gabitril|töflur|10|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|10933|15677|lyfalmen|||00|50|0|17|Icepharma hf|Cephalon France|||10933||10933|15677 105586|C09XA02|Rasilez|filmhtfl|150|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4958|7569|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4958||4958|7569 105597|C09XA02|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|15380|21333|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||15380||15380|21333 105608|C09XA02|Rasilez|filmhtfl|300|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4958|7569|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4958||4958|7569 105620|C09XA02|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|16381|22579|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||16381||16381|22579 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2359|4042|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||2359||2359|4042 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2569|4327|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||2569||2569|4327 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|3554|5663|lyfalmen|||63|14|0|7|Vistor hf|Abbott Scandinavia AB|||3554||3554|5663 106486|C09AA0207|Enalapril Portfarma|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|802|1929|lyfalmen|V0167|1929|0|100|0|50|PortFarma ehf|PortFarma|||802||802|1929 106497|C09AA0207|Enalapril Portfarma|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|1153|2405|lyfalmen|V0168|2405|0|100|0|100|PortFarma ehf|PortFarma|||1153||1153|2405 106508|C09AA0207|Enalapril Portfarma|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|2725|4538|lyfalmen|V0169|4538|0|100|0|200|PortFarma ehf|PortFarma|||2725||2725|4538 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|30|GBP|19086|25630|lyfsjukr|||00|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||19086||19086|25630 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|30|GBP|10555|15008|lyfsjukr|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||10555||10555|15008 106963|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|þpakki||M05BA02|01.03.2004||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|17938|24518|lyfalmen|||10|30|0|15|Icepharma hf|Leiras Oy|||17938||17938|24518 107050|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|15306|21241|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||15306||15306|21241 107061|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|23044|30875|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||23044||23044|30875 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|2071|3651|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2071||2071|3651 107268|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|glas||M05BA02|01.01.1997||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|17938|24518|lyfalmen|||10|30|0|15|Icepharma hf|Leiras Oy|||17938||17938|24518 107532|N02BE0106|Parasupp|eþ-stil|60|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|0|Actavis Group hf|Actavis hf||||||0 107581|N02BE0106|Parasupp|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.06.1984|31.12.2008|L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|0|Actavis Group hf|Actavis hf||||||0 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|ICV|0|0|0|100|XEU|||vetorma|||16|6|0|0|Icepharma hf|Icevet ehf||||||2843 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|30|IKR|1117|2356|lyfalmen|||00|60|0|30|Actavis Group hf|Actavis hf|||1117||1117|2356 108183|N02BE0106|Parasupp|eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.06.1984|31.12.2008|L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|1|Actavis Group hf|Actavis hf||||||0 108209|N02BE0106|Parasupp|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|2|Actavis Group hf|Actavis hf||||||0 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|3078|5017|lyfalmen|||63|100|0|33|Vistor hf|Bayer HealthCare AG|||3078||3078|5017 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|4658|7162|lyfalmen|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|||4658||4658|7162 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|12707|18005|lyfalmen|||00|90|0|0|Vistor hf|Novartis Europharm Ltd|||12707||12707|18005 108803|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|12|hgl|20mg/ml+36mcg/ml|QN01BB52|01.12.2003||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1152|2273|vetalmen|||27|1200|0|0|Icepharma hf|Kela Laboratoria NV|||1152||1152|2273 108845|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1051|2267|lyfalmen|||24|120|0|19|Vistor hf|AstraZeneca A/S DK|||1051||1051|2267 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1539|2929|lyfalmen|V0965|2850|24|120|0|38|Vistor hf|AstraZeneca A/S DK|||1539||1539|2929 108860|N02AX0203|Tramol|hylki|50|mg|20|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|293|1238|lyfalmen|V0730|1238|00|20|0|3|Actavis Group hf|Actavis hf|||293||293|1238 108878|N02AX0203|Tramol|hylki|50|mg|100|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|504|1524|lyfalmen|V0731|1524|00|100|0|17|Actavis Group hf|Actavis hf|||504||504|1524 109207|N02AA5901|Panocod|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|220|1139|lyfalmen|V0775|991|00|20|0|7|Vistor hf|Sanofi-aventis Norge AS|||220||220|1139 109223|N02AA5901|Panocod|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|1|0|0|0|SNO|0|0|1|100|NOK|842|1983|lyfalmen|V0780|1417|00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|||842||842|1983 109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25851|34369|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||25851||25851|34369 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20696|27951|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20696||20696|27951 109462|V01AA0301|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V01AA03|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8035|11744|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8035||8035|11744 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|20|0|3|Actavis Group hf|Actavis hf||||||0 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf||||||0 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|379|1355|lyfalmen|V0772|1355|00|100|0|17|Actavis Group hf|Actavis hf|||379||379|1355 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|681|1765|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|||681||681|1765 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|760|1872|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|||760||760|1872 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3c|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|3|0|0|Ísaga ehf|AGA AB||||||0 110395|G03AA0902|Mercilon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1639|3065|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|||1639||1639|3065 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|4803|7358|lyfalmen|||10|100|0|83|Vistor hf|Orion Corporation|||4803||4803|7358 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|798|1923|lyfalmen|||00|100|0|33|Icepharma hf|GlaxoSmithKline CH A/S|||798||798|1923 112359|S01AA1101|Garamycin|augndr|3|mg/ml|5|ml|1|glas||S01AA11|01.03.1977||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|858|2005|lyfalmen|||06|5|0|0|Vistor hf|Schering-Plough|||858||858|2005 112441|A10BB0701|Mindiab|töflur|2,5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|1364|2691|lyfalmen|||68|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1364||1364|2691 112615|C01DA0201|Discotrine|forðapl|15|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|DKK|3833|6042|lyfalmen|||23|30|0|90|Vistor hf|Meda AB (V)|||3833||3833|6042 113394|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|10272|14780|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||10272|14780 113403|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|28275|37387|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||28275|37387 113412|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|10272|14780|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||10272|14780 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3380|5427|lyfalmen|||00|2|0|10|Vistor hf|Sanofi-aventis Norge AS|||3380||3380|5427 113421|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|28275|37387|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||28275|37387 113639|A02AD0105|Novaluzid|tuggutfl|500|mg|100|stk|1|þpakki||A02AD01|01.03.1983||L|A|3|0|0|0|0|BIP|0|0|0|100|IKR|||lyflausa|||11|100|0|10|Vistor hf|BioPhausia AB|||||| 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5482|8280|lyfalmen|||00|4|0|20|Vistor hf|Sanofi-aventis Norge AS|||5482||5482|8280 113796|L01XC0602|Erbitux (Lyfjaver)|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2008||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|36146|46869|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|||36146||36146|46869 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|784093|978063|lyfsjukr|||00|112|0|0|Vistor hf|Novartis Europharm Ltd|||784093||784093|978063 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|643|1713|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|||643||643|1713 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|938|2113|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|||938||938|2113 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1245|2530|lyfalmen|||00|40|0|20|Vistor hf|Recip AB|||1245||1245|2530 114033|R03AC0210|Ventolin Diskus|innúðadu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|809|1938|lyfalmen|||23|60|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||809||809|1938 114395|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|100|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|30|IKR|2160|3772|lyfalmen|V0919|3772|00|100|0|100|Gróco ehf|Ranbaxy (UK) Ltd|||||2160|3772 114406|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|60|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|30|IKR|1390|2727|lyfalmen|V0918|2727|00|60|0|60|Gróco ehf|Ranbaxy (UK) Ltd|||||1390|2727 114417|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|20|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|30|IKR|526|1554|lyfalmen|V0917|1554|00|20|0|20|Gróco ehf|Ranbaxy (UK) Ltd|||||526|1554 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2773|4603|lyfalmen|V0989|4527|06|5|0|0|Icepharma hf|M.S.D.|||2773||2773|4603 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|4419|6837|lyfalmen|||0|750|0|0|Vistor hf|Boehringer Ingelheim International|||4419||4419|6837 115285|J01CA0410|Amoxicillin Merck NM|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1813|3301|lyfalmen|||00|20|0|15|Actavis Group PTC ehf|Merck NM AB|||1813||1813|3301 115318|B01AE0701|Pradaxa|hylki|75|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|13246|18676|lyfalmen|||0|2250|0|0|Vistor hf|Boehringer Ingelheim International|||13246||13246|18676 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|26493|35169|lyfalmen|||0|4500|0|0|Vistor hf|Boehringer Ingelheim International|||26493||26493|35169 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|4419|6837|lyfalmen|||0|1100|0|0|Vistor hf|Boehringer Ingelheim International|||4419||4419|6837 115353|B01AE0701|Pradaxa|hylki|110|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|13246|18676|lyfalmen|||0|3300|0|0|Vistor hf|Boehringer Ingelheim International|||13246||13246|18676 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|26493|35169|lyfalmen|||0|6600|0|0|Vistor hf|Boehringer Ingelheim International|||26493||26493|35169 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2045|3616|lyfalmen|V1090|3559|06|5|0|17|Icepharma hf|M.S.D.|||2045||2045|3616 115808|R06AX0201|Periactin|töflur|4|mg|100|stk|1|þpakki||R06AX02|01.10.2005||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|1293|2595|lyfalmen|||00|100|0|33|Icepharma hf|M.S.D.|||1293||1293|2595 115931|R03AC1202|Serevent Diskus|innúðadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3735|5909|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3735||3735|5909 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|3|0|0|0|0|NOP|0|0|0|100|IKR|||lyfalmen|||23|55|0|0|Icepharma hf|Norpharma ||||||0 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|4008|5738|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4008||4008|5738 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|2095|3000|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2095||2095|3000 116137|D07AC1301|Elocon|krem|1|mg/g|20|g|1|túpa|feitt|D07AC13|01.04.1994||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|949|2128|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||949||949|2128 116160|D07AC1301|Elocon|krem|1|mg/g|50|g|1|túpa|feitt|D07AC13|01.04.1994||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|2099|3689|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|||2099||2099|3689 116244|D11AF01|Verucid|áburður|0| |10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyfalmen|||23|10|0|10|Icepharma hf|Galderma Nordic AB||||||0 116368|D07AC1301|Elocon|smyrsli|1|mg/g|20|g|1|túpa||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|949|2128|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||949||949|2128 116400|D07AC1301|Elocon|smyrsli|1|mg/g|50|g|1|túpa||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2087|3673|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|||2087||2087|3673 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|20|0|3|Actavis Group hf|Actavis hf|||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|A|2|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|V0670|1284|00|30|0|10|Actavis Group hf|Actavis hf||||||1284 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|þpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|843|1984|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|||843||843|1984 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|472|1481|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|||472||472|1481 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|þpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|1140|2387|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|||1140||1140|2387 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|19398|26335|lyfalmen|||00|84|0|0|Vistor hf|Pfizer Limited|||||19398|26335 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|6865|10157|lyfalmen|||00|28|0|0|Vistor hf|Pfizer Limited|||||6865|10157 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|7292|10736|lyfalmen|||00|28|0|0|Vistor hf|Pfizer Limited|||||7292|10736 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|21972|29540|lyfalmen|||00|84|0|0|Vistor hf|Pfizer Limited|||||21972|29540 116997|N05AX1203|Abilify (Lyfjaver)|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|NOK|32415|42542|lyfalmen|V1702|42542|00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|||32415||32415|42542 117008|N05AX1203|Abilify (Lyfjaver)|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|NOK|32415|42542|lyfalmen|V1703|42542|00|56|0|56|Lyfjaver ehf|Lyfjaver ehf|||32415||32415|42542 117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|9401|18079|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||9401||9401|18079 117515|M01AE0303|Orudis|forðahlk|200|mg|100|stk|1|hylki||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|8027|11733|lyfalmen|||10|100|0|133|Vistor hf|Sanofi-aventis Norge AS|||8027||8027|11733 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|6215|9274|lyfalmen|||00|100|0|33|Icepharma hf|Roche|||6215||6215|9274 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|13242|18671|lyfalmen|||00|100|0|12|Vistor hf|AstraZeneca UK Ltd|||||13242|18671 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|23404|31323|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca UK Ltd|||||23404|31323 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2562|4317|lyfalmen|||10|100|0|8|Icepharma hf|Roche|||2562||2562|4317 117573|N05AH0405|Seroquel Prolong|forðatfl|300|mg|10|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|4047|6332|lyfalmen|||00|10|0|8|Vistor hf|AstraZeneca UK Ltd|||||4047|6332 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|40469|52569|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|||||40469|52569 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|46808|60461|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca UK Ltd|||||46808|60461 117721|D11AF01|Verucid|hlaup|0| |5|g|1|túpa||D11AF|01.08.1984||L|A|3|0|0|0|0|GAN|0|0|0|100|DKK|||lyflausa|||23|5|0|5|Icepharma hf|Galderma Nordic AB|||||| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BHC|0|0|0|100|DKK|10351|17913|vetorma|||00|250|0|0|Vistor hf|Bayer HealthCare AG|||10351||10351|17913 117788|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|2820|4667|lyfalmen|||61|28|0|28|Vistor hf|Bayer HealthCare AG|||2820||2820|4667 117796|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|4961|7573|lyfalmen|||61|98|0|98|Vistor hf|Bayer HealthCare AG|||4961||4961|7573 117820|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|11895|16982|lyfalmen|||61|98|0|196|Vistor hf|Bayer HealthCare AG|||11895||11895|16982 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|6566|12678|vetalmen|||00|1200|0|0|Icepharma hf|Kela Laboratoria NV|||6566||6566|12678 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|11517|22109|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||11517||11517|22109 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|4257|5173|lyfalmen|V0809|4936|00|28|0|7|Actavis Group hf|Actavis Group PTC ehf|||3193||3193|5173 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|6051|7000|lyfalmen|V0810|6661|00|28|0|14|Actavis Group hf|Actavis Group PTC ehf|||4539||4539|7000 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|23466|24097|lyfalmen|V0812|22893|00|56|0|56|Actavis Group hf|Actavis Group PTC ehf|||17600||17600|24097 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|17926|18924|lyfalmen|V0815|18004|00|28|0|42|Actavis Group hf|Actavis Group PTC ehf|||13445||13445|18924 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1804|3288|lyfalmen|||65|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1804||1804|3288 118165|N06AX2103|Cymbalta (Lyfjaver)|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|3841|6053|lyfalmen|V1951|6053|00|28|0|14|Lyfjaver ehf|Lyfjaver ehf|||3841||3841|6053 118176|N06AX2103|Cymbalta (Lyfjaver)|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|18395|25087|lyfalmen|V1955|25087|00|98|0|98|Lyfjaver ehf|Lyfjaver ehf|||18395||18395|25087 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13619|lyfsjukr|||00|4|0|0|Ísaga ehf|AGA AB|||9512||9512|13619 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|A|3|0|0|E|0|ACA|0|0|0|30|IKR|||lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf||||||2172 118315|M01AB0505|Voltaren|eþ-stil|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|758|1869|lyfalmen|||04|5|0|5|Vistor hf|Novartis Healthcare A/S-|||758||758|1869 118323|M01AB0505|Voltaren|eþ-stil|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|7594|11146|lyfalmen|||04|50|0|50|Vistor hf|Novartis Healthcare A/S-|||7594||7594|11146 118349|D07AC1301|Elocon|áburður|1|mg/g|20|ml|1|glas||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|949|2128|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||949||949|2128 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|30|IKR|1062|2282|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|||1062||1062|2282 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|18448|19410|lyfalmen|V0811|18465|00|56|0|42|Actavis Group hf|Actavis Group PTC ehf|||13835||13835|19410 118570|A07EC0203|Pentasa Sachets|forðakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|9789|14125|lyfalmen|||00|50|0|33|Vistor hf|Ferring|||9789||9789|14125 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|28793|38032|lyfalmen|||00|150|0|100|Vistor hf|Ferring|||28793||28793|38032 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008|31.12.2008|R|A|5|0|0|*|0|LVR|0|1|0|100|NOK|||lyfalmen|||00|100|0|8|Lyfjaver ehf|Lyfjaver ehf||2641|2641|2641|| 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008|31.12.2008|R|A|5|0|0|*|0|LVR|0|1|0|100|NOK|||lyfalmen|||00|100|0|33|Lyfjaver ehf|Lyfjaver ehf||7823|7823|7823|| 119031|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|89495|113289|lyfsjukr|||00|5|0|0|Vistor hf|Amgen Europe B.V.|||89495||89495|113289 119305|B05BA0109|Vamin Glukos|irl|0| |1000|ml|6|fl||B05BA01|01.09.1998|31.12.2008|R|A|1.5|0|0|0|1|FRP|0|0|0|100|DKK|21823|29037|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||21823||21823|29037 119719|C09BA0801|Inhibace Comp.|töflur|17,5|mg|98|stk|1|pakki|þp ( 5+ 12,5 mg)|C09BA08|01.12.1997||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|13521|19019|lyfalmen|||00|98|0|98|Icepharma hf|Roche|||13521||13521|19019 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.03.2008||L|A|3|0|0|E|0|POF|0|0|1|100|IKR|||lyfalmen|V0670|1284|00|30|0|10|PortFarma ehf|PortFarma ||||||1284 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|496441|620254|lyfalmen|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||496441|620254 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|496441|620254|lyfalmen|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||496441|620254 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|1038|2249|lyfalmen|||06|10|0|0|K.Pétursson hf|Alcon|||1038||1038|2249 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|50116|64262|lyfsjukr|||00|1|0|0|Eli Lilly Danmark A/S|Lilly ICOS Limited|||||50116|64262 120341|N06DA0402|Reminyl (Lyfjaver)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|13118|17450|lyfalmen|V1370|17450|00|28|0|14|Lyfjaver ehf|Lyfjaver ehf|||12261||12261|17450 120353|N06DA0402|Reminyl (Lyfjaver)|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|40369|49194|lyfalmen|V1371|49194|00|84|0|84|Lyfjaver ehf|Lyfjaver ehf|||37758||37758|49194 120950|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|30|NOK|2822|4670|lyfalmen|V0939|4670|00|28|0|28|Lyfjaver ehf|Lyfjaver ehf|||2822||2822|4670 120961|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|200|stk|1|plglas||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|30|NOK|21066|28412|lyfalmen|||00|200|0|200|Lyfjaver ehf|Lyfjaver ehf|||21066||21066|28412 121269|N05CD0505|Triazolam NM Pharma|töflur|0,25|mg|100|stk|1|glas||N05CD05|01.07.1991||R|A|4|0|0|0|0|MNA|0|0|0|100|SEK|771|1887|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||771||771|1887 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|368|1340|lyfalmen|||24|200|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||368||368|1340 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|416|1405|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis UK Ltd.|||416||416|1405 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|2133|3735|lyfalmen|V0908|1684|00|100|0|25|Vistor hf|Novartis Healthcare A/S-|||2133||2133|3735 121863|A07EC0204|Asacol|eþ-stil|500|mg|30|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|3347|5382|lyfalmen|||98|30|0|10|Icepharma hf|Schering Oy|||3347||3347|5382 123166|M01AE5101|Ibukod|töflur|0| |100|stk|1|glas|10+200 mg|M01AE51|01.10.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1507|2885|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||1507||1507|2885 123216|N05BA0105|Stesolid|eþ-stil|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|587|1637|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|||587||587|1637 123224|N05BA0105|Stesolid|eþ-stil|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|916|2083|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|||916||916|2083 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|LDR|0|0|1|100|IKR|1755|3222|lyfalmen|||00|100|1|40|Parlogis hf|Parlogis - óskráð lyf|||1755||1755|3222 123319|M05BA0704|Optinate Septimum (Lyfjaver)|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|13293|18735|lyfalmen|V1080|18175|00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|||13293||13293|18735 123414|C01AA0504|Lanoxin mite|töflur|62,5|mcg|100|stk|1|glas||C01AA05|01.03.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|331|1290|lyfalmen|||00|100|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||331||331|1290 123596|N02AA5904|Ibukod sterkar|töflur|0| |100|stk|1|glas|30+200 mg|N02AA59|01.10.1998||R|A|2|1|0|0|0|ACA|0|0|1|100|IKR|2116|3712|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|||2116||2116|3712 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|40763|52935|lyfalmen|||00|56|0|28|Vistor hf|Aventis Pharma SA|||40763||40763|52935 124248|R06AD0301|Torecan|töflur|6,5|mg|20|stk|1|þpakki||R06AD03|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|623|1686|lyfalmen|||00|20|1|10|Parlogis hf|Parlogis - óskráð lyf|||623||623|1686 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1065|2286|lyfalmen|||00|30|0|19|Vistor hf|Novartis Healthcare A/S-|||1065||1065|2286 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|612|1671|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|||612||612|1671 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1153|2405|lyfalmen|V0168|2405|00|100|0|100|Actavis Group hf|Actavis hf|||1153||1153|2405 125163|C01BD0101|Cordarone (Lyfjaver)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.01.2009||R|A|5|0|0|B|0|LVR|0|0|0|100|NOK|2343|4020|lyfalmen|V0144|4020|0|30|0|15|Lyfjaver ehf|Lyfjaver ehf|||2343||2343|4020 126163|N05AX1202|Abilify (D.A.C)|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|DAC|0|1|0|100|DKK|23025|26294|lyfalmen|V1701|26294|00|28|0|6|D.A.C. ehf|D.A.C. ehf|||19365||19365|26294 126231|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|18532|25257|lyfalmen|V1732|20015|00|100|0|11|Lyfjaver ehf|Lyfjaver ehf|||18532||18532|25257 126242|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|16444|22658|lyfalmen|V1730|19827|00|100|0|22|Lyfjaver ehf|Lyfjaver ehf|||16444||16444|22658 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|18532|25257|lyfalmen|V1731|25257|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|||18532||18532|25257 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|þpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||10|16|0|3|Vistor hf|Janssen-Cilag AB||||||0 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|115771|146002|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||115771|146002 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|29711|38858|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||29711|38858 126540|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|27016|35502|lyfsjukr|||00|1|0|1|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|||27016||27016|35502 126561|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|E|0|RAN|0|0|0|30|XEU|2110|3704|lyfalmen|||00|28|0|14|Gróco ehf|Ranbaxy (UK) Ltd|||2110||2110|3704 126572|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|E|0|RAN|0|0|0|30|XEU|4222|6570|lyfalmen|||00|56|0|28|Gróco ehf|Ranbaxy (UK) Ltd|||4222||4222|6570 126583|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|28|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|E|0|RAN|0|0|0|30|XEU|3375|5420|lyfalmen|||00|28|0|28|Gróco ehf|Ranbaxy (UK) Ltd|||3375||3375|5420 126594|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|E|0|RAN|0|0|0|30|XEU|6749|9999|lyfalmen|||00|56|0|56|Gróco ehf|Ranbaxy (UK) Ltd|||6749||6749|9999 126649|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|9005|12893|lyfsjukr|||00|1|0|0|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|||9005||9005|12893 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|1765|3236|lyfalmen|||10|100|0|20|Vistor hf|Janssen-Cilag AB|||1765||1765|3236 127383|R02AA0302|Strepsils med honning og citron|sogtfl|0||36|stk|1|þpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyfalmen|||09|36|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 127647|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Actavis Group hf|Braun|||||| 127696|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Actavis Group hf|Braun|||||| 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|10269|6661|lyfalmen|V0810|6661|00|28|0|14|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||4289||4289|6661 128173|C08DA0107|Verapamil Merck NM|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|456|1459|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB|||456||456|1459 128280|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0|Actavis Group hf|Braun|||||| 128306|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|100|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|2000|0|0|Actavis Group hf|Braun|||||| 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1312|2621|lyfalmen|||10|100|0|50|Vistor hf|LEO Pharma A/S|||1312||1312|2621 128769|V07AB09|Sterilt Vatten Braun|leysir|0| |10|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|200|0|0|Actavis Group hf|Braun||||||0 128819|V07AB09|Sterilt Vatten Braun|leysir|0| |20|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|400|0|0|Actavis Group hf|Braun||||||0 128864|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|30|0|2|Vistor hf|McNeil Denmark ApS|||||| 128875|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|30|0|4|Vistor hf|McNeil Denmark ApS|||||| 128886|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|14|Vistor hf|McNeil Denmark ApS|||||| 128897|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|28|Vistor hf|McNeil Denmark ApS|||||| 128926|V07AB09|Sterilt Vatten Braun|leysir|0| |50|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|1000|0|0|Actavis Group hf|Braun||||||0 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|4288|6139|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|||4288||4288|6139 129098|N05AH0301|Zyprexa|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|31363|18465|lyfalmen|V0811|18465|00|56|0|42|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||13076||13076|18465 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|39876|22893|lyfalmen|V0812|22893|00|56|0|56|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||16633||16633|22893 129254|V07AB09|Sterilt Vatten Braun|leysir|0| |100|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|2000|0|0|Actavis Group hf|Braun||||||0 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0|0|Vistor hf|Recip AB||||||2820 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|2|ml|60|plastl|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|5290|8019|lyfalmen|||00|120|0|100|Vistor hf|Boehringer Ingelheim|||5290||5290|8019 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|16566|20183|lyfalmen|V0726|17945|00|100|0|25|Vistor hf|AstraZeneca UK Ltd|||14456||14456|20183 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|26223|30676|lyfalmen|V0727|27689|00|100|0|50|Vistor hf|AstraZeneca UK Ltd|||22884||22884|30676 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|4256|6616|lyfalmen|||02|125|0|31|Gróco ehf|Nycomed Danmark A/S|||4256||4256|6616 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|421|1412|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|||421||421|1412 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|807|1936|lyfalmen|||00|100|0|15|Vistor hf|Recip AB|||807||807|1936 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|884|2040|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|||884||884|2040 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|978|2168|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|||978||978|2168 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5897|8843|lyfalmen|||23|26|0|182|Vistor hf|Janssen-Cilag AB|||5897||5897|8843 131729|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|20|0|1|Vistor hf|McNeil Denmark ApS|||||| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|90|0|6|Vistor hf|McNeil Denmark ApS|||||| 131987|J01AA0203|Doxytab|töflur|100|mg|10|stk|1|glas||J01AA02|01.12.2008|31.12.2008|R|A|4|0|0|0|0|AGP|0|0|1|100|IKR|||lyfalmen|||00|10|0|10|Actavis Group hf|Actavis Group PTC ehf|||||| 131995|J01AA0203|Doxytab|töflur|100|mg|30|stk|1|glas||J01AA02|01.04.1987||R|A|4|0|0|0|0|ACA|0|0|1|100|IKR|1192|2458|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|||1192||1192|2458 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|259|1192|lyfalmen|||00|28|0|4|Actavis Group hf|Actavis UK Ltd.|||259||259|1192 132240|N06AA0905|Amitriptyline|töflur|25|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|342|1304|lyfalmen|||00|28|0|9|Actavis Group hf|Actavis UK Ltd.|||342||342|1304 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|13139|18543|lyfalmen|V0192|18543|00|98|0|196|Actavis Group hf|Actavis Group PTC ehf|||13139||13139|18543 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|9093|13180|lyfalmen|V0191|13180|00|98|0|98|Actavis Group hf|Actavis Group PTC ehf|||9093||9093|13180 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1553|2948|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|||1553||1553|2948 132761|D08AG0201|Betadine|áburður|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyfalmen|||23|8|0|8|Icepharma hf|Napp||||||0 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|ALC|0|0|0|100|USD|1184|2447|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|||1184||1184|2447 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyfalmen|||00|100|0|3|Vistor hf|Abigo Medical AB||||||0 132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|þpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|882|2037|lyfalmen|||23|84|0|84|Vistor hf|Janssen-Cilag AB|||882||882|2037 133074|L03AA1001|Granocyte|sts|33,6|millj ae|1|stk|5|hgl|+ leysir|L03AA10|01.07.1994||R|A|2|0|1|0|1|CSA|0|0|0|100|NOK|82804|104958|lyfsjukr|||02|5|0|4|Vistor hf|Chugai sanofi-aventis|||82804||82804|104958 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|9452|13667|lyfalmen|||10|100|0|25|Icepharma hf|Sandoz GmbH|||9452||9452|13667 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|þpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|117617|148301|lyfsjukr|||00|14|0|7|D.A.C. ehf|D.A.C. ehf|||117617||117617|148301 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|2524|4266|lyfalmen|||00|50|0|5|Vistor hf|Abbott Scandinavia AB|||2524||2524|4266 134862|J05AR0601|Atripla|filmhtfl|0| |30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|175802|220641|lyfsjukr|||00|30|0|0|Lyfjaver ehf|Gilead Science International (L)|||175722||175722|220641 135095|M01AC0101|Felden|töflur|20|mg|60|stk|1|þpakki||M01AC01|01.01.1997||R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|4546|7010|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4546||4546|7010 135111|H01AC0101|Genotropin|sts|0| |12|mg|1|rörlyk|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|76675|97325|lyfsjukr|||00|12|0|18|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||76673||76673|97325 135319|C08DA0107|Verapamil Merck NM|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|835|1974|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|||835||835|1974 135434|R03BA0502|Flixotide Diskus|innúðadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2291|3949|lyfalmen|||23|60|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2291||2291|3949 136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|þpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|882|2037|lyfalmen|||23|63|0|84|Vistor hf|Janssen-Cilag AB|||882||882|2037 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|6560|9743|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|||6560||6560|9743 136564|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|10|hgl|röntgenskuggaefni|V08CA01|01.01.1993||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|107735|135998|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|||107735||107735|135998 136572|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|10|hgl|röntgenskuggaefni|V08CA01|01.06.1997||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|79777|101190|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|||79777||79777|101190 137141|N02BA5102|Treo|freyðit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||14|20|0|3|Vistor hf|McNeil Denmark ApS||||||0 137158|N02BA5102|Treo|freyðit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||14|60|0|10|Vistor hf|McNeil Denmark ApS||||||0 137364|N05AB0301|Trilafon|töflur|4|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1579|2983|lyfalmen|||00|100|0|13|Vistor hf|Schering-Plough|||1579||1579|2983 137455|N05AB0301|Trilafon|töflur|2|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1046|2260|lyfalmen|||00|100|0|7|Vistor hf|Schering-Plough|||1046||1046|2260 137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|með rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0|0|Vistor hf|Novartis Healthcare A/S-||||||1352 137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-||||||1972 137641|S01LA0401|Lucentis|stl|10|mg/ml|0,23|ml|1|hgl|lausn|S01LA04|01.03.2007||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|166591|209273|lyfsjukr|||00|0|0|0|Vistor hf|Novartis Europharm Ltd|||166591||166591|209273 137679|A09AA0205|Creon|sh-hylki|0| |100|stk|1|glas|plastglas|A09AA02|01.04.1990||R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|4636|7132|lyfalmen|||10|100|0|100|Medico ehf|Kali-Chemie|||4636||4636|7132 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|2281|3266|lyfsjukr|||00|500|0|0|Vistor hf|Hospira Enterprises B.V.|||2281||2281|3266 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|3101|4440|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Enterprises B.V.|||3101||3101|4440 138560|S01ED0105|Optimol|augndr|2,5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2138|3742|lyfalmen|||00|15|0|60|Icepharma hf|Santen Oy|||2138||2138|3742 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,5|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2270|3921|lyfalmen|||00|30|0|60|Icepharma hf|Santen Oy|||2270||2270|3921 139410|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|250|ml|1|fl||QP52AC13|01.07.1987||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|2887|4996|vetorma|||13|250|0|0|Icepharma hf|Intervet International B.V.|||2887||2887|4996 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|3174|5148|lyfalmen|||00|100|0|50|Artasan ehf|Novartis Healthcare A/S-A|||3174||3174|5148 140118|A10BA0202|Glucophage (Lyfjaver)|töflur|1000|mg|180|stk|1|glas||A10BA02|01.07.2008||R|A|3|0|0|*|0|LVR|0|0|0|100|NOK|2827|4677|lyfalmen|||00|180|0|90|Lyfjaver ehf|Lyfjaver ehf|||2827||2827|4677 140186|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|þpakki||R03BB01|01.10.1988||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|2670|4464|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|||2670||2670|4464 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1806|3291|lyfalmen|||00|30|0|1|Vistor hf|Boehringer Ingelheim International |||1806||1806|3291 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|14969|20504|lyfsjukr|||02|10|0|33|Lundbeck Export A/S|H. Lundbeck A/S|||14969||14969|20504 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|675|966|lyfsjukr|||02|5|0|3|Vistor hf|Novartis Healthcare A/S-|||675||675|966 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|10|0|3|Vistor hf|McNeil Denmark ApS||||||0 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1428|2778|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1428||1428|2778 141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa|0|N01BB20|01.11.2008||R|A|3|0|0|0|0|DAC|0|0|1|100|SEK|3254|5256|lyfalmen|V2002|5256|00|25|0|5|D.A.C. ehf|D.A.C. ehf|||||3254|5256 141175|J01CA0409|Flemoxin (D.A.C.)|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.10.2008||R|A|4|0|0|0|0|DAC|0|0|1|100|XEU|1441|2796|lyfalmen|V0451|2796|08|80|0|0|D.A.C. ehf|D.A.C. ehf|||1441||1441|2796 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|9421|13489|lyfsjukr|||00|1200|0|4|D.A.C. ehf|D.A.C. ehf|||9421||9421|13489 141208|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.10.2008||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|14525|20269|lyfalmen|V0011|18648|00|25|0|5|D.A.C. ehf|D.A.C. ehf|||14525||14525|20269 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|28555|37418|lyfsjukr|||00|1|0|0|D.A.C. ehf|D.A.C. ehf|||28555||28555|37418 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|3491|5578|lyfalmen|||00|30|0|2|Vistor hf|Boehringer Ingelheim International |||3491||3491|5578 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|9650|13936|lyfalmen|||00|100|0|7|Vistor hf|Boehringer Ingelheim International|||9650||9650|13936 142059|C07AA0509|Propranolol Merck NM|töflur|10|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|274|1212|lyfalmen|||00|100|0|6|Actavis Group PTC ehf|Merck NM AB|||274||274|1212 142190|C07AA0509|Propranolol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|603|1659|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|||603||603|1659 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|7962|11400|lyfsjukr|||02|30|0|8|Vistor hf|Sanofi-aventis Norge AS|||7962||7962|11400 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|997|2193|lyfalmen|V0143|2193|70|30|0|30|Vistor hf|Sanofi-aventis Norge AS|||997||997|2193 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|DKK|2565|4321|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|||2565||2565|4321 142596|C07AA0509|Propranolol Merck NM|töflur|80|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|835|1974|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||835||835|1974 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|2176|3793|lyfalmen|||03|1|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2176||2176|3793 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|4884|6993|lyfsjukr|||03|1|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4884||4884|6993 143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|774|1891|lyfalmen|||07|5|0|0|Vistor hf|Novartis Healthcare A/S-|||774||774|1891 143413|S01JX|Methocel 2%|lausn|20|mg/ml|30|ml|1|glas||S01|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|710|1804|lyfalmen|||00|30|1|0|Distica|Distica - óskráð lyf|||710||710|1804 143511|J07BC2002|Twinrix Peadriatric|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3538|5642|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|||3538||3538|5642 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|978|2168|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|||978||978|2168 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1850|3351|lyfalmen|||00|2|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1850||1850|3351 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2363|4047|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|||2363||2363|4047 143653|N06AB0403|Cipramil (D.A.C.)|töflur|20|mg|98|stk|1|glas||N06AB04|01.11.2008||R|A|3|0|0|B|0|DAC|0|1|0|30|DKK|11446|6404|lyfalmen|V0926|4223|00|98|0|98|D.A.C. ehf|D.A.C. ehf|||4100||4100|6404 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|976|2165|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||976||976|2165 143800|N05AN0101|Litarex|forðatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1275|2571|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|||1275||1275|2571 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2956|4852|lyfalmen|V0429|4814|00|3|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2956||2956|4852 143917|L01DB0301|Farmorubicin|stl|2|mg/ml|5|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|4473|6404|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4473||4473|6404 143933|L01DB0301|Farmorubicin|stl|2|mg/ml|10|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|8597|12309|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8597||8597|12309 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|XEU|4001|6270|lyfalmen|||10|100|0|17|Icepharma hf|M.S.D.|||4001||4001|6270 144089|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5040|7680|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|||5040||5040|7680 144105|L01DB0301|Farmorubicin|stl|2|mg/ml|25|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|15721|21440|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||15721||15721|21440 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|101706|128491|lyfsjukr|||AC|2|0|22|Vistor hf|Novo-Nordisk|||101706||101706|128491 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|63858|81371|lyfsjukr|||AC|2|0|15|Vistor hf|Novo-Nordisk|||63858||63858|81371 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|41521|53561|lyfsjukr|||AC|2|0|7|Vistor hf|Novo-Nordisk|||41521||41521|53561 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|954|2135|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||954||954|2135 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|443|1442|lyfalmen|||00|24|0|8|Actavis Group hf|Actavis Group hf|||443||443|1442 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|766|1880|lyfalmen|||00|24|0|20|Actavis Group hf|Actavis Group hf|||766||766|1880 145292|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3374|5419|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||3374||3374|5419 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|5231|7939|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|||5231||5231|7939 145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|DKK|||lyfalmen|||24|30|0|0|Vistor hf|Recip AB||||||0 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|DKK|||lyfalmen|||23|8|0|0|Vistor hf|Recip AB||||||0 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|þpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|DKK|||lyfalmen|||23|32|0|0|Vistor hf|Recip AB||||||0 145698|N05AH0301|Zyprexa|húðuðtfl|10|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|22197|29820|lyfalmen|||00|28|0|28|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||22197||22197|29820 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|779|1898|lyfalmen|||41|10|0|2|Vistor hf|Sanofi-aventis Norge AS|||779||779|1898 147512|G03DA0202|Perlutex|töflur|5|mg|50|stk|1|þpakki||G03DA02|01.03.1981||R|A|5|0|0|E|0|LEP|0|0|0|100|DKK|1348|2670|lyfalmen|||00|50|0|50|Vistor hf|LEO Pharma A/S|||1348||1348|2670 147702|B05AA0501|Macrodex 60 mg/ml med glukos|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|13066|18135|lyfsjukr|||00|6000|0|6|Icepharma hf|Meda AB|||13066||13066|18135 147728|B05AA0508|Rheomacrodex med glukos|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|20887|27872|lyfsjukr|||00|6000|0|6|Icepharma hf|Meda AB|||20887||20887|27872 147926|J01GB0301|Garamycin|stl|40|mg/ml|2|ml|100|hgl||J01GB03|01.12.1975||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|43025|55434|lyfsjukr|||02|200|0|33|Vistor hf|Schering-Plough|||43025||43025|55434 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|130120|164184|lyfalmen|||00|750|0|30|Icepharma hf|Roche as|||130120||130120|164184 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|1124|2366|lyfalmen|||00|100|0|20|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|||1124||1124|2366 148650|G03AA0703|Neogynon|töflur|0| |63|stk|1|þpakki||G03AA07|01.12.1974|31.12.2008|R|A|5|0|0|0|0|SAG|0|0|0|100|SEK|1105|2340|lyfalmen|||23|63|0|84|Icepharma hf|Schering AG|||1105||1105|2340 148939|D05AX5202|Daivobet (D.A.C.)|smyrsli|0||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.11.2008||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|16604|20098|lyfalmen|V2001|20098|00|120|0|120|D.A.C. ehf|D.A.C. ehf|||14388||14388|20098 148972|C09DA0304|Diovan Comp 160/12,5 mg (D.A.C.)|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|16093|22221|lyfalmen|V0192|18543|00|98|0|196|D.A.C. ehf|D.A.C. ehf|||||16093|22221 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BHC|1|0|0|100|DKK|3857|7518|vetalmen|||27|25|0|0|Vistor hf|Bayer HealthCare AG|||3857||3857|7518 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|IKR|1719|3173|lyfalmen|||00|75|1|19|Distica|Distica - óskráð lyf|||1719||1719|3173 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|14626|20394|lyfalmen|||10|100|0|50|Icepharma hf|Sandoz GmbH|||14626||14626|20394 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3716|5883|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||3716|5883 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|7614|11173|lyfalmen|||02|10|0|50|Lundbeck Export A/S|H. Lundbeck A/S|||7614||7614|11173 151217|G01AF0102|Flagyl|sk-stil|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1051|2267|lyfalmen|||05|10|0|10|Vistor hf|Sanofi-aventis Norge AS|||1051||1051|2267 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|16933|23267|lyfalmen|||00|28|0|28|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|||||16933|23267 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|52283|67277|lyfalmen|||00|28|0|98|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|||||52283|67277 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1707|3157|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1707||1707|3157 151944|N06AA1201|Sinquan|hylki|10|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1177|2438|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1177||1177|2438 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|742|1062|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|||742||742|1062 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|DKK|||lyfalmen|||23|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||||||0 152397|R03BA0202|Pulmicort Turbuhaler|innúðadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4055|6343|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|||4055||4055|6343 152413|R03BA0202|Pulmicort Turbuhaler|innúðadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6274|9355|lyfalmen|||23|200|0|50|Vistor hf|AstraZeneca A/S DK|||6274||6274|9355 152421|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|10130|14587|lyfalmen|||23|200|0|100|Vistor hf|AstraZeneca UK Ltd|||10130||10130|14587 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki||J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1706|3156|lyfalmen|||10|4|0|2|Vistor hf|Janssen-Cilag AB|||1706||1706|3156 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|10|0|10|Actavis Group hf|Actavis hf||||||1185 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1828|3321|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||1828||1828|3321 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf||||||1766 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2067|3645|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||2067||2067|3645 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1651|3081|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||1651||1651|3081 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2214|3845|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||2214||2214|3845 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GSC|0|0|0|100|DKK|393614|491917|lyfsjukr|||00|10|0|14|Swedish Orphan International AB|Gilead Science International (S) |||393614||393614|491917 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|5716|8597|lyfalmen|||10|15|0|8|Vistor hf|Janssen-Cilag AB|||5716||5716|8597 153593|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|5|lykjur||B03BA03|01.12.1972||R|A|2|0|0|E|0|HEX|0|0|1|100|DKK|7269|10705|lyfalmen|||02|5|0|250|Vistor hf|Hexal A/S|||7269||7269|10705 153734|L01CA0101|Velbe|sts|10|mg/hgl|1|sk|1|hgl||L01CA01|01.01.1998||R|K||0|1|0|1|LDR|0|0|0|100|IKR|2880|4123|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||2880||2880|4123 154484|G04CA0102|Xatral Uno|forðatfl|10|mg|30|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|5702|8578|lyfalmen|||00|30|0|40|Vistor hf|Sanofi-aventis Norge AS|||5702||5702|8578 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1433|2785|lyfalmen|||10|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1433||1433|2785 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|5609|8452|lyfalmen|||10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5609||5609|8452 154732|G04CA0102|Xatral Uno|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|12080|17225|lyfalmen|||00|90|0|120|Vistor hf|Sanofi-aventis Norge AS|||12080||12080|17225 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|GSK|0|0|0|100|GBP|1308|2615|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1308||1308|2615 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1789|3268|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|||1789||1789|3268 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|554|1592|lyfalmen|||00|100|0|5|Lundbeck Export A/S|H. Lundbeck A/S|||554||554|1592 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|10815|15517|lyfalmen|||00|28|0|14|Vistor hf|Janssen-Cilag AB|||10815||10815|15517 155903|J05AF0101|Retrovir|mixtúra|10|mg/ml|200|ml|1|glas||J05AF01|01.07.1995|31.12.2008|R|A|2|0|1|0|1|GSK|0|0|0|100|GBP|6472|9266|lyfsjukr|||63|200|0|3|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6472||6472|9266 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|6727|9969|lyfalmen|||00|42|0|14|Icepharma hf|Roche|||6727||6727|9969 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|9840|14194|lyfalmen|||00|84|0|28|Icepharma hf|Roche|||||9840|14194 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|348|1313|lyfalmen|||00|6|0|3|Vistor hf|Janssen-Cilag AB|||348||348|1313 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|10|spr|.|QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|7756|13422|vetorma|||16|260|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||7756||7756|13422 157598|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyfalmen|||00|96|0|13|D.A.C. ehf|D.A.C. ehf|||||| 157609|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyfalmen|||00|204|0|27|D.A.C. ehf|D.A.C. ehf|||||| 157642|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyfalmen|||00|204|0|14|D.A.C. ehf|D.A.C. ehf|||||| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|0| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|IKR|554|1592|lyfalmen|||07|4|1|0|Distica|Distica - óskráð lyf|||554||554|1592 157909|D07XC0101|Diprosalic|áburður|0| |100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3583|5703|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|||3583||3583|5703 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1071|2294|lyfalmen|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|||1071||1071|2294 158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|NOH|0|0|0|100|DKK|1191|2457|lyfalmen|||23|5|0|13|Vistor hf|Novartis Healthcare A/S-|||1191||1191|2457 158725|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|920|2089|lyfalmen|V0608|2089|10|100|0|50|Actavis Group PTC ehf|Mylan AB|||||920|2089 158729|C07AB0208|Selo-ZOC (D.A.C.)|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|SEK|2170|3785|lyfalmen|V2003|3785|00|98|0|31|D.A.C. ehf|D.A.C. ehf|||||2170|3785 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|3738|5913|lyfalmen|V1050|5913|00|5|0|21|Actavis Group hf|Actavis Group PTC ehf|||||3738|5913 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|7198|10608|lyfalmen|V1051|10608|00|5|0|42|Actavis Group hf|Actavis Group PTC ehf|||||7198|10608 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|10073|14510|lyfalmen|V1052|14510|00|5|0|62|Actavis Group hf|Actavis Group PTC ehf|||||10073|14510 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|12109|17261|lyfalmen|V1053|17261|00|5|0|83|Actavis Group hf|Actavis Group PTC ehf|||||12109|17261 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|6911|4732|lyfalmen|V0925|3253|00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|||2868||2868|4732 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|27365|36254|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||27365||27365|36254 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|14148|12849|lyfalmen|V0929|7881|00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|||8849||8849|12849 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|2000|2596|lyfalmen|V0921|1893|00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|||1294||1294|2596 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|3463|3712|lyfalmen|V0923|2562|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|||2116||2116|3712 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|7137|4996|lyfalmen|V0927|3332|00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|||3062||3062|4996 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|ACA|0|0|0|100|DKK|180787|226947|lyfsjukr|||00|2|0|1|Actavis Group PTC ehf|Actavis Group PTC ehf|||180787||180787|226947 159806|QG51BE0001|Streptoc. m/sulfadim., vet.|legstil|0| |50|stk|50|stilar||QG51BE00|01.11.1979||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|10779|20704|vetalmen|||00|2500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||10779||10779|20704 160051|C07AA0701|Sotacor|töflur|160|mg|100|stk|1|þpakki||C07AA07|01.05.1983|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|2395|4091|lyfalmen|V0274||00|100|0|100|Vistor hf|Bristol-Myers Squibb|||2395||2395|4091 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2419|3463|lyfsjukr|||02|50|0|25|Actavis Group hf|Actavis Group hf|||2419||2419|3463 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|45479|58489|lyfsjukr|||00|100|0|0|Icepharma hf|GE Healthcare AS|||45479||45479|58489 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|68218|86799|lyfsjukr|||00|150|0|0|Icepharma hf|GE Healthcare AS|||68218||68218|86799 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|889|2047|lyfalmen|||00|100|0|5|Vistor hf|Sanofi-aventis Norge AS|||889||889|2047 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2519|4259|lyfalmen|||42|50|0|14|Vistor hf|Bristol-Myers Squibb|||2519||2519|4259 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|90958|115110|lyfsjukr|||00|200|0|0|Icepharma hf|GE Healthcare AS|||90958||90958|115110 160739|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|30|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|348|1313|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Mylan AB|||||348|1313 160945|N02AA5901|Panocod|freyðit|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|346|1310|lyfalmen|||14|20|0|7|Vistor hf|Sanofi-aventis Norge AS|||346||346|1310 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PFI|0|0|1|100|DKK|815|1946|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||815||815|1946 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|1908|2732|lyfsjukr|||03|1|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1908||1908|2732 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3272|4685|lyfsjukr|||03|5|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3272||3272|4685 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|748|1855|lyfalmen|||03|1|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||748||748|1855 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5249|7964|lyfalmen|||23|26|0|136|Vistor hf|Janssen-Cilag AB|||5249||5249|7964 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|71560|91277|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||71560||71560|91277 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|3085|4417|lyfsjukr|||00|2|0|1|Icepharma hf|Wyeth AB|||3085||3085|4417 161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|DKK|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|||||| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|6304|9026|lyfsjukr|||00|5|0|2|Icepharma hf|Wyeth AB|||6304||6304|9026 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|16856|22853|lyfsjukr|||00|18|0|6|Icepharma hf|Wyeth AB|||16856||16856|22853 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|2521|4261|lyfalmen|||00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2521||2521|4261 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2291|3949|lyfalmen|||24|120|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2291||2291|3949 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1269|2562|lyfalmen|||00|30|0|10|Vistor hf|Novartis Healthcare A/S-|||||1269|2562 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1715|3168|lyfalmen|||41|30|0|6|Vistor hf|Sanofi-aventis Norge AS|||1715||1715|3168 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3053|4983|lyfalmen|||24|120|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3053||3053|4983 163709|V03AE0101|Resonium|duft|0| |454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|6575|9763|lyfalmen|||00|454|1|0|Parlogis hf|Parlogis - óskráð lyf|||6575||6575|9763 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2882|4751|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2882||2882|4751 164871|A07EC0204|Asacol|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|6556|9737|lyfalmen|V0299|9737|98|60|0|20|Icepharma hf|Schering Oy|||6556||6556|9737 165001|C05AA0102|Proctosedyl|eþ-stil|0| |12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|NOK|||lyfalmen|||04|12|0|0|Vistor hf|Sanofi-aventis Norge AS||||||0 165019|C05AA0102|Proctosedyl|eþ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyfalmen|||00|30|0|0|Vistor hf|Sanofi-aventis Norge AS||||||0 165431|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5202|7900|lyfalmen|||43|98|0|49|Vistor hf|AstraZeneca A/S DK|||5202||5202|7900 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4542|7004|lyfalmen|V0324|3906|43|98|0|196|Vistor hf|AstraZeneca A/S DK|||4542||4542|7004 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2931|4818|lyfalmen|V0316|2769|43|98|0|98|Vistor hf|AstraZeneca A/S DK|||2931||2931|4818 165589|QH02AB0602|Prednisolonacetat, vet."Intervet"|stl|10|mg/ml|50|ml|5|hgl||QH02AB06|01.12.1972||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|7334|14141|vetalmen|||58|250|0|0|Icepharma hf|Intervet International B.V.|||7334||7334|14141 165639|H01CA0201|Synarela|nefúði|200|mcg/sk|4|ml|1|stauk|30 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|15377|21329|lyfalmen|||23|4|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||15377||15377|21329 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCB|0|0|1|100|SEK|924|2094|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|||924||924|2094 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCB|0|0|1|100|SEK|328|1285|lyfalmen|||00|25|0|12|Vistor hf|U.C.B|||328||328|1285 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCB|0|0|1|100|SEK|||lyfalmen|||00|10|0|5|Vistor hf|U.C.B||||||0 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|227395|284974|lyfsjukr|||00|500|0|0|Icepharma hf|GE Healthcare AS|||227395||227395|284974 165928|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||13480||13480|18650 166033|R06AB0201|Polaramin|forðatfl|6|mg|100|stk|1|þpakki||R06AB02|01.06.1980||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2640|4423|lyfalmen|||10|100|0|100|Vistor hf|Schering-Plough|||2640||2640|4423 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|959|2142|lyfalmen|||00|10|0|1|Vistor hf|Pharmaxim Sweden AB|||959||959|2142 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|2359|4042|lyfalmen|||00|100|0|39|Vistor hf|Sanofi-aventis Norge AS|||2359||2359|4042 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|17408|23858|lyfalmen|||23|8|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||17408||17408|23858 166272|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||15297||15297|20912 166918|J02AA0102|Amphocil|irs|50|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|27085|35588|lyfsjukr|||00|1|0|1|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|||27085||27085|35588 167007|J02AA0102|Amphocil|irs|100|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|54169|69308|lyfsjukr|||00|1|0|3|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|||54169||54169|69308 168716|N03AF0105|Tegretol Retard|forðatfl|200|mg|50|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1222|2499|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|||1222||1222|2499 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3976|6236|lyfalmen|V0789|6208|10|200|0|40|Vistor hf|Novartis Healthcare A/S-|||3976||3976|6236 168815|N03AF0105|Tegretol Retard|forðatfl|400|mg|30|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1279|2576|lyfalmen|||10|30|0|12|Vistor hf|Novartis Healthcare A/S-|||1279||1279|2576 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7430|10923|lyfalmen|V0713|10626|10|200|0|80|Vistor hf|Novartis Healthcare A/S-|||7430||7430|10923 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|48794|62616|lyfsjukr|||00|10|0|0|Vistor hf|Pierre Fabre Pharma|||48794||48794|62616 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|221617|277781|lyfsjukr|||00|50|0|0|Vistor hf|Pierre Fabre Pharma|||221617||221617|277781 169524|J01AA0203|Doxytab|töflur|100|mg|14|stk|1|glas||J01AA02|01.07.1993|31.12.2008|R|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|14|0|14|Actavis Group hf|Actavis hf|||720||| 169540|P01BB0101|Paludrin|töflur|100|mg|100|stk|1|glas||P01BB01|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|597|1651|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||597||597|1651 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|30|DKK|25881|34089|lyfsjukr|||00|5|0|5|Icepharma hf|Roche as|||25881||25881|34089 169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|5706|8584|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5706||5706|8584 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3255|5258|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||3255||3255|5258 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3496|5585|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||3496||3496|5585 170092|J07BC2001|Twinrix Adult|bóluefni|0| |1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|5225|7931|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|||5225||5225|7931 170225|R01AA0702|Otrivin|nefdr|1|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A||||||0 170233|R01AA0702|Otrivin|nefdr|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A||||||0 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|5214|7916|lyfalmen|||59|100|0|50|Vistor hf|Abbott Scandinavia AB|||5214||5214|7916 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|9575|13834|lyfalmen|||59|100|0|100|Vistor hf|Abbott Scandinavia AB|||9575||9575|13834 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1491|2864|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||1491||1491|2864 170712|A07AA0901|Vancocin|hylki|125|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988||R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|10000|14411|lyfalmen|V0125|14411|10|30|0|2|Icepharma hf|NordMedica A/S|||10000||10000|14411 170845|A07AA0901|Vancocin|hylki|250|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988|31.12.2008|R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|||lyfalmen|||10|30|0|4|Icepharma hf|NordMedica A/S|||20000||| 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3279|5290|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3279||3279|5290 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3533|5635|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3533||3533|5635 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|IKR|732|1834|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||732||732|1834 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4003|6273|lyfalmen|V0709|6273|00|60|0|5|Vistor hf|Janssen-Cilag AB|||4003||4003|6273 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|6590|9783|lyfalmen|V0710|9783|00|60|0|10|Vistor hf|Janssen-Cilag AB|||6590||6590|9783 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|48969|62834|lyfsjukr|||02|75|0|0|Icepharma hf|Bayer Schering Pharma AG|||48969||48969|62834 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|42066|54240|lyfsjukr|||02|50|0|0|Icepharma hf|Bayer Schering Pharma AG|||42066||42066|54240 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|11900|16989|lyfalmen|V0711|16666|00|60|0|20|Vistor hf|Janssen-Cilag AB|||11900||11900|16989 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|24406|32570|lyfalmen|||00|60|0|40|Vistor hf|Janssen-Cilag AB|||24406||24406|32570 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|73111|92891|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|||73111||73111|92891 172619|L01AB0101|Myleran|töflur|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|0|*|0|GSK|0|0|0|100|GBP|2910|4789|lyfalmen|||00|100|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2910||2910|4789 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|13326|18776|lyfalmen|||00|98|0|0|Vistor hf|AstraZeneca A/S DK|||13326||13326|18776 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7089|10461|lyfalmen|||10|56|0|11|Icepharma hf|Norpharma |||7089||7089|10461 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|13528|19027|lyfalmen|||10|56|0|22|Icepharma hf|Norpharma |||13528||13528|19027 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|22500|30197|lyfalmen|||10|56|0|45|Icepharma hf|Norpharma |||22500||22500|30197 172767|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2446|4160|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||2446||2446|4160 172775|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2446|4160|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||2446||2446|4160 172825|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3484|5568|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||3484||3484|5568 172874|D01AC0801|Fungoral|krem|20|mg/g|30|g|1|túpa||D01AC08|01.10.1989||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|908|2073|lyfalmen|||00|30|0|30|Vistor hf|Janssen-Cilag AB|||908||908|2073 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|25830|34343|lyfalmen|||10|56|0|67|Icepharma hf|Norpharma |||25830||25830|34343 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|VAL|0|0|1|100|DKK|835|1974|lyfalmen|V0901|1953|00|50|0|50|Icepharma hf|Valeant Pharmaceuticals B.V.|||835||835|1974 173310|N05BE0107|Buspiron Merck NM|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|2582|4344|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB (A)|||2582||2582|4344 173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12|Vistor hf|McNeil Denmark ApS||||||3587 173518|N05BE0107|Buspiron Merck NM|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|5512|8320|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB (A)|||5512||5512|8320 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|þpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|MAS|0|0|1|100|DKK|990|2184|lyfalmen|||00|10|0|10|Icepharma hf|Meda AS|||990||990|2184 173856|N05CF0104|Zopiklon Merck NM|töflur|5|mg|30|stk|1|þpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|316|1269|lyfalmen|||00|30|0|20|Actavis Group PTC ehf|Merck NM AB|||316||316|1269 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2087|3673|lyfalmen|||00|250|1|14|Parlogis hf|Parlogis - óskráð lyf|||2087||2087|3673 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|9140|13244|lyfalmen|||00|150|1|50|Parlogis hf|Parlogis - óskráð lyf|||9140||9140|13244 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1469|2103|lyfsjukr|||02|20|0|10|Actavis Group hf|Actavis Group hf|||1469||1469|2103 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|604|1660|lyfalmen|||00|14|0|6|Vistor hf|Recip AB|||604||604|1660 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|618|1679|lyfalmen|||00|14|0|7|Vistor hf|Recip AB|||618||618|1679 174615|N05CF0104|Zopiklon Merck NM|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|234|1158|lyfalmen|V0886|1152|00|30|0|30|Actavis Group PTC ehf|Merck NM AB|||234||234|1158 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|2596|3853|lyfalmen|V0507|3853|00|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2220||2220|3853 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|7410|4936|lyfalmen|V0809|4936|00|28|0|7|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||3018||3018|4936 177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.10.1988||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|4181|6514|lyfalmen|||00|20|0|10|Vistor hf|Sanofi-aventis Norge AS|||4181||4181|6514 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|730|1831|lyfalmen|||43|40|0|5|Vistor hf|Sanofi-aventis Norge AS|||730||730|1831 177295|M02AA1501|Voltaren Emulgel|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|50|0|0|Artasan ehf|Novartis Healthcare A/S-A||||||0 177311|QJ51RC2202|Nafpenzal vet.|spenalyf|0| |3|g|4|spr||QJ51RC22|01.04.1985||R|A|2|0|0|0|0|INI|0|0|0|100|XEU|675|1332|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||675||675|1332 177360|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SPL|0|0|1|100|DKK|781|1900|lyfalmen|||03|1|0|5|Vistor hf|Schering-Plough Europe|||781||781|1900 177741|D07CB0102|Kenalog Comp med Mycostatin|smyrsli|0| |15|g|1|túpa||D07CB01|01.12.1972|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|1|100|DKK|533|1564|lyfalmen|||00|15|0|15|Vistor hf|Bristol-Myers Squibb|||533||533|1564 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|426|1418|lyfalmen|||03|1|1|5|Distica|Distica - óskráð lyf|||426||426|1418 179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|11240|15861|lyfsjukr|||00|60|0|0|Vistor hf|N.V. Organon|||11240||11240|15861 179333|R02AA0304|Strepsils Menthol|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|6141|9174|lyfalmen|||10|100|0|25|Vistor hf|U.C.B|||6141||6141|9174 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A||||||0 180646|C10AA0302|Pravachol|töflur|20|mg|98|stk|1|þpakki||C10AA03|01.08.2008||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|16369|22564|lyfalmen|||00|98|0|98|Vistor hf|Bristol-Myers Squibb|||16369||16369|22564 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|929|2101|lyfalmen|||30|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||929||929|2101 181131|J01EE0103|Primazol|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.04.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|787|1908|lyfalmen|||01|100|0|2|Actavis Group hf|Actavis hf|||787||787|1908 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|0|100|DKK|||lyfalmen|||23|50|0|5|Vistor hf|Bayer A/S||||||0 181396|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|glas||M01AE01|01.01.1988|31.12.2008|R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|||345||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|7951|15317|vetalmen|||16|100|0|0|Icepharma hf|Pfizer vet.|||7951||7951|15317 181750|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|34117|44343|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|||34117||34117|44343 181990|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|46500|59760|lyfsjukr|||00|50|0|0|Icepharma hf|Wyeth AB|||46500||46500|59760 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|SPA|0|0|0|100|DKK|5208|10092|vetalmen|||16|100|0|0|Vistor hf|Schering-Plough A/S|||5208||5208|10092 183293|D08AG0201|Betadine|smyrsli|100|mg/g|40|g|1|túpa||D08AG02|01.07.1988|31.12.2008|L|A|3|0|0|0|0|NAP|0|0|0|100|CHF|||lyflausa|||00|40|0|40|Icepharma hf|Napp|||||| 183319|D08AG0201|Betadine|smyrsli|100|mg/g|80|g|1|túpa||D08AG02|01.07.1988|31.12.2008|L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyfalmen|||00|80|0|80|Icepharma hf|Napp||||||0 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|SPA|1|0|0|100|DKK|5756|11136|vetalmen|||27|50|0|0|Vistor hf|Schering-Plough A/S|||5756||5756|11136 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1269|2562|lyfalmen|||00|100|0|100|Vistor hf|Bristol-Myers Squibb|||1269||1269|2562 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|þpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|856|2002|lyfalmen|||41|21|0|2|Vistor hf|Sanofi-aventis Norge AS|||856||856|2002 184143|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|2|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|1656|3088|lyfalmen|||00|2|0|2|Vistor hf|AstraZeneca UK Ltd|||1656||1656|3088 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|437|1433|lyfalmen|||08|100|0|2|Actavis Group hf|LEK Pharmaceuticals d.d.|||437||437|1433 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|795|1919|lyfalmen|||08|100|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|||795||795|1919 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|555|1594|lyfalmen|||00|15|0|4|Actavis Group hf|LEK Pharmaceuticals d.d.|||555||555|1594 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|4548|7012|lyfalmen|||98|700|0|5|Icepharma hf|Schering Oy|||4548||4548|7012 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|24890|33173|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|||24890||24890|33173 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|65748|84041|lyfalmen|||00|100|0|100|Vistor hf|Novartis Healthcare A/S-|||||65748|84041 184309|R03DA0404|Theo-Dur|forðatfl|200|mg|100|stk|1|glas||R03DA04|01.11.1981||R|A|3|0|0|B|0|BIP|0|0|0|100|SEK|1527|2913|lyfalmen|||10|100|0|50|Vistor hf|BioPhausia AB|||1527||1527|2913 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1104|2339|lyfalmen|||00|16|0|8|Actavis Group hf|LEK Pharmaceuticals d.d.|||1104||1104|2339 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4988|7609|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|||4988||4988|7609 184671|N06AX0306|Mianserin Merck NM|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|A||0|0|B|0|MNA|0|1|0|100|SEK|1071|2294|lyfalmen|V1140|2294|00|90|0|15|Actavis Group PTC ehf|Merck NM AB|||1071||1071|2294 186742|R03DA0404|Theo-Dur|forðatfl|300|mg|100|stk|1|glas||R03DA04|01.11.1981||R|A|3|0|0|B|0|BIP|0|0|0|100|SEK|2166|3780|lyfalmen|||10|100|0|75|Vistor hf|BioPhausia AB|||2166||2166|3780 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|3601|5727|lyfalmen|||00|100|1|20|Distica|Distica - óskráð lyf|||3601||3601|5727 188532|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|50|sk|1|stauk||R03BA02|01.10.1993||R|A|2|0|0|0|1|AZD|0|0|0|100|IKR|2824|4043|lyfsjukr|||23|50|0|25|Vistor hf|AstraZeneca A/S DK|||2824||2824|4043 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3129|5087|lyfalmen|||00|250|0|10|Vistor hf|Desitin Artzneimittel|||3129||3129|5087 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|XEU|2173|3789|lyfalmen|||00|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|||2173||2173|3789 189126|L02BB0301|Casodex|töflur|150|mg|30|stk|1|þpakki||L02BB03|01.05.2000||R|A|4|0|0|*|0|ASZ|0|0|0|100|SEK|52168|67134|lyfalmen|V0561|65341|00|30|0|90|Vistor hf|AstraZeneca UK Ltd|||52168||52168|67134 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOV|0|0|0|100|DKK|11114|15704|lyfsjukr|||00|10|0|0|Icepharma hf|Novartis Healthcare A/S|||11114||11114|15704 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|3243|5241|lyfalmen|||03|5|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3243||3243|5241 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1387|2723|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1387||1387|2723 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|726|1826|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||726||726|1826 190702|M01AB0101|Confortid|eþ-stil|100|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|861|2009|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|||861||861|2009 190728|M01AB0101|Confortid|eþ-stil|50|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|467|1474|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|||467||467|1474 190751|M01AB0101|Confortid|hylki|25|mg|100|stk|1|glas||M01AB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1893|3409|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|||1893||1893|3409 191064|B05XC03|Vitalipid Infant|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4773|6834|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||4773||4773|6834 191247|B05XC02|Vitalipid Adult|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4868|6970|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||4868||4868|6970 191254|B05XC01|Soluvit|irs|0| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|6285|8999|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||6285||6285|8999 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|8|0|5|Vistor hf|AstraZeneca A/S DK||||||0 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|530|1560|lyfalmen|||07|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||530||530|1560 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1715|3168|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|||1715||1715|3168 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|478|1489|lyfalmen|||10|25|0|25|Vistor hf|LEO Pharma A/S|||478||478|1489 193573|R06AB0201|Polaramin|forðatfl|6|mg|25|stk|1|þpakki||R06AB02|01.10.1991||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|719|1816|lyfalmen|||10|25|0|25|Vistor hf|Schering-Plough|||719||719|1816 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|22|Vistor hf|Sandoz A/S||||||1665 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|1202|2472|lyfalmen|||02|50|0|3|Vistor hf|Sandoz A/S|||1202||1202|2472 194076|N02CA5201|Cafergot|töflur|0| |20|stk|1|þpakki||N02CA52|01.03.1999||R|A|3|0|0|E|0|LDR|0|0|0|100|IKR|2645|4430|lyfalmen|||00|20|1|5|Parlogis hf|Parlogis - óskráð lyf|||2645||2645|4430 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|1341|1920|lyfsjukr|||02|2|0|0|Icepharma hf|Wyeth AB|||1341||1341|1920 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2195|3819|lyfalmen|||00|100|0|17|Vistor hf|Boehringer Ingelheim|||2195||2195|3819 194266|A03BB0101|Buscopan|töflur|10|mg|20|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|528|1557|lyfalmen|||00|20|0|3|Vistor hf|Boehringer Ingelheim|||528||528|1557 194720|N03AX0901|Lamictal|dreifit.|5|mg|28|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|639|1708|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||639||639|1708 194795|M05BA0301|Aredia|irs|90|mg/hgl|1|hgl|1|pakki|+ 10 ml leysir|M05BA03|01.03.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|46226|59419|lyfsjukr|||00|1|0|2|Vistor hf|Novartis Healthcare A/S-|||46226||46226|59419 194977|J01MA0202|Ciproxin|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|1907|3428|lyfalmen|V0514|1374|00|10|0|2|Vistor hf|Bayer HealthCare AG|||1907||1907|3428 194985|J01MA0202|Ciproxin|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|4137|6454|lyfalmen|V0518|1706|00|20|0|5|Vistor hf|Bayer HealthCare AG|||4137||4137|6454 195032|J01MA0202|Ciproxin|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|4052|6339|lyfalmen|V0522|1718|00|10|0|5|Vistor hf|Bayer HealthCare AG|||4052||4052|6339 195065|J01MA0202|Ciproxin|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|7859|11505|lyfalmen|V0526|2425|00|20|0|10|Vistor hf|Bayer HealthCare AG|||7859||7859|11505 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|3371|5415|lyfalmen|||03|5|0|250|Actavis Group hf|Actavis Group hf|||3371||3371|5415 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|840|1980|lyfalmen|||03|1|0|50|Actavis Group hf|Actavis Group hf|||840||840|1980 195354|A07DA0301|Imodium|töflur|2|mg|40|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|932|2105|lyfalmen|||10|40|0|8|Vistor hf|Janssen-Cilag AB|||932||932|2105 195610|G03AC0801|Implanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2001||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|23162|31022|lyfalmen|||00|1|0|1015|Vistor hf|N.V. Organon|||23162||23162|31022 195669|D01AC2002|Pevisone|krem|0| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|720|1817|lyfalmen|||20|15|0|15|Vistor hf|Janssen-Cilag AB|||720||720|1817 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|347|1311|lyfalmen|||10|30|0|15|Vistor hf|Recip AB|||347||347|1311 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|821|1955|lyfalmen|||10|100|0|50|Vistor hf|Recip AB|||821||821|1955 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1308|2615|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|||1308||1308|2615 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2729|5370|vetalmen|||27|10|0|0|Icepharma hf|Intervet International B.V.|||2729||2729|5370 197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|12994|24923|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||12994||12994|24923 197343|D11AX0101|Regaine|húðlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988||L|A|4|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||00|60|0|60|Vistor hf|McNeil Denmark ApS||||||6231 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|813|1944|lyfalmen|||06|10|0|0|Vistor hf|Novartis Healthcare A/S-|||813||813|1944 197533|N03AX0901|Lamictal|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3690|5347|lyfalmen|V0705|5347|00|56|0|19|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3321||3321|5347 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|909|2074|lyfalmen|||00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||909||909|2074 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4305|6682|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4305||4305|6682 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2556|4309|lyfalmen|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|||2556||2556|4309 198432|N02BE5102|Parkodin|eþ-stil|510|mg|10|stk|1|pakki|10+500 mg|N02BE51|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|498|1516|lyfalmen|||04|10|0|2|Actavis Group hf|Actavis hf|||498||498|1516 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|GSK|0|0|0|100|GBP|1758|3226|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1758||1758|3226 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|10838|15361|lyfsjukr|||02|200|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10838||10838|15361 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|444|636|lyfsjukr|||02|5|0|2|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|||444||444|636 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|39560|51437|lyfalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||39560||39560|51437 199307|L01CB0101|Vepesid|stl|20|mg/ml|5|ml|10|hgl||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|17114|23174|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||17114||17114|23174 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PFI|0|0|1|100|DKK|940|2116|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||940||940|2116 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|8180|11941|lyfalmen|||44|8|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8180||8180|11941 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|XEU|60116|76712|lyfsjukr|||00|5|0|0|Icepharma hf|Centocor -|||60116||60116|76712 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4982|7601|lyfalmen|||00|60|1|12|Distica|Distica - óskráð lyf|||4982||4982|7601 327817|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykursaft|A03AA07|01.01.2000||R|A||0|1|E|0|LDR|0|0|0|100|IKR|3959|6213|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||3959||3959|6213 335968|A04AD0102|Skopolamin|stl|0,3|mg/ml|1|ml|10|lykjur||A04AD01|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|6034|9029|lyfalmen|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||6034||6034|9029 336792|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykurlaus|A03AA07|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2125|3724|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||2125||2125|3724 338236|C01CA0301|Noradrenalin|stl|1|mg/ml|2|ml|10|lykjur||C01CA03|01.01.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3940|5641|lyfsjukr|||00|20|1|3|Parlogis hf|Parlogis - óskráð lyf|||3940||3940|5641 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|609|872|lyfsjukr|||02|1|0|0|Icepharma hf|Roche|||609||609|872 370353|V08AB0501|Ultravist|stl/irl|300|mg J/ml|20|ml|10|hgl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|18922|25425|lyfsjukr|||02|200|0|0|Icepharma hf|Bayer Schering Pharma AG|||18922||18922|25425 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|336|481|lyfsjukr|||03|1|0|0|Icepharma hf|NordMedica ApS|||336||336|481 371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||23|240|0|1|Vistor hf|Ferring Lægemidler A/S||||||0 371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||23|120|0|1|Vistor hf|Ferring Lægemidler A/S||||||0 371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10|Vistor hf|Ferring Lægemidler A/S||||||7771 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|A|3|0|0|E|0|ACA|0|0|0|30|IKR|||lyfalmen|||00|10|0|5|Actavis Group hf|Actavis hf||||||1300 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|2864|4727|lyfalmen|||00|30|0|4|Vistor hf|Sanofi-aventis Norge AS|||2864||2864|4727 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|8030|11737|lyfalmen|||00|90|0|11|Vistor hf|Sanofi-aventis Norge AS|||8030||8030|11737 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4390|6798|lyfalmen|||00|100|0|17|Icepharma hf|Roche|||4390||4390|6798 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|42|0|7|Vistor hf|McNeil Denmark ApS||||||0 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|18|0|3|Vistor hf|McNeil Denmark ApS||||||0 372615|M05BA0401|Fosamax|töflur|10|mg|98|stk|1|þpakki||M05BA04|01.01.1996||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|19937|27007|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|||19937||19937|27007 372714|N05AL0501|Solian|töflur|200|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|9575|13834|lyfalmen|||00|30|0|15|Vistor hf|Sanofi-aventis Norge AS|||9575||9575|13834 372722|B02BD0801|NovoSeven|sts|1,2|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|127650|160792|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|||127650||127650|160792 372730|B02BD0801|NovoSeven|sts|2,4|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|254888|319203|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|||254888||254888|319203 372748|B02BD0801|NovoSeven|sts|4,8|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|586346|731868|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|||586346||586346|731868 373001|G03AB0501|Gracial|töflur|0| |66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2661|4451|lyfalmen|||23|66|0|88|Vistor hf|N.V. Organon|||2661||2661|4451 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|25388|33793|lyfalmen|||00|90|0|45|Vistor hf|Sanofi-aventis Norge AS|||25388||25388|33793 373324|R03AK0602|Seretide Diskus|innúðadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|4457|6889|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4457||4457|6889 373340|R03AK0602|Seretide Diskus|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|6961|10287|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||6961|10287 373365|R03AK0602|Seretide Diskus|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|9110|13203|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||9110|13203 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3105|5054|lyfalmen|||44|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3105||3105|5054 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|XEU|834|1972|lyfalmen|||00|100|0|25|Icepharma hf|Merck Santé s.a.s.|||834||834|1972 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|5270|7992|lyfalmen|||00|30|0|30|Vistor hf|Yamanouchi Europe|||5270||5270|7992 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|30|GBP|11705|16725|lyfalmen|||00|60|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||11705||11705|16725 374504|G01AF0502|Pevaryl Depot|krem/sti|0| |15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||00|15|0|2|Vistor hf|Janssen-Cilag AB||||||0 374520|L02BB0301|Casodex|töflur|50|mg|30|stk|1|þpakki||L02BB03|01.04.1997||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|20163|27288|lyfalmen|V0560|21952|00|30|0|30|Vistor hf|AstraZeneca UK Ltd|||20163||20163|27288 374579|R01AC0101|Lomudal Nasal|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.10.1992||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2584|4347|lyfalmen|||23|15|0|15|Vistor hf|Sanofi-aventis Norge AS|||2584||2584|4347 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|7423|10914|lyfalmen|||00|6|0|30|Vistor hf|Sanofi-aventis Norge AS|||7423||7423|10914 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|8255|12043|lyfalmen|||00|8|0|40|Vistor hf|Sanofi-aventis Norge AS|||8255||8255|12043 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|11253|16111|lyfalmen|||00|10|0|50|Vistor hf|Sanofi-aventis Norge AS|||11253||11253|16111 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|4768|7311|lyfalmen|||63|14|0|14|Vistor hf|Abbott Scandinavia AB|||4768||4768|7311 377259|J01FA0901|Klacid|töflur|500|mg|100|stk|1|glas||J01FA09|01.04.1992||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|39001|50741|lyfalmen|||63|100|0|100|Vistor hf|Abbott Scandinavia AB|||39001||39001|50741 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|11336|13983|lyfalmen|V0508|13983|00|42|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||9685||9685|13983 379669|H01CB0202|Sandostatin Lar|sts|5|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|167397|210277|lyfsjukr|||00|2|0|14|Vistor hf|Novartis Healthcare A/S-|||167397||167397|210277 379677|H01CB0202|Sandostatin Lar|sts|10|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|186844|234488|lyfsjukr|||00|2|0|29|Vistor hf|Novartis Healthcare A/S-|||186844||186844|234488 379685|H01CB0202|Sandostatin Lar|sts|15|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|234523|293849|lyfsjukr|||00|2|0|43|Vistor hf|Novartis Healthcare A/S-|||234523||234523|293849 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1602|3014|lyfalmen|||00|12|0|2|Actavis Group hf|Actavis Group hf|||1602||1602|3014 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1980|3527|lyfalmen|||00|12|0|5|Actavis Group hf|Actavis Group hf|||1980||1980|3527 379925|L01CD0201|Taxotere|irs|40|mg/ml|0,5|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|1,5|0|1|0|1|AVS|0|0|0|100|NOK|27046|35540|lyfsjukr|||00|0|0|0|Vistor hf|Aventis Pharma SA|||27046||27046|35540 379933|L01CD0201|Taxotere|irs|40|mg/ml|2|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|2|0|1|0|1|AVS|0|0|0|100|NOK|108598|137072|lyfsjukr|||00|2|0|0|Vistor hf|Aventis Pharma SA|||108598||108598|137072 380642|A10AD0402|Humalog Mix50 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.12.2001||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6372|9487|lyfalmen|||17|15|0|38|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||6372||6372|9487 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6261|9337|lyfalmen|||00|15|0|38|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||6261||6261|9337 382531|C10AA0101|Zocor|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.07.1995||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|16128|12474|lyfalmen|V0367|3035|00|98|0|261|Icepharma hf|M.S.D.|||8573||8573|12474 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6264|9341|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca A/S DK|||6264||6264|9341 383075|N02AA5904|Ibukod sterkar|töflur|0| |20|stk|1|glas|30+200 mg|N02AA59|01.02.1999||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|460|1465|lyfalmen|||00|20|0|7|Actavis Group hf|Actavis hf|||460||460|1465 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BHC|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer HealthCare AG||||||1819 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BHC|0|0|0|100|DKK|8224|14232|vetorma|||00|20|0|0|Vistor hf|Bayer HealthCare AG|||8224||8224|14232 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||23|60|0|60|Actavis Group hf|Actavis hf||||||0 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|V0355|2143|23|120|0|120|Actavis Group hf|Actavis hf||||||2143 383737|R06AX1301|Clarityn|freyðit|10|mg|10|stk|1|þpakki||R06AX13|01.10.1995||L|A|2|0|0|E|0|SCP|0|0|1|100|DKK|||lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough||||||1937 386953|L02BG0301|Arimidex|töflur|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|54674|70254|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca UK Ltd|||54674||54674|70254 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|777|1533|vetalmen|||00|100|0|0|Icepharma hf|Icepharma hf|||777||777|1533 387746|J02AA0101|Abelcet|irþ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|ZPL|0|0|0|100|DKK|238320|298576|lyfsjukr|||00|200|0|29|Zeneus Pharma Limited|Zeneus Pharma Limited|||238320||238320|298576 388256|N01BB2001|Emla|krem|0| |5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3320|5346|lyfalmen|V2002|5256|00|25|0|5|Vistor hf|AstraZeneca A/S DK|||3320||3320|5346 388264|N01BB2001|Emla|krem|0| |30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3745|5923|lyfalmen|||00|30|0|30|Vistor hf|AstraZeneca A/S DK|||3745||3745|5923 388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|0|Vistor hf|AstraZeneca A/S DK||||||0 388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|6988|10323|lyfalmen|||23|20|0|0|Vistor hf|AstraZeneca A/S DK|||6988||6988|10323 388660|C09BA0201|Darazið|töflur|22,5|mg|100|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2966|4865|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||2966||2966|4865 389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2526|4268|lyfalmen|V0388|4268|23|84|0|84|Vistor hf|BioPhausia AB|||2526||2526|4268 389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2308|3972|lyfalmen|||23|84|0|84|Vistor hf|BioPhausia AB|||2308||2308|3972 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|953|2134|lyfalmen|V0408|2134|00|84|0|84|Vistor hf|BioPhausia AB|||953||953|2134 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|678|1760|lyfalmen|||00|84|0|42|Vistor hf|BioPhausia AB|||678||678|1760 389361|V08AB0501|Ultravist|stl/irl|300|mg J/ml|500|ml|8|fl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|331490|414573|lyfsjukr|||02|4000|0|0|Icepharma hf|Bayer Schering Pharma AG|||331490||331490|414573 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1032|2241|lyfalmen|||00|3|0|0|Vistor hf|Novartis Healthcare A/S-|||1032||1032|2241 389577|A04AA0201|Kytril|töflur|2|mg|5|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|12708|18006|lyfalmen|||00|5|0|5|Icepharma hf|Roche as|||12708||12708|18006 389783|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2549|4299|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|||2549||2549|4299 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|3600|5726|lyfalmen|||01|100|0|7|Vistor hf|Bristol-Myers Squibb|||3600||3600|5726 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|7974|11661|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7974||7974|11661 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|3198|5180|lyfalmen|||00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3198||3198|5180 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|15030|20897|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||15030||15030|20897 391730|N01BB0203|Xylocain|úðalyf|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3024|4944|lyfalmen|||00|50|0|0|Vistor hf|AstraZeneca A/S DK|||3024||3024|4944 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|XEU|5344|10351|vetalmen|||16|24|0|0|Icepharma hf|Pfizer Oy Animal Health|||5344||5344|10351 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A||||||0 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A||||||0 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A||||||0 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A||||||0 395715|D10AD0301|Differin|hlaup|0,1|%|30|g|1|túpa||D10AD03|01.07.2001||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|1002|2200|lyfalmen|||00|30|0|30|Icepharma hf|Galderma Nordic AB|||1002||1002|2200 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|192068|240992|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|||192068||192068|240992 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|11441|16112|lyfsjukr|||00|60|0|0|Icepharma hf|Roche|||11441||11441|16112 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|66326|84443|lyfsjukr|||00|120|0|0|Icepharma hf|Roche|||66326||66326|84443 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3343|lyfalmen|V0703|3343|00|56|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1844||1844|3343 399527|N03AX0901|Lamictal|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|6434|8873|lyfalmen|V0706|8873|00|56|0|37|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5919||5919|8873 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|11530|16487|lyfalmen|||02|3|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11530||11530|16487 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|DKK|||lyfalmen|||00|2|0|2|Artasan ehf|Novartis Healthcare A/S-A||||||0 400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1593|3002|lyfalmen|||06|8|0|0|Vistor hf|Sanofi-aventis Norge AS|||1593||1593|3002 400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|150|0|0|Actavis Group hf|Actavis hf||||||0 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5934|8893|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5934||5934|8893 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|386|1364|lyfalmen|||00|25|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||386||386|1364 400275|N05BA0402|Sobril|töflur|15|mg|250|stk|1|glas||N05BA04|01.01.1985|31.12.2008|R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|2577|4337|lyfalmen|||00|250|0|75|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2577||2577|4337 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|629|1694|lyfalmen|||00|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||629||629|1694 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|274|1212|lyfalmen|||00|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||274||274|1212 400804|N07BA0103|Nicorette|forðapl|15|mg/16kls|7|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|7|0|8|Vistor hf|McNeil Denmark ApS||||||0 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|808|1937|lyfalmen|||00|100|0|13|Lundbeck Export A/S|H. Lundbeck A/S|||808||808|1937 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1293|2595|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|||1293||1293|2595 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1246|2531|lyfalmen|V0162|2531|00|100|0|50|Actavis Group hf|Actavis hf|||1246||1246|2531 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2000|3554|lyfalmen|V0166|3554|00|100|0|100|Actavis Group hf|Actavis hf|||2000||2000|3554 402651|J07BB0205|Influvac|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOP|0|0|0|100|XEU|695|1784|lyfalmen|||51|0|0|0|Icepharma hf|Solvay Pharmaceuticals|||695||695|1784 402743|QJ01RA0102|Streptocillin, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1695|3345|vetalmen|||58|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1695||1695|3345 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|SPA|1|0|0|100|DKK|5476|10602|vetalmen|||27|20|0|0|Vistor hf|Schering-Plough A/S|||5476||5476|10602 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|7460|10964|lyfalmen|||10|100|0|50|Vistor hf|Novartis Healthcare A/S-|||7460||7460|10964 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1273|2568|lyfalmen|||06|14|0|0|Vistor hf|Sanofi-aventis Norge AS|||1273||1273|2568 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0|0|Icepharma hf|Santen Oy||||||1766 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|105527|133249|lyfsjukr|||02|1|0|0|Vistor hf|Boehringer Ingelheim|||105527||105527|133249 404640|A07AA0904|Vancomycin Alpharma|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|12888|18231|lyfalmen|V0125|13450|00|28|0|2|Actavis Group hf|Alpharma ApS|||12888||12888|18231 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|668|956|lyfsjukr|||02|5|0|2|Icepharma hf|Roche|||668||668|956 405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1822|3313|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1822||1822|3313 405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|22485|30179|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||22485||22485|30179 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|21975|29544|lyfalmen|||00|28|0|21|Lundbeck Export A/S|H. Lundbeck A/S|||21975||21975|29544 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||20662||20662|27592 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|21975|29544|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|||21975||21975|29544 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|21975|29544|lyfalmen|||00|28|0|35|Lundbeck Export A/S|H. Lundbeck A/S|||21975||21975|29544 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|22194|29817|lyfalmen|||00|100|0|25|Lundbeck Export A/S|H. Lundbeck A/S|||22194||22194|29817 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||23122||23122|30654 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|66910|85488|lyfalmen|||00|100|0|75|Lundbeck Export A/S|H. Lundbeck A/S|||66910||66910|85488 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|72572|92537|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|||72572||72572|92537 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|78234|99586|lyfalmen|||00|100|0|125|Lundbeck Export A/S|H. Lundbeck A/S|||78234||78234|99586 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|7416|10904|lyfalmen|||00|30|0|8|Lundbeck Export A/S|H. Lundbeck A/S|||7416||7416|10904 406751|M01AB0101|Confortid|hylki|25|mg|30|stk|1|þpakki||M01AB01|01.05.1974||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|610|1668|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis Group hf|||610||610|1668 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|2043|3613|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|||2043||2043|3613 407403|A01AB0402|Fungizone|sogtfl|10|mg|60|stk|1|þpakki||A01AB04|01.04.1993|31.12.2008|R|A|1,5|0|0|E|0|BRS|0|0|1|100|DKK|1214|2488|lyfalmen|||00|60|0|15|Vistor hf|Bristol-Myers Squibb|||1214||1214|2488 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|1|100|DKK|260|1193|lyfalmen|||00|25|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||260||260|1193 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|0|100|DKK|732|1834|lyfalmen|||00|100|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||732||732|1834 408724|D07AC0104|Diproderm|smyrsli|0,5|mg/g|20|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1131|2375|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||1131||1131|2375 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|5191|7885|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|||5191||5191|7885 408757|D07AC0104|Diproderm|áburður|0,5|mg/ml|20|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1131|2375|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||1131||1131|2375 408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3091|5035|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|||3091||3091|5035 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|5557|8382|lyfalmen|||08|35|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5557||5557|8382 409193|N02BE0101|Panodil|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.07.1975|31.12.2008|L|A|5|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|20|0|3|Icepharma hf|GlaxoSmithKline CH A/S||||||0 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|4104|6410|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |||4104||4104|6410 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|3978|6239|lyfalmen|V0966|6132|23|200|0|100|Vistor hf|AstraZeneca A/S DK|||3978||3978|6239 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|13258|18691|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |||13258||13258|18691 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|3234|5229|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |||3234||3234|5229 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PSW|1|0|0|100|DKK|11283|21664|vetalmen|||27|120|0|0|Vistor hf|Pharmaxim Sweden AB|||11283||11283|21664 409631|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.04.1987||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|575|1621|lyfalmen|V0290|1621|00|100|0|33|Actavis Group hf|Actavis hf|||575||575|1621 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|10743|15419|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |||10743||10743|15419 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1187|2451|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|||1187||1187|2451 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|695|1784|lyfalmen|||23|30|0|30|Vistor hf|Janssen-Cilag AB|||695||695|1784 411033|M03BX0104|Baklofen Merck NM|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|608|1665|lyfalmen|||00|50|0|10|Actavis Group PTC ehf|Merck NM AB|||608||608|1665 411157|M03BX0104|Baklofen Merck NM|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|1324|2637|lyfalmen|V0712|2637|00|50|0|25|Actavis Group PTC ehf|Merck NM AB|||1324||1324|2637 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|7795|11160|lyfsjukr|||02|50|0|17|Icepharma hf|Roche|||7795||7795|11160 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|25818|34011|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|||25818||25818|34011 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|þpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|1983|3531|lyfalmen|||67|100|0|25|Vistor hf|Novartis Healthcare A/S-|||1983||1983|3531 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|8077|11799|lyfalmen|||98|6|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||8075||8075|11799 412049|L02AE0301|Zoladex|vefjatfl|3,6|mg|1|stk|1|glas|+ dæla|L02AE03|01.01.1990||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|22608|30332|lyfalmen|||00|1|0|28|Vistor hf|AstraZeneca UK Ltd|||22608||22608|30332 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3299|4723|lyfsjukr|||00|3|0|15|Vistor hf|Sanofi-aventis Norge AS|||3299||3299|4723 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|10667|20490|vetalmen|||02|100|0|0|Vistor hf|Merial|||10667||10667|20490 412825|L02BA0106|Tamoxifen NM Pharma|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|2016|3576|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||2016||2016|3576 412833|L02BA0106|Tamoxifen NM Pharma|töflur|20|mg|30|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1288|2588|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|||1288||1288|2588 413245|J06BA0205|Sandoglobulin|irs|12|g/fl|12|g|1|sett|leys+áhöld|J06BA02|01.04.1993||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|113236|142846|lyfsjukr|||00|12|0|0|Icepharma hf|CSL Denmark ApS|||113236||113236|142846 413369|S01AX1201|Noroxin|augndr|3|mg/ml|5|ml|1|glas||S01AX12|01.04.1992||R|A|3|0|0|E|0|LBO|0|0|1|100|XEU|690|1777|lyfalmen|||06|5|0|0|Laboratories THEA|Laboratories THEA|||690||690|1777 413856|M05BA0301|Aredia|irs|15|mg/hgl|4|hgl|1|pakki|+ 4 x 5 ml leysir|M05BA03|01.04.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|35097|45563|lyfsjukr|||00|4|0|1|Vistor hf|Novartis Healthcare A/S-|||35097||35097|45563 413864|M05BA0301|Aredia|irs|30|mg/hgl|2|hgl|1|pakki|+ 2 x 10 ml leysir|M05BA03|01.04.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|35097|45563|lyfsjukr|||00|2|0|1|Vistor hf|Novartis Healthcare A/S-|||35097||35097|45563 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|IKR|2026|3590|lyfalmen|||00|2|1|0|Parlogis hf|Parlogis - óskráð lyf|||2026||2026|3590 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|4839|7407|lyfalmen|||00|90|0|54|Icepharma hf|Servier|||4839||4839|7407 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1546|2938|lyfalmen|||00|300|0|6|Vistor hf|Novartis Healthcare A/S-|||1546||1546|2938 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki|+stjaka|G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2181|3800|lyfalmen|V0418|3740|05|15|0|15|Vistor hf|Novo-Nordisk|||2181||2181|3800 415687|V08BA0101|E-Z-HD|mixtduft|0| |12|0z|24|stk|plastdósir|V08BA01|01.01.1988||R|A|4|0|0|0|1|EZE|0|0|0|100|USD|18183|24505|lyfsjukr|||08|288|0|0|Icepharma hf|E-Z-Em|||18183||18183|24505 415711|V08BA0102|Polibar ACB|innhl|933|mg/g|16|0z|24|stk|plastpokar|V08BA01|01.01.1988||R|A|2|0|0|0|1|EZE|0|0|0|100|USD|51122|65514|lyfsjukr|||00|384|0|0|Icepharma hf|E-Z-Em|||51122||51122|65514 415737|V08BA0102|Polibar ACB|innhl|933|mg/g|20|0z|24|stk|plastpokar|V08BA01|01.01.1988||R|A|2|0|0|0|1|EZE|0|0|0|100|USD|63905|81429|lyfsjukr|||00|480|0|0|Icepharma hf|E-Z-Em|||63905||63905|81429 416222|C09DA0101|Cozaar Comp|töflur|62,5|mg|28|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|3816|6019|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|||3816||3816|6019 416446|C09DA0101|Cozaar Comp|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|10179|10994|lyfalmen|V0198|9980|00|98|0|98|Icepharma hf|M.S.D.|||7482||7482|10994 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|30|IKR|3849|6064|lyfalmen|||00|300|1|15|Parlogis hf|Parlogis - óskráð lyf|||3849||3849|6064 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|3081|5021|lyfalmen|||23|10|0|0|Icepharma hf|Colgate Palmolive A/S|||3081||3081|5021 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|25912|34445|lyfalmen|||23|150|0|0|Icepharma hf|Colgate Palmolive A/S|||25912||25912|34445 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|1102|2336|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|||1102||1102|2336 417030|A02AD0104|Balancid Novum|tuggutfl|0| |30|stk|1|þpakki||A02AD01|01.10.1992||L|A|3|0|0|0|0|BIP|0|0|0|100|IKR|||lyflausa|||11|30|0|3|Vistor hf|BioPhausia AB|||||| 417238|QM01AE0301|Romefen, vet.|töflur|10|mg|10|stk|1|þpakki||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|0|0|0|100|XEU|564|1113|vetalmen|||00|10|0|0|Vistor hf|Merial|||564||564|1113 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|42258|54479|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|||42258||42258|54479 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|þpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|4329|6715|lyfalmen|||10|100|0|17|Vistor hf|Sanofi-aventis Norge AS|||4329||4329|6715 418665|D07XC0101|Diprosalic|smyrsli|0| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1855|3358|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|||1855||1855|3358 418731|A07EC0201|Mesasal|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|8804|12788|lyfalmen|V0299|9737|00|60|0|20|Vistor hf|Sanofi-aventis Norge AS|||8804||8804|12788 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2076|4097|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||2076||2076|4097 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dæla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2694|5303|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||2694||2694|5303 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4351|6745|lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S|||4351||4351|6745 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|10275|14784|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|||10275||10275|14784 419440|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.05.1999||R|K|1,6|0|1|0|1|SCP|0|0|0|100|DKK|71182|90489|lyfsjukr|||00|10|0|0|Vistor hf|Schering-Plough|||71182||71182|90489 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|XEU|59056|75392|lyfsjukr|||00|180|0|30|Icepharma hf|M.S.D.|||59056||59056|75392 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|49897|63989|lyfsjukr|||00|100|0|8|Swedish Orphan International AB|Orphan Europe (S)|||49897||49897|63989 419945|D07AD0101|Dermovat|áburður|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|854|1999|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||854||854|1999 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|12849|18182|lyfalmen|||02|10|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12849||12849|18182 420356|B01AB0401|Fragmin|stl|2500|ae/ml|4|ml|10|hgl||B01AB04|01.04.1993||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|12872|17893|lyfsjukr|||00|40|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12872||12872|17893 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|5597|8436|lyfalmen|||02|2|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5597||5597|8436 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|8126|11868|lyfalmen|||02|2|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8126||8126|11868 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|2390|4084|lyfalmen|V0144|4020|70|30|0|15|Vistor hf|Sanofi-aventis Norge AS|||2390||2390|4084 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3339|5372|lyfalmen|||43|98|0|62|Vistor hf|AstraZeneca A/S DK|||3339||3339|5372 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6576|9764|lyfalmen|||43|98|0|124|Vistor hf|AstraZeneca A/S DK|||6576||6576|9764 422402|G03FB0505|Estracomb|forðapl|0| |8|stk|1|pakki|samsett pk|G03FB05|01.04.1993||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2733|4549|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|||2733||2733|4549 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|DKK|8546|12438|lyfalmen|||49|100|0|50|Icepharma hf|Meda AS|||8546||8546|12438 424846|M04AA0103|Hexanurat|töflur|100|mg|100|stk|1|glas||M04AA01|01.02.2006||R|A||0|0|E|0|PCO|0|0|0|100|IKR|391|1371|lyfalmen|||00|100|1|25|Distica|Distica - óskráð lyf|||391||391|1371 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dæl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||16|24|0|0|Icepharma hf|Intervet International B.V.||||||2158 425181|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|955|2136|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||955||955|2136 425538|N04BC0102|Parlodel|hylki|10|mg|100|stk|1|þpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|DKK|29656|39107|lyfalmen|||52|100|0|25|Icepharma hf|Meda AS|||29656||29656|39107 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|0|Vistor hf|AstraZeneca A/S DK||||||0 426312|J02AC0101|Diflucan|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.04.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3645|5787|lyfalmen|V0555|2796|10|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3645||3645|5787 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|604|1660|lyfalmen|||00|20|0|5|Vistor hf|Recip AB|||604||604|1660 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|789|1911|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|||789||789|1911 427351|N07BA0103|Nicorette|forðapl|5|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|14|0|5|Vistor hf|McNeil Denmark ApS||||||0 427369|N07BA0103|Nicorette|forðapl|10|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|14|0|10|Vistor hf|McNeil Denmark ApS||||||0 427377|N07BA0103|Nicorette|forðapl|15|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|14|0|15|Vistor hf|McNeil Denmark ApS||||||0 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45|Vistor hf|Boehringer Ingelheim International ||||||1824 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1060|2279|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|||1060||1060|2279 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|964|2149|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|||964||964|2149 428565|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|31166|40669|lyfsjukr|||00|1000|0|4|Vistor hf|Bayer HealthCare AG|||31166||31166|40669 428656|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|48808|62633|lyfsjukr|||00|2000|0|8|Vistor hf|Bayer HealthCare AG|||48808||48808|62633 428672|J01CA0406|Flemoxin Solutab|lausnart|125|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|535|1566|lyfalmen|||23|14|0|2|Vistor hf|Astellas Pharma A/S|||535||535|1566 428680|J01CA0406|Flemoxin Solutab|lausnart|250|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|882|2037|lyfalmen|||23|14|0|4|Vistor hf|Astellas Pharma A/S|||882||882|2037 428813|C07AB0309|Atenolol Actavis|töflur|25|mg|30|stk|1|glas||C07AB03|01.01.1992||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|180|1085|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|||180||180|1085 429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dælu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5922|8877|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||5922||5922|8877 429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|44296|57333|lyfalmen|||AC|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||44296||44296|57333 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|6110|9132|lyfalmen|||00|100|0|133|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6110||6110|9132 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1766|2528|lyfsjukr|||02|50|0|0|Vistor hf|Janssen-Cilag AB|||1766||1766|2528 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2078|2975|lyfsjukr|||02|50|0|3|Icepharma hf|Roche|||2078||2078|2975 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|SPA|0|0|0|100|DKK|4078|7939|vetalmen|||27|100|0|0|Vistor hf|Schering-Plough A/S|||4078||4078|7939 430710|J07AP0301|Typhim Vi|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2707|4514|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||2707||2707|4514 430967|N07BA0105|Nicorette Mint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|2|Vistor hf|McNeil Denmark ApS||||||0 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|811|1941|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|||811||811|1941 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|þpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|1222|2499|lyfalmen|||00|100|0|17|Vistor hf|Recip AB|||1222||1222|2499 431106|N07BA0105|Nicorette Mint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|14|Vistor hf|McNeil Denmark ApS||||||0 431122|N07BA0105|Nicorette Mint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|4|Vistor hf|McNeil Denmark ApS||||||0 431171|N07BA0105|Nicorette Mint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|28|Vistor hf|McNeil Denmark ApS||||||0 431205|C08DB0107|Korzem|töflur|30|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|785|1906|lyfalmen|||00|100|0|12|Actavis Group hf|Actavis hf|||785||785|1906 432336|J01GB0701|Netilyn|stl/irþ|10|mg/ml|1,5|ml|10|lykjur||J01GB07|01.01.1986|30.11.2008|R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|2449|3506|lyfsjukr|||02|15|0|0|Vistor hf|Schering-Plough|||2449||2449|3506 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|952|2132|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|||952||952|2132 432971|J01DC0201|Cefuroxim Scand Pharm|sts|750|mg/hgl|750|mg|1|hgl||J01DC02|01.01.1996|31.12.2008|R|A|3|0|0|0|1|GEN|0|0|0|100|IKR|230|329|lyfsjukr|||00|750|0|0|NM Pharma ehf|Generics|||230||230|329 432989|J01DC0201|Cefuroxim Scand Pharm|sts/irs|1,5|g/hgl|1,5|g|1|hgl||J01DC02|01.01.1996|31.12.2008|R|A|3|0|0|0|1|GEN|0|0|0|100|IKR|459|657|lyfsjukr|||00|2|0|0|NM Pharma ehf|Generics|||459||459|657 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|13177|18590|lyfalmen|V0729|18262|00|100|0|20|Vistor hf|Orion Corporation|||13177||13177|18590 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2643|4427|lyfalmen|||00|28|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2643||2643|4427 433300|N02AA0106|Contalgin Uno|forðahlk|60|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|4848|7419|lyfalmen|||00|28|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4848||4848|7419 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6483|9638|lyfalmen|||00|28|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6483||6483|9638 433326|N02AA0106|Contalgin Uno|forðahlk|120|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|8116|11854|lyfalmen|||00|28|0|34|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8116||8116|11854 433342|N02AA0106|Contalgin Uno|forðahlk|150|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|9351|13530|lyfalmen|||00|28|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||9351||9351|13530 433359|N02AA0106|Contalgin Uno|forðahlk|200|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|12625|17903|lyfalmen|||00|28|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12625||12625|17903 433722|J01EE0104|Primazol sterkar|töflur|960|mg|10|stk|1|glas|160+800 mg|J01EE01|01.07.1989||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|486|1500|lyfalmen|||00|10|0|5|Actavis Group hf|Actavis hf|||486||486|1500 433730|J01EE0104|Primazol sterkar|töflur|960|mg|20|stk|1|glas|160+800 mg|J01EE01|01.07.1989||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|929|2101|lyfalmen|||00|20|0|10|Actavis Group hf|Actavis hf|||929||929|2101 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|10|0|0|Icepharma hf|Intervet International B.V.||||||1374 434670|D01AC2001|Daktacort|krem|0| |50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|JAS|0|0|1|100|SEK|1483|2853|lyfalmen|||20|50|0|50|Vistor hf|Janssen-Cilag AB|||1483||1483|2853 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|ALK|0|0|1|100|DKK|7707|11299|lyfalmen|||00|1|0|1|Vistor hf|ALK-Abello A/S|||7707||7707|11299 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|ALK|0|0|1|100|DKK|7707|11299|lyfalmen|||00|1|0|0|Vistor hf|ALK-Abello A/S|||7707||7707|11299 434852|N06AB0302|Fontex|lausnart|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|30|XEU|11487|16429|lyfalmen|||00|100|0|100|Icepharma hf|Eli Lilly Danmark A/S|||11487||11487|16429 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|þpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|6012|8999|lyfalmen|||00|6|0|12|Vistor hf|AstraZeneca UK Ltd|||6012||6012|8999 435578|N02CC0301|Zomig|töflur|2,5|mg|3|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|2570|4328|lyfalmen|||00|3|0|3|Vistor hf|AstraZeneca UK Ltd|||2570||2570|4328 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|5021|7654|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|||5021||5021|7654 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|7419|9625|lyfalmen|V0725|8364|00|100|0|6|Vistor hf|AstraZeneca UK Ltd|||6473||6473|9625 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|2844|4700|lyfalmen|||00|250|0|42|Vistor hf|Recip AB|||2844||2844|4700 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3966|6222|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|||3966||3966|6222 436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|11366|16265|lyfalmen|V0191|13180|00|98|0|98|Vistor hf|Novartis Healthcare A/S-|||11366||11366|16265 436071|N04BC0401|Requip|töflur|0,25|mg|210|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6187|9236|lyfalmen|||00|210|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6187||6187|9236 436139|N04BC0401|Requip|töflur|0,5|mg|21|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|1041|2253|lyfalmen|||00|21|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1041||1041|2253 436147|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|A|5|0|0|E|0|MNA|0|0|1|100|SEK|||lyfalmen|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB||||||1550 436238|N04BC0401|Requip|töflur|1|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6809|10081|lyfalmen|||00|84|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6809||6809|10081 436279|N04BC0401|Requip|töflur|2|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|12346|17556|lyfalmen|V0728|17231|00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||12346||12346|17556 436295|N04BC0401|Requip|töflur|5|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|26243|34858|lyfalmen|||00|84|0|70|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||26243||26243|34858 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|790|1912|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|||790||790|1912 436527|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1989|3540|lyfalmen|||10|100|0|50|Actavis Group PTC ehf|Merck NM AB|||1989||1989|3540 436550|M01AE0211|Naproxen-E NM Pharma|sh-tfl|375|mg|20|stk|1|þpakki||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|797|1922|lyfalmen|||10|20|0|15|Actavis Group PTC ehf|Merck NM AB|||797||797|1922 436626|M01AE0216|Naproxen-E Merck NM|sh-tfl|375|mg|100|stk|1|glas||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3292|5308|lyfalmen|||10|100|0|75|Actavis Group PTC ehf|Merck NM AB|||3292||3292|5308 436808|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3765|5950|lyfalmen|||10|100|0|100|Actavis Group PTC ehf|Merck NM AB|||3765||3765|5950 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|927|2098|lyfalmen|||00|100|0|12|Vistor hf|Janssen-Cilag AB|||927||927|2098 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|3249|5249|lyfalmen|||00|100|0|50|Vistor hf|Janssen-Cilag AB|||3249||3249|5249 438218|N06AX1602|Efexor Depot|forðahlk|75|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|20204|27339|lyfalmen|V0955|19625|00|100|0|75|Icepharma hf|Wyeth AB|||20204||20204|27339 438333|N06AX1602|Efexor Depot|forðahlk|150|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|10279|14789|lyfalmen|||00|28|0|42|Icepharma hf|Wyeth AB|||||10279|14789 438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|498|1516|lyfalmen|||00|20|1|4|Parlogis hf|Parlogis - óskráð lyf|||498||498|1516 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|0| |10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|1308|2615|lyfalmen|||00|10|0|0|K.Pétursson hf|Alcon|||1308||1308|2615 438424|N06AX1602|Efexor Depot|forðahlk|75|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|5420|8196|lyfalmen|||00|28|0|21|Icepharma hf|Wyeth AB|||5420||5420|8196 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|18668|25427|lyfalmen|V0955|19233|00|98|0|74|Icepharma hf|Wyeth AB|||18668||18668|25427 438457|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|35278|46106|lyfalmen|V0956|34666|00|98|0|147|Icepharma hf|Wyeth AB|||35278||35278|46106 438465|N06AX1602|Efexor Depot|forðahlk|150|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|38146|49677|lyfalmen|V0956|35373|00|100|0|150|Icepharma hf|Wyeth AB|||38146||38146|49677 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|A|4|0|0|E|0|SCP|0|0|1|100|DKK|||lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough||||||1797 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|2090|3677|lyfalmen|V0982|1895|00|30|0|30|Vistor hf|Schering-Plough|||2090||2090|3677 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|6310|9403|lyfalmen|V0984|3662|00|100|0|100|Vistor hf|Schering-Plough|||6310||6310|9403 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2346|4024|lyfalmen|||66|14|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2346||2346|4024 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10400|14954|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|||10400||10400|14954 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A||||||0 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2287|lyfalmen|||00|70|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1066||1066|2287 440123|S01BA0401|Ultracortenol|augndr|5|mg/ml|5|ml|1|glas||S01BA04|01.12.1972||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|774|1891|lyfalmen|||29|5|0|0|Vistor hf|Novartis Healthcare A/S-|||774||774|1891 440677|J01CE0105|Penicillin Alpharma|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1578|2259|lyfsjukr|||00|10|0|2|Actavis Group hf|Actavis Group hf|||1578||1578|2259 440693|J01CE0105|Penicillin Alpharma|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2491|3566|lyfsjukr|||00|10|0|3|Actavis Group hf|Actavis Group hf|||2491||2491|3566 440933|M01AB0507|Vostar|eþ-stil|50|mg|10|stk|1|pakki||M01AB05|01.01.1990||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|548|1584|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis hf|||548||548|1584 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1542|2933|lyfalmen|V0221|2921|00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1542||1542|2933 441279|D01AC2002|Pevisone|krem|0| |30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1375|2706|lyfalmen|||20|30|0|30|Vistor hf|Janssen-Cilag AB|||1375||1375|2706 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|GBP|||lyflausa|||00|59|0|0|GlaxoSmithKline ehf|ACO Hud AB|||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|894|2054|lyfalmen|||00|30|0|30|Icepharma hf|Bayer Schering Pharma AG|||894||894|2054 442152|J05AF0101|Retrovir|hylki|250|mg|40|stk|1|þpakki||J05AF01|01.07.1995||R|A|5|0|1|0|1|GSK|0|0|0|100|GBP|31067|40546|lyfsjukr|||61|40|0|17|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||31067||31067|40546 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|3906|6141|lyfalmen|||02|1|0|1|Vistor hf|Novo-Nordisk|||3906||3906|6141 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|33793|44257|lyfalmen|||10|90|0|180|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||33793||33793|44257 444240|J05AF0401|Zerit|hylki|30|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|48084|61732|lyfsjukr|||00|56|0|21|Vistor hf|Bristol-Myers Squibb|||48084||48084|61732 444299|J05AF0401|Zerit|hylki|40|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|48771|62587|lyfsjukr|||00|56|0|28|Vistor hf|Bristol-Myers Squibb|||48771||48771|62587 444315|N06AB0302|Fontex|lausnart|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|30|XEU|3451|5524|lyfalmen|V0914|2128|00|30|0|30|Icepharma hf|Eli Lilly Danmark A/S|||3451||3451|5524 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3040|4966|lyfalmen|||00|100|0|8|Icepharma hf|Roche|||3040||3040|4966 444927|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|19344|25951|lyfsjukr|||00|2|0|0|Icepharma hf|Roche|||19344||19344|25951 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1919|3445|lyfalmen|||00|30|0|30|Vistor hf|LEO A/S|||1919||1919|3445 445759|G04CB0101|Proscar|töflur|5|mg|98|stk|1|þpakki||G04CB01|01.04.1993||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|13056|6011|lyfalmen|V0411|6011|10|98|0|98|Icepharma hf|M.S.D.|||3810||3810|6011 445965|H01AC0104|Saizen|sts|0| |1,33|mg|1|hgl|+ leysir|H01AC01|01.07.1992|31.12.2008|R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|5733|8208|lyfsjukr|||02|1|0|2|Gróco ehf|Serono Nordic|||5733||5733|8208 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1540|3039|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||1540||1540|3039 446807|J02AC0101|Diflucan|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4307|6685|lyfalmen|V0551|3202|10|7|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4307||4307|6685 446930|J02AC0101|Diflucan|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|1835|3331|lyfalmen|V0554|1864|10|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1835||1835|3331 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12004|17130|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12004||12004|17130 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|6847|10132|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6847||6847|10132 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8388|12223|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8388||8388|12223 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10071|14507|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10071||10071|14507 447912|C08DB0107|Korzem|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|706|1798|lyfalmen|V0352|1798|00|100|0|25|Actavis Group hf|Actavis hf|||706||706|1798 448217|C05AA0801|Doloproct|eþ-stil|0| |10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|E|0|IGB|0|0|0|100|SEK|566|1608|lyfalmen|||04|10|0|0|Icepharma hf|Intendis GmbH Berlin|||566||566|1608 448233|C05AA0801|Doloproct|eþ-krem|0| |30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|E|0|IGB|0|0|0|100|SEK|1105|2340|lyfalmen|||00|30|0|0|Icepharma hf|Intendis GmbH Berlin|||1105||1105|2340 448498|R03DA0503|Aminophylline|stl|30|mg/ml|10|ml|10|lykjur||R03DA05|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|4138|6456|lyfalmen|||02|100|1|5|Parlogis hf|Parlogis - óskráð lyf|||4138||4138|6456 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2511|4248|lyfalmen|V0712|2637|00|50|0|25|Vistor hf|Novartis Healthcare A/S-|||2511||2511|4248 449595|C07AB0310|Atenolol Merck NM|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|850|1994|lyfalmen|||00|98|0|65|Actavis Group PTC ehf|Merck NM AB|||||850|1994 449611|C07AB0310|Atenolol Merck NM|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1250|2537|lyfalmen|V0306|1907|00|98|0|131|Actavis Group PTC ehf|Merck NM AB|||1250||1250|2537 449819|J01CE0105|Penicillin Alpharma|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|5907|8457|lyfsjukr|||00|10|0|8|Actavis Group hf|Actavis Group hf|||5907||5907|8457 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|þp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2233|lyfalmen|V0466|2233|00|12|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1026||1026|2233 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1112|1720|lyfalmen|V0902|1617|00|20|0|20|Vistor hf|Sanofi-aventis Norge AS|||648||648|1720 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|3506|4895|lyfalmen|V0903|4483|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|||2988||2988|4895 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|45479|58806|lyfalmen|||00|100|0|0|Icepharma hf|GE Healthcare AS|||45479||45479|58806 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|68218|87116|lyfalmen|||00|150|0|0|Icepharma hf|GE Healthcare AS|||68218||68218|87116 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|90958|115428|lyfalmen|||00|200|0|0|Icepharma hf|GE Healthcare AS|||90958||90958|115428 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|þpakki||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|6098|8288|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|||5488||5488|8288 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|20229|26479|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|||19513||19513|26479 452268|J02AC0101|Diflucan|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|17675|24190|lyfalmen|V0552|10534|10|30|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||17675||17675|24190 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1237|2519|lyfalmen|||00|5|0|5|Icepharma hf|Roche as|||1237||1237|2519 452300|J02AC0101|Diflucan|hylki|50|mg|100|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|59196|75884|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||59196||59196|75884 452482|V07AB09|Sterilt Vatten Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|1000|0|0|Actavis Group hf|Braun|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|DKK|13845|19422|lyfalmen|||00|3000|0|3|Vistor hf|Laboratories 3M Santé|||13845||13845|19422 452896|A06AD1701|Phosphoral|mixtúra|0| |45|ml|2|fl||A06AD17|01.03.1999||L|A|3|0|0|0|0|LCF|0|0|0|100|IKR|||lyfalmen|||00|90|0|0|Vistor hf|Laboratorios Casen-Fleet S.L.U.||||||0 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2723|4536|lyfalmen|||10|28|0|4|Icepharma hf|Norpharma |||2723||2723|4536 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|8962|13002|lyfalmen|||10|98|0|13|Icepharma hf|Norpharma |||8962||8962|13002 452953|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2688|4488|lyfalmen|||10|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2688||2688|4488 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|5143|7820|lyfalmen|||10|28|0|7|Icepharma hf|Norpharma |||5143||5143|7820 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|||vetorma|||16|6|0|0|Vistor hf|Merial (MSD)||||||2720 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|16283|22457|lyfalmen|||10|98|0|26|Icepharma hf|Norpharma |||16283||16283|22457 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|10360|14899|lyfalmen|||10|28|0|15|Icepharma hf|Norpharma |||10360||10360|14899 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|27955|36989|lyfalmen|||10|98|0|52|Icepharma hf|Norpharma|||27955||27955|36989 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PFI|0|1|0|100|DKK|3847|5508|lyfsjukr|||02|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3847||3847|5508 453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dæla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2451|4167|lyfalmen|||00|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||2451||2451|4167 454199|C10AA0101|Zocor|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.01.1991||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|10830|8596|lyfalmen|V0365|2265|00|98|0|131|Icepharma hf|M.S.D.|||5715||5715|8596 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|16379|22577|lyfalmen|||00|28|0|19|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||16379||16379|22577 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|50639|65231|lyfalmen|V0375|65231|00|98|0|65|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||50639||50639|65231 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|18479|25191|lyfalmen|||00|28|0|37|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||18479||18479|25191 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|54791|70400|lyfalmen|V0376|70399|00|98|0|131|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||54791||54791|70400 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|GSK|0|0|0|100|GBP|54449|69657|lyfsjukr|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||54449||54449|69657 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1166|2301|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1166||1166|2301 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|912|2078|lyfalmen|||00|30|0|5|Vistor hf|Bayer HealthCare AG|||912||912|2078 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|3275|5285|lyfalmen|||00|120|0|20|Vistor hf|Bayer HealthCare AG|||3275||3275|5285 455428|B03XA0103|NeoRecormon|sts|10000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|68161|86728|lyfsjukr|||00|3|0|30|Icepharma hf|Roche|||68161||68161|86728 455527|B03XA0103|NeoRecormon|sts|20000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|135523|170594|lyfsjukr|||00|3|0|60|Icepharma hf|Roche|||135523||135523|170594 455576|B03XA0103|NeoRecormon|sts|100000|ae/hgl|5|ml|1|hgl|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|221744|277939|lyfsjukr|||00|5|0|10|Icepharma hf|Roche|||221744||221744|277939 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|30|DKK|23370|31281|lyfalmen|||00|21|0|14|Vistor hf|Novartis Healthcare A/S-|||23370||23370|31281 455717|C05AD0102|Sulgan|eþ-smyr|0| |30|g|1|túpa||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|CHF|||lyfalmen|||00|30|0|0|Icepharma hf|Doetsch Grether||||||0 455725|C05AD0102|Sulgan|eþ-stil|0| |10|stk|1|pakki||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|CHF|||lyfalmen|||00|10|0|0|Icepharma hf|Doetsch Grether||||||0 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1063|2283|lyfalmen|||00|10|0|10|Actavis Group hf|Actavis hf|||1063||1063|2283 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1160|2415|lyfalmen|||0|15|0|15|Actavis Group hf|Actavis hf|||1160||1160|2415 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|2541|4289|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|||2541||2541|4289 456079|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|6000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4381|6272|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||4381||4381|6272 456202|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|6000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4381|6272|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||4381||4381|6272 456277|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|5000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4783|6848|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||4783||4783|6848 456392|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|5000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4783|6848|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||4783||4783|6848 457002|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7160|10251|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7160||7160|10251 457036|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7160|10251|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7160||7160|10251 457069|B05DB0001|Dianeal PD1 Glucose|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7160|10251|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7160||7160|10251 457119|B05DA0002|Dianeal PD1 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8963|12833|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||8963||8963|12833 457127|N05BA1202|Paxal|töflur|0,25|mg|20|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|117|999|lyfalmen|V0844|999|00|20|0|5|Actavis Group hf|Actavis hf|||117||117|999 457135|N05BA1202|Paxal|töflur|0,25|mg|50|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|246|1174|lyfalmen|V0848|1174|00|50|0|12|Actavis Group hf|Actavis hf|||246||246|1174 457143|N05BA1202|Paxal|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.04.1990|31.12.2008|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|100|0|25|Actavis Group hf|Actavis hf|||461||| 457150|N05BA1202|Paxal|töflur|0,5|mg|20|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|199|1110|lyfalmen|V0856|1110|00|20|0|10|Actavis Group hf|Actavis hf|||199||199|1110 457192|N05BA1202|Paxal|töflur|0,5|mg|50|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|440|1437|lyfalmen|V0860|1437|00|50|0|25|Actavis Group hf|Actavis hf|||440||440|1437 457242|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8738|12511|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||8738||8738|12511 457291|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11617|16331|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11617||11617|16331 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|ARA|0|0|1|100|SEK|1052|2268|lyfalmen|||00|25|0|5|Vistor hf|Astra|||1052||1052|2268 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1706|3156|lyfalmen|||43|20|0|7|Vistor hf|LEO Pharma A/S|||1706||1706|3156 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2558|4312|lyfalmen|||43|30|0|10|Vistor hf|LEO Pharma A/S|||2558||2558|4312 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|þpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9311|13476|lyfalmen|V0456|13476|00|100|0|33|Vistor hf|LEO Pharma A/S|||9311||9311|13476 458737|B05DA0003|Dianeal PD4 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11708|16444|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11708||11708|16444 458778|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11708|16444|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11708||11708|16444 458794|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11708|16444|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11708||11708|16444 459214|B05DB0004|Nutrineal PD4 1,1% Amino Acids Clear|kvið.sk|0| |2000|ml|5|pokar||B05DB00|01.06.2004||R|S|2|0|0|0|1|BAM|0|0|0|100|SEK|13929|19209|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||13929||13929|19209 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1516|2171|lyfsjukr|||02|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1516||1516|2171 459412|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|5|lykjur||M05BA06|01.02.2002||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|91028|115197|lyfsjukr|||00|10|0|2|Icepharma hf|Roche|||91028||91028|115197 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1859|2662|lyfsjukr|||02|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1859||1859|2662 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2154|3763|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|||2154||2154|3763 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2362|4046|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|||2362||2362|4046 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|DKK|2390|4084|lyfalmen|||00|30|0|8|Icepharma hf|Meda AS|||2390||2390|4084 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|DKK|4861|7437|lyfalmen|||00|60|0|15|Icepharma hf|Meda AS|||4861||4861|7437 460071|J01CA0406|Flemoxin Solutab|lausnart|250|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1073|2296|lyfalmen|||23|20|0|5|Vistor hf|Astellas Pharma A/S|||1073||1073|2296 460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4525|6981|lyfalmen|||51|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|||4525||4525|6981 460196|J01CA0406|Flemoxin Solutab|lausnart|500|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1605|3018|lyfalmen|||23|20|0|10|Vistor hf|Astellas Pharma A/S|||1605||1605|3018 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2918|4800|lyfalmen|||23|20|0|15|Vistor hf|Astellas Pharma A/S|||2918||2918|4800 460618|L01AX0301|Temodal|hylki|5|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|19299|25895|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|||19299||19299|25895 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|V0355|2143|23|120|0|120|Vistor hf|Janssen-Cilag AB||||||3299 460972|J07BB0205|Influvac|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOP|0|0|0|100|XEU|6474|9626|lyfalmen|||51|5|0|0|Icepharma hf|Solvay Pharmaceuticals|||6474||6474|9626 461178|L01AX0301|Temodal|hylki|20|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|77190|97969|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|||77190||77190|97969 461335|L01AX0301|Temodal|hylki|100|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|94369|119357|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|||94369||94369|119357 461467|L01AX0301|Temodal|hylki|250|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|203685|255455|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|||203685||203685|255455 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|193|1102|lyfalmen|||00|10|0|2|Actavis Group hf|Actavis hf|||193||193|1102 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|682|1766|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||682||682|1766 462036|D07AD0101|Dermovat|krem|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2684|4483|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2684||2684|4483 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|682|1766|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||682||682|1766 462051|D07AD0101|Dermovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2684|4483|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2684||2684|4483 462143|B05AA0703|Hemohes 10%|irl|100|mg/ml|500|ml|10|fl||B05AA07|01.11.1999||R|A|3|0|0|0|1|BRA|0|0|0|100|XEU|22868|30338|lyfsjukr|||00|5000|0|5|Actavis Group hf|Braun|||22868||22868|30338 462226|B05AA0702|Hemohes 6%|irl|60|mg/ml|500|ml|10|fl||B05AA07|01.11.1999||R|A|3|0|0|0|1|BRA|0|0|0|100|XEU|17227|23315|lyfsjukr|||00|5000|0|5|Actavis Group hf|Braun|||17227||17227|23315 462358|A07EA0601|Entocort|innhl|20|mcg/ml|7|stk|1|pakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7692|11279|lyfalmen|V0297|10600|56|7|0|7|Vistor hf|AstraZeneca A/S DK|||7692||7692|11279 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|7146|13783|vetalmen|||02|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||7146||7146|13783 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5700|11029|vetalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||5700||5700|11029 463778|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|glas||M01AE01|01.01.1989|31.12.2008|L|A|5|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|20|0|3|Actavis Group hf|Actavis hf||||||0 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|30|0|5|Icepharma hf|GlaxoSmithKline CH A/S||||||0 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|OVA|0|1|0|100|DKK|1886|3400|lyfalmen|||00|100|0|8|Swedish Orphan International AB|Ovation Healthcare International Ltd.|||1886||1886|3400 465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|S|3|0|0|0|0|INI|0|0|0|100|DKK|1266|2498|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1266||1266|2498 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1196|2360|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1196||1196|2360 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1282|2530|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1282||1282|2530 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|675|1332|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||675||675|1332 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|800|1926|lyfalmen|||10|25|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||800||800|1926 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2806|4648|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2806||2806|4648 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1701|3149|lyfalmen|||10|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1701||1701|3149 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6829|10108|lyfalmen|||10|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6829||6829|10108 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|3272|5281|lyfalmen|||10|25|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3272||3272|5281 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|9128|13228|lyfalmen|||10|50|0|5|Vistor hf|Novartis Healthcare A/S-|||9128||9128|13228 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5237|7947|lyfalmen|||10|25|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5237||5237|7947 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|DKK|5331|8075|lyfalmen|||64|100|0|50|Icepharma hf|Meda AS|||5331||5331|8075 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|16912|22923|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|||16912||16912|22923 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|26505|34866|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|||26505||26505|34866 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|28699|37595|lyfsjukr|||00|1|0|9|Vistor hf|Schering-Plough|||28697||28697|37595 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|46746|60066|lyfsjukr|||00|1|0|15|Vistor hf|Schering-Plough|||46746||46746|60066 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|USD|42608|55232|lyfalmen|||00|60|0|20|Icepharma hf|Wyeth Europe|||42608||42608|55232 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|17697|24218|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|||17697||17697|24218 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|95688|120999|lyfsjukr|||00|1|0|30|Vistor hf|Schering-Plough|||95688||95688|120999 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|33495|43886|lyfalmen|||10|50|0|20|Vistor hf|Novartis Healthcare A/S-|||33495||33495|43886 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|748|1071|lyfsjukr|||00|5|0|3|Vistor hf|Janssen-Cilag AB|||748||748|1071 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|6831|6848|lyfalmen|V0922|4508|00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|||4427||4427|6848 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|436|624|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|||436||436|624 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|11918|6518|lyfalmen|V0926|4309|00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|||4184||4184|6518 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|25131|13316|lyfalmen|V0930|8459|00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|||9193||9193|13316 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|10834|15543|lyfalmen|||00|98|0|49|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10834||10834|15543 469742|N02AX0206|Nobligan Retard|forðatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|3094|5039|lyfalmen|||00|20|0|13|Icepharma hf|Grunenthal|||3094||3094|5039 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|12609|17883|lyfalmen|V0738|14192|00|100|0|67|Icepharma hf|Grunenthal|||12609||12609|17883 469866|N02AX0206|Nobligan Retard|forðatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2419|4123|lyfalmen|||00|20|0|10|Icepharma hf|Grunenthal|||2419||2419|4123 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|9575|13834|lyfalmen|V0736|10980|00|100|0|50|Icepharma hf|Grunenthal|||9575||9575|13834 469890|N02AX0206|Nobligan Retard|forðatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1644|3071|lyfalmen|V0733|2529|00|20|0|7|Icepharma hf|Grunenthal|||1644||1644|3071 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|6540|9715|lyfalmen|V0734|7448|00|100|0|33|Icepharma hf|Grunenthal|||6540||6540|9715 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5508|8315|lyfalmen|||24|120|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5508||5508|8315 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6223|8910|lyfsjukr|||02|150|0|0|Icepharma hf|GE Healthcare AS|||6223||6223|8910 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|7625|10917|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||7625||7625|10917 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6396|9157|lyfsjukr|||02|100|0|0|Icepharma hf|GE Healthcare AS|||6396||6396|9157 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9018|12912|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||9018||9018|12912 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9600|13745|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||9600||9600|13745 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|2122|3720|lyfalmen|||68|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2122||2122|3720 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|20|0|0|Icepharma hf|Intervet International B.V.||||||2492 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|2207|3835|lyfalmen|||00|100|0|0|Icepharma hf|Baxter Medical AB|||2207||2207|3835 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|5075|9838|vetalmen|||27|10|0|0|Vistor hf|Orion Corporation|||5075||5075|9838 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2213|3844|lyfalmen|V2003|3785|43|98|0|31|Vistor hf|AstraZeneca A/S DK|||2213||2213|3844 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2550|4301|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2550||2550|4301 473348|A03AA0402|Spasmerin|töflur|135|mg|50|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|957|2139|lyfalmen|||00|50|0|22|Actavis Group hf|Actavis hf|||957||957|2139 473371|A03AA0402|Spasmerin|töflur|135|mg|100|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|1680|3120|lyfalmen|||00|100|0|45|Actavis Group hf|Actavis hf|||1680||1680|3120 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|13885|19154|lyfsjukr|||00|400|0|0|Icepharma hf|Meda AB|||13885||13885|19154 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|GBP|||lyflausa|||00|50|0|0|Icepharma hf|Mentholatum Company Ltd.|||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|996|2192|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|||996||996|2192 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|GBP|||lyflausa|||00|15|0|0|Icepharma hf|Mentholatum Company Ltd.|||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|þpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|44410|57158|lyfsjukr|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |||44410||44410|57158 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2056|3630|lyfalmen|||00|140|0|35|Vistor hf|Schering-Plough|||2056||2056|3630 475327|N02BE0113|Pinex Junior|eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|1|Actavis Group hf|Actavis Group hf||||||0 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|720|1817|lyfalmen|||00|100|0|27|Actavis Group hf|Actavis hf|||720||720|1817 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4052|6339|lyfalmen|||23|26|0|91|Vistor hf|Janssen-Cilag AB|||4052||4052|6339 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|111|991|lyfalmen|V0775|991|00|20|0|7|Actavis Group hf|Actavis hf|||111||111|991 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|188|1096|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|||188||188|1096 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|IKR|425|1417|lyfalmen|V0780|1417|00|100|0|33|Actavis Group hf|Actavis hf|||425||425|1417 475756|C09AA0801|Inhibace|töflur|2,5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|6648|9862|lyfalmen|||00|98|0|98|Icepharma hf|Roche|||6648||6648|9862 475798|R03AC1302|Oxis Turbuhaler|innúðadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|3312|5335|lyfalmen|||00|60|0|11|Vistor hf|AstraZeneca A/S DK|||3312||3312|5335 475822|R03AC1302|Oxis Turbuhaler|innúðadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|4431|6853|lyfalmen|||00|60|0|22|Vistor hf|AstraZeneca A/S DK|||4431||4431|6853 475889|C09AA0801|Inhibace|töflur|5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|12749|18057|lyfalmen|||00|98|0|196|Icepharma hf|Roche|||12749||12749|18057 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6264|9341|lyfalmen|||00|15|0|38|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||6264||6264|9341 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|5049|7692|lyfalmen|||51|15|0|38|Icepharma hf|Eli Lilly Danmark A/S|||5049||5049|7692 476580|R03AC0206|Ventoline|lausn|2|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1177|2438|lyfalmen|||00|50|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1177||1177|2438 476648|N05AH0401|Seroquel|töflur|100|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|6758|10009|lyfalmen|||00|30|0|8|Vistor hf|AstraZeneca UK Ltd|||6756||6756|10009 476655|N05AH0401|Seroquel|töflur|200|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|10269|14776|lyfalmen|||00|30|0|15|Vistor hf|AstraZeneca UK Ltd|||10269||10269|14776 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|4620|7110|lyfalmen|||00|12|0|3|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4620||4620|7110 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|200|0|0|Icepharma hf|Fresenius Kabi||||||0 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|500|0|0|Icepharma hf|Fresenius Kabi||||||0 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|200|0|0|Icepharma hf|Fresenius Kabi||||||0 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|500|0|0|Icepharma hf|Fresenius Kabi||||||0 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|1000|0|0|Icepharma hf|Fresenius Kabi||||||0 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|DKK|9915|14296|lyfalmen|||00|98|0|131|Icepharma hf|Meda AS|||9915||9915|14296 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|DKK|21271|28667|lyfalmen|||00|98|0|261|Icepharma hf|Meda AS|||21271||21271|28667 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|ELD|0|0|0|100|IKR|3183|5160|lyfalmen|||00|28|0|28|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||3183||3183|5160 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|ELD|0|0|0|100|IKR|9486|13713|lyfalmen|||00|84|0|84|Eli Lilly Danmark A/S|Eli Lilly Nederland -|||||9486|13713 481168|N06AX1201|Zyban|forðatfl|150|mg|60|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|7738|11341|lyfalmen|||00|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||7738|11341 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|11941|17045|lyfalmen|||00|100|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||11941||11941|17045 481598|M03AX0102|Dysport|sts|500|ein|1|hgl|1|pakki||M03AX01|01.05.2003||R|K|2|0|1|0|1|INP|0|0|0|100|XEU|42241|54458|lyfsjukr|||02|1|0|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|||42241||42241|54458 483552|J02AC0101|Diflucan|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.08.2000||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|66162|84557|lyfalmen|V0557|33109|10|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||66162||66162|84557 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3836|5492|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3836||3836|5492 483636|N07BA0103|Nicorette|tungur.t|2|mg|30|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|2|Vistor hf|McNeil Denmark ApS||||||0 483644|N07BA0103|Nicorette|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|7|Vistor hf|McNeil Denmark ApS||||||0 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|5813|8323|lyfsjukr|||00|100|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5813||5813|8323 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|87715|111073|lyfsjukr|||00|3|0|84|Vistor hf|Ferring|||87715||87715|111073 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|7131|10517|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|||7131||7131|10517 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|DKK|1308|2615|lyfalmen|||00|300|0|0|Vistor hf|Meda AB (V)|||1308||1308|2615 484832|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|1|fl||B05BB01|01.05.2004||R|A||0|0|0|1|LDR|0|0|0|100|IKR|543|777|lyfsjukr|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||543||543|777 486779|M01AE0215|Naproxen Merck NM|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|A|4|0|0|E|0|MNA|0|0|1|100|SEK|||lyfalmen|||00|20|0|10|Actavis Group PTC ehf|Merck NM AB||||||1162 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|725|1824|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|||725||725|1824 486886|S01CA0101|Maxitrol|augndr|0| |5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|713|1808|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|||713||713|1808 487264|C09AA0401|Coversyl|töflur|2|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|2653|4441|lyfalmen|||00|30|0|15|Icepharma hf|Servier|||2653||2653|4441 487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|3872|6095|lyfalmen|||00|30|0|30|Icepharma hf|Servier|||3872||3872|6095 487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|þpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|793|1917|lyfalmen|||00|25|0|6|Vistor hf|Recip AB|||793||793|1917 487959|N02BE0113|Pinex Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|0|Actavis Group hf|Actavis Group hf||||||0 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|853|1998|lyfalmen|||00|20|0|10|Icepharma hf|Meda AB|||853||853|1998 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2540|4287|lyfalmen|||00|60|0|30|Icepharma hf|Meda AB|||2540||2540|4287 488114|N02BE0114|Pinex|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|2|Actavis Group hf|Actavis Group hf||||||0 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|10377|14922|lyfalmen|||67|50|0|14|Actavis Group PTC ehf|Actavis Group PTC ehf|||10377||10377|14922 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|18732|25506|lyfalmen|||67|50|0|36|Actavis Group PTC ehf|Actavis Group PTC ehf|||18732||18732|25506 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1101|lyfalmen|||67|10|0|5|Vistor hf|Novartis Healthcare A/S-|||192||192|1101 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|960|1474|lyfalmen|V0609|1455|67|30|0|15|Vistor hf|Novartis Healthcare A/S-|||467||467|1474 490417|G03FB0504|Evorel Sequi|forðapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2387|4080|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|||2387||2387|4080 490425|G03FA0104|Evorel Conti|forðapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2797|4636|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|||2797||2797|4636 490557|A04AA0201|Kytril|stl|1|mg/ml|1|ml|5|lykjur||A04AA02|01.10.1999||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|9143|13248|lyfalmen|||00|5|0|2|Icepharma hf|Roche as|||9143||9143|13248 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5030|7666|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5030||5030|7666 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11539|10994|lyfalmen|V0337|6756|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7482||7482|10994 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|7806|11434|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7806||7806|11434 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|16375|14973|lyfalmen|V0338|9234|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10414||10414|14973 490839|C10AA0501|Zarator|töflur|40|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12117|17271|lyfalmen|||00|30|0|120|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12117||12117|17271 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|20826|18541|lyfalmen|V0339|11516|00|100|0|400|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||13137||13137|18541 491639|N06DA0301|Exelon|mixtúra|2|mg/ml|120|ml|1|fl||N06DA03|01.05.2003||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|23493|31434|lyfalmen|||00|120|0|27|Vistor hf|Novartis Europharm Ltd|||23493||23493|31434 491753|C10AC0102|Questran Loc|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1992|31.12.2008|R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|2922|4806|lyfalmen|||00|50|0|14|Vistor hf|Bristol-Myers Squibb|||2922||2922|4806 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|51589|66096|lyfsjukr|||00|3|0|21|Vistor hf|N.V. Organon|||51589||51589|66096 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|hylki|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3617|5749|lyfalmen|||10|100|0|17|Icepharma hf|Roche|||3617||3617|5749 492520|A02BC0105|Losec MUPS|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|8045|11758|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca A/S DK|||8045||8045|11758 492587|N06AX0303|Mianserin NM Pharma|töflur|10|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|1404|2746|lyfalmen|V1140|2549|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|||1404||1404|2746 493148|C10AA0302|Pravachol|töflur|20|mg|28|stk|1|þpakki||C10AA03|01.07.1989||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|4565|7035|lyfalmen|||00|28|0|28|Vistor hf|Bristol-Myers Squibb|||4565||4565|7035 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1515|2896|lyfalmen|||00|100|0|17|Vistor hf|Sanofi-aventis Norge AS|||1515||1515|2896 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|4186|6521|lyfalmen|||00|100|0|33|Vistor hf|Novartis Healthcare A/S-|||4186||4186|6521 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|93120|117802|lyfsjukr|||00|20|0|0|Icepharma hf|Roche Registration Limited|||93120||93120|117802 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|232802|291706|lyfsjukr|||00|50|0|0|Icepharma hf|Roche Registration Limited|||232802||232802|291706 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2417|4120|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2417||2417|4120 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2758|4583|lyfalmen|V0408|2134|23|84|0|84|Vistor hf|Novo-Nordisk|||2758||2758|4583 494724|G03FA0102|Kliogest|töflur|0| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3498|5587|lyfalmen|V0388|4268|23|84|0|84|Vistor hf|Novo-Nordisk|||3498||3498|5587 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|3369|5412|lyfalmen|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |||3369||3369|5412 495259|A02BA0205|Zantac|freyðit|150|mg|15|stk|2|stauk|2 x 15 stk.|A02BA02|01.04.1990||L|A|2|0|0|E|0|GSK|0|0|0|30|GBP|||lyfalmen|||14|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf||||||5258 495267|A04AA0101|Zofran|töflur|4|mg|100|stk|1|glas||A04AA01|01.01.1991|31.12.2008|R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|95283|120812|lyfalmen|||00|100|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||95283||95283|120812 495275|A04AA0101|Zofran|töflur|8|mg|100|stk|1|glas||A04AA01|01.01.1991|31.12.2008|R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|134227|169298|lyfalmen|||00|100|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||134227||134227|169298 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|18962|25793|lyfalmen|||00|15|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||18962||18962|25793 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7375|10849|lyfalmen|V1088|7729|02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||7375||7375|10849 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|10537|15140|lyfalmen|V1089|12111|02|20|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||10537||10537|15140 495572|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.04.2002||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|18291|24957|lyfalmen|||00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||18291||18291|24957 495580|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.04.2002||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|30833|40572|lyfalmen|||00|100|0|44|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||30833||30833|40572 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|2893|4766|lyfalmen|||00|20|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2893||2893|4766 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|4179|6511|lyfalmen|||02|100|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4179||4179|6511 496554|C07AG0101|Trandate|töflur|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|1055|2272|lyfalmen|||00|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1055||1055|2272 496752|C07AG0101|Trandate|töflur|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|3311|5334|lyfalmen|||00|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3311||3311|5334 496935|N02AG0201|Ketogan|eþ-stil|0| |10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|594|1646|lyfalmen|||04|10|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||594||594|1646 496950|N02AG0201|Ketogan|töflur|0| |20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|903|2066|lyfalmen|||00|20|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||903||903|2066 497099|N02AG0201|Ketogan|töflur|0| |100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|3439|5507|lyfalmen|||00|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3439||3439|5507 497263|N06BA0103|Amfetamin Actavis|töflur|5|mg|30|stk|1|glas||N06BA01|01.07.1991||R|A|3|1|0|0|0|ACA|0|0|0|100|IKR|1036|2246|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|||1036||1036|2246 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|419|1409|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|||419||419|1409 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|802|1929|lyfalmen|V0167|1929|00|100|0|50|Actavis Group hf|Actavis hf|||802||802|1929 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2725|4538|lyfalmen|V0169|4538|00|100|0|200|Actavis Group hf|Actavis hf|||2725||2725|4538 497511|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.12.1983||L|A|3|0|0|0|0|BIG|0|0|0|100|SEK|||lyflausa|||00|250|0|250|Icepharma hf|Bioglan AB|||||| 497818|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|789|1911|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|||789||789|1911 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1450|2808|lyfalmen|||03|2|0|35|Vistor hf|Schering-Plough|||1450||1450|2808 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|19514|26480|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||19514||19514|26480 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|21037|28376|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||21037||21037|28376 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|28466|37625|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||28466||28466|37625 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|32712|42911|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||32712||32712|42911 500314|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|789|1911|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|||789||789|1911 500751|M01AB0101|Confortid|hylki|50|mg|30|stk|1|plglas||M01AB01|01.01.1977|31.12.2008|R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1068|2290|lyfalmen|||10|30|0|15|Actavis Group hf|Actavis Group hf|||1068||1068|2290 500769|M01AB0101|Confortid|hylki|50|mg|100|stk|1|glas||M01AB01|01.01.1977|31.12.2008|R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|||lyfalmen|||10|100|0|50|Actavis Group hf|Actavis Group hf||2323|2323|2323|| 501734|M01AB0508|Vostar-R|forðatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|3199|5182|lyfalmen|||67|100|0|75|Actavis Group hf|Actavis hf|||3199||3199|5182 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3775|5963|lyfalmen|||10|100|0|17|Icepharma hf|Roche|||3775||3775|5963 502187|D07AB0201|Locoid|lausn|1|mg/ml|100|ml|1|glas||D07AB02|01.03.1977||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2245|3887|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2245||2245|3887 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|3180|5156|lyfalmen|||00|100|0|25|Vistor hf|Amdipharm Ltd|||3180||3180|5156 502930|N05AB0301|Trilafon|töflur|16|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|4632|7126|lyfalmen|||00|100|0|53|Vistor hf|Schering-Plough|||4632||4632|7126 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|32909|42839|lyfsjukr|||00|1|0|28|Vistor hf|Ferring|||32909||32909|42839 503722|A01AC0102|Kenalog|munnh.pa|1|mg/g|10|g|1|túpa||A01AC01|01.05.1998|31.12.2008|R|A|5|0|0|E|0|BRS|0|0|1|100|DKK|1267|2558|lyfalmen|||20|10|0|0|Vistor hf|Bristol-Myers Squibb|||1267||1266|2558 503961|D07AC0301|Ibaril|krem|2,5|mg/g|50|g|1|túpa||D07AC03|01.10.1976||R|A|5|0|0|B|0|SNO|0|0|1|100|NOK|2111|3705|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|||2111||2111|3705 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2367|4053|lyfalmen|||00|90|0|45|Vistor hf|N.V. Organon|||2367||2367|4053 504746|R06AB0201|Polaramin|forðatfl|6|mg|50|stk|1|þpakki||R06AB02|01.01.1977||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1380|2713|lyfalmen|||10|50|0|50|Vistor hf|Schering-Plough|||1380||1380|2713 504753|R06AB0201|Polaramin|töflur|2|mg|50|stk|1|pakki|þp|R06AB02|01.06.2007||R|A|5|0|0|E|0|SCP|0|0|0|100|DKK|643|1713|lyfalmen|||00|50|0|0|Vistor hf|Schering-Plough|||643||643|1713 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1361|2687|lyfalmen|||00|100|0|30|Icepharma hf|Roche|||1361||1361|2687 505644|A01AA0104|Fluorette|tyggigúm|0,25|mg|90|stk|1|stk||A01AA01|01.01.1996|31.12.2008|L|A|1,5|0|0|0|0|FET|0|0|1|100|DKK|||lyfalmen|||00|90|0|20|Icepharma hf|Fertin A/S||||||0 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|8748|12712|lyfalmen|||00|100|0|75|Vistor hf|Amdipharm Ltd|||8748||8748|12712 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|3521|5041|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3521||3521|5041 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|6855|9815|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6855||6855|9815 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|12163|17010|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12163||12163|17010 506774|J01GB0301|Garamycin|stl|10|mg/ml|2|ml|10|lykjur||J01GB03|01.11.1977||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|3329|4766|lyfsjukr|||02|20|0|1|Vistor hf|Schering-Plough|||3329||3329|4766 506949|N01AB0601|Forene|innönd.l|0| |250|ml|1|stauk||N01AB06|01.10.1993||R|A|5|0|0|0|1|ABS|0|0|0|100|DKK|30865|40294|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|||30865||30865|40294 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|2610|4382|lyfalmen|||10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2610||2610|4382 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||10|25|0|12|Vistor hf|Orion Pharma||||||0 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|426|1418|lyfalmen|||10|100|0|50|Vistor hf|Orion Pharma|||426||426|1418 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||1215 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|120|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||5164 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|9685|16760|vetorma|||13|1000|0|0|Icepharma hf|Intervet International B.V.|||9685||9685|16760 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|SPA|0|0|0|100|DKK|2679|5274|vetalmen|||27|50|0|0|Vistor hf|Schering-Plough A/S|||2679||2679|5274 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|5689|8561|lyfalmen|||10|98|0|98|Vistor hf|Abbott Scandinavia AB|||5689||5689|8561 508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4367|8490|vetalmen|||0|50|0|0|Vistor hf|Bayer Animal Health GmbH|||4367||4367|8490 508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|13509|25904|vetalmen|||0|100|0|0|Vistor hf|Bayer Animal Health GmbH|||13509||13509|25904 508952|G03FB0902|Nuvelle|töflur|0| |84|stk|1|þpakki||G03FB09|01.08.1997||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|3265|5271|lyfalmen|||00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|||3265||3265|5271 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|10634|15271|lyfalmen|||02|10|0|133|Lundbeck Export A/S|H. Lundbeck A/S|||10634||10634|15271 509091|J01CF0101|Diclocil|hylki|500|mg|100|stk|1|þpakki||J01CF01|01.09.1977|31.12.2008|R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|10473|15051|lyfalmen|||10|100|0|25|Vistor hf|Bristol-Myers Squibb|||10473||10472|15051 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75|Vistor hf|N.V. Organon||||||2786 509448|D10AE0102|Panoxyl|hlaup|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|437|1433|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|||437||437|1433 509455|D10AE0102|Panoxyl|hlaup|100|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|493|1509|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|||493||493|1509 509463|D10AE0102|Panoxyl|áburður|50|mg/ml|30|ml|1|fl||D10AE01|01.12.1982||R|A|3|0|0|0|0|STI|0|0|0|100|XEU|361|1330|lyfalmen|||23|30|0|30|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|||361||361|1330 509471|D10AE0102|Panoxyl|krem|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|437|1433|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|||437||437|1433 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|49042|62925|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||49042||49042|62925 510248|B03XA0103|NeoRecormon|stl|1000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|14002|19300|lyfsjukr|||00|2|0|6|Icepharma hf|Roche|||14002||14002|19300 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|28005|36734|lyfsjukr|||00|2|0|12|Icepharma hf|Roche|||28005||28005|36734 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|40883|52767|lyfsjukr|||00|2|0|18|Icepharma hf|Roche|||40883||40883|52767 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|69055|87841|lyfsjukr|||00|2|0|30|Icepharma hf|Roche|||69055||69055|87841 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|114591|144533|lyfsjukr|||00|4|0|60|Icepharma hf|Roche|||114591||114591|144533 510321|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|261879|327907|lyfsjukr|||00|4|0|120|Icepharma hf|Roche|||261879||261879|327907 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|4464|6898|lyfalmen|V0411|6011|00|98|0|98|Actavis Group hf|Actavis hf|||4464||4464|6898 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|þpakki||C09CA07|01.03.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|3038|4963|lyfalmen|||00|28|0|14|Vistor hf|Boehringer Ingelheim International |||3038||3038|4963 511303|G03FB0501|Trisekvens|töflur|0| |84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2868|4732|lyfalmen|V0385|4637|23|84|0|84|Vistor hf|Novo-Nordisk|||2868||2868|4732 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|20887|27872|lyfsjukr|||00|6000|0|6|Icepharma hf|Meda AB|||20887||20887|27872 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|13066|18135|lyfsjukr|||00|6000|0|6|Icepharma hf|Meda AB|||13066||13066|18135 512608|B05XA3101|Peditrace|irþ|0| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|10132|14482|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||10132||10132|14482 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|SEK|||lyfalmen|||00|35|0|0|Vistor hf|AstraZeneca A/S DK||||||1634 514265|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1961|3502|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|||1961||1961|3502 515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|2237|3876|lyfalmen|||00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2237||2237|3876 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|5365|8121|lyfalmen|||00|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5365||5365|8121 516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999||R|A|2|0|0|E|0|AZD|0|0|0|30|SEK|1564|2963|lyfalmen|||00|14|0|7|Vistor hf|AstraZeneca A/S DK|||1564||1564|2963 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|4200|6540|lyfalmen|||00|90|0|11|Vistor hf|Novo-Nordisk|||4200||4200|6540 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|4930|7531|lyfalmen|||00|90|0|22|Vistor hf|Novo-Nordisk|||4930||4930|7531 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|6064|9070|lyfalmen|||00|90|0|45|Vistor hf|Novo-Nordisk|||6064||6064|9070 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|978|2168|lyfalmen|||00|20|0|15|Actavis Group hf|Actavis Group hf|||978||978|2168 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|4648|7148|lyfalmen|||00|100|0|75|Actavis Group hf|Actavis Group hf|||4648||4648|7148 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2221|3854|lyfalmen|||23|84|0|84|Vistor hf|N.V. Organon|||2221||2221|3854 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|989|2182|lyfalmen|||08|125|0|3|Vistor hf|Recip AB|||989||989|2182 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|8815|12803|lyfalmen|||02|2|0|6|Gróco ehf|Nycomed Danmark A/S|||8815||8815|12803 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5128|7799|lyfalmen|||00|4|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5128||5128|7799 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5791|8699|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5791||5791|8699 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|17562|24050|lyfalmen|||00|12|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||17562||17562|24050 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6215|9274|lyfalmen|V1300|8886|00|4|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6215||6215|9274 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|18596|25337|lyfalmen|||00|12|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||18596||18596|25337 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1623|3043|lyfalmen|V0308|3043|00|100|0|100|Actavis Group hf|Actavis hf|||1623||1623|3043 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2644|4428|lyfalmen|V0310|4428|00|100|0|200|Actavis Group hf|Actavis hf|||2644||2644|4428 520759|M03BC5101|Norgesic|töflur|0| |30|stk|1|þpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|DKK|399|1382|lyfalmen|||00|30|0|9|Vistor hf|Meda AB (V)|||399||399|1382 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|35989|46991|lyfalmen|||00|100|0|28|Vistor hf|Boehringer Ingelheim International|||35989||35989|46991 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|8676|12422|lyfsjukr|||00|100|1|0|Distica|Distica - óskráð lyf|||8676||8676|12422 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|0| |8|g|40|spr||QJ51RC23|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|8511|16383|vetalmen|||16|320|0|0|Vistor hf|Boehringer Ingelheim Danmark|||8511||8511|16383 522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|K|3,5|0|0|0|0|SPM|0|0|0|100|XEU|3542|5647|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||3542||3542|5647 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|283014|354220|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Europharm Ltd|||283014||283014|354220 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|436|1432|lyfalmen|||00|20|0|3|Vistor hf|Lannacher Heimittel Gmbh|||436||436|1432 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|1802|3286|lyfalmen|||00|100|0|17|Vistor hf|Lannacher Heimittel Gmbh|||1802||1802|3286 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|10373|14917|lyfalmen|||00|250|0|208|Vistor hf|Lannacher Heimittel Gmbh|||10373||10373|14917 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|917|2085|lyfalmen|V0732|2085|02|10|0|2|Vistor hf|Lannacher Heimittel Gmbh|||917||917|2085 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörð|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9469|13690|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|||9469||9469|13690 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|220|1139|lyfalmen|||00|40|0|13|Actavis Group hf|Actavis hf|||220||220|1139 523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann||||||1199 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1153|2405|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|||1153||1153|2405 523886|L02BB0101|Eulexin|töflur|250|mg|84|stk|1|þpakki||L02BB01|01.01.1993||R|A|5|0|0|*|0|SCP|0|0|0|100|DKK|25423|33837|lyfalmen|||00|84|0|28|Vistor hf|Schering-Plough|||25423||25423|33837 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1003|2201|lyfalmen|||43|28|0|21|Vistor hf|AstraZeneca A/S DK|||1003||1003|2201 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2516|4255|lyfalmen|||43|98|0|74|Vistor hf|AstraZeneca A/S DK|||2516||2516|4255 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3|Actavis Group hf|Actavis Group hf||||||1144 524710|C01DA0204|Nitromex|tungur.t|0,5|mg|30|stk|1|glas||C01DA02|01.11.1981||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|6|Actavis Group hf|Actavis Group hf||||||1124 525014|M03BC5101|Norgesic|töflur|0| |100|stk|1|þpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|DKK|1095|2326|lyfalmen|||00|100|0|29|Vistor hf|Meda AB (V)|||1095||1095|2326 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|1077|2302|lyfalmen|||00|15|0|0|Vistor hf|Novartis Healthcare A/S-|||1077||1077|2302 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1532|2919|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|||1532||1532|2919 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|5105|7768|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|||5105||5105|7768 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|11733|16763|lyfalmen|||00|30|0|10|Vistor hf|N.V. Organon|||11733||11733|16763 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0|Actavis Group hf|Braun|||||| 526004|V07AB09|Sterilt Vatten Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|1000|0|0|Actavis Group hf|Braun|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|7769|11383|lyfalmen|||00|100|0|33|Icepharma hf|Roche|||7769||7769|11383 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4900|7490|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|||4900||4900|7490 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|SPA|0|0|0|100|DKK|7099|13694|vetalmen|||16|188|0|0|Vistor hf|Schering-Plough A/S|||7099||7099|13694 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4346|6738|lyfalmen|||10|100|0|40|Vistor hf|Desitin Artzneimittel|||4346||4346|6738 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|13849|19110|lyfsjukr|||00|2000|0|7|Vistor hf|Sanofi-aventis Norge AS|||13849||13849|19110 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1320|2632|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|||1320||1320|2632 529263|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|2043|2925|lyfsjukr|||00|7|0|2|Vistor hf|Schering-Plough|||2043||2043|2925 529289|R02AA0301|Strepsils|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|0| |3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|A|1.5|0|0|0|0|PAL|0|0|0|100|DKK|4555|8848|vetalmen|||16|72|0|0|Icepharma hf|Pfizer Oy Animal Health|||4555||4555|8848 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|3923|7644|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||3923||3923|7644 529586|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|5224|7479|lyfsjukr|||00|7|0|7|Vistor hf|Schering-Plough|||5224||5224|7479 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PFI|0|0|0|100|DKK|85133|107858|lyfsjukr|||00|100|0|11|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||85133||85133|107858 530030|J06BA0205|Sandoglobulin|irs|1|g/fl|1|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|10440|14865|lyfsjukr|||00|1|0|0|Icepharma hf|CSL Denmark ApS|||10440||10440|14865 530048|J06BA0205|Sandoglobulin|irs|3|g/fl|3|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|28309|37112|lyfsjukr|||00|3|0|0|Icepharma hf|CSL Denmark ApS|||28309||28309|37112 530055|J06BA0205|Sandoglobulin|irs|6|g/fl|6|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|56618|72357|lyfsjukr|||00|6|0|0|Icepharma hf|CSL Denmark ApS|||56618||56618|72357 530741|G03FA0105|Activelle|töflur|0| |84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3676|5829|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|||3676||3676|5829 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2670|4464|lyfalmen|||43|100|0|50|Vistor hf|AstraZeneca A/S DK|||2670||2670|4464 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|9649|13815|lyfsjukr|||00|240|0|6|Vistor hf|Boehringer Ingelheim International |||9649||9649|13815 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|339|1300|lyfalmen|||01|30|0|3|Vistor hf|Janssen-Cilag AB|||339||339|1300 532739|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|5|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Actavis Group hf|Braun|||||| 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1803|3287|lyfalmen|||43|100|0|33|Vistor hf|AstraZeneca A/S DK|||1803||1803|3287 534537|J01EE0103|Primazol|töflur|480|mg|20|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|476|1486|lyfalmen|||00|20|0|5|Actavis Group hf|Actavis hf|||476||476|1486 534552|J01EE0103|Primazol|töflur|480|mg|100|stk|1|glas|80+400 mg|J01EE01|01.10.1995|31.12.2008|R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|100|0|25|Actavis Group hf|Actavis hf||2062|2062|2062|| 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BPA|0|0|0|100|IKR|||lyfalmen|||00|100|0|0|Icepharma hf|Bioglan Pharma AB||||||0 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|þpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|5832|8755|lyfalmen|||00|84|0|28|Vistor hf|Sanofi-aventis Norge AS|||5832||5832|8755 536029|S01EB0105|Isopto Carpine|augndr|10|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|384|1361|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|||384||384|1361 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|465|1471|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|||465||465|1471 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|594|1646|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|||594||594|1646 536938|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|þpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|DKK|15379|21332|lyfalmen|||52|100|0|12|Icepharma hf|Meda AS|||15379||15379|21332 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||668 537720|L01CB0101|Vepesid|hylki|100|mg|10|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13691|18913|lyfsjukr|||00|10|1|0|Distica|Distica - óskráð lyf|||13691||13691|18913 537811|G03CA0401|Ovestin|sk-stil|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|38|Vistor hf|N.V. Organon||||||2352 538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyfalmen|||00|24|0|2|Icepharma hf|Bayer AB||||||0 538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyfalmen|||00|48|0|5|Icepharma hf|Bayer AB||||||0 538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyfalmen|||00|96|0|10|Icepharma hf|Bayer AB||||||0 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|134564|169400|lyfsjukr|||00|6|0|61|Gróco ehf|Serono Nordic|||134564||134564|169400 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|10513|15107|lyfalmen|||00|100|0|25|Vistor hf|Sanofi-aventis Norge AS|||10513||10513|15107 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|187|1094|lyfalmen|||00|25|0|5|Actavis Group hf|Actavis Group hf|||187||187|1094 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|406|1391|lyfalmen|||00|100|0|20|Actavis Group hf|Actavis Group hf|||406||406|1391 539783|D01AC2001|Daktacort|krem|0| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||20|15|0|15|Vistor hf|Janssen-Cilag AB||||||0 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2709|4517|lyfalmen|||23|40|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2709||2709|4517 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|2969|4869|lyfalmen|||00|250|0|250|Icepharma hf|Smith & Nephew|||2969||2969|4869 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|8320|12131|lyfalmen|||06|15|0|0|Icepharma hf|M.S.D.|||8320||8320|12131 541060|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1844|3343|lyfalmen|V0987|3331|23|200|0|50|Vistor hf|AstraZeneca A/S DK|||1844||1844|3343 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|10126|14582|lyfalmen|||10|200|0|60|Swedish Orphan International AB|Sandoz GmbH (S)|||10126||10126|14582 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|16402|22605|lyfalmen|||10|200|0|100|Swedish Orphan International AB|Sandoz GmbH (S)|||16402||16402|22605 541169|R02AA0302|Strepsils med honning og citron|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 542803|C08DA0103|Isoptin retard|forðatfl|240|mg|28|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1593|3002|lyfalmen|||10|28|0|28|Vistor hf|Abbott Scandinavia AB|||1593||1593|3002 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1638|3063|lyfalmen|||00|100|1|100|Parlogis hf|Parlogis - óskráð lyf|||1638||1638|3063 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|4687|7201|lyfalmen|||00|98|0|65|Vistor hf|Novartis Healthcare A/S-|||4687||4687|7201 543413|R06AA5201|Koffinatin|töflur|0| |10|stk|1|þpakki||R06AA52|01.12.1982||L|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|10|0|2|Actavis Group hf|Actavis hf||||||0 543686|B02BD0203|ReFacto|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|27811|36492|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|||27811||27811|36492 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyfalmen|||42|250|0|22|Vistor hf|Recip AB||||||0 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|8|0|9|Vistor hf|AstraZeneca A/S DK||||||0 543827|B02BD0203|ReFacto|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|55112|70482|lyfsjukr|||00|1|0|1|Icepharma hf|Wyeth Europe|||55112||55112|70482 543835|B02BD0203|ReFacto|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|109481|138171|lyfsjukr|||00|1|0|2|Icepharma hf|Wyeth Europe|||109481||109481|138171 543850|B02BD0203|ReFacto|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2004||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|199056|249692|lyfsjukr|||00|1|0|4|Icepharma hf|Wyeth Europe|||199056||199056|249692 543926|D11AC0302|Selsun Blue|hársápa|10|mg/ml|120|ml|1|glas||D11AC03|01.08.1984||L|A|3|0|0|0|0|CHT|0|0|0|100|DKK|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|||||| 544049|C01DA1402|Monit-L|forðahlk|60|mg|100|stk|1|glas||C01DA14|01.10.1992|31.12.2008|R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2489|4218|lyfalmen|||10|100|0|150|Actavis Group hf|Actavis hf|||2489||2489|4218 544502|G03GA0501|Gonal-F|sts|37,5|ae/lykju|10|lyk|1|pakki|+ leysir 1 ml|G03GA05|01.02.2002||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|24901|33187|lyfalmen|||00|10|0|5|Gróco ehf|Serono Nordic|||24901||24901|33187 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|750|1858|lyfalmen|||00|15|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||750||750|1858 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1268|2558|lyfalmen|||00|100|0|7|Lundbeck Export A/S|H. Lundbeck A/S|||1266||1266|2558 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|3369|5412|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|||3369||3369|5412 545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|32185|42255|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||32185||32185|42255 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|25950|34493|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||25950||25950|34493 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|32375|42492|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||32375||32375|42492 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|27504|36427|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||27504||27504|36427 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|30|0|5|Actavis Group hf|Actavis hf||||||0 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|þpakki||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|521|1547|lyfalmen|||10|100|0|17|Actavis Group hf|Actavis hf|||521||521|1547 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|IKR|6004|8988|lyfalmen|||00|56|1|37|Parlogis hf|Parlogis - óskráð lyf|||6004||6004|8988 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|30|DKK|||lyfalmen|||23|60|0|15|Vistor hf|Orion Corporation||||||4454 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|10473|14906|lyfsjukr|||00|100|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||10473||10473|14906 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|3451|4941|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||3451||3451|4941 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|9128|13228|lyfalmen|||63|0|0|1|Vistor hf|N.V. Organon|||9128||9128|13228 547869|G03GA0601|Puregon|stl|150|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|56753|72842|lyfalmen|||63|2|0|5|Vistor hf|N.V. Organon|||56753||56753|72842 547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|4688|7202|lyfalmen|||63|0|0|0|Vistor hf|N.V. Organon|||4688||4688|7202 547901|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|22820|30596|lyfalmen|||63|2|0|2|Vistor hf|N.V. Organon|||22820||22820|30596 548297|A08AA1001|Reductil|hylki|10|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|18307|24977|lyfalmen|||00|98|0|98|Vistor hf|Abbott Laboratories A/S|||18307||18307|24977 548347|A08AA1001|Reductil|hylki|15|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|18307|24977|lyfalmen|||00|98|0|147|Vistor hf|Abbott Laboratories A/S|||18307||18307|24977 548511|J01CF0101|Diclocil|sts/irs|500|mg|1|stk|10|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2235|3200|lyfsjukr|||03|10|0|2|Vistor hf|Bristol-Myers Squibb|||2235||2235|3200 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|5458|8247|lyfalmen|||00|28|0|28|Vistor hf|Sanofi-aventis Norge AS|||5458||5458|8247 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|14898|20733|lyfalmen|||00|84|0|84|Vistor hf|Sanofi-aventis Norge AS|||14898||14898|20733 548792|M05BA0701|Optinate|filmhtfl|30|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|38188|49729|lyfalmen|||00|28|0|168|Vistor hf|Sanofi-aventis Norge AS|||38188||38188|49729 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|110469|139401|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|||110469||110469|139401 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|8495|12369|lyfalmen|||02|5|0|152|Vistor hf|Janssen-Cilag AB|||8495||8495|12369 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|158390|199063|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|||158390||158390|199063 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|2186|3807|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2186||2186|3807 550061|N02BE0102|Panodil Brus|freyðit|500|mg|24|stk|1|þpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|24|0|4|Icepharma hf|GlaxoSmithKline CH A/S||||||0 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|60|0|0|Icepharma hf|GlaxoSmithKline CH A/S||||||0 550731|N02BE0103|Panodil Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|10|0|0|Icepharma hf|GlaxoSmithKline CH A/S||||||0 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|9825|14173|lyfalmen|||00|12|0|12|Vistor hf|AstraZeneca UK Ltd|||9825||9825|14173 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1637|3062|lyfalmen|||03|1|0|3|Icepharma hf|Meda AB|||1637||1637|3062 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|3733|5906|lyfalmen|||00|100|0|50|Icepharma hf|Meda AB|||3733||3733|5906 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|905|2069|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|||905||905|2069 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|2751|4574|lyfalmen|||00|28|0|14|Vistor hf|Eisai Ltd|||2751||2751|4574 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|4474|6912|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|||4474||4474|6912 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|2435|4145|lyfalmen|||00|14|0|14|Vistor hf|Eisai Ltd|||2435||2435|4145 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|4257|6617|lyfalmen|||00|28|0|28|Vistor hf|Eisai Ltd|||4257||4257|6617 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|8520|12402|lyfalmen|||00|56|0|56|Vistor hf|Eisai Ltd|||8520||8520|12402 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BHC|0|0|0|100|SEK|3849|6064|lyfalmen|||63|100|0|67|Vistor hf|Bayer HealthCare AG|||3849||3849|6064 552703|M01AB0509|Modifenac|forðahlk|75|mg|10|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|639|1708|lyfalmen|||00|10|0|8|Actavis Group hf|Actavis Group hf|||639||639|1708 552877|N05CF0104|Zopiklon Merck NM|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|4505|6954|lyfalmen|||00|500|0|500|Actavis Group PTC ehf|Merck NM AB|||4505||4505|6954 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3721|5890|lyfalmen|||00|100|0|15|Vistor hf|Novartis Healthcare A/S-|||3721||3721|5890 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3694|5853|lyfalmen|||00|50|0|15|Vistor hf|Novartis Healthcare A/S-|||3694||3694|5853 553313|N02CC0601|Relpax|töflur|40|mg|3|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2537|4283|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2537||2537|4283 553339|N02CC0601|Relpax|töflur|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4902|7493|lyfalmen|||00|6|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4902||4902|7493 554154|QA12CE9902|Selevitan, vet.|stl|0| |100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|7716|14869|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||7716||7716|14869 555607|N06AB0601|Zoloft|mixtúra|20|mg/ml|60|ml|1|fl||N06AB06|01.03.2001||R|A|3|0|0|B|0|PFI|0|1|0|30|DKK|5199|7896|lyfalmen|||00|60|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5199||5199|7896 556589|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3362|4814|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||3362||3362|4814 556654|B05BA0313|Glucos 500 mg/ml Fresenius Kabi|irl|500|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.05.2004||R|A|1|0|0|0|1|FRP|0|0|0|100|DKK|6468|9261|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||6468||6468|9261 556662|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5485|7853|lyfsjukr|||00|6000|0|0|Icepharma hf|Fresenius Kabi|||5485||5485|7853 556738|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4041|5786|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||4041||4041|5786 556753|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3757|5379|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||3757||3757|5379 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5852|8782|lyfalmen|||00|100|0|30|Vistor hf|Novartis Healthcare A/S-|||5852||5852|8782 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7163|10561|lyfalmen|||00|50|0|30|Vistor hf|Novartis Healthcare A/S-|||7163||7163|10561 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|12750|18059|lyfalmen|||00|100|0|60|Vistor hf|Novartis Healthcare A/S-|||12750||12750|18059 557546|D10AF0202|Zineryt|áburður|0| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1701|3149|lyfalmen|||38|30|0|30|Vistor hf|Astellas Pharma A/S|||1701||1701|3149 558585|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|10|hgl|röntgenskuggaefni|V08CA01|01.07.1992||R|A|5|0|0|0|1|SAG|0|0|0|100|SEK|163292|205166|lyfsjukr|||02|200|0|0|Icepharma hf|Schering AG|||163292||163292|205166 559013|C08DA0103|Isoptin retard|forðatfl|120|mg|28|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|1042|2254|lyfalmen|||10|28|0|14|Vistor hf|Abbott Scandinavia AB|||1042||1042|2254 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|2337|4012|lyfalmen|||10|98|0|49|Vistor hf|Abbott Scandinavia AB|||2337||2337|4012 559062|N02AX0201|Nobligan|hylki|50|mg|100|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1114|2352|lyfalmen|V0731|1524|10|100|0|17|Icepharma hf|Grunenthal|||1114||1114|2352 559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|624|1687|lyfalmen|V0730|1238|10|20|0|3|Icepharma hf|Grunenthal|||624||624|1687 559104|N02AX0201|Nobligan|eþ-stil|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1743|3206|lyfalmen|||04|20|0|7|Icepharma hf|Grunenthal|||1743||1743|3206 559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1002|2200|lyfalmen|V0732|2085|02|10|0|2|Icepharma hf|Grunenthal|||1002||1002|2200 559146|J06BA0201|Gammagard S/D|irs|0,5|g/fl|1|fl|1|pakki|+ leysir 10 ml|J06BA02|01.10.1991|31.10.2008|R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|3080|4410|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||3080||3080|4410 559153|J06BA0201|Gammagard S/D|irs|2,5|g/fl|1|fl|1|pakki|+ leysir 50 ml|J06BA02|01.10.1991|31.10.2008|R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|15402|21043|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||15402||15402|21043 559161|J06BA0201|Gammagard S/D|irs|5|g/fl|1|fl|1|pakki|+ leysir 96 ml|J06BA02|01.10.1991|31.10.2008|R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|30808|40223|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||30808||30808|40223 559187|J06BA0201|Gammagard S/D|irs|10|g/fl|1|fl|1|pakki|+ leysir 192 ml|J06BA02|01.10.1991|31.10.2008|R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|61605|78566|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||61605||61605|78566 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|XEU|||lyfalmen|||00|100|0|100|Icepharma hf|STADA Arzneimittel AG||||||0 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2582|4344|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|||2582||2582|4344 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|XEU|||lyfalmen|||00|100|0|0|Icepharma hf|STADA Arzneimittel AG||||||0 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7552|11089|lyfalmen|||23|1|0|90|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7552||7552|11089 559963|C01DA0201|Discotrine|forðapl|5|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|DKK|2832|4684|lyfalmen|||23|30|0|30|Vistor hf|Meda AB (V)|||2832||2832|4684 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|DKK|3128|5085|lyfalmen|||23|30|0|60|Vistor hf|Meda AB (V)|||3128||3128|5085 559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|DKK|10567|15023|lyfsjukr|||00|240|0|0|Icepharma hf|Baxter|||10567||10567|15023 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0|0|Actavis Group hf|Gerhard Mann||||||1309 560193|C09AA0101|Capoten|töflur|12,5|mg|100|stk|1|þpakki||C09AA01|01.07.1990|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|2182|3800|lyfalmen|||00|100|0|25|Vistor hf|Bristol-Myers Squibb|||2182||2181|3800 560235|C09AA0101|Capoten|töflur|25|mg|100|stk|1|þpakki||C09AA01|01.04.1995|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|3166|5137|lyfalmen|V0162||00|100|0|50|Vistor hf|Bristol-Myers Squibb|||3166||3166|5137 560250|C09AA0101|Capoten|töflur|50|mg|100|stk|1|þpakki||C09AA01|01.04.1995|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|5286|8014|lyfalmen|V0166||00|100|0|100|Vistor hf|Bristol-Myers Squibb|||5286||5286|8014 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|30|GBP|3120|5074|lyfalmen|||00|25|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3120||3120|5074 560334|J05AB0102|Zovir|töflur|200|mg|100|stk|1|þpakki||J05AB01|01.07.1994||R|A|5|0|0|E|0|GSK|0|0|1|30|GBP|12284|17479|lyfalmen|||00|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||12284||12284|17479 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||20|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S||||||0 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1779|3255|lyfalmen|||07|4|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1779||1779|3255 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|5946|8909|lyfalmen|||00|125|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5946||5946|8909 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|6448|9591|lyfalmen|||00|100|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6448||6448|9591 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|115274|145384|lyfsjukr|||00|5|0|1|Vistor hf|Abbott Scandinavia AB|||115274||115274|145384 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|607575|570596|lyfsjukr|||00|20|0|5|Vistor hf|Abbott Scandinavia AB|||456810||456810|570596 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2588|4352|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|||2588||2588|4352 561571|N06AX1101|Remeron|töflur|30|mg|250|stk|1|glas|til notkunar vélskömmtun lyfja|N06AX11|01.11.2002||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|35466|46340|lyfalmen|||00|250|0|250|Vistor hf|N.V. Organon|||35466||35466|46340 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|26504|35182|lyfalmen|||02|6|0|17|Gróco ehf|Nycomed Danmark A/S|||26504||26504|35182 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|40800|52981|lyfalmen|||02|10|0|29|Gróco ehf|Nycomed Danmark A/S|||40800||40800|52981 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|694|1782|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||694||694|1782 563387|D07AC1701|Cutivat|krem|0,5|mg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2154|3763|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2154||2154|3763 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|694|1782|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||694||694|1782 563403|D07AC1701|Cutivat|smyrsli|50|mcg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2154|3763|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2154||2154|3763 563494|N02AA0101|Contalgin|forðatfl|5|mg|25|stk|1|þpakki||N02AA01|01.10.1993|31.12.2008|R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|613|1672|lyfalmen|||10|25|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||613||613|1672 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1725|3181|lyfalmen|||10|100|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1725||1725|3181 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|219177|275060|lyfalmen|||02|60|0|172|Gróco ehf|Nycomed Danmark A/S|||219177||219177|275060 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5054|7699|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|||5054||5054|7699 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5324|8065|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|||5324||5324|8065 563684|C10AA0401|Lescol|hylki|20|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9403|13601|lyfalmen|||00|98|0|49|Vistor hf|Novartis Healthcare A/S-|||9403||9403|13601 563700|C10AA0401|Lescol|hylki|40|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|11905|16996|lyfalmen|||00|98|0|98|Vistor hf|Novartis Healthcare A/S-|||11905||11905|16996 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|30|DKK|161632|203099|lyfsjukr|||00|168|0|34|Vistor hf|Schering-Plough|||161632||161632|203099 565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|4100|6404|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||4100||4100|6404 565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|6153|9190|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||6153||6153|9190 565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|1088|2317|lyfalmen|||00|28|1|5|Parlogis hf|Parlogis - óskráð lyf|||1088||1088|2317 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|12298|17496|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|||12298||12298|17496 566018|D01BA0201|Lamisil|töflur|125|mg|14|stk|1|þpakki||D01BA02|01.07.1995||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|3141|2835|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|||1470||1470|2835 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1474|2841|lyfalmen|||06|5|0|25|K.Pétursson hf|Alcon|||1474||1474|2841 566661|L04AB0101|Enbrel|sts|0| |25|mg|4|hgl|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|116951|147471|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|||116951||116951|147471 566984|A10BG0201|Avandia|töflur|4|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000|31.12.2008|R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|5178|7866|lyfalmen|||00|28|0|19|GlaxoSmithKline ehf|SmithKline Beecham PLC|||5178||5177|7866 566992|J02AC0101|Diflucan|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.10.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|6155|9193|lyfalmen|V0556|4233|10|4|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6155||6155|9193 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1505|2883|lyfalmen|||00|100|0|4|Vistor hf|Sanofi-aventis Norge AS|||1505||1505|2883 567073|A10BG0201|Avandia|töflur|4|mg|56|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|8149|11899|lyfalmen|||00|56|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|||||8149|11899 567149|A10BG0201|Avandia|töflur|8|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|6452|9596|lyfalmen|||00|28|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|||6452||6452|9596 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|6096|9113|lyfalmen|V0791|4040|00|60|0|12|Vistor hf|Janssen-Cilag AB|||6096||6096|9113 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|13421|18894|lyfalmen|V0793|8270|00|60|0|24|Vistor hf|Janssen-Cilag AB|||13421||13421|18894 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|22306|29956|lyfalmen|V0794|11709|00|60|0|36|Vistor hf|Janssen-Cilag AB|||22306||22306|29956 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|29556|38982|lyfalmen|V0795|18331|00|60|0|48|Vistor hf|Janssen-Cilag AB|||29556||29556|38982 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||24|15|0|12|Vistor hf|Janssen-Cilag AB||||||0 567719|C10AA0302|Pravachol|töflur|40|mg|98|stk|1|þpakki||C10AA03|01.06.1998||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|22056|29645|lyfalmen|||00|98|0|196|Vistor hf|Bristol-Myers Squibb|||22056||22056|29645 567990|V08AB0901|Visipaque|stl|150|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|14023|19326|lyfsjukr|||02|1200|0|0|Icepharma hf|GE Healthcare AS|||14023||14023|19326 568022|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||27452||27452|36045 568030|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5568|7972|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||5568||5568|7972 568055|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||28937||28937|37894 568238|A02BC0401|Pariet|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.05.2002||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|17401|23849|lyfalmen|||00|120|0|120|Vistor hf|Eisai Ltd|||17401||17401|23849 568519|N05AB0301|Trilafon|töflur|8|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|2145|3751|lyfalmen|||00|100|0|27|Vistor hf|Schering-Plough|||2145||2145|3751 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1115|2353|lyfalmen|||00|3|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1115||1115|2353 568790|N02AA5902|Parkodin forte|eþ-stil|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.07.1993||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|489|1504|lyfalmen|||04|10|0|3|Actavis Group hf|Actavis hf|||489||489|1504 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1463|2826|lyfalmen|V0316|2826|10|100|0|100|Actavis Group hf|Actavis hf|||1463||1463|2826 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2318|3986|lyfalmen|V0324|3986|10|100|0|200|Actavis Group hf|Actavis hf|||2318||2318|3986 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|18936|25443|lyfsjukr|||02|5|0|18|Vistor hf|Novartis Healthcare A/S-|||18936||18936|25443 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|18936|25443|lyfsjukr|||02|20|0|18|Vistor hf|Novartis Healthcare A/S-|||18936||18936|25443 569897|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2446|4160|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||2446||2446|4160 569913|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|án nálar|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3484|5568|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||3484||3484|5568 572768|B02BC1001|Tisseel Duo Quick|vefjalím|0| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|133336|167871|lyfsjukr|||00|5|0|0|Icepharma hf|Baxter|||133336||133336|167871 572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|174529|219156|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter|||174529||174529|219156 572784|B02BC1001|Tisseel Duo Quick|vefjalím|0| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|328333|410642|lyfsjukr|||00|20|0|0|Icepharma hf|Baxter|||328333||328333|410642 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3626|5761|lyfalmen|||23|26|0|46|Vistor hf|Janssen-Cilag AB|||3626||3626|5761 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|108760|137274|lyfsjukr|||00|1|0|0|Icepharma hf|Roche|||108760||108760|137274 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|28262|37054|lyfsjukr|||00|5000|0|2|Vistor hf|AstraZeneca UK Ltd|||28262||28262|37054 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|55314|70733|lyfsjukr|||00|10|0|5|Vistor hf|AstraZeneca UK Ltd|||55314||55314|70733 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|2756|2507|lyfalmen|V0610|2451|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|||1228||1228|2507 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|3829|3564|lyfalmen|V0931|2428|00|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2007||2007|3564 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|12666|9737|lyfalmen|V0933|6361|00|98|0|98|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6556||6556|9737 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|6567|5411|lyfalmen|V0935|3559|00|28|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3368||3368|5411 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|20661|15881|lyfalmen|V0937|10351|00|98|0|196|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11083||11083|15881 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyfalmen|||23|40|0|0|Icepharma hf|Norpharma ||||||0 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|5821|8334|lyfsjukr|||00|12|0|0|Vistor hf|Sanofi - Aventis|||5821||5821|8334 575787|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.12.2000||R|K|3|0|1|0|1|CEO|0|0|0|100|DKK|100919|127512|lyfsjukr|||00|1|0|27|Vistor hf|Centocor B.V.|||100919||100919|127512 577494|M05BA0101|Didronate|töflur|200|mg|28|stk|1|þpakki||M05BA01|01.04.1996||R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|6793|10059|lyfalmen|||00|28|0|14|Sofus Consulting AB|Procter & Gamble-|||6793||6793|10059 577668|C07FB0201|Logimax|forðatfl|55|mg|28|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3013|4929|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|||3013||3013|4929 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1173|2432|lyfalmen|||02|10|0|0|Vistor hf|AstraZeneca A/S DK|||1173||1173|2432 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|WAB|0|0|0|100|USD|940|2116|lyfalmen|||00|30|0|30|Icepharma hf|Wyeth AB|||940||940|2116 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|32692|42569|lyfsjukr|||02|1|0|9|Icepharma hf|Eli Lilly Danmark A/S|||32692||32692|42569 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|65089|82903|lyfsjukr|||02|1|0|18|Icepharma hf|Eli Lilly Danmark A/S|||65089||65089|82903 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|130468|164300|lyfsjukr|||02|1|0|36|Icepharma hf|Eli Lilly Danmark A/S|||130468||130468|164300 582213|R01AA0503|Nezeril|nefúði|0,1|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|8|0|2|Vistor hf|AstraZeneca A/S DK||||||0 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|5288|9151|vetorma|||16|50|0|0|Icepharma hf|Pfizer Oy Animal Health|||5288||5288|9151 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|19928|34486|vetorma|||16|200|0|0|Icepharma hf|Pfizer Oy Animal Health|||19928||19928|34486 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|39554|51112|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||39554||39554|51112 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|70812|90028|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|||70812||70812|90028 582775|C07AB0205|Seloken|töflur|50|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|529|1558|lyfalmen|||00|28|0|9|Vistor hf|AstraZeneca A/S DK|||529||529|1558 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|731|1832|lyfalmen|||00|28|0|19|Vistor hf|AstraZeneca A/S DK|||731||731|1832 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||27452||27452|36045 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|53298|68224|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|||53298||53298|68224 583443|C07AA0704|Sotalol Merck NM|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1063|2283|lyfalmen|V0272|2283|00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||1063||1063|2283 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|82356|104401|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|||82356||82356|104401 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||28937||28937|37894 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|61388|78296|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|||61388||61388|78296 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|92841|117455|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|||92841||92841|117455 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4048|5796|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|||4048||4048|5796 583856|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2108|3018|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||2108||2108|3018 583914|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|7785|11146|lyfsjukr|||00|1500|0|0|Icepharma hf|Fresenius Kabi|||7785||7785|11146 583922|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6386|9143|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|||6386||6386|9143 583930|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3102|4441|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||3102||3102|4441 584011|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8867|12695|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|||8867||8867|12695 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3508|5023|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||3508||3508|5023 584102|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4182|5988|lyfsjukr|||00|9000|0|0|Icepharma hf|Fresenius Kabi|||4182||4182|5988 584276|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2364|3385|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||2364||2364|3385 584284|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |100|ml|30|pokar|excel umbúðir|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|3000|0|0|Icepharma hf|Fresenius Kabi||||||0 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|DKK|3661|5809|lyfalmen|||64|30|0|30|Icepharma hf|Meda AS|||3661||3661|5809 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|10585|15046|lyfsjukr|||02|20|0|50|Vistor hf|LEO Pharma A/S|||10585||10585|15046 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|3856|5521|lyfsjukr|||02|25|0|12|Vistor hf|LEO Pharma A/S|||3856||3856|5521 585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988||R|A|2|0|0|0|1|MSD|0|0|0|100|XEU|37899|49052|lyfsjukr|||00|12|0|3|Icepharma hf|M.S.D.|||37899||37899|49052 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3703|5866|lyfalmen|||02|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3703||3703|5866 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|36713|47893|lyfalmen|||00|50|0|20|Vistor hf|Novartis Healthcare A/S-|||36713||36713|47893 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|2793|4631|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2793||2793|4631 587667|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3286|4705|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||3286||3286|4705 588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1400|2740|lyfalmen|||06|5|0|0|Vistor hf|Sanofi-aventis Norge AS|||1400||1400|2740 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2328|4000|lyfalmen|V0426|3936|43|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2328||2328|4000 588590|B01AC0501|Ticlid|töflur|250|mg|30|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|3920|6160|lyfalmen|||00|30|0|15|Vistor hf|Sanofi-aventis Norge AS|||3920||3920|6160 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|12351|17562|lyfalmen|||00|100|0|50|Vistor hf|Sanofi-aventis Norge AS|||12351||12351|17562 588723|B03AA0702|Ferlen-R|forðatfl|100|mg|60|stk|1|glas||B03AA07|01.01.1994||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|60|0|30|Actavis Group hf|Actavis hf|||||| 588772|H05BA0103|Miacalcic Nasal|nefúði|200|ae/sk|2|ml|1|úðagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|9318|13485|lyfalmen|||23|2|0|14|Vistor hf|Novartis Healthcare A/S-|||9318||9318|13485 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6464|11186|vetorma|||16|3|0|0|Icepharma hf|Pfizer Animal Health|||6464||6464|11186 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2505|4335|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||2505||2505|4335 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6236|10792|vetorma|||16|6|0|0|Icepharma hf|Pfizer Animal Health|||6236||6236|10792 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3368|5828|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||3368||3368|5828 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3499|6055|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||3499||3499|6055 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2710|4690|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||2710||2710|4690 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2566|4323|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||2566||2566|4323 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5480|8277|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||5480||5480|8277 589911|L01BB0501|Fludara|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.01.1996||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|147243|185185|lyfsjukr|||00|250|0|0|Icepharma hf|Bayer Schering Pharma AG|||147243||147243|185185 590315|J05AE0301|Norvir|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.08.2003||R|K|2|0|1|0|1|ABL|0|0|0|100|DKK|91106|115294|lyfsjukr|||00|336|0|28|Vistor hf|Abbott Laboratories A/S|||91106||91106|115294 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|1|100|DKK|||lyfalmen|||00|20|0|20|Vistor hf|Bayer A/S||||||0 590539|A01AD1101|Bonjela|hlaup|0| |15|g|1|túpa|hlaup í munn|A01AD11|01.01.1996||L|A|3|0|0|0|0|REB|0|0|1|100|IKR|||lyfalmen|||00|15|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.||||||0 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1404|2746|lyfalmen|V0139|2746|10|98|0|147|Actavis Group hf|Actavis hf|||1404||1404|2746 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|28136|37214|lyfalmen|||02|10|0|250|Lundbeck Export A/S|H. Lundbeck A/S|||28136||28136|37214 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|207488|260190|lyfsjukr|||00|1|0|1|Vistor hf|Boehringer Ingelheim|||207488||207488|260190 591131|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|31979|41681|lyfsjukr|||00|1200|0|0|Icepharma hf|GE Healthcare AS|||31979||31979|41681 591149|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|36833|47725|lyfsjukr|||00|1200|0|0|Icepharma hf|GE Healthcare AS|||36833||36833|47725 592097|N01AF0301|Pentothal Natrium|sts|500|mg|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|3452|4942|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|||3452||3452|4942 592147|D05AX0301|Silkis|smyrsli|3|mcg/g|100|g|1|túpa||D05AX03|01.06.2001||R|A|3|0|0|B|0|GAN|0|0|0|100|XEU|6658|9876|lyfalmen|||00|100|0|0|Icepharma hf|Galderma Nordic AB|||6658||6658|9876 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|SEK|||lyflausa|||00|500|0|500|Vistor hf|Regent Medical Overseas Limited|||||| 592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|þpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||09|30|0|2|Actavis Group hf|Actavis hf||||||0 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|688|1774|lyfalmen|||00|50|0|3|Icepharma hf|Roche|||688||688|1774 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1074|2298|lyfalmen|||00|150|0|9|Icepharma hf|Roche|||1074||1074|2298 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1825|3317|lyfalmen|||00|100|0|25|Icepharma hf|Roche|||1825||1825|3317 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|19191|26078|lyfalmen|||03|12|0|32|Icepharma hf|Meda AB|||19191||19191|26078 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||621 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||5164 594903|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3029|4337|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|||3029||3029|4337 594945|QA12CE9903|Selenevit, vet.|stl|26|mg/ml|100|ml|1|hgl|1+25 mg/ml|QA12CE99|01.09.1982||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1087|2145|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1087||1087|2145 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|9245|13237|lyfsjukr|||02|5|0|5|Vistor hf|Novartis Healthcare A/S-|||9245||9245|13237 595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|631|1697|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||631||631|1697 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|SEK|||lyflausa|||00|250|0|250|Vistor hf|Regent Medical Overseas Limited|||||| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4124|6437|lyfalmen|||43|24|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4124||4124|6437 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||00|30|0|30|Vistor hf|Janssen-Cilag AB||||||0 597575|D01AC0301|Pevaryl|húðduft|10|mg/g|30|g|1|stauk||D01AC03|01.07.1991||L|A|5|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||00|30|0|30|Vistor hf|Janssen-Cilag AB||||||0 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|932|2105|lyfalmen|||00|150|0|25|Vistor hf|Sanofi-aventis Norge AS|||932||932|2105 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1218|2493|lyfalmen|||00|20|1|0|Distica|Distica - óskráð lyf|||1218||1218|2493 907024|A04AD0501|Vogalene|eþ-stil|5|mg|10|stk|1|pakki||A04AD05|01.01.1998||R|A||0|0|E|0|PCO|0|0|1|100|IKR|1597|3008|lyfalmen|||00|10|1|3|Distica|Distica - óskráð lyf|||1597||1597|3008 908048|J07AM5201|Immunoglob. mot tetanus|bóluefni|250|ae|1,2|ml|1|hgl||J07AM52|01.01.1998||R|K||0|0|0|0|LDR|0|0|1|100|IKR|9865|14228|lyfalmen|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||9865||9865|14228 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4276|6643|lyfalmen|||00|50|1|25|Distica|Distica - óskráð lyf|||4276||4276|6643 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|3981|lyfalmen|||00|100|1|33|Distica|Distica - óskráð lyf|||2314||2314|3981 922866|N05BA0602|Ativan|stl|4|mg/ml|1|ml|4|lykjur||N05BA06|01.11.2005||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3294|4716|lyfsjukr|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|||3294||3294|4716 923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1492|lyfalmen|||00|4|1|0|Distica|Distica - óskráð lyf|||480||480|1492 923608|C03BA0801|Metenix|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|4460|6893|lyfalmen|||00|100|1|100|Distica|Distica - óskráð lyf|||4460||4460|6893 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|8792|12772|lyfalmen|||00|20|1|200|Distica|Distica - óskráð lyf|||8792||8792|12772 927361|A12AA1201|Phos-Ex|töflur|167|mg|180|stk|1|glas||A12AA12|01.01.1998||R|A||0|1|0|0|LDR|0|0|0|100|IKR|1768|3240|lyfalmen|||00|180|1|15|Parlogis hf|Parlogis - óskráð lyf|||1768||1768|3240 937980|C01CA2403|Adrenalin|stl|0,1|mg/ml|10|ml|1|spr||C01CA24|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1461|2092|lyfsjukr|||02|10|1|2|Parlogis hf|Parlogis - óskráð lyf|||1461||1461|2092 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|8233|12013|lyfalmen|||00|100|1|160|Parlogis hf|Parlogis - óskráð lyf|||8233||8233|12013 938417|N07BC0201|Metadon|stl|10|mg/ml|1,1|ml|10|lykjur||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|1770|3242|lyfalmen|||00|11|1|4|Parlogis hf|Parlogis - óskráð lyf|||1770||1770|3242 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2510|4247|lyfalmen|||00|100|1|50|Parlogis hf|Parlogis - óskráð lyf|||2510||2510|4247 938524|G04BE0201|Papaverin|stl|40|mg/ml|1|ml|10|lykjur||G04BE02|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|3002|4914|lyfalmen|||00|10|1|4|Parlogis hf|Parlogis - óskráð lyf|||3002||3002|4914 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|35415|46277|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||35415||35415|46277 938665|A12CX0001|K-Phos Neutral|töflur|0| |100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2993|4902|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||2993||2993|4902 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|7401|10884|lyfalmen|||00|100|1|2|Parlogis hf|Parlogis - óskráð lyf|||7401||7401|10884 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|8792|12772|lyfalmen|||00|10|1|100|Distica|Distica - óskráð lyf|||8792||8792|12772 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2245|3887|lyfalmen|||00|1|1|83|Parlogis hf|Parlogis - óskráð lyf|||2245||2245|3887 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|4490|6934|lyfalmen|||00|1|1|167|Parlogis hf|Parlogis - óskráð lyf|||4490||4490|6934 940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|8395|12233|lyfalmen|||00|1|1|333|Parlogis hf|Parlogis - óskráð lyf|||8395||8395|12233 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1837|3333|lyfalmen|||00|1|1|1|Parlogis hf|Parlogis - óskráð lyf|||1837||1837|3333 942468|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|PCO|0|0|1|100|IKR|3163|5133|lyfalmen|||00|20|1|20|Distica|Distica - óskráð lyf|||3163||3163|5133 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|IKR|4544|7007|lyfalmen|||00|100|1|13|Distica|Distica - óskráð lyf|||4544||4544|7007 944745|G03BA0302|Testosteron|vefjatfl|25|mg|1|stk|1|pakki||G03BA03|01.01.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1061|2280|lyfalmen|||00|1|1|8|Parlogis hf|Parlogis - óskráð lyf|||1061||1061|2280 944852|A06AX0102|Glycerol infant|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944886|H02AB0601|Prednisolon|töflur|1|mg|28|stk|1|pakki||H02AB06|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|122|1006|lyfalmen|||00|28|1|3|Parlogis hf|Parlogis - óskráð lyf|||122||122|1006 944985|A06AX0103|Glycerol adult|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944993|V03AB1702|Methylen Blue|stl|10|mg/ml|10|ml|10|lykjur||V03AB17|01.11.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|10030|14355|lyfsjukr|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||10030||10030|14355 945602|A11EA08|Vitamin B-komplex|stl|0| |2|ml|10|lykjur||A11EA|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1202|2472|lyfalmen|||00|20|1|0|Parlogis hf|Parlogis - óskráð lyf|||1202||1202|2472 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|1548|2941|lyfalmen|||00|10|1|10|Distica|Distica - óskráð lyf|||1548||1548|2941 947236|N06BC0101|Koffein|töflur|200|mg|50|stk|1|glas||N06BC01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1558|2955|lyfalmen|||00|50|1|25|Parlogis hf|Parlogis - óskráð lyf|||1558||1558|2955 947690|C01CA2403|Adrenalin|stl|1|mg/ml|1|ml|10|lykjur||C01CA24|01.07.2000||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1301|2606|lyfalmen|||00|10|1|20|Parlogis hf|Parlogis - óskráð lyf|||1301||1301|2606 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3266|5273|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||3266||3266|5273 947822|H02AB0203|Dexamethason|töflur|4|mg|50|stk|1|glas||H02AB02|01.11.2001||R|A||0|0|E|0|LDR|0|0|1|100|IKR|8756|12723|lyfalmen|||00|50|1|133|Parlogis hf|Parlogis - óskráð lyf|||8756||8756|12723 947913|A11HA0203|Vitamin B6 Heve|stl|12,5|mg/ml|2|ml|10|lykjur||A11HA02|01.06.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|582|1630|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|||582||582|1630 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1166|2423|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||1166||1166|2423 949620|G03DA0401|Utrogestan|hylki|100|mg|30|stk|1|pakki||G03DA04|01.01.1999||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2001|3556|lyfalmen|||00|30|1|10|Parlogis hf|Parlogis - óskráð lyf|||2001||2001|3556 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1307|1871|lyfsjukr|||55|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||1307||1307|1871 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|549|1585|lyfalmen|||00|21|1|21|Parlogis hf|Parlogis - óskráð lyf|||549||549|1585 951287|J01CA0101|Ampicillin|sts|0| |1|g|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4952|7090|lyfsjukr|||00|10|1|5|Parlogis hf|Parlogis - óskráð lyf|||4952||4952|7090 952251|J01CA0101|Ampicillin|sts|0| |500|mg|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4403|6304|lyfsjukr|||00|5000|1|2|Parlogis hf|Parlogis - óskráð lyf|||4403||4403|6304 952798|A03BA0101|Atropin|stl|1|mg/ml|1|ml|10|lykjur||A03BA01|01.07.2004||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1315|2625|lyfalmen|||00|10|1|7|Parlogis hf|Parlogis - óskráð lyf|||1315||1315|2625 952855|N02AA0102|Morfin|eþ-stil|10|mg|12|stk|1|pakki||N02AA01|01.10.2004||R|S||1|0|E|0|LDR|0|0|0|100|IKR|3127|5084|lyfalmen|||00|12|1|4|Parlogis hf|Parlogis - óskráð lyf|||3127||3127|5084 953374|N05AB0602|Stelazine|töflur|1|mg|112|stk|1|glas||N05AB06|01.06.2007||R|A||0|0|*|0|LDR|0|0|0|100|IKR|1890|3405|lyfalmen|||00|112|1|6|Parlogis hf|Parlogis - óskráð lyf|||1890||1890|3405 953621|R03DA0504|Theofyllamin EDA Ratiopharm|stl|120|mg/ml|1|ml|5|lykja||R03DA05|01.09.2004||R|A||0|0|0|0|LDR|0|0|0|100|IKR|289|1233|lyfalmen|||00|5|1|1|Parlogis hf|Parlogis - óskráð lyf|||289||289|1233 955239|A11GA0108|Vitamin C 500|stl|100|mg/ml|5|ml|5|lykjur||A11GA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|551|1588|lyfalmen|||00|25|1|12|Parlogis hf|Parlogis - óskráð lyf|||551||551|1588 956302|N07AA0101|Neostigmin|stl|0,5|mg/ml|1|ml|10|lykjur||N07AA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|647|1718|lyfalmen|||00|10|1|2|Parlogis hf|Parlogis - óskráð lyf|||647||647|1718 958613|V03AB1503|Naloxon|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.01.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|8246|11806|lyfsjukr|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||8246||8246|11806 958829|A06AD0002|Miralax|lausnduf|0| |238|g|1|stauk||A06AD00|01.05.2007||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2093|3681|lyfalmen|||00|238|1|0|Parlogis hf|Parlogis - óskráð lyf|||2093||2093|3681 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009||R|A||0|1|0|1|PCO|0|0|0|100|IKR|9780|14003|lyfsjukr|||00|30|1|112|Distica|Distica - óskráð lyf|||9780||9780|14003 961286|H02AB0905|Hydrocortisone|töflur|20|mg|30|stk|1|glas|0|H02AB09|01.10.2008|31.12.2008|R|A|0|0|0|E|0|LDR|0|0|1|100|IKR|4836|7403|lyfalmen|||00|30|1|20|Parlogis hf|Parlogis - óskráð lyf|||4836||4836|7403 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|4400|6811|lyfalmen|||00|25|1|17|Parlogis hf|Parlogis - óskráð lyf|||4400||4400|6811